
<html lang="en"     class="pb-page"  data-request-id="cf1523a1-229c-402d-88d1-0becda8ad532"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c01743"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3 Interaction and Exert Anti-inflammatory Activity" /></meta><meta name="dc.Creator" content="Qingxuan  Zeng" /></meta><meta name="dc.Creator" content="Hongbin  Deng" /></meta><meta name="dc.Creator" content="Yinghong  Li" /></meta><meta name="dc.Creator" content="Tianyun  Fan" /></meta><meta name="dc.Creator" content="Yang  Liu" /></meta><meta name="dc.Creator" content="Sheng  Tang" /></meta><meta name="dc.Creator" content="Wei  Wei" /></meta><meta name="dc.Creator" content="Xiaojia  Liu" /></meta><meta name="dc.Creator" content="Xixi  Guo" /></meta><meta name="dc.Creator" content="Jiandong  Jiang" /></meta><meta name="dc.Creator" content="Yanxiang  Wang" /></meta><meta name="dc.Creator" content="Danqing  Song" /></meta><meta name="dc.Description" content="Berberine (BBR), a traditional Chinese medicine, has therapeutic effects on a variety of inflammation-related diseases, but its direct proteomic targets remain unknown. Using activity-based protein..." /></meta><meta name="Description" content="Berberine (BBR), a traditional Chinese medicine, has therapeutic effects on a variety of inflammation-related diseases, but its direct proteomic targets remain unknown. Using activity-based protein..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 1, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01743" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01743" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01743" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01743" /></link>
        
    
    

<title>Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3 Interaction and Exert Anti-inflammatory Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01743" /></meta><meta property="og:title" content="Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3 Interaction and Exert Anti-inflammatory Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0012.jpeg" /></meta><meta property="og:description" content="Berberine (BBR), a traditional Chinese medicine, has therapeutic effects on a variety of inflammation-related diseases, but its direct proteomic targets remain unknown. Using activity-based protein profiling, we first demonstrated that BBR directly targets the NEK7 protein via the hydrogen bond between the 2,3-methylenedioxy and 121-arginine (R121) residues. The fact that R121 is located precisely within the key domain involved in the NEK7–NLRP3 interaction allows BBR to specifically block the NEK7–NLRP3 interaction and successively inhibit IL-1β release, independent of the NF-κB and TLR4 signaling pathways. Moreover, BBR displays in vivo anti-inflammatory efficacy in a NEK7-dependent manner. Therefore, we consider NEK7 to be a key target of BBR in the treatment of NLRP3-related inflammatory diseases, and the development of novel NEK7–NLRP3 interaction inhibitors might be easily achieved using NEK7 as a target." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01743"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01743">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01743&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01743&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01743&amp;href=/doi/10.1021/acs.jmedchem.0c01743" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 768-781</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01735" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01747" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3 Interaction and Exert Anti-inflammatory Activity</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Qingxuan Zeng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qingxuan Zeng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qingxuan++Zeng">Qingxuan Zeng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hongbin Deng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hongbin Deng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hongbin++Deng">Hongbin Deng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yinghong Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yinghong Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yinghong++Li">Yinghong Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tianyun Fan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tianyun Fan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tianyun++Fan">Tianyun Fan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yang Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yang Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yang++Liu">Yang Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sheng Tang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sheng Tang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sheng++Tang">Sheng Tang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wei Wei</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wei Wei</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Wei">Wei Wei</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaojia Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaojia Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaojia++Liu">Xiaojia Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xixi Guo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xixi Guo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xixi++Guo">Xixi Guo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jiandong Jiang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiandong Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiandong++Jiang">Jiandong Jiang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yanxiang Wang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yanxiang Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#8dfaece3eaf4ece3f5e4ece3eacde4e0efa3fdf8e0eea3e8e9f8a3eee3"><span class="__cf_email__" data-cfemail="6116000f0618000f1908000f0621080c034f11140c024f0405144f020f">[email protected]</span></a>. Phone: +86 10 6303 3012. Fax: +86 106316 5268.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yanxiang++Wang">Yanxiang Wang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9124-071X" title="Orcid link">http://orcid.org/0000-0001-9124-071X</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Danqing Song</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Danqing Song</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#f0839f9e9794919e81999e97839481b0989f849d91999cde939f9d"><span class="__cf_email__" data-cfemail="75061a1b1211141b041c1b12061104351d1a0118141c195b161a18">[email protected]</span></a>. Phone: +86 10 6316 5268. Fax: +86 10 6316 5268.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Danqing++Song">Danqing Song</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2557-5009" title="Orcid link">http://orcid.org/0000-0002-2557-5009</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01743&amp;href=/doi/10.1021%2Facs.jmedchem.0c01743" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 768–781</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 1, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 October 2020</li><li><span class="item_label"><b>Published</b> online</span>1 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01743" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01743</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D768%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DQingxuan%2BZeng%252C%2BHongbin%2BDeng%252C%2BYinghong%2BLi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D1%26contentID%3Dacs.jmedchem.0c01743%26title%3DBerberine%2BDirectly%2BTargets%2Bthe%2BNEK7%2BProtein%2Bto%2BBlock%2Bthe%2BNEK7%25E2%2580%2593NLRP3%2BInteraction%2Band%2BExert%2BAnti-inflammatory%2BActivity%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D781%26publicationDate%3DJanuary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01743"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1625</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01743" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3 Interaction and Exert Anti-inflammatory Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Qingxuan&quot;,&quot;last_name&quot;:&quot;Zeng&quot;},{&quot;first_name&quot;:&quot;Hongbin&quot;,&quot;last_name&quot;:&quot;Deng&quot;},{&quot;first_name&quot;:&quot;Yinghong&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Tianyun&quot;,&quot;last_name&quot;:&quot;Fan&quot;},{&quot;first_name&quot;:&quot;Yang&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Sheng&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Xiaojia&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Xixi&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Jiandong&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Yanxiang&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Danqing&quot;,&quot;last_name&quot;:&quot;Song&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;768-781&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01743&quot;},&quot;abstract&quot;:&quot;Berberine (BBR), a traditional Chinese medicine, has therapeutic effects on a variety of inflammation-related diseases, but its direct proteomic targets remain unknown. Using activity-based protein profiling, we first demonstrated that BBR directly targets the NEK7 protein via the hydrogen bond between the 2,3-methylenedioxy and 121-arginine (R121) residues. The fact that R121 is located precisely within the key domain involved in the NEK7–NLRP3 interaction allows BBR to specifically block the NEK7–NLRP3 interaction and successively inhibit IL-1β release, independent of the NF-κB and TLR4 signaling pathways. Moreover, BBR displays in vivo anti-inflammatory efficacy in a NEK7-dependent manner. Therefore, we consider NEK7 to be a key target of BBR in the treatment of NLRP3-related inflammatory diseases, and the development of novel NEK7–NLRP3 interaction inhibitors might be easily achieved using NEK7 as a target.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01743&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01743" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01743&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01743" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01743&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01743" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01743&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01743&amp;href=/doi/10.1021/acs.jmedchem.0c01743" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01743" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01743" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (11 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01743%26sid%3Dliteratum%253Aachs%26pmid%3D33440945%26genre%3Darticle%26aulast%3DZeng%26date%3D2021%26atitle%3DBerberine%2BDirectly%2BTargets%2Bthe%2BNEK7%2BProtein%2Bto%2BBlock%2Bthe%2BNEK7%25E2%2580%2593NLRP3%2BInteraction%2Band%2BExert%2BAnti-inflammatory%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D1%26spage%3D768%26epage%3D781%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291774" title="Nuclear magnetic resonance spectroscopy">Nuclear magnetic resonance spectroscopy</a>,</li><li><a href="/action/doSearch?ConceptID=291161" title="Inflammation">Inflammation</a>,</li><li><a href="/action/doSearch?ConceptID=292601" title="Probes">Probes</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/jmcmar.2021.64.issue-1/20210114/jmcmar.2021.64.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Berberine (BBR), a traditional Chinese medicine, has therapeutic effects on a variety of inflammation-related diseases, but its direct proteomic targets remain unknown. Using activity-based protein profiling, we first demonstrated that BBR directly targets the NEK7 protein <i>via</i> the hydrogen bond between the 2,3-methylenedioxy and 121-arginine (R121) residues. The fact that R121 is located precisely within the key domain involved in the NEK7–NLRP3 interaction allows BBR to specifically block the NEK7–NLRP3 interaction and successively inhibit IL-1β release, independent of the NF-κB and TLR4 signaling pathways. Moreover, BBR displays <i>in vivo</i> anti-inflammatory efficacy in a NEK7-dependent manner. Therefore, we consider NEK7 to be a key target of BBR in the treatment of NLRP3-related inflammatory diseases, and the development of novel NEK7–NLRP3 interaction inhibitors might be easily achieved using NEK7 as a target.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Evolution through natural selection over long periods of time has extensive pharmacological effects on natural products and a precise and complex biological mechanism network, which is worthy of in-depth exploration. Berberine (BBR, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) has been used in China for half a century as a natural over-the-counter antidiarrheal drug, and its application in various inflammatory disorders, such as type 2 diabetes, hyperlipidemia, atherosclerosis, and Alzheimer’s disease, has been investigated.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8">(1−8)</a> However, its underlying mode of action and direct targets are still unknown, which has greatly limited its further clinical applications. This is a common scientific issue for many natural medicines, such as artemisinin and metformin,<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9−12)</a> for which the underlying mechanisms of their multiple pharmacological effects must be determined.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structure of BBR and the rational design of BBR probes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Three main hypotheses to explain the multiple biological activities of BBR have been proposed as follows: mitochondria,<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13−15)</a> intestinal flora,<a onclick="showRef(event, 'ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19">(16−19)</a> and inflammation.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20−22)</a> Canakinumab, known as the interleukin-1β (IL-1β) antibody, was proven to be beneficial for the improvement of several inflammation-related cardiovascular end-points, which suggested that the inhibition of IL-1β might be an effective strategy for the treatment of inflammation-related diseases.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> The production of IL-1β is closely related to the regulation of the nucleotide-binding domain (NOD)-like receptor protein 3 (NLRP3) inflammasome, which consists of the sensor protein NLRP3, NIMA-related kinase 7 (NEK7), and the adaptor protein apoptosis-associated speck-like protein (ASC), as well as procaspase-1.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> The inhibitory effect of BBR on different inflammatory factors, such as IL-1β, nuclear factor-κB (NF-κB), and IL-6, plays a vital role in preventing or alleviating inflammation-related diseases.<a onclick="showRef(event, 'ref14 ref20 ref21 ref22 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref14 ref20 ref21 ref22 ref27 ref28 ref29">(14,20−22,27−29)</a> Therefore, taking IL-1β as a biomarker, the direct proteomic targets of BBR against inflammation could be explored and identified to understand and elucidate the mechanism of BBR’s various biological activities from the perspective of inflammation and then discover new targets associated with inflammatory diseases for the development of innovative drugs.</div><div class="NLM_p last">In this study, using the activity-based protein profiling (ABPP) technology, we demonstrated that BBR directly targets the NEK7 protein by binding to the 121-arginine (R121) residue <i>via</i> hydrogen bonds and specifically blocks the NEK7–NLRP3 interaction to exert anti-inflammatory activity. The <i>in vivo</i> NEK7-dependent anti-inflammatory effect of BBR is also described.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Inhibitory Activity of BBR on IL-1β Secretion</h3><div class="NLM_p last">To evaluate the anti-inflammatory activity of BBR, we initially constructed a screening model for IL-1β secretion in phorbol 12-myristate 13-acetate-differentiated human monocytic cell line-1 (PMA-THP-1) cells triggered by lipopolysaccharide (LPS) plus nigericin.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_001.pdf" class="ext-link">Supporting Information</a> Figure 1a–d, the time- and dose-dependent inhibitory effects of BBR on caspase-1 cleavage and IL-1β secretion were analyzed by both Western blot and enzyme-linked immunosorbent assay (ELISA), and BBR displayed moderate activity against IL-1β release with an IC<sub>50</sub> value of 5.1 μM, which was confirmed in mouse bone marrow-derived macrophages (BMDMs) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_001.pdf" class="ext-link">Supporting Information</a> Figure 1e). In addition, no cell death or apoptosis was observed up to a concentration of 40 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_001.pdf" class="ext-link">Supporting Information</a> Figure 1f–h), indicating that the inhibitory effect of BBR was independent of its cytotoxicity.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6"> Construction and Synthesis of BBR Probes</h4><div class="NLM_p">As displayed in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, BBR was used as a pharmacophore according to our previous structure–activity relationship (SAR) results,<a onclick="showRef(event, 'ref3 ref31'); return false;" href="javascript:void(0);" class="ref ref3 ref31">(3,31)</a> and target BBR probes were constructed by connecting BBR with a biotin tag through alkane or polyethylene glycol linkers. Sixteen biotinylated affinity-based BBR probes with different linkers at positions 3, 9, or 10 were designed and prepared, taking <b>1</b>,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a><b>5</b>,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a><b>12</b>,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> or commercially available jatrorrhizine (<b>JTH</b>) as the starting material. As shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, all probes were semisynthesized through a three-step procedure, including nucleophilic substitution, deprotection, and condensation reactions with overall yields of 25–51%. For the synthesis of <b>4a–d</b>, a propane or diethylene glycol linker with a commercially available <i>tert</i>-butoxycarbonyl (BOC)-protected N-terminus was added to the 9-OH of compound <b>1</b> in the presence of K<sub>2</sub>CO<sub>3</sub> to produce the key intermediates <b>2a–d</b>. After the removal of BOC protection, the exposed primary amine group was condensed with the carboxylic acid of biotin to obtain the desired products <b>4a–d</b>. Following a similar procedure, target probes <b>8a–d</b>, <b>11a–d</b>, and <b>15a–d</b> were also obtained from starting materials <b>5</b>, <b>JTH</b>, and <b>12</b>, respectively.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis Scheme for <b>4a–d</b>, <b>8a–d</b>, <b>11a–d</b>, and <b>15a–d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Br-R-NHBoc or TsO-R-NHBoc, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux; (b) CH<sub>3</sub>OH/HCl; (c) <span class="smallcaps smallerCapital">D</span>-biotin, EDCI/HOBT, DMF.</p></p></figure><div class="NLM_p">For the synthesis of the photoaffinity-based BBR probe <b>16</b> bearing both diazirine and alkyne functional groups (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), <b>7d</b> was condensed with the photoaffinity-labeling (<b>PAL</b>) group<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> with a 32% yield, as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. All probes were purified by flash chromatography using CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH as the gradient eluent.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis Scheme for <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EDCI/HOBT, DMF.</p></p></figure></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Acquisition of Active Probe</h3><div class="NLM_p">All newly synthesized biotinylated probes were screened for their inhibitory effects on IL-1β-release activities in PMA-THP-1 cells at a concentration of 20 μM by the immunosorbent assay. First, compounds <b>4a–d</b> with 9-biotinylated substituents were tested, and only <b>4c</b> and <b>4d</b> showed weak activity on the downregulation of IL-1β (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_001.pdf" class="ext-link">Supporting Information</a> Figure 2), inferior to that of BBR. When the biotinylated moiety was switched to position 10, compounds <b>8a–d</b> were formed. Among them, compound <b>8d</b> with a 9-polyethylene glycol moiety exhibited the highest potency with an inhibitory rate of 83%, which is higher than that of BBR. Then, modification of the 3-position was carried out, and the methylenedioxy ring was selectively opened to yield compounds <b>11a–d</b>. The results showed that only compounds <b>11b</b> and <b>11c</b> displayed moderate inhibitory potency. Compound <b>11d</b> sharing the same linker with <b>8d</b> displayed a complete loss in activity, hinting that an appropriate substituent at position 10 might be beneficial for IL-1β inhibitory potency. Meanwhile, compounds <b>15a–d</b> without methylenedioxy fragments were constructed as negative probes based on our previous SAR showing that the methylenedioxy moiety in BBR was essential for activity.<a onclick="showRef(event, 'ref3 ref31'); return false;" href="javascript:void(0);" class="ref ref3 ref31">(3,31)</a> As expected, compound <b>15d,</b> with the same 9-polyethylene glycol linker as compound <b>8d</b>, completely lost its ability to downregulate IL-1β expression. Therefore, <b>8d</b> was selected as the positive probe, while inactive <b>15d</b> was chosen as the negative probe for the next investigation.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures and Inhibitory Effects of Target Compounds on IL-1β-Release Activity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0011.gif" alt="" id="GRAPHIC-d7e576-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">inhibitory rate %<sup>[</sup><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>]</sup></th><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">inhibitory rate %<sup>[</sup><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>]</sup></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">–92</td><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">–49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>5</sub></td><td class="colsep0 rowsep0" align="left">–2</td><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>5</sub></td><td class="colsep0 rowsep0" align="left">70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>O(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left"><b>11c</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>O(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">((CH<sub>2</sub>)<sub>2</sub>O)<sub>2</sub>(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left"><b>11d</b></td><td class="colsep0 rowsep0" align="left">((CH<sub>2</sub>)<sub>2</sub>O)<sub>2</sub>(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">–79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left"><b>15a</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>5</sub></td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>5</sub></td><td class="colsep0 rowsep0" align="left">77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>O(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left"><b>15c</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>O(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8d</b></td><td class="colsep0 rowsep0" align="left">((CH<sub>2</sub>)<sub>2</sub>O)<sub>2</sub>(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left"><b>15d</b></td><td class="colsep0 rowsep0" align="left">((CH<sub>2</sub>)<sub>2</sub>O)<sub>2</sub>(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">–78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left"><b>BBR</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">72</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last"><i>In vitro</i> assay. Values are the mean of two independent determinations.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Fishing and Identification of Direct Target Proteins</h3><div class="NLM_p">Taking <b>8d</b> and <b>15d</b> as chemical tools (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a), we carried out proteomic target fishing and verified the effect of BBR against IL-1β. The overall process of target identification is briefly described in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b. The conjugates of <b>8d</b> or <b>15d</b> and streptavidin magnetic beads were prepared <i>via</i> biotin–avidin interaction and then treated with PMA-THP-1 cell lysates to allow direct binding between the conjugate and target proteins.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The proteomes labeled by the BBR probes were separated after streptavidin enrichment, released from the beads, and run on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by silver staining, using DMSO treatment as the blank control. Compared with the <b>15d</b> treatment, one distinct band between 25 and 37 kDa was detected in the <b>8d</b> treatment (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c), from which 75 proteins were further identified by liquid chromatography–mass spectrometry/mass spectrometry (LC–MS/MS) analysis. Among the 75 proteins, 10 were enzymes, while the rest were ribosomal proteins, spliceosomes, tubulins, and others. Considering that enzymes are the most likely target,<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> six enzymes with available crystal structures,<a onclick="showRef(event, 'ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39">(36−39)</a> named PGAM5 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MXO">3MXO</a>), NMNAT1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KQN">1KQN</a>), UCK2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UFQ">1UFQ</a>), NSUN5 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2B9E">2B9E</a>), NEK7 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WQN">2WQN</a>), and DIM1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZQ9">1ZQ9</a>), were first selected as candidate target proteins for further investigation (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_001.pdf" class="ext-link">Supporting Information</a> Figure 3 and Table 1). Based on the molecular docking results with Discovery Studio 4.5 software, BBR fitted well in the binding pockets of three enzymes, NEK7, UCK2, and NMNAT1, which were therefore selected as key candidate targets for further verification by the immunoblot assay. As displayed in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>d, only the NEK7 protein was successfully identified with its specific antibody, implying a direct interaction between BBR and the NEK7 protein.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. BBR labeling of the direct proteomic target. (a,e) Structures of <b>8d</b>, <b>15d</b>, and <b>16</b>. (b) General workflow of the ABPP approach. (c,d) Cell lysates of PMA-THP-1 cells that were pulled down. The total proteins were silver-stained (c) and proteins pulled down were immunoblotted (d). (f) Cy3<b>-</b>labeled target proteins identified using fluorescent gel imaging. (g) Biotin-labeled target proteins identified using immunoblotting. (h) Purified human NEK7 protein pulled down with or without BBR pretreatment. (i) Dose-dependent labeling of NEK7 recombinant proteins with <b>8d</b> beads. (j) ATPase activity assay for purified human NEK7 in the presence of different concentrations of BBR. (k) SPR sensorgrams obtained on an NEK7-coated chip at different concentrations of BBR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To further validate the specific binding between BBR and NEK7 <i>in situ</i>, an active photoaffinity BBR probe <b>16</b> with an alkyne group was incubated with PMA-THP-1 cells to directly label the target proteins <i>in situ</i>. Then, under 365 nm light exposure, the diazirine fragment in <b>16</b> was readily switched to the highly active carbene, which promptly formed a covalent bond with the target protein in the active pocket. The alkyne group in the formed <b>16</b>–protein complex was appended with a Cy3-azide or biotin-azide through a click reaction to generate new fluorescent or biotin-labeled complexes<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> for further target identification. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>f, the differentiated band between 25 and 37 kDa was detected by fluorescence imaging assay, and fluorescence weakening occurred after the addition of BBR (100 μM) competitive inhibition. In addition, the differentiated band was further confirmed to be NEK7 protein by streptavidin-bead enrichment and immunoblot assay, and differentiation could be distinctly weakened by the addition of BBR at the same concentration (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>g). The following pull-down results indicated that <b>8d</b> could specifically bind to the recombinant protein NEK7, which could also be competitively inhibited by BBR (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>h), again indicating a direct interaction between BBR and NEK7. Next, the dose-dependent interaction between <b>8d</b> and recombinant NEK7 is demonstrated in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>i. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>j, BBR displayed a moderate inhibitory effect on NEK7 kinase with an IC<sub>50</sub> value of 4.2 μM, consistent with its previous IC<sub>50</sub> result against IL-1β release. Furthermore, BBR also showed dose-dependent binding with immobilized NEK-7 in SPR analysis, with a <i>K</i><sub>d</sub> value of 15.6 μM (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>k). Taken together, we demonstrate the specific interaction between BBR and NEK7 and identify NEK7 as a direct proteomic target of BBR at both the biochemical and cellular levels using the ABPP technology.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Interaction of BBR and NEK7 <i>Via</i> Hydrogen Bonding</h3><div class="NLM_p">To further understand the interaction pattern of BBR and NEK7, we conducted molecular docking between BBR and NEK7 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_001.pdf" class="ext-link">Supporting Information</a> Figure 4), mainly focusing on the NEK7 ATP active cavity.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Based on the theoretical hydrogen bond and the ionic bond between BBR and binding sites, seven key amino acid residues, including D115, D118, R121, K163, M203, W220, and F236, were predicted to be responsible for the interactions. Then, single-point mutations for all these residues were performed in turns, changing them into alanine (A), which is incapable of forming hydrogen bonds or ionic bonds. As depicted in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a,b, only the R121A mutation abolished BBR’s binding affinity to NEK7, consistent with the deletion mutation result, indicating that BBR targeted the 34–212 peptide segment in the NEK7 catalytic domain.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> On the other hand, compound <i>O</i>-BBR lacking a methylenedioxy group (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>c) lost its activity against IL-1β activation completely (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>d), again highlighting the importance of the hydrogen bond between methylenedioxy and R121 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a). According to the docking results in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>e, BBR fit well in the ATP-binding pocket of the NEK7 protein by binding to the R121 residue, consistent with the results of the point-mutation experiment.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. BBR interaction with NEK7. (a) HEK-293 cells transfected with Flag-tagged WT or the indicated mutant NEK7 constructs. The lysates were pulled down using <b>8d</b> beads. (b) WT or mutant NEK7 was pulled down with <b>8d</b> beads in HEK-293 cells and analyzed by immunoblotting. (c) Structure of <i>O</i>-BBR. (d) Immunoblot analysis of cleaved IL-1β and activated caspase-1 in the SN from LPS/nigericin-stimulated PMA-THP-1 cells pretreated with BBR (10 μM) or <i>O</i>-BBR (10 μM). (e) Molecular docking results for NEK7 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2%2520WQN">2 WQN</a>) with BBR or ATP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Mechanism of BBR in the NEK7–NLRP3 Interaction</h3><div class="NLM_p">Interestingly, the R121 residue of NEK7 is located exactly in one of the key interaction domains between NEK7 and NLRP3, and a single-point mutation in R121A could greatly abolish NEK7–NLRP3 interactions.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Thus, we measured the impact of BBR on the interactions between NEK7 and NLRP3 <i>via</i> a coimmunoprecipitation (Co-IP) assay. As displayed in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a, BBR dose-dependent inhibition of the NEK7–NLRP3 interaction in 293 cells overexpressing exogenous NEK7/NLRP3 proteins was observed, which was further shown in PMA-THP-1 cells by endogenous Co-IP assay (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b). In contrast, <i>O</i>-BBR without the methylenedioxy moiety was incapable of blocking the NEK7–NLRP3 interaction (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>c), and BBR failed to suppress their correlation, while 121-arginine was mutated to alanine in 293 cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>d). These results further demonstrated that BBR could directly prevent the NEK7–NLRP3 interaction <i>via</i> methylenedioxy binding to the R121 residue of NEK7, thereby suppressing the activation of the NLRP3 inflammasome and the subsequent release of a series of inflammatory factors, including IL-1β.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. BBR blocking the NEK7 and NLRP3 interaction. (a) Co-IP and immunoblot analysis of the NEK7–NLRP3 interaction with different concentrations of BBR in HEK-293 cells. (b) Endogenous Co-IP with the NLRP3 antibody or isotype antibody performed in PMA-THP-1 cells stimulated with LPS/nigericin with or without BBR (10 μM). (c) Co-IP and immunoblot analysis of the NEK7–NLRP3 interaction with BBR (10 μM) or <i>O</i>-BBR (10 μM) in HEK-293T cells. (d) Co-IP and immunoblot analysis of the interaction between NLRP3 and WT or mutant NEK7 in HEK-293T cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> BBR Specifically Blocks the NEK7–NLRP3 Interaction</h3><div class="NLM_p">To further identify whether BBR exerts the anti-inflammatory activity by specifically blocking the NEK7–NLRP3 interaction, we evaluated the IL-1β inhibitory potency in the early stage to exclude the impact of the NF-κB and TLR4 signaling pathways, which are also responsible for BBR’s anti-IL-1β activity by downregulating NLRP3 and pro-IL-1β expression after treatment for 12 h or longer.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> We found that BBR dose-dependently inhibited caspase-1 activation and IL-1β production (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a) but had no effect on NLRP3 and pro-IL-1β expression in either human THP-1 cells (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a) or BMDM cells (data not shown), suggesting that BBR acts solely by targeting the NEK7–NLRP3 mechanism rather than suppressing the NF-κB and TLR4 pathways against inflammation. Although BBR could regulate NLRP3 expression through other pathways,<a onclick="showRef(event, 'ref45 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47 ref48">(45−48)</a> our findings, for the first time, elucidate that BBR could directly bind the NEK7–NLRP3 complex in the early anti-inflammatory stage, independent of the NLRP3 pathways, by BBR, which is an effective method for profiling the complex anti-inflammatory mechanism network of BBR. Then, the above mechanism was further confirmed by the fact that BBR abolished the formation of LPS/nigericin-triggered ASC pyroptosomes (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b,c). In addition, BBR did not inhibit the activation of IL-1β induced by AIM2 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>d) or the NLRC4 inflammasome (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>e), which reconfirmed that BBR specifically inhibited the NEK7–NLRP3 interaction mediating IL-1β activation.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. BBR specifically inhibits the NEK7–NLRP3 pathway. (a) PMA-THP-1 cells primed with LPS and stimulated with nigericin with or without BBR (10 μM) pretreatment for 4 h. Immunoblot analysis of cleaved IL-1β and activated caspase-1 in the SN and pro-IL-1β, procaspase-1, and NLRP3 in lysates of PMA-THP-1 cells. (b,c) Immunoblot analysis of ASC oligomerization (b) and ASC pyroptosome immunofluorescence analysis (c) of PMA-THP-1 cells stimulated with LPS/nigericin, with or without BBR (10 μM) pretreatment for 4 h. (d,e) PMA-THP-1 cells pretreated with or without BBR (10 μM) for 2 h, followed by transfection with 1 μg of poly(dA:dT) using lipofectamine (d) or stimulation with Salmonella (e). The SN and lysates were collected 8 h after transfection or infection and analyzed for IL-1β and caspase-1 activation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> BBR Suppresses NEK7-dependent Inflammation <i>In Vivo</i></h3><div class="NLM_p">To verify NEK7 as the target of BBR against inflammation <i>in vivo</i>, a <i>NEK7</i> knockdown mouse model was successfully established to evaluate the effect of BBR on IL-1β production (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a). After the mice were infected with adenovirus (Adv) shNEK7 by intravenous injection for 10 days, the expression of NEK7 obviously decreased compared with that in the control group (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>b). Then, WT mice and <i>NEK7</i> knockdown mice were administered with BBR three times every 12 h, followed by LPS. The mice received an intraperitoneal injection (i.p.) at a dose of 5 mg/kg; therefore, the theoretical exposure concentrations of unbound BBR in the plasma and liver could reach over 1 and 10 μM, respectively.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> BBR obviously alleviated IL-1β production in the control group (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>c), while no significant change was observed in the <i>NEK7</i> gene knockdown group with BBR treatment, indicating a NEK7-dependent effect of BBR against IL-1β. These results indicated that BBR exerted <i>in vivo</i> effects due to NEK7 inhibition in synergy with other mechanisms.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. BBR inhibits IL-1β <i>via</i> NEK7 <i>in vivo</i>. (a) Mice transfected with Adv for 10 days and treated with BBR three times every 12 h before LPS stimulation. (b) Immunoblot analysis of NEK7 expression in mouse livers. (c) ELISA of IL-1β in mouse serum. (d) Representative H&E staining of liver sections of mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We also found that BBR could reduce inflammatory infiltration in the liver compared with that in the LPS-induced group, as expected (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>d), while no significant lesions were found in other tissues (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_001.pdf" class="ext-link">Supporting Information</a> Figure 5). These results provide convincing results that BBR inhibits the secretion of IL-1β by targeting NEK7, thereby exerting its anti-inflammatory effect. Meanwhile, no obvious pathological changes were observed in the <i>NEK7</i> knockdown group (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>d and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_001.pdf" class="ext-link">Supporting Information</a> Figure 5), which indicated that NEK7 might serve as a druggable target against inflammation with favorable safety characteristics.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">With an ABPP-based chemical proteomic strategy, we first identified NEK7 as an important direct proteomic target of BBR against inflammation and elucidated that BBR exerts its anti-inflammatory efficacy by specifically blocking the NEK7–NLRP3 interaction through hydrogen bonding with the key R121 residue in NEK7, as shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>. It is the noncovalent bond that makes BBR display only moderate potency against IL-1β activation and thereby moderate the anti-inflammatory activity. As R121 is located in the key interaction domain of NEK7–NLRP3, BBR specifically blocks the NEK7–NLRP3 interaction <i>via</i> R121, thereby suppressing ASC oligomerization and the activation of NLPR3 inflammasomes as well as of IL-1β release, independent of the NF-κB and TLR4-signaling pathways. Moreover, BBR displays efficacy against IL-1β release <i>in vivo</i> in a NEK7-dependent manner.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Proposed model of BBR inhibiting NLRP3 inflammasome activation by targeting NEK7.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Our data demonstrate for the first time that NEK7 is one of the key direct targets of BBR in the treatment of inflammation-related diseases, such as type 2 diabetes, atherosclerosis, nonalcoholic fatty liver, and neurodegenerative diseases,<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref14 ref51'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref14 ref51">(1−8,14,51)</a> which might partly explain the mechanism of BBR’s multiple pharmacological activities related to inflammation through the NEK7–NLRP3 interaction. Taking NEK7 kinase as a target for screening, novel NEK7–NLRP3 interaction inhibitors might be easily achieved to combat various inflammation-related diseases. As a multitarget natural product, several other direct proteomic targets of BBR, such as UHRF1, RXRα, actin, and ephrin-B2, have been identified to explain its multiple pharmacological activities, including the anticancer activity.<a onclick="showRef(event, 'ref52 ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54 ref55">(52−55)</a> Therefore, these findings provide an important explanation to achieve a comprehensive understanding and interpretation of BBR’s polypharmacological activities and its natural evolution. Our results fully support NEK7 as one of the key direct targets of BBR with multipharmacological efficacy, and verification of other direct target proteins of BBR with effects against inflammation is actively underway.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42267" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42267" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemical Materials and Methods</h3><div class="NLM_p">All reagents and solvents used are commercially available and used without further purification. Melting points (mp) were obtained with an MPA 100 OptiMelt Automated Melting Point System (Stanford Research Systems, California, USA). <sup>1</sup>H NMR spectra were obtained on a Varian INOVA spectrometer (Varian, San Francisco, CA, USA), and <sup>13</sup>C NMR spectra were obtained on a Bruker Avance III 400 spectrometer in DMSO-<i>d</i><sub>6</sub> or CD<sub>3</sub>OD, with Me<sub>4</sub>Si as the internal standard. ESI high-resolution mass spectra (HRMS) were recorded on an AutoSpec Ultima-TOF mass spectrometer (Micromass UK Ltd., Manchester, UK). Flash chromatography was performed on a CombiFlash Rf 200 (Teledyne, Nebraska, USA). The purities of all the target probes were greater than 95%, as determined by high-performance liquid chromatography (HPLC). The HPLC traces and other analytical data for key target compounds <b>8d</b>, <b>15d</b>, and <b>16</b> are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_001.pdf" class="ext-link">Supporting Information</a> (Figures 6–9).</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> General Procedure for the Preparation of <b>4a–d</b>, <b>8a–d</b>, <b>11a–d</b>, and <b>15a–d</b></h4><div class="NLM_p">Compound <b>1</b> was obtained as a yellow solid according to the reported procedure.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> To a stirred solution of <b>1</b> (1.0 g, 2.8 mmol) in anhydrous CH<sub>3</sub>CN, K<sub>2</sub>CO<sub>3</sub> (3 eq) was added and heated to 70 °C. Then, the corresponding Br-R-NHBoc or TsO-R-NHBoc (1.5–2.0 eq) was added, then the mixture was stirred for 24 h, cooled to precipitate completely, and filtered. The residue was purified by flash chromatography over silica gel using CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH as the gradient eluent to afford <b>2a–d</b>. Compounds <b>2a–d</b> were dissolved in CH<sub>3</sub>OH/HCl, and the mixture was stirred for 5–6 h, filtered, and washed with ethanol to acquire <b>3a–d</b>. <span class="smallcaps smallerCapital">D</span>-Biotin (1.1 eq), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI) (1.2 eq), hydroxybenzotriazole (HOBT) (1.2 eq), and triethylamine (2.8 eq) were mixed in DMF (5 mL), to which <b>3a–d</b> were added, and the mixture was stirred overnight. After flash purification, <b>4a–d</b> were obtained as yellow solids.</div><div class="NLM_p">Similarly, target probes <b>8a–d</b>, <b>11a–d</b>, and <b>15a–d</b> were synthesized through the abovementioned method, taking <b>5</b>, <b>JTH</b>, and <b>12</b> as raw materials, respectively.</div><div class="NLM_p">2,3-Methylenedioxy-9-(3-((biotinyl)amino)propoxy)-10-methoxyprotoberberine chloride (<b>4a</b>): Yellow solid, yield: 33%; mp: 125–127 °C (dec.); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.95 (s, 1H), 8.96 (s, 1H), 8.20 (d, <i>J</i> = 9.2 Hz, 1H), 8.15 (t, <i>J</i> = 5.8 Hz, 1H), 8.00 (d, <i>J</i> = 9.1 Hz, 1H), 7.81 (s, 1H), 7.11 (s, 1H), 6.42 (s, 1H), 6.39 (s, 1H), 6.18 (s, 2H), 5.02 (t, <i>J</i> = 6.3 Hz, 2H), 4.32–4.24 (m, 3H), 4.14–3.92 (m, 4H), 3.42–3.33 (m, 2H), 3.23 (t, <i>J</i> = 6.3 Hz, 2H), 3.04–2.95 (m, 1H), 2.75 (dd, <i>J</i> = 12.4, 5.1 Hz, 1H), 2.57–2.53 (m, 1H), 2.11 (t, <i>J</i> = 7.3 Hz, 2H), 2.01–1.93 (m, 2H), 1.62–1.20 (m, 6H); <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 174.7, 164.5, 150.7, 150.6, 148.5, 145.2, 143.3, 138.2, 133.7, 130.5, 126.4, 123.1, 122.1, 120.5, 120.0, 108.0, 105.1, 102.2, 71.0, 61.9, 60.1, 56.2, 55.7, 55.6, 39.6, 35.4, 35.3, 29.9, 28.4, 28.2, 26.8, 25.5; HRMS: calcd for C<sub>32</sub>H<sub>37</sub>N<sub>4</sub>O<sub>6</sub>SCl, [M – Cl]<sup>+</sup> 605.2428; found, 605.2427.</div><div class="NLM_p">2,3-Methylenedioxy-9-((5-((biotinyl)amino)pentyl)oxy)-10-methoxyprotoberberine chloride (<b>4b</b>): Yellow solid, yield: 37%; mp: 141–143 °C (dec.); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.79 (s, 1H), 8.97 (s, 1H), 8.20 (d, <i>J</i> = 9.1 Hz, 1H), 8.00 (d, <i>J</i> = 9.1 Hz, 1H), 7.96–7.92 (m, 1H), 7.81 (s, 1H), 7.10 (s, 1H), 6.44 (s, 1H), 6.39 (s, 1H), 6.18 (s, 2H), 4.99 (t, <i>J</i> = 6.3 Hz, 2H), 4.39–4.23 (m, 3H), 4.12–4.08 (m, 1H), 4.06 (s, 3H), 3.22 (t, <i>J</i> = 6.3 Hz, 2H), 3.11–3.04 (m, 3H), 2.78 (dd, <i>J</i> = 12.4, 5.1 Hz, 1H), 2.55 (d, <i>J</i> = 12.4 Hz, 1H), 2.52–2.49 (m, 2H), 2.06 (t, <i>J</i> = 7.4 Hz, 2H), 1.92–1.85 (m, 2H), 1.67–1.17 (m, 10H); <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 174.5, 164.5, 150.7, 150.6, 148.4, 144.8, 143.5, 138.2, 133.7, 130.4, 126.4, 122.9, 122.1, 120.4, 120.1, 107.9, 105.1, 102.2, 74.2, 61.9, 60.1, 56.1, 55.8, 55.5, 39.5, 38.6, 35.4, 29.3, 28.8, 28.3, 28.1, 26.8, 25.5, 22.9; HRMS: calcd for C<sub>34</sub>H<sub>41</sub>N<sub>4</sub>O<sub>6</sub>SCl, [M – Cl]<sup>+</sup> 633.2741; found, 633.2750.</div><div class="NLM_p">2,3-Methylenedioxy-9-(2-(2-((biotinyl)amino)ethoxy)ethoxy)-10-methoxyprotoberberine chloride (<b>4c</b>): Yellow solid, yield: 44%; mp: 159–161 °C (dec.); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.79 (s, 1H), 8.98 (s, 1H), 8.21 (d, <i>J</i> = 9.1 Hz, 1H), 8.01 (d, <i>J</i> = 9.1 Hz, 1H), 7.93 (t, <i>J</i> = 5.7 Hz, 1H), 7.82 (s, 1H), 7.11 (s, 1H), 6.42 (s, 1H), 6.39 (s, 1H), 6.18 (s, 2H), 4.98 (t, <i>J</i> = 6.3 Hz, 2H), 4.47–4.38 (m, 2H), 4.29 (dd, <i>J</i> = 7.7, 5.0 Hz, 1H), 4.18–3.99 (m, 4H), 3.86–3.72 (m, 2H), 3.46 (t, <i>J</i> = 6.1 Hz, 2H), 3.25–3.16 (m, 4H), 3.06–3.01 (m, 1H), 2.78 (dd, <i>J</i> = 12.4, 5.1 Hz, 1H), 2.56 (d, <i>J</i> = 12.4 Hz, 1H), 2.03 (t, <i>J</i> = 7.4 Hz, 2H), 1.64–1.18 (m, 6H); <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 174.7, 164.5, 150.8, 150.7, 148.5, 145.1, 143.1, 138.3, 133.7, 130.5, 126.3, 123.4, 122.4, 120.5, 120.1, 108.0, 105.1, 102.2, 73.0, 69.6, 69.1, 61.8, 60.1, 56.2, 56.0, 55.5, 39.6, 38.8, 35.2, 28.2, 28.0, 26.8, 25.4; HRMS: calcd for C<sub>33</sub>H<sub>39</sub>N<sub>4</sub>O<sub>7</sub>SCl, [M – Cl]<sup>+</sup> 635.2534; found, 635.2534.</div><div class="NLM_p">2,3-Methylenedioxy-9-(2-(2-(2-(biotinyl)amino)ethoxy)ethoxy)ethoxy-10-methoxyprotoberberine chloride (<b>4d</b>): Yellow solid, yield: 31%; mp: 79–81 °C (dec.); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.79 (s, 1H), 8.98 (s, 1H), 8.21 (d, <i>J</i> = 9.1 Hz, 1H), 8.02 (d, <i>J</i> = 9.1 Hz, 1H), 7.96–7.85 (m, 1H), 7.82 (s, 1H), 7.10 (s, 1H), 6.43 (s, 1H), 6.39 (s, 1H), 6.18 (s, 2H), 4.95 (t, <i>J</i> = 6.3 Hz, 2H), 4.46–4.38 (m, 2H), 4.30 (dd, <i>J</i> = 7.8, 5.1 Hz, 1H), 4.13–4.09 (m, 1H), 4.07 (s, 3H), 3.88–3.72 (m, 2H), 3.60 (dd, <i>J</i> = 5.9, 3.5 Hz, 2H), 3.51 (dd, <i>J</i> = 5.8, 3.5 Hz, 2H), 3.34 (s, 2H), 3.23 (t, <i>J</i> = 6.4 Hz, 2H), 3.14 (q, <i>J</i> = 6.0 Hz, 2H), 3.09–3.03 (m, 1H), 2.80 (dd, <i>J</i> = 12.4, 5.1 Hz, 1H), 2.57 (d, <i>J</i> = 12.4 Hz, 1H), 2.02 (t, <i>J</i> = 7.4 Hz, 2H), 1.64–1.18 (m, 7H); <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 174.6, 164.5, 150.9, 150.5, 148.5, 145.3, 143.0, 138.2, 133.6, 130.4, 126.2, 123.5, 122.5, 120.4, 120.1, 107.9, 105.1, 102.2, 73.0, 69.7(2), 69.6, 68.9, 61.9, 60.2, 56.2, 55.9, 55.5, 39.5, 38.6, 35.2, 28.3, 28.0, 26.8, 25.3; HRMS: calcd for C<sub>35</sub>H<sub>43</sub>N<sub>4</sub>O<sub>8</sub>SCl, [M – Cl]<sup>+</sup> 679.2769; found, 679.2789.</div><div class="NLM_p">2,3-Methylenedioxy-9-(3-((biotinyl)amino)propoxy)-10-methoxyprotoberberine chloride (<b>8a</b>): Yellow solid, yield: 43%; mp: 82–84 °C (dec.); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.90 (s, 1H), 8.96 (s, 1H), 8.19–8.12 (m, 1H), 8.02 (t, <i>J</i> = 5.6 Hz, 1H), 7.99 (d, <i>J</i> = 9.1 Hz, 1H), 7.81 (s, 1H), 7.09 (s, 1H), 6.41 (s, 1H), 6.37 (s, 1H), 6.18 (s, 2H), 4.94 (t, <i>J</i> = 6.4 Hz, 2H), 4.36–4.24 (m, 3H), 4.14 (s, 3H), 4.13–4.08 (m, 1H), 3.29 (q, <i>J</i> = 6.5 Hz, 2H), 3.21 (t, <i>J</i> = 6.4 Hz, 2H), 3.10–3.05 (m, 1H), 2.80 (dd, <i>J</i> = 12.4, 5.1 Hz, 1H), 2.56 (d, <i>J</i> = 12.4 Hz, 1H), 2.09 (t, <i>J</i> = 7.3 Hz, 2H), 1.99–1.94 (m, 2H), 1.66–1.21 (m, 6H); <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 174.8, 164.6, 150.7, 149.9, 148.5, 144.9, 144.4, 138.3, 133.8, 130.5, 127.4, 123.0, 122.0, 120.4, 120.0, 107.9, 105.1, 102.2, 67.4, 61.9, 61.4, 60.2, 55.7, 55.6, 39.6, 35.8, 35.3, 29.1, 28.3, 28.1, 26.8, 25.4; HRMS: calcd for C<sub>32</sub>H<sub>37</sub>N<sub>4</sub>O<sub>6</sub>SCl, [M – Cl]<sup>+</sup> 605.2428; found, 605.2426.</div><div class="NLM_p">2,3-Methylenedioxy-9-methoxy-10-((5-((biotinyl)amino)pentyl)oxy)protoberberine chloride (<b>8b</b>): Yellow solid, yield: 39%; mp: 131–133 °C (dec.); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.89 (s, 1H), 8.95 (s, 1H), 8.19 (d, <i>J</i> = 9.1 Hz, 1H), 7.99–7.95 (m, 1H), 7.83 (t, <i>J</i> = 5.7 Hz, 1H), 7.80 (s, 1H), 7.09 (s, 1H), 6.41 (s, 1H), 6.36 (s, 1H), 6.18 (s, 2H), 4.94 (t, <i>J</i> = 6.4 Hz, 2H), 4.34–4.22 (m, 3H), 4.12 (s, 4H), 3.21 (t, <i>J</i> = 6.4 Hz, 2H), 3.11–3.04 (m, 3H), 2.80 (dd, <i>J</i> = 12.5, 5.1 Hz, 1H), 2.56 (d, <i>J</i> = 12.4 Hz, 1H), 2.05 (t, <i>J</i> = 7.4 Hz, 2H), 1.84 (t, <i>J</i> = 6.8 Hz, 2H), 1.63–1.25 (m, 10H); <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 174.5, 164.6, 150.7, 150.0, 148.4, 144.9, 144.3, 138.2, 133.7, 130.4, 127.4, 123.0, 121.9, 120.4, 120.0, 107.9, 105.1, 102.2, 69.7, 61.9, 61.2, 60.1, 55.7, 55.5, 39.6, 38.6, 35.4, 28.7, 28.6, 28.3, 28.1, 26.8, 25.5, 23.0; HRMS: calcd for C<sub>34</sub>H<sub>41</sub>N<sub>4</sub>O<sub>6</sub>SCl, [M – Cl]<sup>+</sup> 633.2741; found, 633.2741.</div><div class="NLM_p">2,3-Methylenedioxy-9-methoxy-10-(2-(2-((biotinyl)amino)ethoxy)ethoxy)protoberberine chloride (<b>8c</b>): Yellow solid, yield: 33%; mp: 152–154 °C (dec.); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.90 (s, 1H), 8.96 (d, <i>J</i> = 2.8 Hz, 1H), 8.20 (d, <i>J</i> = 9.2 Hz, 1H), 7.97 (d, <i>J</i> = 9.1 Hz, 1H), 7.90 (d, <i>J</i> = 6.1 Hz, 1H), 7.81 (s, 1H), 7.09 (s, 1H), 6.41 (s, 1H), 6.37 (s, 1H), 6.18 (s, 2H), 4.94 (t, <i>J</i> = 6.4 Hz, 2H), 4.50–4.39 (m, 2H), 4.33–4.26 (m, 1H), 4.14 (s, 3H), 4.12–4.04 (m, 1H), 3.88–3.78 (m, 2H), 3.51 (t, <i>J</i> = 6.0 Hz, 2H), 3.25–3.19 (m, 4H), 3.10–3.05 (m, 1H), 2.80 (dd, <i>J</i> = 12.4, 5.1 Hz, 1H), 2.56 (d, <i>J</i> = 12.4 Hz, 1H), 2.05 (t, <i>J</i> = 7.5 Hz, 2H), 1.68–1.14 (m, 6H); <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 174.7, 164.6, 150.8, 149.8, 148.4, 144.9, 144.7, 138.4, 134.1, 130.5, 128.2, 122.9, 121.9, 120.4, 120.1, 107.9, 105.2, 102.2, 69.6, 69.2, 69.1, 61.9, 61.4, 60.2, 55.7, 55.5, 39.6, 38.9, 35.3, 28.3, 28.0, 26.7, 25.4; HRMS: calcd for C<sub>33</sub>H<sub>39</sub>N<sub>4</sub>O<sub>7</sub>SCl, [M – Cl]<sup>+</sup> 635.2534; found, 635.2534.</div><div class="NLM_p">2,3-Methylenedioxy-(9-methoxy-10-(2-(2-(2-(biotinyl)amino)ethoxy)ethoxy)ethoxy) protoberberine chloride (<b>8d</b>): Yellow solid, yield: 29%. mp: 69–71 °C (dec.), <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.90 (s, 1H), 8.96 (s, 1H), 8.20 (d, <i>J</i> = 9.1 Hz, 1H), 7.97 (d, <i>J</i> = 9.0 Hz, 1H), 7.87 (t, <i>J</i> = 5.8 Hz, 1H), 7.81 (s, 1H), 7.09 (s, 1H), 6.41 (s, 1H), 6.37 (s, 1H), 6.18 (s, 2H), 4.94 (t, <i>J</i> = 6.4 Hz, 2H), 4.48–4.39 (m, 2H), 4.29 (dd, <i>J</i> = 7.8, 5.1 Hz, 1H), 4.14 (s, 3H), 4.11 (dd, <i>J</i> = 7.8, 4.6 Hz, 1H), 3.92–3.82 (m, 2H), 3.63 (dd, <i>J</i> = 5.9, 3.6 Hz, 2H), 3.54 (dd, <i>J</i> = 5.8, 3.6 Hz, 2H), 3.45–3.42 (m, 2H), 3.21 (t, <i>J</i> = 6.4 Hz, 2H), 3.15 (q, <i>J</i> = 6.0 Hz, 2H), 3.10–3.05 (m, 1H), 2.80 (dd, <i>J</i> = 12.4, 5.1 Hz, 1H), 2.57 (d, <i>J</i> = 12.4 Hz, 1H), 2.05 (t, <i>J</i> = 7.5 Hz, 2H), 1.67–1.17 (m, 6H); <sup>13</sup>C NMR (151 MHz): δ 173.8, 163.8, 150.0, 148.9, 147.7, 144.2, 144.0, 137.7, 133.3, 129.7, 127.4, 122.0, 121.2, 119.6, 119.3, 107.2, 104.4, 101.4, 69.5, 69.1, 68.7, 68.6, 68.3, 61.1, 60.6, 59.4, 54.9, 54.8, 38.8, 38.1, 34.5, 27.5, 27.3, 25.9, 24.6; HRMS: calcd for C<sub>35</sub>H<sub>43</sub>N<sub>4</sub>O<sub>8</sub>SCl, [M – Cl]<sup>+</sup> 679.2796; found, 679.2795.</div><div class="NLM_p">3-(3-((Biotinyl)amino)propoxy)-2,9,10-trimethoxyprotoberberine chloride (<b>11a</b>): Yellow solid, yield: 25%; mp: 121–123 °C (dec.); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.90 (s, 1H), 9.10 (s, 1H), 8.22 (d, <i>J</i> = 9.2 Hz, 1H), 8.05 (d, <i>J</i> = 9.1 Hz, 1H), 7.97 (t, <i>J</i> = 5.6 Hz, 1H), 7.74 (s, 1H), 7.08 (s, 1H), 6.42 (s, 1H), 6.37 (s, 1H), 4.96 (t, <i>J</i> = 6.4 Hz, 2H), 4.32–4.27 (m, 1H), 4.13–4.08 (m, 6H), 4.08 (s, 3H), 3.95 (s, 3H), 3.25–3.20 (m, 4H), 3.11–3.07 (m, 1H), 2.81 (dd, <i>J</i> = 12.4, 5.1 Hz, 1H), 2.57 (d, <i>J</i> = 12.4 Hz, 1H), 2.09 (t, <i>J</i> = 7.4 Hz, 2H), 1.94–1.87 (m, 2H), 1.66–1.24 (m, 6H); <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 174.7, 164.6, 151.6, 150.5, 149.6, 144.9, 144.3, 138.3, 133.8, 128.5, 126.6, 123.0, 121.8, 119.8, 119.1, 111.8, 108.7, 66.8, 61.9, 61.1, 60.2, 56.2, 55.9, 55.7, 55.6, 39.6, 36.3, 35.4, 28.6, 28.3, 28.1, 26.4, 25.4; HRMS: calcd for C<sub>33</sub>H<sub>41</sub>N<sub>4</sub>O<sub>6</sub>SCl, [M – Cl]<sup>+</sup> 621.2741; found, 621.2736.</div><div class="NLM_p">3-((5-((Biotinyl)amino)pentyl)oxy)-2,9,10-trimethoxyprotoberberine chloride (<b>11b</b>): Yellow solid, yield: 35%; mp: 117–119 °C (dec.); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.89 (s, 1H), 9.06 (s, 1H), 8.21 (d, <i>J</i> = 9.1 Hz, 1H), 8.04 (d, <i>J</i> = 9.1 Hz, 1H), 7.83 (t, <i>J</i> = 5.7 Hz, 1H), 7.72 (s, 1H), 7.09 (s, 1H), 6.42 (s, 1H), 6.36 (s, 1H), 4.95 (t, <i>J</i> = 6.4 Hz, 2H), 4.29 (dd, <i>J</i> = 7.7, 5.0 Hz, 1H), 4.14–4.11 (m, 1H), 4.10 (s, 3H), 4.08 (s, 3H), 4.06 (d, <i>J</i> = 6.4 Hz, 2H), 3.94 (s, 3H), 3.22 (t, <i>J</i> = 6.5 Hz, 2H), 3.12–3.01 (m, 3H), 2.80 (dd, <i>J</i> = 12.4, 5.1 Hz, 1H), 2.56 (d, <i>J</i> = 12.4 Hz, 1H), 2.06 (t, <i>J</i> = 7.4 Hz, 2H), 1.80–1.74 (m, 2H), 1.65–1.23 (m, 8H); <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 174.6, 164.6, 151.8, 150.4, 149.6, 144.9, 144.3, 138.4, 133.8, 128.6, 126.6, 123.0, 121.8, 119.8, 118.9, 111.8, 108.8, 68.6, 61.9, 61.1, 60.1, 56.2, 55.9, 55.6, 55.5, 39.6, 38.7, 35.4, 28.6(2), 28.3, 28.1, 26.4, 25.5, 23.0; HRMS: calcd for C<sub>35</sub>H<sub>45</sub>N<sub>4</sub>O<sub>6</sub>SCl, [M – Cl]<sup>+</sup> 649.3054; found, 649.3055.</div><div class="NLM_p">3-(2-(2-((Biotinyl)amino)ethoxy)ethoxy)-2,9,10-trimethoxyprotoberberine chloride (<b>11c</b>): Yellow solid, yield: 44%; mp: 138–140 °C (dec.); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.90 (s, 1H), 9.08 (d, <i>J</i> = 6.2 Hz, 1H), 8.22 (d, <i>J</i> = 9.2 Hz, 1H), 8.05 (d, <i>J</i> = 9.1 Hz, 1H), 7.90 (d, <i>J</i> = 5.6 Hz, 1H), 7.74 (s, 1H), 7.12 (s, 1H), 6.41 (s, 1H), 6.36 (s, 1H), 4.96 (t, <i>J</i> = 6.4 Hz, 2H), 4.29 (dd, <i>J</i> = 7.8, 5.0 Hz, 1H), 4.20 (t, <i>J</i> = 4.7 Hz, 2H), 4.10 (s, 3H), 4.08 (s, 3H), 3.95 (d, <i>J</i> = 2.1 Hz, 3H), 3.79 (dd, <i>J</i> = 5.4, 3.7 Hz, 2H), 3.50 (t, <i>J</i> = 6.0 Hz, 2H), 3.26–3.19 (m, 4H), 3.10–3.05 (m, 1H), 2.80 (dd, <i>J</i> = 12.4, 5.1 Hz, 1H), 2.56 (d, <i>J</i> = 12.4 Hz, 1H), 2.07 (t, <i>J</i> = 7.4 Hz, 2H), 1.63–1.27 (m, 6H); <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 174.7, 164.6, 151.5, 150.5, 149.6, 145.0, 144.3, 138.3, 133.8, 128.6, 126.6, 123.0, 121.8, 119.9, 119.3, 112.1, 108.8, 69.2, 68.7, 68.5, 62.8, 61.1, 60.1, 56.2, 55.9, 55.6, 55.5, 39.6, 38.1, 35.3, 28.3, 28.0, 26.3, 25.4; HRMS: calcd for C<sub>34</sub>H<sub>43</sub>N<sub>4</sub>O<sub>7</sub>SCl, [M – Cl]<sup>+</sup> 651.2847; found, 651.2850.</div><div class="NLM_p">3-(2-(2-(2-(Biotinyl)amino)ethoxy)ethoxy)ethoxy-2,9,10-trimethoxyprotoberberine chloride (<b>11d</b>): Yellow solid, yield: 51%; mp: 94–96 °C (dec.); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.90 (s, 1H), 9.06 (s, 1H), 8.22 (d, <i>J</i> = 9.1 Hz, 1H), 8.04 (d, <i>J</i> = 9.1 Hz, 1H), 7.86 (t, <i>J</i> = 5.7 Hz, 1H), 7.73 (s, 1H), 7.12 (s, 1H), 6.41 (s, 1H), 6.36 (s, 1H), 4.95 (t, <i>J</i> = 6.4 Hz, 2H), 4.29 (dd, <i>J</i> = 7.8, 5.0 Hz, 1H), 4.25–4.15 (m, 2H), 4.12 (d, <i>J</i> = 4.8 Hz, 1H), 4.10 (s, 3H), 4.08 (s, 3H), 3.95 (s, 3H), 3.83–3.75 (m, 2H), 3.64–3.60 (m, 2H), 3.56–3.53 (m, 2H), 3.45–3.40 (m, 2H), 3.25–3.15 (m, 4H), 3.10–3.05 (m, 1H), 2.80 (dd, <i>J</i> = 12.5, 5.1 Hz, 1H), 2.56 (d, <i>J</i> = 12.4 Hz, 1H), 2.06 (t, <i>J</i> = 7.4 Hz, 2H), 1.64–1.21 (m, 6H); <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 174.6, 164.5, 151.6, 150.5, 149.6, 144.9, 144.3, 138.3, 133.8, 128.5, 126.6, 123.0, 121.8, 119.9, 119.3, 112.2, 108.8, 70.4, 69.8, 69.2, 69.1, 68.5, 61.9, 61.1, 60.1, 56.2, 55.9, 55.6, 55.6, 39.6, 38.9, 35.2, 28.3, 28.0, 26.4, 25.4; HRMS: calcd for C<sub>36</sub>H<sub>47</sub>N<sub>4</sub>O<sub>8</sub>SCl, [M – Cl]<sup>+</sup> 695.3109; found, 651.3123.</div><div class="NLM_p">2,3,10-Methylenedioxy-9-(3-((biotinyl)amino)propoxy)protoberberine chloride (<b>15a</b>): Yellow solid, yield: 31%; mp: 139–141 °C (dec.); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.90 (s, 1H), 9.02 (s, 1H), 8.18 (d, <i>J</i> = 9.1 Hz, 1H), 8.04 (t, <i>J</i> = 5.7 Hz, 1H), 8.00 (d, <i>J</i> = 9.0 Hz, 1H), 7.70 (s, 1H), 7.09 (s, 1H), 6.37 (s, 1H), 6.33 (s, 1H), 5.00 (t, <i>J</i> = 6.5 Hz, 2H), 4.30–4.21 (m, 3H), 4.03 (s, 4H), 3.91 (s, 3H), 3.85 (s, 3H), 3.38–3.34 (m, 1H), 3.22 (t, <i>J</i> = 6.5 Hz, 2H), 3.00–2.94 (m, 1H), 2.72 (dd, <i>J</i> = 12.4, 5.1 Hz, 1H), 2.52–2.48 (m, 2H), 2.08 (t, <i>J</i> = 7.3 Hz, 2H), 1.99–1.91 (m, 2H), 1.60–1.17 (m, 6H); <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 174.7, 164.5, 152.3, 150.5, 149.4, 145.2, 143.2, 138.3, 133.8, 128.7, 126.3, 123.0, 122.0, 119.8, 119.0, 110.8, 108.5, 70.9, 61.9, 60.1, 56.1, 55.93, 55.57(2), 55.25, 39.5, 35.3, 35.3, 29.9, 28.3, 28.1, 26.4, 25.4; HRMS: calcd for C<sub>33</sub>H<sub>41</sub>N<sub>4</sub>O<sub>6</sub>SCl, [M – Cl]<sup>+</sup> 621.2741; found, 621.2744.</div><div class="NLM_p">2,3,10-Methylenedioxy-9-((5-((biotinyl)amino)pentyl)oxy)protoberberine chloride (<b>15b</b>): Yellow solid, yield: 35%; mp: 156–158 °C (dec.); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.74 (s, 1H), 9.04 (s, 1H), 8.17 (d, <i>J</i> = 9.0 Hz, 1H), 8.00 (d, <i>J</i> = 9.1 Hz, 1H), 7.85 (t, <i>J</i> = 5.5 Hz, 1H), 7.70 (s, 1H), 7.08 (s, 1H), 6.38 (s, 1H), 6.33 (s, 1H), 4.97 (t, <i>J</i> = 6.4 Hz, 2H), 4.28–4.23 (m, 3H), 4.09–4.05 (m, 1H), 4.03 (s, 3H), 3.91 (s, 3H), 3.85 (s, 3H), 3.21 (t, <i>J</i> = 6.4 Hz, 2H), 3.06 (d, <i>J</i> = 5.9 Hz, 2H), 3.05–2.99 (m, 1H), 2.79–2.70 (m, 1H), 2.52 (d, <i>J</i> = 12.4 Hz, 1H), 2.03 (t, <i>J</i> = 7.4 Hz, 2H), 1.91–1.81 (m, 2H), 1.61–1.19 (m, 10H); <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 174.5, 164.5, 152.3, 150.5, 149.4, 144.7, 143.5, 138.3, 133.8, 128.6, 126.4, 122.9, 122.1, 119.9, 119.1, 110.8, 108.5, 74.18, 61.9, 60.1, 56.1, 56.0, 55.6 (2), 55.2, 39.6, 38.6, 35.4, 29.3, 28.88, 28.3, 28.1, 26.4, 25.53, 22.9; HRMS: calcd for C<sub>35</sub>H<sub>45</sub>N<sub>4</sub>O<sub>6</sub>SCl, [M – Cl]<sup>+</sup> 649.3054; found, 649.3051.</div><div class="NLM_p">2,3,10-Methylenedioxy-9-(2-(2-((biotinyl)amino)ethoxy)ethoxy)protoberberine chloride (<b>15c</b>): Yellow solid, yield: 23%; mp: 116–118 °C (dec.); <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.75 (s, 1H), 9.05 (s, 1H), 8.18 (d, <i>J</i> = 9.1 Hz, 1H), 8.02 (d, <i>J</i> = 9.1 Hz, 1H), 7.88 (t, <i>J</i> = 5.7 Hz, 1H), 7.70 (s, 1H), 7.09 (s, 1H), 6.36 (s, 1H), 6.34 (s, 1H), 4.96 (t, <i>J</i> = 6.4 Hz, 2H), 4.45–4.36 (m, 2H), 4.25 (dd, <i>J</i> = 7.8, 5.0 Hz, 1H), 4.10–4.05 (m, 1H), 4.04 (s, 2H), 3.92 (s, 3H), 3.85 (s, 3H), 3.82–3.73 (m, 2H), 3.44 (t, <i>J</i> = 6.1 Hz, 2H), 3.22 (t, <i>J</i> = 6.4 Hz, 2H), 3.19–3.13 (m, 2H), 3.05–2.98 (m, 1H), 2.78–2.71 (m, 1H), 2.53 (d, <i>J</i> = 12.4 Hz, 1H), 2.00 (t, <i>J</i> = 7.4 Hz, 2H), 1.43–1.21 (m, 6H); <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 174.6, 164.5, 152.3, 150.7, 149.4, 145.1, 143.0, 138.4, 133.7, 128.6, 126.2, 123.3, 122.3, 119.9, 119.0, 110.8, 108.5, 73.0, 69.6, 69.1, 61.8, 61.2, 60.1, 56.2, 56.1, 55.5, 55.5, 55.2, 39.5, 38.8, 35.2, 28.2, 28.0, 26.4, 25.3; HRMS: calcd for C<sub>34</sub>H<sub>43</sub>N<sub>4</sub>O<sub>7</sub>SCl, [M – Cl]<sup>+</sup> 651.2847; found, 651.2842.</div><div class="NLM_p">2,3,10-Methylenedioxy-(9-(2-(2-(2-(biotinyl)amino)ethoxy)ethoxy)ethoxy)protoberberine chloride (<b>15d</b>): Yellow solid, yield: 45%. mp: 41–42 °C; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.75 (s, 1H), 9.04 (s, 1H), 8.18 (d, <i>J</i> = 9.0 Hz, 1H), 8.02 (d, <i>J</i> = 9.0 Hz, 1H), 7.81 (t, <i>J</i> = 5.6 Hz, 1H), 7.70 (s, 1H), 7.08 (s, 1H), 6.37 (s, 1H), 6.34 (s, 1H), 4.92 (t, <i>J</i> = 6.4 Hz, 2H), 4.41–4.37 (m, 2H), 4.26 (dd, <i>J</i> = 7.7, 5.1 Hz, 1H), 4.09–4.06 (m, 1H), 4.04 (s, 3H), 3.92 (s, 3H), 3.85 (s, 3H), 3.81–3.76 (m, 2H), 3.57 (dd, <i>J</i> = 5.9, 3.6 Hz, 2H), 3.48 (dd, <i>J</i> = 5.8, 3.6 Hz, 2H), 3.34–3.32 (m, 2H), 3.22 (t, <i>J</i> = 6.4 Hz, 2H), 3.13–3.09 (m, 2H), 3.05–3.01 (m, 1H), 2.79–2.74 (m, 1H), 2.53 (d, <i>J</i> = 12.4 Hz, 1H), 1.99 (t, <i>J</i> = 7.4 Hz, 2H), 1.61–1.17 (m, 6H); <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 174.5, 164.5, 152.3, 150.8, 149.4, 145.3, 142.9, 138.3, 133.7, 128.6, 126.2, 123.4, 122.4, 119.9, 119.0, 110.8, 108.5, 72.9, 69.7, 69.7, 68.9, 61.9, 60.1, 56.1, 56.1, 55.6 (2), 55.3, 47.9, 39.6, 38.6, 35.2, 28.3, 28.0, 26.4, 25.3; HRMS: calcd for C<sub>35</sub>H<sub>45</sub>N<sub>4</sub>O<sub>6</sub>SCl, [M – Cl]<sup>+</sup> 649.3054; found, 649.3051.</div><div class="NLM_p last">2,3-Methylenedioxy-(9-(2-(2-(2-(2-(prop-2-yn-1-yloxy)ethoxy)-4-(3-(trifluoromethyl)-3H-diazirin-3-yl)benzamido)ethoxy)ethoxy)ethoxy)-10-methoxyprotoberberine chloride (<b>16</b>): Starting from commercially available <i>m</i>-bromoanisoles, the key intermediate <b>PAL</b><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> was condensed with <b>7d</b> to obtain <b>16</b> using a procedure similar to that of <b>8d</b> as a yellow solid. Yield: 32%. mp: 85–87 °C (dec.), <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.84 (d, <i>J</i> = 2.6 Hz, 1H), 8.90 (d, <i>J</i> = 2.5 Hz, 1H), 8.21 (t, <i>J</i> = 5.7 Hz, 1H), 8.14 (d, <i>J</i> = 9.1 Hz, 1H), 7.91 (dd, <i>J</i> = 9.2, 2.0 Hz, 1H), 7.84 (d, <i>J</i> = 8.2 Hz, 1H), 7.75 (s, 1H), 7.05 (s, 1H), 7.00 (d, <i>J</i> = 8.1 Hz, 1H), 6.76 (d, <i>J</i> = 1.7 Hz, 1H), 6.15 (s, 2H), 4.90 (t, <i>J</i> = 6.4 Hz, 2H), 4.44–4.37 (m, 2H), 4.30–4.24 (m, 2H), 4.22 (d, <i>J</i> = 2.4 Hz, 2H), 4.10 (s, 3H), 3.86–3.81 (m, 2H), 3.80 (dd, <i>J</i> = 5.4, 3.6 Hz, 2H), 3.62 (dd, <i>J</i> = 5.9, 3.4 Hz, 2H), 3.55 (dd, <i>J</i> = 5.8, 3.5 Hz, 2H), 3.48 (t, <i>J</i> = 6.0 Hz, 2H), 3.47–3.44 (m, 1H), 3.38 (q, <i>J</i> = 5.9 Hz, 2H), 3.17 (t, <i>J</i> = 6.3 Hz, 2H). <sup>13</sup>C NMR (151 MHz): δ 164.0, 156.8, 150.2, 149.8, 148.1, 145.8, 144.4, 138.0, 133.6, 132.1, 131.8, 131.1, 128.4, 124.9, 123.5, 122.1, 121.8, 120.8, 120.5, 119.5, 111.8, 108.8, 105.8, 102.5, 80.4, 77.9 (2), 70.3, 70.1, 69.5, 69.3, 69.2, 68.8, 67.6, 62.2, 58.0, 55.5, 40.4, 26.7. HRMS: calcd for C<sub>39</sub>H<sub>38</sub>O<sub>9</sub>N<sub>4</sub>F<sub>3</sub>Cl, [M – Cl]<sup>+</sup> 763.2585; found, 763.2585.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Biological Evaluation</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Mice</h4><div class="NLM_p last">C57BL/6J mice free of specific pathogens were purchased from SPF (Beijing) Biotechnology Co., Ltd. and maintained under a 12 h light cycle (from 07:00 a.m. to 07:00 p.m.). All animal experiment protocols were approved by the Animal Care and Use Committee at NIFDC, Beijing, China. Animal experiments were approved by the Ethics Committee of the Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing China, with the approval number IBM20190510D301.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Reagents</h4><div class="NLM_p last">Anti-IL-1β and anticaspase1 were purchased from R&D Systems; anticleaved caspase1, anti-NLRP3, anti-Flag, anti-HA, anti-EGFP, anti-GAPDH, and antitubulin were purchased from Cell Signaling Technology; and anti-ASC, anti-NEK7, anti-ATPG, anti-UCK2, and recombinant NEK7 were purchased from Abcam. Protein G agarose, ultrapure LPS, nigericin, and CuSO<sub>4</sub> were obtained from Sigma-Aldrich. The human IL-1β ELISA kit and the mouse IL-1β ELISA kit were purchased from Boster Biological Technology. AntiFlag magnetic beads and anti-HA magnetic beads were purchased from Bimake. Pierce Streptavidin Magnetic Beads were purchased from Thermo Fisher Scientific. Cy3-azide and biotin-azide were purchased from Lumiprobe Corporation, and tris(2-carboxyethyl)phosphine (TCEP) and tris[(1-benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]amine (TBTA) were purchased from J&K Scientific.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Cell Preparation and Stimulation</h3><div class="NLM_p">BMDMs were isolated from 6–8-week-old mouse bone marrow and cultured for 6 to 7 days in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% FBS and 30% supernatant from L929 cells. HEK-293T and L929 cells were cultured in DMEM with 10% FBS. THP-1 cells were cultured in Roswell Park Memorial Institute medium (RPMI) with 10% FBS and differentiated for 24–48 h with 50 nM PMA before stimulation.</div><div class="NLM_p last">For the induction of inflammasome activation, PMA-THP-1 cells were plated in 6-well plates and primed for 3 h with ultrapure LPS (1 μg/mL) with or without BBR pretreatment. Then, the cells were stimulated for 30 min with nigericin (5 μM). Cells were transfected with poly(dA:dT) (1 μg) for 8 h using Lipofectamine 2000 with or without BBR pretreatment. The cells were stimulated with <i>Salmonella typhimurium</i> (multiplicity of infection, MOI 100) for 12 h with or without BBR pretreatment. BMDMs were plated in 6-well plates and primed for 1 h with ultrapure LPS (1 μg/mL). After that, BBR was added to the culture for another 2 h and then the cells were stimulated for 30 min with nigericin (5 μM). Cell extracts and precipitated supernatants were analyzed by immunoblot and ELISA.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Plasmid Construction</h3><div class="NLM_p last">The EGFP-NLRP3 plasmid was purchased from Addgene, and the Flag-NEK7 plasmid was purchased from Sino Biological. Restriction enzymes were purchased from TaKaRa. PCRs were performed using PrimeSTAR Max DNA Polymerase (TaKaRa), and gene mutation was performed using the QuikChange Lightning site-directed mutagenesis kit (Agilent). The deletion mutation of NEK7 was amplified by PCR using Flag-NEK7 as a template. HA-NLRP3 was amplified by PCR using EGFP-NLRP3 as a template. All primer sequences used are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_001.pdf" class="ext-link">Supporting Information</a> Table 2.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Cell Impedance Assay</h3><div class="NLM_p last">PMA-THP-1 cells were freshly plated at 1 × 10<sup>4</sup>/well in E16 plates (Roche Diagnostics, Basel, Switzerland). The plate was connected to a xCELLigence RTCA SP instrument (Roche Diagnostics) within a humidified cell culture incubator. After 24 h of incubation, cells were treated with BBR. Data were analyzed using RTCA software 1.2 program (Roche Diagnostics). All data are presented as the mean normalized cellular index ± standard error of the mean (SEM) over time.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Protein Labeling and Pull-Down</h3><div class="NLM_p last">The probe or DMSO was incubated with Pierce Streptavidin Magnetic Beads for 2 h at room temperature. The immobilized beads were washed three times with TBS-T buffer. PMA-THP-1 cells were lysed using HEPES buffer (25 mM HEPES, pH 7.5, 150 mM NaCl, 2 mM MgCl<sub>2</sub>) containing 1% NP-40. The protein concentration was determined by the Bradford protein assay (Bio-Rad USA). Then, the lysates were incubated with immobilized beads for 2 h at room temperature. After washing five times with TBS-T, the beads were mixed with 1 × SDS loading buffer, followed by boiling at 95 °C for 10 min. Samples were resolved on a 10% SDS-PAGE gel and silver-stained using the Pierce Silver Stain for Mass Spectrometry kit (Thermo Fisher).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> LC–MS/MS Analysis</h3><div class="NLM_p last">The target bands were identified by a gel-based LC–MS/MS approach (Beijing Qinglian Biotech Co., Ltd., China). MS data were analyzed using MaxQuant software (version 1.5.3.30) with the UniProtKB/Swiss-Prot human database.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>In Situ</i> Labeling of PMA-THP-1 Cells</h3><div class="NLM_p last">For <i>in situ</i> labeling, cells were grown to 80–90% confluence in 6-well plates under the conditions described above. The medium was removed, the cells were washed twice with PBS, and then treated with 2 mL of growth medium containing the probe in the presence or absence of excess BBR (100 μM). After 8 h of incubation at 37 °C/5% CO<sub>2</sub>, the medium was aspirated, and the cells were gently washed twice with PBS to remove the excessive probe followed by UV irradiation (∼365 nm) for 30 min. The cells were then lysed and pelleted by centrifugation, and the protein concentrations were determined. Equal amounts of samples with different treatments were used for flagging or biotin tagging. For each click reaction, SDS (0.1%), TCEP (1 mM), CuSO<sub>4</sub> (1 mM), TBTA (100 μM), and Cy3-azide or biotin-azide (100 μM) were sequentially added to the lysates. Samples were incubated at room temperature for 3 h. Next, the labeled proteins were precipitated with acetone. For fluorescence detection, the samples were dissolved in 1 × SDS loading buffer, followed by boiling at 95 °C for 10 min. For immunoblot detection, the samples were dissolved in HEPES buffer with 1% SDS and incubated with washed beads for 2 h at room temperature. After washing five times with TBS-T, the beads were mixed with 1 × SDS loading buffer, followed by boiling at 95 °C for 10 min. Samples were detected by gel fluorescence or immunoblot blot assay (Tanon 5200 system, Tanon, Shanghai, China).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> NEK7 ATPase Activity</h3><div class="NLM_p last">Purified recombinant human NEK7 (Abcam) was incubated at 37 °C with different concentrations of BBR for 15 min in a reaction buffer. ATP and substrate were then added, and the mixture was further incubated at 37 °C for another 40 min. The amount of ATP converted into adenosine diphosphate (ADP) was determined by luminescent ADP detection with an ADP-Glo Kinase Assay kit (Promega) according to the manufacturer’s protocol.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Surface-Plasmon Resonance Assay</h3><div class="NLM_p last">The SPR assay was performed on a BIAcore T200 biosensor system (GE Healthcare Life Sciences, Piscataway, NJ, USA) at 25 °C using a CM5 chip. The binding of NEK7 at different concentrations of BBR was performed in 1 × PBS-P+ (GE Healthcare Life Sciences) at a flow rate of 20 μL/min for 120 s. After each binding reaction, a further dissociation time of 60 s was applied after each injection to allow the signal to return to the baseline.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Co-IP Assay</h3><div class="NLM_p last">For the endogenous interaction assay, PMA-THP-1 cells were stimulated and lysed with HEPES lysis buffer with protease inhibitors. The cell lysates were incubated overnight at 4 °C with primary antibodies and Protein G agarose (Sigma-Aldrich). The proteins bound by the antibody were pulled down and subjected to immunoblotting analysis. For the exogenous interaction assay, HEK-293T cells were transfected with plasmids in 6-well plates. After 6 h, the cells were treated with or without BBR for another 24 h, and then the cells were collected and lysed with HEPES lysis buffer with protease inhibitors. Extracts were immunoprecipitated with anti-Flag or anti-HA beads (Bimake) and then assessed by immunoblot analysis.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Molecular Modeling Analysis</h3><div class="NLM_p last">An automated docking study was carried out with the 3D structure of NEK7 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2%2520WQN">2 WQN</a>) using Discovery Studio 4.5 software. The regularized protein was used to determine the important amino acids in the predicted binding pocket. Interactive docking using the LibDock protocol was carried out for all conformers of the ligand BBR to the selected active site after energy minimization using the prepared ligand protocol. The docked compound was assigned a score according to its binding mode onto the binding site.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> ASC Oligomerization Assay</h3><div class="NLM_p last">Briefly, the treated cells were lysed in ice-cold buffer A (20 mM HEPES-KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl<sub>2</sub>, 1 mM EDTA, 1 mM EGTA, and 320 mM sucrose) by shearing through a 21-gauge needle. The supernatants were diluted in a 1:1 ratio with buffer A, mixed with 1 volume of CHAPS buffer (20 mM HEPES–KOH, pH 7.5, 5 mM MgCl<sub>2</sub>, 0.5 mM EGTA, 0.1 mM phenylmethylsulfonyl fluoride, 0.1% CHAPS) and centrifuged to pellet ASC oligomers. The pellets were resuspended in CHAPS buffer containing 4 mM disuccinimidyl suberate to cross-link proteins. The supernatant was discarded and pellets were assessed by immunoblot analysis.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Immunofluorescence</h3><div class="NLM_p last">PMA<b>-</b>THP-1 cells were plated in 24-well plates and stimulated as described previously. Following treatment, cells were fixed with 4% paraformaldehyde and permeabilized with 0.3% Triton X-100. After blocking with 1% BSA for 1 h, cells were stained with ASC antibodies overnight at 4 °C. After three washes with PBS, cells were stained with Alexa Fluor 484 secondary antibodies (Abcam) for another hour. Hoechst was used to stain nuclei. Images were recorded on a fluorescence microscope (AxioVert.A1; Carl Zeiss, Oberkochen, Germany).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Adv Knockdown</h3><div class="NLM_p last">The mice were transfected with adenovirus (Adv-shNEK7-GFP) to knock down <i>NEK7</i> (targeting sequence: TGGAGTGCCGGTAGCGTTAAA<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a>) and adenovirus-expressing GFP (Adv-GFP) as a mock control. Adv-shNEK7-GFP and Adv-GFP were purchased from GenePharma (Shanghai, China). Briefly, 50 μL of Adv (10<sup>11</sup> pfu/mL) was injected into mice <i>via</i> the tail vein.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> LPS-Induced Acute Inflammation in Mice</h3><div class="NLM_p last">Ten-week-old male C57BL/6 mice were injected i.p. with BBR (5 mg/kg) or saline three times every 12 h before the i.p. injection of LPS (30 mg/kg). After 3 h, mice were sacrificed, and blood and tissues were obtained and detected by ELISA or HE staining.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Statistical Analyses</h3><div class="NLM_p last">All values are expressed as mean and SEM. Statistical analysis was performed by one-way ANOVA using SPSS 16.0 with all data points showing a normal distribution, *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001. No exclusion of data points was performed. The researchers were not blinded to the distribution of treatment groups when performing experiments and data assessment. Sample sizes were selected on the basis of preliminary results to ensure adequate power.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01743" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01743?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01743</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Results of IL-1β release inhibition, cytotoxicity of BBR, structures of bio-BBR probes, LC–MS/MS analyses of <b>8d</b>, docking for NEK7 and BBR, pathological examinations, spectra (<sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS, and HPLC) of compounds, target identification, and sequences of primers (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES spreadsheet and molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Docking BBR to NEK7 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Docking ADP to NEK7 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_004.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_001.pdf">jm0c01743_si_001.pdf (1.47 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_002.csv">jm0c01743_si_002.csv (1.96 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_003.pdb">jm0c01743_si_003.pdb (362.16 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_004.pdb">jm0c01743_si_004.pdb (336.03 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01743" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78137" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78137" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yanxiang Wang</span> - <span class="hlFld-Affiliation affiliation">Institute of Medicinal Biotechnology,
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9124-071X" title="Orcid link">http://orcid.org/0000-0001-9124-071X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6a1d0b040d130b0412030b040d2a030708441a1f0709440f0e1f440904"><span class="__cf_email__" data-cfemail="bfc8ded1d8c6ded1c7d6ded1d8ffd6d2dd91cfcad2dc91dadbca91dcd1">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Danqing Song</span> - <span class="hlFld-Affiliation affiliation">Institute of Medicinal Biotechnology,
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2557-5009" title="Orcid link">http://orcid.org/0000-0002-2557-5009</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2a5945444d4e4b445b43444d594e5b6a42455e474b434604494547"><span class="__cf_email__" data-cfemail="f88b97969f9c99968991969f8b9c89b890978c95999194d69b9795">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qingxuan Zeng</span> - <span class="hlFld-Affiliation affiliation">Institute of Medicinal Biotechnology,
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongbin Deng</span> - <span class="hlFld-Affiliation affiliation">Institute of Medicinal Biotechnology,
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yinghong Li</span> - <span class="hlFld-Affiliation affiliation">Institute of Medicinal Biotechnology,
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tianyun Fan</span> - <span class="hlFld-Affiliation affiliation">Institute of Medicinal Biotechnology,
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yang Liu</span> - <span class="hlFld-Affiliation affiliation">Institute of Medicinal Biotechnology,
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sheng Tang</span> - <span class="hlFld-Affiliation affiliation">Institute of Medicinal Biotechnology,
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Wei</span> - <span class="hlFld-Affiliation affiliation">Institute of Medicinal Biotechnology,
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaojia Liu</span> - <span class="hlFld-Affiliation affiliation">Institute of Medicinal Biotechnology,
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xixi Guo</span> - <span class="hlFld-Affiliation affiliation">Institute of Medicinal Biotechnology,
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiandong Jiang</span> - <span class="hlFld-Affiliation affiliation">Institute of Medicinal Biotechnology,
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Q.Z., H.D., and Y.L. made equal contributions to the work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the CAMS Initiative for Innovative Medicine (2016-I2M-1-011) and the Drug Innovation Major Project (2018ZX09711-001).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ABPP</td><td class="NLM_def"><p class="first last">activity-based protein profiling</p></td></tr><tr><td class="NLM_term">Adv</td><td class="NLM_def"><p class="first last">adenovirus</p></td></tr><tr><td class="NLM_term">BBR</td><td class="NLM_def"><p class="first last">berberine</p></td></tr><tr><td class="NLM_term">BMDMs</td><td class="NLM_def"><p class="first last">bone marrow-derived macrophages</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">enzyme-linked immunosorbent assay</p></td></tr><tr><td class="NLM_term">IL-1β</td><td class="NLM_def"><p class="first last">interleukin-1β</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">NEK7</td><td class="NLM_def"><p class="first last">NIMA-related kinase 7</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor-κB</p></td></tr><tr><td class="NLM_term">NLRP3</td><td class="NLM_def"><p class="first last">nucleotide-binding domain-like receptor protein 3</p></td></tr><tr><td class="NLM_term">PMA</td><td class="NLM_def"><p class="first last">phorbol 12-myristate 13-acetate</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SDS-PAGE</td><td class="NLM_def"><p class="first last">SDS-polyacrylamide gel electrophoresis</p></td></tr><tr><td class="NLM_term">THP-1</td><td class="NLM_def"><p class="first last">human monocytic cell line-1</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 55 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span> <span> </span><span class="NLM_article-title">Learning from berberine: Treating chronic diseases through multiple targets</span>. <i>Sci. China: Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">854</span>– <span class="NLM_lpage">859</span>, <span class="refDoi"> DOI: 10.1007/s11427-013-4568-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1007%2Fs11427-013-4568-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=24174332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSlsr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=854-859&author=J.+Yaoauthor=W.+Kongauthor=J.+Jiang&title=Learning+from+berberine%3A+Treating+chronic+diseases+through+multiple+targets&doi=10.1007%2Fs11427-013-4568-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Learning from berberine: Treating chronic diseases through multiple targets</span></div><div class="casAuthors">Yao, Jing; Kong, WeiJia; Jiang, JianDong</div><div class="citationInfo"><span class="NLM_cas:title">Science China: Life Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">854-859</span>CODEN:
                <span class="NLM_cas:coden">SCLSCJ</span>;
        ISSN:<span class="NLM_cas:issn">1674-7305</span>.
    
            (<span class="NLM_cas:orgname">Science China Press</span>)
        </div><div class="casAbstract">Although advances have been made, chemotherapy for chronic, multifactorial diseases such as cancers, Alzheimer's disease, cardiovascular diseases and diabetes is far from satisfactory.  Agents with different mechanisms of action are required.  The botanic compd. berberine (BBR) has been used as an over-the-counter antibacterial for diarrhea in China for many decades.  Recent clin. studies have shown that BBR may be therapeutic in various types of chronic diseases.  This review addresses BBR's mol. mechanisms of action and clin. efficacy and safety in patients with type 2 diabetes, hyperlipidemia, heart diseases, cancers and inflammation.  One of the advantages of BBR is its multiple-target effects in each of these diseases.  The therapeutic efficacy of BBR may reflect a synergistic regulation of these targets, resulting in a comprehensive effect against these various chronic disorders.  The safety of BBR may be due to its harmonious distribution into those targets.  Although the single-target concept is still the principle for drug discovery and research, this review emphasizes the concept of a multiple target strategy, which may be an important approach toward the successful treatment of multifactorial chronic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVDNoyh8G5D7Vg90H21EOLACvtfcHk0lieMbcC3WNYVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSlsr7N&md5=a65a056b9c6a1fddfca5b991e0480020</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs11427-013-4568-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11427-013-4568-z%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DJ.%26atitle%3DLearning%2520from%2520berberine%253A%2520Treating%2520chronic%2520diseases%2520through%2520multiple%2520targets%26jtitle%3DSci.%2520China%253A%2520Life%2520Sci.%26date%3D2015%26volume%3D58%26spage%3D854%26epage%3D859%26doi%3D10.1007%2Fs11427-013-4568-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heidarian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafieian-Kopaei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoshdel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakhshesh, M.</span></span> <span> </span><span class="NLM_article-title">Metabolic effects of berberine on liver phosphatidate phosphohydrolase in rats fed on high lipogenic diet: an additional mechanism for the hypolipidemic effects of berberine</span>. <i>Asian Pac. J. Trop. Biomed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">S429</span>– <span class="NLM_lpage">S435</span>, <span class="refDoi"> DOI: 10.12980/apjtb.4.2014c474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.12980%2FAPJTB.4.2014C474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=25183123" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=S429-S435&author=E.+Heidarianauthor=M.+Rafieian-Kopaeiauthor=A.+Khoshdelauthor=M.+Bakhshesh&title=Metabolic+effects+of+berberine+on+liver+phosphatidate+phosphohydrolase+in+rats+fed+on+high+lipogenic+diet%3A+an+additional+mechanism+for+the+hypolipidemic+effects+of+berberine&doi=10.12980%2Fapjtb.4.2014c474"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.12980%2FAPJTB.4.2014C474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12980%252FAPJTB.4.2014C474%26sid%3Dliteratum%253Aachs%26aulast%3DHeidarian%26aufirst%3DE.%26aulast%3DRafieian-Kopaei%26aufirst%3DM.%26aulast%3DKhoshdel%26aufirst%3DA.%26aulast%3DBakhshesh%26aufirst%3DM.%26atitle%3DMetabolic%2520effects%2520of%2520berberine%2520on%2520liver%2520phosphatidate%2520phosphohydrolase%2520in%2520rats%2520fed%2520on%2520high%2520lipogenic%2520diet%253A%2520an%2520additional%2520mechanism%2520for%2520the%2520hypolipidemic%2520effects%2520of%2520berberine%26jtitle%3DAsian%2520Pac.%2520J.%2520Trop.%2520Biomed.%26date%3D2014%26volume%3D4%26spage%3DS429%26epage%3DS435%26doi%3D10.12980%2Fapjtb.4.2014c474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, T.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, D.-Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Identification of Novel Berberine Derivatives as Potent Inhibitors against TNF-α-Induced NF-κB Activation</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1257</span>, <span class="refDoi"> DOI: 10.3390/molecules22081257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.3390%2Fmolecules22081257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1ektLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1257&author=Y.-X.+Wangauthor=L.+Liuauthor=Q.-X.+Zengauthor=T.-Y.+Fanauthor=J.-D.+Jiangauthor=H.-B.+Dengauthor=D.-Q.+Song&title=Synthesis+and+Identification+of+Novel+Berberine+Derivatives+as+Potent+Inhibitors+against+TNF-%CE%B1-Induced+NF-%CE%BAB+Activation&doi=10.3390%2Fmolecules22081257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and identification of novel berberine derivatives as potent inhibitors against TNF-α-induced NF-κB activation</span></div><div class="casAuthors">Wang, Yan-Xiang; Liu, Lu; Zeng, Qing-Xuan; Fan, Tian-Yun; Jiang, Jian-Dong; Deng, Hong-Bin; Song, Dan-Qing</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1257/1-1257/14</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Twenty-three new berberine (BBR) analogs contg. substituents on ring D, I [R1 = OMe, NH2, cyclopropanecarbonyloxy, (4-nitrophenyl)sulfonyloxy, etc., R2 = OMe, (adamantan-1-yl)acetoxy, (adamantane-10-carbonyloxy)], were synthesized and evaluated for their activity for suppression of tumor necrosis factor (TNF)-α-induced nuclear factor (NF)-κB activation.  Structure-activity relationship (SAR) anal. indicated that suitable tertiary/quaternary carbon substitutions at the 9-position or a rigid fragment at position 10 might be beneficial for enhancing their anti-inflammatory potency.  Among them, compds. I [R1 = (1-methylcyclohexane-1-carbonyl)oxy, 2-(bicyclo[2.2.1]heptan-2-yl)acetoxy, (2'-propylpentanoyl)oxy, (p-tert-butylbenzoyl)oxy, R2 = OMe] exhibited satisfactory inhibitory potency against NF-κB activation, with an inhibitory rate of around 90% (5 μM), much better than BBR.  A preliminary mechanism study revealed that all of them could inhibit TNF-α-induced NF-κB activation via impairing IκB kinase (IKK) phosphorylation as well as cytokines interleukin (IL)-6 and IL-8 induced by TNF-α.  Therefore, the results provided powerful information on further structural modifications and development of BBR derivs. into a new class of anti-inflammatory candidates for the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsD1huNq0TDrVg90H21EOLACvtfcHk0lipqiTlTfU7SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1ektLnN&md5=098585ac3341d2b4684d21a0aebe7fc3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22081257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22081257%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-X.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DQ.-X.%26aulast%3DFan%26aufirst%3DT.-Y.%26aulast%3DJiang%26aufirst%3DJ.-D.%26aulast%3DDeng%26aufirst%3DH.-B.%26aulast%3DSong%26aufirst%3DD.-Q.%26atitle%3DSynthesis%2520and%2520Identification%2520of%2520Novel%2520Berberine%2520Derivatives%2520as%2520Potent%2520Inhibitors%2520against%2520TNF-%25CE%25B1-Induced%2520NF-%25CE%25BAB%2520Activation%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D1257%26doi%3D10.3390%2Fmolecules22081257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span> <span> </span><span class="NLM_article-title">Cardiovascular actions of berberine</span>. <i>Cardiovasc. Drug Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1111/j.1527-3466.2001.tb00068.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1111%2Fj.1527-3466.2001.tb00068.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=11607041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD38XktFKntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=234-244&author=C.+W.+Lauauthor=X.+Q.+Yaoauthor=Z.+Y.+Chenauthor=W.+H.+Koauthor=Y.+Huang&title=Cardiovascular+actions+of+berberine&doi=10.1111%2Fj.1527-3466.2001.tb00068.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular actions of berberine</span></div><div class="casAuthors">Lau, Chi-Wai; Yao, Xiao-Qiang; Chen, Zhen-Yu; Ko, Wing-Hung; Huang, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Drug Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">234-244</span>CODEN:
                <span class="NLM_cas:coden">CDREEA</span>;
        ISSN:<span class="NLM_cas:issn">0897-5957</span>.
    
            (<span class="NLM_cas:orgname">Neva Press</span>)
        </div><div class="casAbstract">A review.  Berberine, is an alkaloid from Hydrastis canadensis L., Chinese herb Huanglian, and many other plants.  It is widely used in traditional Chinese medicine as an antimicrobial in the treatment of dysentery and infectious diarrhea.  This manuscript describes cardiovascular effects of berberine and its derivs., tetrahydroberberine and 8-oxoberberine.  Berberine has pos. inotropic, neg. chronotropic, antiarrhythmic, and vasodilator properties.  Both derivs. of berberine have antiarrhythmic activity.  Some of cardiovascular effects of berberine and its derivs. are attributed to the blockade of K+ channels (delayed rectifier and KATP) and stimulation of Na+-Ca2+ exchanger.  Berberine has been shown to prolong the duration of ventricular action potential.  Its vasodilator activity has been attributed to multiple cellular mechanisms.  The cardiovascular effects of berberine suggest its possible clin. usefulness in the treatment of arrhythmias and/or heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAAoHvb0M7v7Vg90H21EOLACvtfcHk0lipqiTlTfU7SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktFKntQ%253D%253D&md5=41741fa9c29ae0730f7801bd88b15bc5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3466.2001.tb00068.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3466.2001.tb00068.x%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DC.%2BW.%26aulast%3DYao%26aufirst%3DX.%2BQ.%26aulast%3DChen%26aufirst%3DZ.%2BY.%26aulast%3DKo%26aufirst%3DW.%2BH.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DCardiovascular%2520actions%2520of%2520berberine%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D2001%26volume%3D19%26spage%3D234%26epage%3D244%26doi%3D10.1111%2Fj.1527-3466.2001.tb00068.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, D.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-D.</span></span> <span> </span><span class="NLM_article-title">Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression</span>. <i>Metabolism</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1016/j.metabol.2008.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.metabol.2008.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=19059538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOjurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2009&pages=109-119&author=W.-J.+Kongauthor=H.+Zhangauthor=D.-Q.+Songauthor=R.+Xueauthor=W.+Zhaoauthor=J.+Weiauthor=Y.-M.+Wangauthor=N.+Shanauthor=Z.-X.+Zhouauthor=P.+Yangauthor=X.-F.+Youauthor=Z.-R.+Liauthor=S.-Y.+Siauthor=L.-X.+Zhaoauthor=H.-N.+Panauthor=J.-D.+Jiang&title=Berberine+reduces+insulin+resistance+through+protein+kinase+C-dependent+up-regulation+of+insulin+receptor+expression&doi=10.1016%2Fj.metabol.2008.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression</span></div><div class="casAuthors">Kong, Wei-Jia; Zhang, Hao; Song, Dan-Qing; Xue, Rong; Zhao, Wei; Wei, Jing; Wang, Yue-Ming; Shan, Ning; Zhou, Zhen-Xian; Yang, Peng; You, Xue-Fu; Li, Zhuo-Rong; Si, Shu-Yi; Zhao, Li-Xun; Pan, Huai-Ning; Jiang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-119</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Natural product berberine (BBR) was reported to have hypoglycemic and insulin-sensitizing activities; however, its mechanism remains unclear.  This study was designed to investigate the mol. mechanism of BBR against insulin resistance.  Here, we identify insulin receptor (InsR) as a target of BBR to increase insulin sensitivity.  In cultured human liver cells, BBR increased InsR mRNA and protein expression in a dose- and time-dependent manner.  Berberine increased InsR expression in the L6 rat skeletal muscle cells as well.  Berberine-enhanced InsR expression improved cellular glucose consumption only in the presence of insulin.  Silencing InsR gene with small interfering RNA or blocking the phosphoinositol-3-kinase diminished this effect.  Berberine induced InsR gene expression through a protein kinase C (PKC)-dependent activation of its promoter.  Inhibition of PKC abolished BBR-caused InsR promoter activation and InsR mRNA transcription.  In animal models, treatment of type 2 diabetes mellitus rats with BBR lowered fasting blood glucose and fasting serum insulin, increased insulin sensitivity, and elevated InsR mRNA as well as PKC activity in the liver.  In addn., BBR lowered blood glucose in KK-Ay type 2 but not in NOD/LtJ type 1 diabetes mellitus mice that were insulin deficient.  Our results suggest that BBR is a unique natural medicine against insulin resistance in type 2 diabetes mellitus and metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9ThdnyQdtPbVg90H21EOLACvtfcHk0lipqiTlTfU7SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOjurfL&md5=2c3757c097e4b3b8b49b20466df8977c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2008.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2008.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DW.-J.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSong%26aufirst%3DD.-Q.%26aulast%3DXue%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.-M.%26aulast%3DShan%26aufirst%3DN.%26aulast%3DZhou%26aufirst%3DZ.-X.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DYou%26aufirst%3DX.-F.%26aulast%3DLi%26aufirst%3DZ.-R.%26aulast%3DSi%26aufirst%3DS.-Y.%26aulast%3DZhao%26aufirst%3DL.-X.%26aulast%3DPan%26aufirst%3DH.-N.%26aulast%3DJiang%26aufirst%3DJ.-D.%26atitle%3DBerberine%2520reduces%2520insulin%2520resistance%2520through%2520protein%2520kinase%2520C-dependent%2520up-regulation%2520of%2520insulin%2520receptor%2520expression%26jtitle%3DMetabolism%26date%3D2009%26volume%3D58%26spage%3D109%26epage%3D119%26doi%3D10.1016%2Fj.metabol.2008.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abidi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-D.</span></span> <span> </span><span class="NLM_article-title">Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1344</span>– <span class="NLM_lpage">1351</span>, <span class="refDoi"> DOI: 10.1038/nm1135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fnm1135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=15531889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCisbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1344-1351&author=W.+Kongauthor=J.+Weiauthor=P.+Abidiauthor=M.+Linauthor=S.+Inabaauthor=C.+Liauthor=Y.+Wangauthor=Z.+Wangauthor=S.+Siauthor=H.+Panauthor=S.+Wangauthor=J.+Wuauthor=Y.+Wangauthor=Z.+Liauthor=J.+Liuauthor=J.-D.+Jiang&title=Berberine+is+a+novel+cholesterol-lowering+drug+working+through+a+unique+mechanism+distinct+from+statins&doi=10.1038%2Fnm1135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins</span></div><div class="casAuthors">Kong, Weijia; Wei, Jing; Abidi, Parveen; Lin, Meihong; Inaba, Satoru; Li, Cong; Wang, Yanling; Wang, Zizheng; Si, Shuyi; Pan, Huaining; Wang, Shukui; Wu, Jingdan; Wang, Yue; Li, Zhuorong; Liu, Jingwen; Jiang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1344-1351</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We identify berberine (BBR), a compd. isolated from a Chinese herb, as a new cholesterol-lowering drug.  Oral administration of BBR in 32 hypercholesterolemic patients for 3 mo reduced serum cholesterol by 29%, triglycerides by 35% and LDL-cholesterol by 25%.  Treatment of hyperlipidemic hamsters with BBR reduced serum cholesterol by 40% and LDL-cholesterol by 42%, with a 3.5-fold increase in hepatic LDLR mRNA and a 2.6-fold increase in hepatic LDLR protein.  Using human hepatoma cells, we show that BBR upregulates LDLR expression independent of sterol regulatory element binding proteins, but dependent on ERK activation.  BBR elevates LDLR expression through a post-transcriptional mechanism that stabilizes the mRNA.  Using a heterologous system with luciferase as a reporter, we further identify the 5' proximal section of the LDLR mRNA 3' untranslated region responsible for the regulatory effect of BBR.  These findings show BBR as a new hypolipidemic drug with a mechanism of action different from that of statin drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2ndzFTq9UTLVg90H21EOLACvtfcHk0lgfoO1wARIVfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCisbfK&md5=624ed3ede1279d0da1afcda5a7682360</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnm1135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1135%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DW.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DAbidi%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DInaba%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DSi%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DJ.-D.%26atitle%3DBerberine%2520is%2520a%2520novel%2520cholesterol-lowering%2520drug%2520working%2520through%2520a%2520unique%2520mechanism%2520distinct%2520from%2520statins%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D1344%26epage%3D1351%26doi%3D10.1038%2Fnm1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span> <span> </span><span class="NLM_article-title">Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer’s disease</span>. <i>BMC Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">78</span>, <span class="refDoi"> DOI: 10.1186/1471-2202-7-78</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1186%2F1471-2202-7-78" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=17137520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A280%3ADC%252BD28jhvVCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=78&author=F.+Zhuauthor=C.+Qian&title=Berberine+chloride+can+ameliorate+the+spatial+memory+impairment+and+increase+the+expression+of+interleukin-1beta+and+inducible+nitric+oxide+synthase+in+the+rat+model+of+Alzheimer%E2%80%99s+disease&doi=10.1186%2F1471-2202-7-78"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease</span></div><div class="casAuthors">Zhu Feiqi; Qian Caiyun</div><div class="citationInfo"><span class="NLM_cas:title">BMC neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">78</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Berberine is the major alkaloidal component of Rhizoma coptidis, and has multiple pharmacological effects including inhibiting acetylcholinesterase, reducing cholesterol and glucose, lowering mortality in patients with chronic congestive heart failure and anti-inflammation etc.  Thus berberine is a promising drug for diabetes, hyperlipemia, coronary artery disease and ischemic stroke etc.  The present study was carried out to investigate the effect of berberine chloride on the spatial memory, inflammation factors interleukin-1 beta (IL-1beta) and inducible nitric oxide synthase (iNOS) expression in the rat model of Alzheimer's disease (AD) which was established by injecting Abeta (1-40) (5 microgram) into the rats hippocampuses bilaterally.  RESULTS:  The rats were given berberine chloride (50 mg/kg) by intragastric administration once daily for 14 days.  The spatial memory was assayed by Morris water maze test, IL-1beta and iNOS in the hippocampus were assayed by immunohistochemistry and real time polymerase chain reaction (PCR).  Intragastric administration of berberine significantly ameliorated the spatial memory impairment and increased the expression of IL-1beta, iNOS in the rat model of AD.  CONCLUSION:  Berberine might be beneficial to AD by intragastric administration though it might exaggerate the inflammation reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMRFyXK2nLlrHHuJhbyicZfW6udTcc2eYVQgBXCu_nurntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jhvVCmsA%253D%253D&md5=50b4ad0c040a6ab25aa43d96ae57182e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-7-78&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-7-78%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DF.%26aulast%3DQian%26aufirst%3DC.%26atitle%3DBerberine%2520chloride%2520can%2520ameliorate%2520the%2520spatial%2520memory%2520impairment%2520and%2520increase%2520the%2520expression%2520of%2520interleukin-1beta%2520and%2520inducible%2520nitric%2520oxide%2520synthase%2520in%2520the%2520rat%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBMC%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D78%26doi%3D10.1186%2F1471-2202-7-78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span> <span> </span><span class="NLM_article-title">Suppressive effects of berberine on atherosclerosis via downregulating visfatin expression and attenuating visfatin-induced endothelial dysfunction</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1939</span>– <span class="NLM_lpage">1948</span>, <span class="refDoi"> DOI: 10.3892/ijmm.2018.3440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.3892%2Fijmm.2018.3440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=29393413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFGru7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2018&pages=1939-1948&author=Q.+Wanauthor=Z.+Liuauthor=Y.+Yangauthor=X.+Cui&title=Suppressive+effects+of+berberine+on+atherosclerosis+via+downregulating+visfatin+expression+and+attenuating+visfatin-induced+endothelial+dysfunction&doi=10.3892%2Fijmm.2018.3440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Suppressive effects of berberine on atherosclerosis via downregulating visfatin expression and attenuating visfatin-induced endothelial dysfunction</span></div><div class="casAuthors">Wan, Qiang; Liu, Zhongyong; Yang, Yuping; Cui, Xiaobing</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1939-1948</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1791-244X</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Berberine (BBR) possesses significant anti-atherosclerosis properties.  Visfatin is one of the most promising biomarkers of incoming atherosclerosis.  However, research on the effect of BBR on regulating visfatin expression in atherogenesis remains largely unknown.  In this study, we investigated the effects of BBR on visfatin expression and atherogenesis in apolipoprotein E knockout (ApoE-/-) mice.  The effect of BBR on attenuating visfatin-induced endothelial dysfunction was also evaluated in cultured human umbilical vein endothelial cells (HUVECs).  In vivo expts. showed that BBR treatment (5 mg/kg/day) significantly reduced the serum levels of visfatin, lipid, interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), the protein expression of visfatin, p-p38 MAPK and p-c-Jun N-terminal kinase (JNK) in mice aorta and the distribution of visfatin in the atherosclerotic lesions in ApoE-/- mice fed with a Western diet.  In addn., in vitro expts. indicated that visfatin (100μg/l) significantly increased apoptosis, the contents of IL-6 and TNF-α, the protein levels of p-p38 MAPK, p-JNK and Bax in HUVECs, which were reversed by BBR administration (50μmol/l).  Our findings suggest that BBR significantly ameliorates Western diet-induced atherosclerosis in ApoE-/- mice via downregulating visfatin expression, which is related to the inhibition of p38 MAPK and JNK signaling pathways and subsequent suppression of visfatin-induced endothelial dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqmQNRJKWDQrVg90H21EOLACvtfcHk0lgfoO1wARIVfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFGru7%252FF&md5=621de13319dc2a79662adc54b454e535</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2018.3440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2018.3440%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCui%26aufirst%3DX.%26atitle%3DSuppressive%2520effects%2520of%2520berberine%2520on%2520atherosclerosis%2520via%2520downregulating%2520visfatin%2520expression%2520and%2520attenuating%2520visfatin-induced%2520endothelial%2520dysfunction%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2018%26volume%3D41%26spage%3D1939%26epage%3D1948%26doi%3D10.3892%2Fijmm.2018.3440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Y.</span></span> <span> </span><span class="NLM_article-title">Artemisinin-A gift from traditional chinese medicine to the world (Nobel Lecture)</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10210</span>– <span class="NLM_lpage">10226</span>, <span class="refDoi"> DOI: 10.1002/anie.201601967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1002%2Fanie.201601967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=27488942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A280%3ADC%252BC2s3nsVeqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=10210-10226&author=Y.+Tu&title=Artemisinin-A+gift+from+traditional+chinese+medicine+to+the+world+%28Nobel+Lecture%29&doi=10.1002%2Fanie.201601967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin-A Gift from Traditional Chinese Medicine to the World (Nobel Lecture)</span></div><div class="casAuthors">Tu Youyou</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10210-26</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria has long been a devastating and life-threatening global epidemic disease in human history.  Artemisinin, the active substance against malaria, was first isolated and tested in the 1970s in China.  The important role played by traditional Chinese medicine in the discovery of artemisinin is described by Y.  Tu in her Nobel Lecture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5Y2rsGFOf4XWEEzDrymxmfW6udTcc2eaMFwxiWQo7CLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3nsVeqtQ%253D%253D&md5=d657305553f17af13ca043159ba97393</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fanie.201601967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201601967%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DY.%26atitle%3DArtemisinin-A%2520gift%2520from%2520traditional%2520chinese%2520medicine%2520to%2520the%2520world%2520%2528Nobel%2520Lecture%2529%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2016%26volume%3D55%26spage%3D10210%26epage%3D10226%26doi%3D10.1002%2Fanie.201601967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rena, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, E. R.</span></span> <span> </span><span class="NLM_article-title">The mechanisms of action of metformin</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1577</span>– <span class="NLM_lpage">1585</span>, <span class="refDoi"> DOI: 10.1007/s00125-017-4342-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1007%2Fs00125-017-4342-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28776086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yiurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1577-1585&author=G.+Renaauthor=D.+G.+Hardieauthor=E.+R.+Pearson&title=The+mechanisms+of+action+of+metformin&doi=10.1007%2Fs00125-017-4342-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanisms of action of metformin</span></div><div class="casAuthors">Rena, Graham; Hardie, D. Grahame; Pearson, Ewan R.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1577-1585</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Metformin is a widely-used drug that results in clear benefits in relation to glucose metab. and diabetes-related complications.  The mechanisms underlying these benefits are complex and still not fully understood.  Physiol., metformin has been shown to reduce hepatic glucose prodn., yet not all of its effects can be explained by this mechanism and there is increasing evidence of a key role for the gut.  At the mol. level the findings vary depending on the doses of metformin used and duration of treatment, with clear differences between acute and chronic administration.  Metformin has been shown to act via both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms; by inhibition of mitochondrial respiration but also perhaps by inhibition of mitochondrial glycerophosphate dehydrogenase, and a mechanism involving the lysosome.  In the last 10 years, we have moved from a simple picture, that metformin improves glycemia by acting on the liver via AMPK activation, to a much more complex picture reflecting its multiple modes of action.  More work is required to truly understand how this drug works in its target population: individuals with type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1XNiaJVVDOLVg90H21EOLACvtfcHk0lirK9xKCpVbLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yiurvP&md5=52c9c90d4a3968f61a500ec87884dab4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00125-017-4342-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-017-4342-z%26sid%3Dliteratum%253Aachs%26aulast%3DRena%26aufirst%3DG.%26aulast%3DHardie%26aufirst%3DD.%2BG.%26aulast%3DPearson%26aufirst%3DE.%2BR.%26atitle%3DThe%2520mechanisms%2520of%2520action%2520of%2520metformin%26jtitle%3DDiabetologia%26date%3D2017%26volume%3D60%26spage%3D1577%26epage%3D1585%26doi%3D10.1007%2Fs00125-017-4342-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Berberine protects against palmitate-induced endothelial dysfunction: involvements of upregulation of AMPK and eNOS and downregulation of NOX4</span>. <i>Mediators Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">260464</span>, <span class="refDoi"> DOI: 10.1155/2013/260464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1155%2F2013%2F260464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=24385682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A280%3ADC%252BC2czhvF2itQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=260464&author=M.+Zhangauthor=C.+M.+Wangauthor=J.+Liauthor=Z.+J.+Mengauthor=S.+N.+Weiauthor=J.+Liauthor=R.+Bucalaauthor=Y.+L.+Liauthor=L.+Chen&title=Berberine+protects+against+palmitate-induced+endothelial+dysfunction%3A+involvements+of+upregulation+of+AMPK+and+eNOS+and+downregulation+of+NOX4&doi=10.1155%2F2013%2F260464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine protects against palmitate-induced endothelial dysfunction: involvements of upregulation of AMPK and eNOS and downregulation of NOX4</span></div><div class="casAuthors">Zhang Ming; Li Jing; Meng Zhao-Jie; Wei Sheng-Nan; Li Ji; Li Yu-Lin; Chen Li; Wang Chun-Mei; Bucala Richard</div><div class="citationInfo"><span class="NLM_cas:title">Mediators of inflammation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">260464</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Endothelial dysfunction is a critical factor during the initiation of cardiovascular complications in diabetes.  Berberine can ameliorate endothelial dysfunction induced by diabetes.  However, the underlying mechanisms remain unclear.  The aim of this study was to investigate the protective effect and mechanism of berberine on palmitate-induced endothelial dysfunction in human umbilical vein endothelial cells (HUVECs).  The cell viability of HUVECs was determined by MTT assays.  Nitric oxide (NO) level and production of reactive oxygen species (ROS) were determined in supernatants or in the cultured HUVECs.  The mRNA level of endothelial nitric oxide synthase (eNOS) was measured by RT-PCR, and the protein levels of eNOS, p-eNOS, Akt, p-Akt, AMPK, p-AMPK, and NADPH oxidase (NOX4) were analyzed.  The results demonstrated that berberine significantly elevated NO levels and reduced the production of ROS.  The expressions of eNOS were significantly increased, while NOX4 protein expression was decreased in berberine-treated HUVECs.  Moreover, berberine upregulated the protein expression of AMPK and p-AMPK in palmitate-treated HUVECs, but had no effect on the levels of Akt.  Therefore, berberine ameliorates palmitate-induced endothelial dysfunction by upregulating eNOS expression and downregulating expression of NOX4.  This regulatory effect of berberine may be related to the activation of AMPK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCVyomBbfR5_xQvRxYU81tfW6udTcc2eaMFwxiWQo7CLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czhvF2itQ%253D%253D&md5=7f4ab9f8a5626f7b1cd414c16e3379f8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1155%2F2013%2F260464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F260464%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DC.%2BM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMeng%26aufirst%3DZ.%2BJ.%26aulast%3DWei%26aufirst%3DS.%2BN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBucala%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%2BL.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DBerberine%2520protects%2520against%2520palmitate-induced%2520endothelial%2520dysfunction%253A%2520involvements%2520of%2520upregulation%2520of%2520AMPK%2520and%2520eNOS%2520and%2520downregulation%2520of%2520NOX4%26jtitle%3DMediators%2520Inflammation%26date%3D2013%26volume%3D2013%26spage%3D260464%26doi%3D10.1155%2F2013%2F260464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ansari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodagholi, F.</span></span> <span> </span><span class="NLM_article-title">Natural products as promising drug candidates for the treatment of Alzheimer’s disease: molecular mechanism aspect</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.2174/1570159x11311040005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.2174%2F1570159X11311040005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=24381531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFajs7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=414-429&author=N.+Ansariauthor=F.+Khodagholi&title=Natural+products+as+promising+drug+candidates+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+molecular+mechanism+aspect&doi=10.2174%2F1570159x11311040005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect</span></div><div class="casAuthors">Ansari, Niloufar; Khodagholi, Fariba</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">414-429</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common neurodegenerative disorder to date, with no curative or preventive therapy.  Histopathol. hallmarks of AD include deposition of β-amyloid plaques and formation of neurofibrillary tangles.  Extent studies on pathol. of the disease have made important discoveries regarding mechanism of disease and potential therapeutic targets.  Many cellular changes including oxidative stress, disruption of Ca2+ homeostasis, inflammation, metabolic disturbances, and accumulation of unfolded/misfolded proteins can lead to programmed cell death in AD.  Despite intensive research, only five approved drugs are available for the management of AD.  Hence, there is a need to look at alternative therapies.  Use of natural products and culinary herbs in medicine has gained popularity in recent years.  Several natural substances with neuroprotective effects have been widely studied.  Most of these compds. have remarkable antioxidant properties and act mainly by scavenging free radical species.  Some of them increase cell survival and improve cognition by directly affecting amyloidogenesis and programmed cell death pathways.  Further studies on these natural products and their mechanism of action, parallel with the use of novel pharmaceutical drug design and delivery techniques, enable us to offer an addn. to conventional medicine.  This review discussed some natural products with potential neuroprotective properties against Aβ with respect to their mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjnqzQt4z-pLVg90H21EOLACvtfcHk0lg_ZRY_f4YrgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFajs7nI&md5=03ccd58248c1da97ee5993a4b341ba18</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1570159X11311040005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X11311040005%26sid%3Dliteratum%253Aachs%26aulast%3DAnsari%26aufirst%3DN.%26aulast%3DKhodagholi%26aufirst%3DF.%26atitle%3DNatural%2520products%2520as%2520promising%2520drug%2520candidates%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520molecular%2520mechanism%2520aspect%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2013%26volume%3D11%26spage%3D414%26epage%3D429%26doi%3D10.2174%2F1570159x11311040005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekavali</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pottabathini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhull, D. K.</span></span> <span> </span><span class="NLM_article-title">Current knowledge and pharmacological profile of berberine: An update</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>761</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2015.05.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.ejphar.2015.05.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=26092760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSitrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=761&publication_year=2015&pages=288-297&author=A.+Kumarauthor=+Ekavaliauthor=K.+Chopraauthor=M.+Mukherjeeauthor=R.+Pottabathiniauthor=D.+K.+Dhull&title=Current+knowledge+and+pharmacological+profile+of+berberine%3A+An+update&doi=10.1016%2Fj.ejphar.2015.05.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Current knowledge and pharmacological profile of berberine: An update</span></div><div class="casAuthors">Kumar, Anil; Ekavali; Chopra, Kanwaljit; Mukherjee, Madhurima; Pottabathini, Raghavender; Dhull, Dinesh K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">761</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">288-297</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Berberine, a benzylisoquinoline alkaloid, occurs as an active constituent in numerous medicinal plants and has an array of pharmacol. properties.  It has been used in Ayurvedic and Chinese medicine for its antimicrobial, antiprotozoal, antidiarrheal and antitrachoma activity.  Moreover, several clin. and preclin. studies demonstrate ameliorative effect of berberine against several disorders including metabolic, neurol. and cardiol. problems.  This review provides a summary regarding the pharmacokinetic and pharmacodynamic features of berberine, with a focus on the different mechanisms underlying its multispectrum activity.  Studies regarding the safety profile, drug interactions and important clin. trials of berberine have also been included.  Clin. trials with respect to neurol. disorders need to be undertaken to exploit the beneficiary effects of berberine against serious disorders such as Alzheimer's and Parkinson's disease.  Also, clin. studies to detect rare adverse effects of berberine need to be initiated to draw a complete safety profile of berberine and strengthen its applicability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxeLvc6JGyNLVg90H21EOLACvtfcHk0lg_ZRY_f4YrgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSitrfM&md5=b0461156a3888c3c84688618f36c7f14</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.05.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.05.068%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DEkavali%26aulast%3DChopra%26aufirst%3DK.%26aulast%3DMukherjee%26aufirst%3DM.%26aulast%3DPottabathini%26aufirst%3DR.%26aulast%3DDhull%26aufirst%3DD.%2BK.%26atitle%3DCurrent%2520knowledge%2520and%2520pharmacological%2520profile%2520of%2520berberine%253A%2520An%2520update%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D761%26spage%3D288%26epage%3D297%26doi%3D10.1016%2Fj.ejphar.2015.05.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span> <span> </span><span class="NLM_article-title">Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">864</span>– <span class="NLM_lpage">874</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2017.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.biopha.2017.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28282788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvFant7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2017&pages=864-874&author=H.+Zhouauthor=L.+Fengauthor=F.+Xuauthor=Y.+Sunauthor=Y.+Maauthor=X.+Zhangauthor=H.+Liuauthor=G.+Xuauthor=X.+Wuauthor=Y.+Shenauthor=Y.+Sunauthor=X.+Wuauthor=Q.+Xu&title=Berberine+inhibits+palmitate-induced+NLRP3+inflammasome+activation+by+triggering+autophagy+in+macrophages%3A+A+new+mechanism+linking+berberine+to+insulin+resistance+improvement&doi=10.1016%2Fj.biopha.2017.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement</span></div><div class="casAuthors">Zhou, Hang; Feng, Lili; Xu, Fang; Sun, Yi; Ma, Yuxiang; Zhang, Xiong; Liu, Hailiang; Xu, Ge; Wu, Xuefeng; Shen, Yan; Sun, Yang; Wu, Xudong; Xu, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">864-874</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">NLRP3 (Nod-like receptor family pyrin domain contg. 3) inflammasome has been reported to contribute to obesity-induced inflammation and insulin resistance.  However, there are few drugs targeting NLRP3 inflammasome for the treatment of insulin resistance.  In the present study, we showed that berberine (BBR) significantly suppressed satd. fatty acid palmitate (PA)-induced NLRP3 inflammasome activation and interleukin-1β (IL-1β) release in macrophages, which was one of the most important mediators in the insulin sensitivity of adipose tissue.  BBR treatment dramatically upregulated macrophage autophagic level while knockdown beclin1 and autophagy inhibitor reversed BBR's suppression on inflammasome.  Furthermore, AMPK (adenosine monophosphate-activated protein kinase) inhibitor Adenine 9-β-D-arabinofuranoside (Ara-A) blocked most effects of BBR, suggesting that AMPK signals may be involved in BBR-induced macrophage autophagy.  Importantly, BBR also prevented NLRP3 inflammasome-dependent inflammation and metabolic disorder in a high-fat-diet-induced insulin resistance model.  Adoptive transfer of BBR-treated bone marrow-derived macrophages (BMDMs), which was induced by lipopolysaccharide (LPS) plus palmitate-bovine serum albumin (PA-BSA), significantly ameliorated insulin resistance of ob/ob mice as compared with control mice.  However, the co-treatment of the BMDMs with autophagy inhibitor 3-Methyladenine (3-MA) reversed the effect of BBR almost completely.  Taken together, BBR exerted its anti-inflammatory effects through activation of AMPK-dependent autophagy in adipose tissue macrophages (ATMs).  This study amplified the mechanisms of BBR and its potential in attenuating insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMISF82LNtL7Vg90H21EOLACvtfcHk0lg_ZRY_f4YrgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvFant7w%253D&md5=008a82c587134d63b0f6aec8e1a1b729</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2017.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2017.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26atitle%3DBerberine%2520inhibits%2520palmitate-induced%2520NLRP3%2520inflammasome%2520activation%2520by%2520triggering%2520autophagy%2520in%2520macrophages%253A%2520A%2520new%2520mechanism%2520linking%2520berberine%2520to%2520insulin%2520resistance%2520improvement%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D89%26spage%3D864%26epage%3D874%26doi%3D10.1016%2Fj.biopha.2017.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharvan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, S.</span></span> <span> </span><span class="NLM_article-title">Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1231</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2017.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.biopha.2017.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28931215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFWitLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2017&pages=1225-1231&author=L.+Liauthor=X.+Wangauthor=R.+Sharvanauthor=J.+Gaoauthor=S.+Qu&title=Berberine+could+inhibit+thyroid+carcinoma+cells+by+inducing+mitochondrial+apoptosis%2C+G0%2FG1+cell+cycle+arrest+and+suppressing+migration+via+PI3K-AKT+and+MAPK+signaling+pathways&doi=10.1016%2Fj.biopha.2017.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways</span></div><div class="casAuthors">Li, Liang; Wang, Xingchun; Sharvan, Rampersad; Gao, Jingyang; Qu, Shen</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1225-1231</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Berberine, an important natural isoquinoline alkaloid from traditional Chinese medicine, is reported to exhibit multiple pharmacol. properties, including anti-microbial, anti-diabetes, anti-obesity, anti-inflammatory and anti-carcinogenic activities.  Although studies have shown that a wide range of carcinoma cells could be inhibited by berberine, few studies involved thyroid carcinoma.  We therefore examd. the effect of berberine on papillary thyroid carcinoma (PTC, the most common subtype) and anaplastic thyroid carcinoma (ATC, the most malignant and aggressive subtype).  Three thyroid carcinoma cell lines with different aberrant genotypes and one normal thyroid cell line were selected, including C643 (ATC, with H-RAS mutation), OCUT1 (ATC, with BRAFV600E and PIK3CA mutations), TPC1 (PTC, with RET/PTC1 rearrangement) and Htori3 (normal).  We found that berberine inhibited the proliferation of C643, OCUT1 and TPC1 thyroid carcinoma cells in a dose- and time-dependent manner (p < 0.01, compared with the control), while normal human thyroid cells showed less sensitivity to the cytotoxicity of berberine.  Berberine-induced significant mitochondrial apoptosis, G0/G1 cell cycle arrest and inhibitive migration in thyroid carcinoma cells were also obsd. (p < 0.05 or p < 0.01, compared with the control).  Increased Bax/Bcl-2, cleaved Caspase 3, P21 and decreased Cyclin E1, CDK2 and Vimentin were verified by western blot.  Addnl., berberine caused markedly decreased p-AKT1 expression and disturbances in classic ERK MAPK as well as P38 and JNK MAPK pathways in diverse thyroid carcinoma cells.  Therefore, berberine could modulate PI3K-AKT and MAPK signaling pathways in thyroid carcinoma cells, which leads to mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressive migration.  Berberine may represent a promising chemotherapy for the treatment of thyroid carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEtYuURreQQLVg90H21EOLACvtfcHk0lgr8sHaTtctpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFWitLjN&md5=4873ae099d833cc95a1b8b6946b25d24</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2017.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2017.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSharvan%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DS.%26atitle%3DBerberine%2520could%2520inhibit%2520thyroid%2520carcinoma%2520cells%2520by%2520inducing%2520mitochondrial%2520apoptosis%252C%2520G0%252FG1%2520cell%2520cycle%2520arrest%2520and%2520suppressing%2520migration%2520via%2520PI3K-AKT%2520and%2520MAPK%2520signaling%2520pathways%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D95%26spage%3D1225%26epage%3D1231%26doi%3D10.1016%2Fj.biopha.2017.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.-N.</span></span> <span> </span><span class="NLM_article-title">Berberine attenuates sodium palmitate-induced lipid accumulation, oxidative stress and apoptosis in grass carp(Ctenopharyngodon idella)hepatocyte in vitro</span>. <i>Fish Shellfish Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">518</span>– <span class="NLM_lpage">527</span>, <span class="refDoi"> DOI: 10.1016/j.fsi.2019.02.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.fsi.2019.02.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=30880233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtVChtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2019&pages=518-527&author=S.-S.+Yangauthor=C.-B.+Yuauthor=Z.+Luoauthor=W.-L.+Luoauthor=J.+Zhangauthor=J.-X.+Xuauthor=W.-N.+Xu&title=Berberine+attenuates+sodium+palmitate-induced+lipid+accumulation%2C+oxidative+stress+and+apoptosis+in+grass+carp%28Ctenopharyngodon+idella%29hepatocyte+in+vitro&doi=10.1016%2Fj.fsi.2019.02.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine attenuates sodium palmitate-induced lipid accumulation, oxidative stress and apoptosis in grass carp(Ctenopharyngodon idella)hepatocyte in vitro</span></div><div class="casAuthors">Yang, Shuo-Shuo; Yu, Cheng-Bing; Luo, Zhen; Luo, Wen-Li; Zhang, Jing; Xu, Jian-Xiong; Xu, Wei-Na</div><div class="citationInfo"><span class="NLM_cas:title">Fish & Shellfish Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">518-527</span>CODEN:
                <span class="NLM_cas:coden">FSIMEP</span>;
        ISSN:<span class="NLM_cas:issn">1050-4648</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The objective of this work was to investigate the effect of berberine (BBR) on the Cell viability, lipid accumulation, apoptosis, cytochrome c, caspase-9 and caspase-3 in lipid accumulation-hepatocytes induced by sodium palmitate in vitro.  The lipid accumulation-hepatocytes (induced by 0.5 mM sodium palmitate for 24 h) were treated with 5μM berberine for 12 h.  Then, the Cell viability, intracellular triglyceride (TG) content, lipid peroxide (LPO), malonaldehyde (MDA) content, cytochrome c, caspase-9, caspase-3 and apoptosis were detected.  Sodium palmitate decreased Cell viability and increased intracellular TG content, lipid droplet accumulation, LPO and MDA concns., caused caspase-3 and caspase-9 activation, then led to apoptosis accompanied by cytochrome c release from mitochondria into the cytoplasm.  Beberine could improve intracellular lipid droplet accumulation and oxidative stress, while reduce apoptosis induced by sodium palmitate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7GPyAt9fie7Vg90H21EOLACvtfcHk0lgr8sHaTtctpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtVChtbg%253D&md5=409ab794892956f5f72bf0e68cda2a77</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.fsi.2019.02.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fsi.2019.02.055%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.-S.%26aulast%3DYu%26aufirst%3DC.-B.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DW.-L.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.-X.%26aulast%3DXu%26aufirst%3DW.-N.%26atitle%3DBerberine%2520attenuates%2520sodium%2520palmitate-induced%2520lipid%2520accumulation%252C%2520oxidative%2520stress%2520and%2520apoptosis%2520in%2520grass%2520carp%2528Ctenopharyngodon%2520idella%2529hepatocyte%2520in%2520vitro%26jtitle%3DFish%2520Shellfish%2520Immunol.%26date%3D2019%26volume%3D88%26spage%3D518%26epage%3D527%26doi%3D10.1016%2Fj.fsi.2019.02.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, K.</span></span> <span> </span><span class="NLM_article-title">Hypoglycemic mechanism of the berberine organic acid salt under the synergistic effect of intestinal flora and oxidative stress</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">8930374</span>, <span class="refDoi"> DOI: 10.1155/2018/8930374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1155%2F2018%2F8930374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=30662584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A280%3ADC%252BB3cjjtlGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=8930374&author=H.-X.+Cuiauthor=Y.-N.+Huauthor=J.-W.+Liauthor=K.+Yuan&title=Hypoglycemic+mechanism+of+the+berberine+organic+acid+salt+under+the+synergistic+effect+of+intestinal+flora+and+oxidative+stress&doi=10.1155%2F2018%2F8930374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoglycemic Mechanism of the Berberine Organic Acid Salt under the Synergistic Effect of Intestinal Flora and Oxidative Stress</span></div><div class="casAuthors">Cui Hong-Xin; Hu Ya-Nan; Cui Hong-Xin; Li Jing-Wan; Yuan Ke</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2018</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8930374</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Both alterations to the intestinal microflora and chronic systemic inflammation predispose towards type 2 diabetes (T2D).  Changes in the composition of the intestinal microflora are associated with glucose metabolism changes in rats with T2D.  Here, we demonstrate that a berberine fumarate (BF) has a hypoglycemic effect by regulating the intestinal microflora and metabolism of diabetic rats.  The T2D rats had disorders of glucose and lipid metabolism, an abnormal intestinal microflora, fewer butyrate-producing and probiotic-type bacteria, larger numbers of potentially pathogenic and sulfate-reducing bacteria, and tissue inflammation.  Administration of berberine fumarate significantly ameliorated the metabolic disorder; increased the populations of Bacteroidetes, Clostridia, Lactobacillales, Prevotellaceae, and Alloprevotella; and reduced those of Bacteroidales, Lachnospiraceae, Rikenellaceae, and Desulfovibrio.  In addition, it reduced inflammation, inhibiting the overexpression of TLR4 and p-JNK and increasing the expression of PI3K, GLUT2, and other proteins, which are closely related to oxidative stress, thereby promoting the metabolism of glucose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJQ-lYDmh02XT4ugvCDgnZfW6udTcc2eZJ0xUeQiPn47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjjtlGjsQ%253D%253D&md5=868429a3789e9e0145b3bf5b85c43c94</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1155%2F2018%2F8930374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2018%252F8930374%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DH.-X.%26aulast%3DHu%26aufirst%3DY.-N.%26aulast%3DLi%26aufirst%3DJ.-W.%26aulast%3DYuan%26aufirst%3DK.%26atitle%3DHypoglycemic%2520mechanism%2520of%2520the%2520berberine%2520organic%2520acid%2520salt%2520under%2520the%2520synergistic%2520effect%2520of%2520intestinal%2520flora%2520and%2520oxidative%2520stress%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2018%26volume%3D2018%26spage%3D8930374%26doi%3D10.1155%2F2018%2F8930374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shou, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, B.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-D.</span></span> <span> </span><span class="NLM_article-title">Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism</span>. <i>Metabolism</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1016/j.metabol.2017.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.metabol.2017.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28403947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVKjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2017&pages=72-84&author=Y.+Wangauthor=J.-W.+Shouauthor=X.-Y.+Liauthor=Z.-X.+Zhaoauthor=J.+Fuauthor=C.-Y.+Heauthor=R.+Fengauthor=C.+Maauthor=B.-Y.+Wenauthor=F.+Guoauthor=X.-Y.+Yangauthor=Y.-X.+Hanauthor=L.-L.+Wangauthor=Q.+Tongauthor=X.-F.+Youauthor=Y.+Linauthor=W.-J.+Kongauthor=S.-Y.+Siauthor=J.-D.+Jiang&title=Berberine-induced+bioactive+metabolites+of+the+gut+microbiota+improve+energy+metabolism&doi=10.1016%2Fj.metabol.2017.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism</span></div><div class="casAuthors">Wang, Yan; Shou, Jia-Wen; Li, Xiao-Yang; Zhao, Zhen-Xiong; Fu, Jie; He, Chi-Yu; Feng, Ru; Ma, Chao; Wen, Bao-Ying; Guo, Fang; Yang, Xin-Yi; Han, Yan-Xing; Wang, Lu-Lu; Tong, Qian; You, Xue-Fu; Lin, Yuan; Kong, Wei-Jia; Si, Shu-Yi; Jiang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">72-84</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Berberine (BBR) clin. lowers blood lipid and glucose levels via multi-target mechanisms.  One of the possible mechanisms is related to its effect on the short chain fatty acids (SCFAs) of the gut microbiota.  The goal of this study is to investigate the therapeutic effect and mode of action of BBR working through SCFAs of the gut microbiota (esp., butyrate).  Gas chromatog. (GC) was used to detect butyrate and other SCFAs chem.  The effect of BBR on butyrate prodn. was investigated in vitro as well as in several animal systems.  Microarrays were used to analyze the compn. change in the intestinal bacteria community after treatment with BBR.  BBR-induced change in the energy prodn. and gene regulation of intestinal bacteria was examd. in order to elucidate the underlying mol. mechanisms.  We show that oral administration of BBR in animals promoted the gut microbiota to produce butyrate, which then enters the blood and reduces blood lipid and glucose levels.  Incubating gut bacterial strains in vitro with BBR increased butyrate prodn.  Orally treating animals directly with butyrate reduced blood lipid and glucose levels through a mechanism different from that of BBR.  I.p. BBR administration did not increase butyrate but reduced blood lipid and glucose levels, suggesting that BBR has two modes of action: the direct effect of the circulated BBR and the indirect effect working through butyrate of the gut microbiota.  Pre-treating animals orally with antibiotics abolished the effect of BBR on butyrate.  A mechanism study showed that BBR (given orally) modified mice intestinal bacterial compn. by increasing the abundance of butyrate-producing bacteria.  Furthermore, BBR suppressed bacterial ATP prodn. and NADH levels, resulting in increased butyryl-CoA and, eventually, butyrate prodn. via upregulating phosphotransbutyrylase/butyrate kinase and butyryl-CoA:acetate-CoA transferase in bacteria.  Promotion of butyrate (etc) prodn. in gut microbiota might be one of the important mechanisms of BBR in regulating energy metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrev6tZGqob97Vg90H21EOLACvtfcHk0lgG_ihWOdSqYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVKjtbg%253D&md5=73548e9e0cf0419ea87b833b7a02d27f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2017.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2017.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DShou%26aufirst%3DJ.-W.%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DZhao%26aufirst%3DZ.-X.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DC.-Y.%26aulast%3DFeng%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DWen%26aufirst%3DB.-Y.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DX.-Y.%26aulast%3DHan%26aufirst%3DY.-X.%26aulast%3DWang%26aufirst%3DL.-L.%26aulast%3DTong%26aufirst%3DQ.%26aulast%3DYou%26aufirst%3DX.-F.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DW.-J.%26aulast%3DSi%26aufirst%3DS.-Y.%26aulast%3DJiang%26aufirst%3DJ.-D.%26atitle%3DBerberine-induced%2520bioactive%2520metabolites%2520of%2520the%2520gut%2520microbiota%2520improve%2520energy%2520metabolism%26jtitle%3DMetabolism%26date%3D2017%26volume%3D70%26spage%3D72%26epage%3D84%26doi%3D10.1016%2Fj.metabol.2017.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shou, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. D.</span></span> <span> </span><span class="NLM_article-title">Transforming berberine into its intestine-absorbable form by the gut microbiota</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">12155</span>, <span class="refDoi"> DOI: 10.1038/srep12155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fsrep12155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=26174047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlWhtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=12155&author=R.+Fengauthor=J.+W.+Shouauthor=Z.+X.+Zhaoauthor=C.+Y.+Heauthor=C.+Maauthor=M.+Huangauthor=J.+Fuauthor=X.+S.+Tanauthor=X.+Y.+Liauthor=B.+Y.+Wenauthor=X.+Chenauthor=X.+Y.+Yangauthor=G.+Renauthor=Y.+Linauthor=Y.+Chenauthor=X.+F.+Youauthor=Y.+Wangauthor=J.+D.+Jiang&title=Transforming+berberine+into+its+intestine-absorbable+form+by+the+gut+microbiota&doi=10.1038%2Fsrep12155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Transforming berberine into its intestine-absorbable form by the gut microbiota</span></div><div class="casAuthors">Feng, Ru; Shou, Jia-Wen; Zhao, Zhen-Xiong; He, Chi-Yu; Ma, Chao; Huang, Min; Fu, Jie; Tan, Xiang-Shan; Li, Xiao-Yang; Wen, Bao-Ying; Chen, Xi; Yang, Xin-Yi; Ren, Gang; Lin, Yuan; Chen, Yangchao; You, Xue-Fu; Wang, Yan; Jiang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12155</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The gut microbiota is important in the pathogenesis of energy-metab. related diseases.  We focused on the interaction between intestinal bacteria and orally administered chem. drugs.  Oral administration of berberine (BBR) effectively treats patients with metabolic disorders.  However, because BBR exhibits poor soly., its absorption mechanism remains unknown.  Here, we show that the gut microbiota converts BBR into its absorbable form of dihydroberberine (dhBBR), which has an intestinal absorption rate 5-fold that of BBR in animals.  The redn. of BBR to dhBBR was performed by nitroreductases of the gut microbiota.  DhBBR was unstable in soln. and reverted to BBR in intestine tissues via oxidization.  Heat inactivation of intestinal homogenate did not inhibit dhBBR oxidization, suggesting the process a non-enzymic reaction.  The diminution of intestinal bacteria via orally treating KK-Ay mice with antibiotics decreased the BBR-to-dhBBR conversion and blood BBR; accordingly, the lipid- and glucose-lowering efficacy of BBR was reduced.  Conclusively, the gut microbiota reduces BBR into its absorbable form of dhBBR, which then oxidizes back to BBR after absorption in intestine tissues and enters the blood.  Thus, interaction(s) between the gut microbiota and orally administrated drugs may modify the structure and function of chems. and be important in drug investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_D-NDwkLniLVg90H21EOLACvtfcHk0lgG_ihWOdSqYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlWhtbnL&md5=6c709063725e05afc77c8d8fc43d279a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsrep12155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep12155%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DR.%26aulast%3DShou%26aufirst%3DJ.%2BW.%26aulast%3DZhao%26aufirst%3DZ.%2BX.%26aulast%3DHe%26aufirst%3DC.%2BY.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DX.%2BS.%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DWen%26aufirst%3DB.%2BY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DX.%2BY.%26aulast%3DRen%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DX.%2BF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DJ.%2BD.%26atitle%3DTransforming%2520berberine%2520into%2520its%2520intestine-absorbable%2520form%2520by%2520the%2520gut%2520microbiota%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D12155%26doi%3D10.1038%2Fsrep12155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pirillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catapano, A. L.</span></span> <span> </span><span class="NLM_article-title">Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>243</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2015.09.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.atherosclerosis.2015.09.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=26520899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKgs7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=2015&pages=449-461&author=A.+Pirilloauthor=A.+L.+Catapano&title=Berberine%2C+a+plant+alkaloid+with+lipid-+and+glucose-lowering+properties%3A+From+in+vitro+evidence+to+clinical+studies&doi=10.1016%2Fj.atherosclerosis.2015.09.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies</span></div><div class="casAuthors">Pirillo, Angela; Catapano, Alberico Luigi</div><div class="citationInfo"><span class="NLM_cas:title">Atherosclerosis (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">243</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">449-461</span>CODEN:
                <span class="NLM_cas:coden">ATHSBL</span>;
        ISSN:<span class="NLM_cas:issn">0021-9150</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Berberine (BBR) is an isoquinoline plant alkaloid endowed with several pharmacol. activities, including anti-microbial, glucose- and cholesterol-lowering, anti-tumoral and immunomodulatory properties.  The main mechanism by which BBR exerts a protective role in atherosclerosis relates to its cholesterol-lowering activity.  BBR significantly increases hepatic low d. lipoprotein receptor (LDLR) expression and reduces the expression and secretion of the LDLR modulator proprotein convertase subtilisin/kexin type 9 (PCSK9).  In addn. to this, several other atheroprotective effects have been ascribed to BBR, including anti-inflammatory and anti-oxidant properties, inhibition of vascular smooth muscle cell proliferation and improvement of endothelial dysfunction.  BBR also increases glucose utilization in adipocytes and myocytes, while decreases glucose absorption in intestinal cells, resulting in a net hypoglycemic effect.  In hypercholesterolemic animals, BBR significantly decreases LDL-C and total cholesterol (TC) levels and reduces aortic lesions, an effect similar to that of statins.  In diabetic animals, BBR significantly reduces glucose levels, improves glucose tolerance, reduces body wt. gain and adipose tissue mass.  Several clin. studies have also tested the efficacy of BBR in humans.  In hypercholesterolemic subjects, BBR induces a significant redn. of TC, triglycerides and LDL-C levels and a significant increase of HDL-C levels, without major adverse effects.  BBR also reduces glycemia and plasma cholesterol in diabetic patients, improves lipid and glucose profile and decreases body mass index and waist circumference in subjects with metabolic syndrome.  These findings, together with the good tolerability, suggest that BBR administration might be considered a potential therapeutic approach for the treatment of hypercholesterolemia or diabetes.  Given the level of evidence available to date well-designed randomized controlled trials to test safety and efficacy of BBR are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9FC5DQK4Ir7Vg90H21EOLACvtfcHk0lgG_ihWOdSqYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKgs7vM&md5=e78fdb4c6b43a60c17bad780785a85df</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2015.09.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2015.09.032%26sid%3Dliteratum%253Aachs%26aulast%3DPirillo%26aufirst%3DA.%26aulast%3DCatapano%26aufirst%3DA.%2BL.%26atitle%3DBerberine%252C%2520a%2520plant%2520alkaloid%2520with%2520lipid-%2520and%2520glucose-lowering%2520properties%253A%2520From%2520in%2520vitro%2520evidence%2520to%2520clinical%2520studies%26jtitle%3DAtherosclerosis%26date%3D2015%26volume%3D243%26spage%3D449%26epage%3D461%26doi%3D10.1016%2Fj.atherosclerosis.2015.09.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W. J.</span></span> <span> </span><span class="NLM_article-title">Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus</span>. <i>J. Evidence-Based Complementary Altern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2014</i></span>,  <span class="NLM_fpage">289264</span>, <span class="refDoi"> DOI: 10.1155/2014/289264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1155%2F2014%2F289264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=24669227" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=289264&author=Z.+Liauthor=Y.+N.+Gengauthor=J.+D.+Jiangauthor=W.+J.+Kong&title=Antioxidant+and+anti-inflammatory+activities+of+berberine+in+the+treatment+of+diabetes+mellitus&doi=10.1155%2F2014%2F289264"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1155%2F2014%2F289264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F289264%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGeng%26aufirst%3DY.%2BN.%26aulast%3DJiang%26aufirst%3DJ.%2BD.%26aulast%3DKong%26aufirst%3DW.%2BJ.%26atitle%3DAntioxidant%2520and%2520anti-inflammatory%2520activities%2520of%2520berberine%2520in%2520the%2520treatment%2520of%2520diabetes%2520mellitus%26jtitle%3DJ.%2520Evidence-Based%2520Complementary%2520Altern.%2520Med.%26date%3D2014%26volume%3D2014%26spage%3D289264%26doi%3D10.1155%2F2014%2F289264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunnumakkara, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, B. B.</span></span> <span> </span><span class="NLM_article-title">Berberine Modifies Cysteine 179 of IκBα Kinase, Suppresses Nuclear Factor-κB-Regulated Antiapoptotic Gene Products, and Potentiates Apoptosis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">5370</span>– <span class="NLM_lpage">5379</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-08-0511</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1158%2F0008-5472.CAN-08-0511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=18593939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFyjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=5370-5379&author=M.+K.+Pandeyauthor=B.+Sungauthor=A.+B.+Kunnumakkaraauthor=G.+Sethiauthor=M.+M.+Chaturvediauthor=B.+B.+Aggarwal&title=Berberine+Modifies+Cysteine+179+of+I%CE%BAB%CE%B1+Kinase%2C+Suppresses+Nuclear+Factor-%CE%BAB-Regulated+Antiapoptotic+Gene+Products%2C+and+Potentiates+Apoptosis&doi=10.1158%2F0008-5472.can-08-0511"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine Modifies Cysteine 179 of IκBα Kinase, Suppresses Nuclear Factor-κB-Regulated Antiapoptotic Gene Products, and Potentiates Apoptosis</span></div><div class="casAuthors">Pandey, Manoj K.; Sung, Bokyung; Kunnumakkara, Ajaikumar B.; Sethi, Gautam; Chaturvedi, Madan M.; Aggarwal, Bharat B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5370-5379</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Berberine, an isoquinoline alkaloid derived from a plant used traditionally in Chinese and Ayurvedic medicine, has been reported to exhibit chemopreventive and anti-inflammatory activities through unknown mechanism.  Because of the crit. role of the transcription factor nuclear factor-κB (NF-κB) in these processes, we investigated the effect of berberine on this pathway.  We found that berberine suppressed NF-κB activation induced by various inflammatory agents and carcinogens.  This alkaloid also suppressed constitutive NF-κB activation found in certain tumor cells.  Suppression of NF-κB activation occurred through the inhibition of phosphorylation and degrdn. of IκBα by the inhibition of IκB kinase (IKK) activation, leading to suppression of phosphorylation and nuclear translocation of p65, and finally to inhibition of NF-κB reporter activity.  Inhibition of IKK by berbeine was direct and could be reversed by reducing agents.  Site-specific mutagenesis suggested the involvement of cysteine residue 179 in IKK.  Berberine also suppressed the expression of NF-κB-regulated gene products involved in antiapoptosis (Bcl-xL, Survivin, IAP1, IAP2, and cFLIP), proliferation (cyclin D1), inflammation (cyclooxygenase-2), and invasion (matrix metalloproteinase-9).  Suppression of antiapoptotic gene products correlated with enhancement of apoptosis induced by tumor necrosis factor (TNF)-α and chemotherapeutic agents and with inhibition of TNF-induced cellular invasion.  Overall, our results indicate that chemopreventive, apoptotic, and anti-inflammatory activities displayed by berberine may be mediated in part through the suppression of the NF-κB activation pathway.  This may provide the mol. basis for the ability of berberine to act as an anticancer and anti-inflammatory agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBbwsRNYck3bVg90H21EOLACvtfcHk0lhxjbPj3iPY5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFyjtL8%253D&md5=ab890bc1897177be9b22ae873b52d0e6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-0511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-0511%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DM.%2BK.%26aulast%3DSung%26aufirst%3DB.%26aulast%3DKunnumakkara%26aufirst%3DA.%2BB.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DM.%2BM.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DBerberine%2520Modifies%2520Cysteine%2520179%2520of%2520I%25CE%25BAB%25CE%25B1%2520Kinase%252C%2520Suppresses%2520Nuclear%2520Factor-%25CE%25BAB-Regulated%2520Antiapoptotic%2520Gene%2520Products%252C%2520and%2520Potentiates%2520Apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D5370%26epage%3D5379%26doi%3D10.1158%2F0008-5472.can-08-0511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ridker, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuren, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFadyen, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballantyne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anker, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastelein, J. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornel, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pais, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genest, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cifkova, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzatti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forster, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobalava, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vida-Simiti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flather, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dellborg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, P. R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troquay, R. P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libby, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynn, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Group, C. T.</span></span> <span> </span><span class="NLM_article-title">Antiinflammatory therapy with canakinumab for atherosclerotic disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>377</i></span>,  <span class="NLM_fpage">1119</span>– <span class="NLM_lpage">1131</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1707914</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1056%2FNEJMoa1707914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28845751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOqurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2017&pages=1119-1131&author=P.+M.+Ridkerauthor=B.+M.+Everettauthor=T.+Thurenauthor=J.+G.+MacFadyenauthor=W.+H.+Changauthor=C.+Ballantyneauthor=F.+Fonsecaauthor=J.+Nicolauauthor=W.+Koenigauthor=S.+D.+Ankerauthor=J.+J.+P.+Kasteleinauthor=J.+H.+Cornelauthor=P.+Paisauthor=D.+Pellaauthor=J.+Genestauthor=R.+Cifkovaauthor=A.+Lorenzattiauthor=T.+Forsterauthor=Z.+Kobalavaauthor=L.+Vida-Simitiauthor=M.+Flatherauthor=H.+Shimokawaauthor=H.+Ogawaauthor=M.+Dellborgauthor=P.+R.+F.+Rossiauthor=R.+P.+T.+Troquayauthor=P.+Libbyauthor=R.+J.+Glynnauthor=C.+T.+Group&title=Antiinflammatory+therapy+with+canakinumab+for+atherosclerotic+disease&doi=10.1056%2Fnejmoa1707914"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Antiinflammatory therapy with canakinumab for atherosclerotic disease</span></div><div class="casAuthors">Ridker, P. M.; Everett, B. M.; Thuren, T.; MacFadyen, J. G.; Chang, W. H.; Ballantyne, C.; Fonseca, F.; Nicolau, J.; Koenig, W.; Anker, S. D.; Kastelein, J. J. P.; Cornel, J. H.; Pais, P.; Pella, D.; Genest, J.; Cifkova, R.; Lorenzatti, A.; Forster, T.; Kobalava, Z.; Vida-Simiti, L.; Flather, M.; Shimokawa, H.; Ogawa, H.; Dellborg, M.; Rossi, P. R. F.; Troquay, R. P. T.; Libby, P.; Glynn, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1119-1131</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background Exptl. and clin. data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease.  Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. methods We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per L.  The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered s.c. every 3 mo) with placebo.  The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. results At 48 mo, the median redn. from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group.  There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). conclusions Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 mo led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfwYFxFQ_i_LVg90H21EOLACvtfcHk0lhxjbPj3iPY5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOqurnE&md5=50570e06cca89d8b3f654333047f223d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1707914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1707914%26sid%3Dliteratum%253Aachs%26aulast%3DRidker%26aufirst%3DP.%2BM.%26aulast%3DEverett%26aufirst%3DB.%2BM.%26aulast%3DThuren%26aufirst%3DT.%26aulast%3DMacFadyen%26aufirst%3DJ.%2BG.%26aulast%3DChang%26aufirst%3DW.%2BH.%26aulast%3DBallantyne%26aufirst%3DC.%26aulast%3DFonseca%26aufirst%3DF.%26aulast%3DNicolau%26aufirst%3DJ.%26aulast%3DKoenig%26aufirst%3DW.%26aulast%3DAnker%26aufirst%3DS.%2BD.%26aulast%3DKastelein%26aufirst%3DJ.%2BJ.%2BP.%26aulast%3DCornel%26aufirst%3DJ.%2BH.%26aulast%3DPais%26aufirst%3DP.%26aulast%3DPella%26aufirst%3DD.%26aulast%3DGenest%26aufirst%3DJ.%26aulast%3DCifkova%26aufirst%3DR.%26aulast%3DLorenzatti%26aufirst%3DA.%26aulast%3DForster%26aufirst%3DT.%26aulast%3DKobalava%26aufirst%3DZ.%26aulast%3DVida-Simiti%26aufirst%3DL.%26aulast%3DFlather%26aufirst%3DM.%26aulast%3DShimokawa%26aufirst%3DH.%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DDellborg%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DP.%2BR.%2BF.%26aulast%3DTroquay%26aufirst%3DR.%2BP.%2BT.%26aulast%3DLibby%26aufirst%3DP.%26aulast%3DGlynn%26aufirst%3DR.%2BJ.%26aulast%3DGroup%26aufirst%3DC.%2BT.%26atitle%3DAntiinflammatory%2520therapy%2520with%2520canakinumab%2520for%2520atherosclerotic%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2017%26volume%3D377%26spage%3D1119%26epage%3D1131%26doi%3D10.1056%2Fnejmoa1707914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ridker, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFadyen, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuren, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libby, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynn, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Group, C. T.</span></span> <span> </span><span class="NLM_article-title">Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">1833</span>– <span class="NLM_lpage">1842</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(17)32247-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2FS0140-6736%2817%2932247-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28855077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2gurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2017&pages=1833-1842&author=P.+M.+Ridkerauthor=J.+G.+MacFadyenauthor=T.+Thurenauthor=B.+M.+Everettauthor=P.+Libbyauthor=R.+J.+Glynnauthor=C.+T.+Group&title=Effect+of+interleukin-1%CE%B2+inhibition+with+canakinumab+on+incident+lung+cancer+in+patients+with+atherosclerosis%3A+exploratory+results+from+a+randomised%2C+double-blind%2C+placebo-controlled+trial&doi=10.1016%2FS0140-6736%2817%2932247-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomized, double-blind, placebo-controlled trial</span></div><div class="casAuthors">Ridker, Paul M.; MacFadyen, Jean G.; Thuren, Tom; Everett, Brendan M.; Libby, Peter; Glynn, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">390</span>
        (<span class="NLM_cas:issue">10105</span>),
    <span class="NLM_cas:pages">1833-1842</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Inflammation in the tumor microenvironment mediated by interleukin 1β is hypothesised to have a major role in cancer invasiveness, progression, and metastases.  We did an addnl. anal. in the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS), a randomized trial of the role of interleukin-1β inhibition in atherosclerosis, with the aim of establishing whether inhibition of a major product of the Nod-like receptor protein 3 (NLRP3) inflammasome with canakinumab might alter cancer incidence.  We did a randomized, double-blind, placebo-controlled trial of canakinumab in 10 061 patients with atherosclerosis who had had a myocardial infarction, were free of previously diagnosed cancer, and had concns. of high-sensitivity C-reactive protein (hsCRP) of 2 mg/L or greater.  To assess dose-response effects, patients were randomly assigned by computer-generated codes to three canakinumab doses (50 mg, 150 mg, and 300 mg, s.c. every 3 mo) or placebo.  Participants were followed up for incident cancer diagnoses, which were adjudicated by an oncol. endpoint committee masked to drug or dose allocation.  Anal. was by intention to treat.  The trial is registered with ClinicalTrials.gov, NCT01327846.  The trial is closed (the last patient visit was in June, 2017).  Baseline concns. of hsCRP (median 6·0 mg/L vs 4·2 mg/L; p<0·0001) and interleukin 6 (3·2 vs 2·6 ng/L; p<0·0001) were significantly higher among participants subsequently diagnosed with lung cancer than among those not diagnosed with cancer.  During median follow-up of 3·7 years, compared with placebo, canakinumab was assocd. with dose-dependent redns. in concns. of hsCRP of 26-41% and of interleukin 6 of 25-43% (p<0·0001 for all comparisons).  Total cancer mortality (n=196) was significantly lower in the pooled canakinumab group than in the placebo group (p=0·0007 for trend across groups), but was significantly lower than placebo only in the 300 mg group individually (hazard ratio [HR] 0·49 [95% CI 0·31-0·75]; p=0·0009).  Incident lung cancer (n=129) was significantly less frequent in the 150 mg (HR 0·61 [95% CI 0·39-0·97]; p=0·034) and 300 mg groups (HR 0·33 [95% CI 0·18-0·59]; p<0·0001; p<0·0001 for trend across groups).  Lung cancer mortality was significantly less common in the canakinumab 300 mg group than in the placebo group (HR 0·23 [95% CI 0·10-0·54]; p=0·0002) and in the pooled canakinumab population than in the placebo group (p=0·0002 for trend across groups).  Fatal infections or sepsis were significantly more common in the canakinumab groups than in the placebo group.  All-cause mortality did not differ significantly between the canakinumab and placebo groups (HR 0·94 [95% CI 0·83-1·06]; p=0·31).  Our hypothesis-generating data suggest the possibility that anti-inflammatory therapy with canakinumab targeting the interleukin-1β innate immunity pathway could significantly reduce incident lung cancer and lung cancer mortality.  Replication of these data in formal settings of cancer screening and treatment is required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxUhgLfpzhtbVg90H21EOLACvtfcHk0lhR3L5QURRvWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2gurvL&md5=d95abebf214508583dfb7f27c4e999af</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2932247-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252932247-X%26sid%3Dliteratum%253Aachs%26aulast%3DRidker%26aufirst%3DP.%2BM.%26aulast%3DMacFadyen%26aufirst%3DJ.%2BG.%26aulast%3DThuren%26aufirst%3DT.%26aulast%3DEverett%26aufirst%3DB.%2BM.%26aulast%3DLibby%26aufirst%3DP.%26aulast%3DGlynn%26aufirst%3DR.%2BJ.%26aulast%3DGroup%26aufirst%3DC.%2BT.%26atitle%3DEffect%2520of%2520interleukin-1%25CE%25B2%2520inhibition%2520with%2520canakinumab%2520on%2520incident%2520lung%2520cancer%2520in%2520patients%2520with%2520atherosclerosis%253A%2520exploratory%2520results%2520from%2520a%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DLancet%26date%3D2017%26volume%3D390%26spage%3D1833%26epage%3D1842%26doi%3D10.1016%2FS0140-6736%2817%2932247-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motro, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, G.</span></span> <span> </span><span class="NLM_article-title">NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>530</i></span>,  <span class="NLM_fpage">354</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1038/nature16959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fnature16959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=26814970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFyitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=530&publication_year=2016&pages=354-357&author=Y.+Heauthor=M.+Y.+Zengauthor=D.+Yangauthor=B.+Motroauthor=G.+N%C3%BA%C3%B1ez&title=NEK7+is+an+essential+mediator+of+NLRP3+activation+downstream+of+potassium+efflux&doi=10.1038%2Fnature16959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux</span></div><div class="casAuthors">He, Yuan; Zeng, Melody Y.; Yang, Dahai; Motro, Benny; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">530</span>
        (<span class="NLM_cas:issue">7590</span>),
    <span class="NLM_cas:pages">354-357</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inflammasomes are intracellular protein complexes that drive the activation of inflammatory caspases.  So far, four inflammasomes involving NLRP1, NLRP3, NLRC4 and AIM2 have been described that recruit the common adaptor protein ASC to activate caspase-1, leading to the secretion of mature IL-1β and IL-18 proteins.  The NLRP3 inflammasome has been implicated in the pathogenesis of several acquired inflammatory diseases as well as cryopyrin-assocd. periodic fever syndromes (CAPS) caused by inherited NLRP3 mutations.  Potassium efflux is a common step that is essential for NLRP3 inflammasome activation induced by many stimuli.  Despite extensive investigation, the mol. mechanism leading to NLRP3 activation in response to potassium efflux remains unknown.  Here the authors report the identification of NEK7, a member of the family of mammalian NIMA-related kinases (NEK proteins), as an NLRP3-binding protein that acts downstream of potassium efflux to regulate NLRP3 oligomerization and activation.  In the absence of NEK7, caspase-1 activation and IL-1β release were abrogated in response to signals that activate NLRP3, but not NLRC4 or AIM2 inflammasomes.  NLRP3-activating stimuli promoted the NLRP3-NEK7 interaction in a process that was dependent on potassium efflux.  NLRP3 assocd. with the catalytic domain of NEK7, but the catalytic activity of NEK7 was shown to be dispensable for activation of the NLRP3 inflammasome.  Activated macrophages formed a high-mol.-mass NLRP3-NEK7 complex, which, along with ASC oligomerization and ASC speck formation, was abrogated in the absence of NEK7.  NEK7 was required for macrophages contg. the CAPS-assocd. NLRP3(R258W) activating mutation to activate caspase-1.  Mouse chimeras reconstituted with wild-type, Nek7-/- or Nlrp3-/- hematopoietic cells showed that NEK7 was required for NLRP3 inflammasome activation in vivo.  These studies demonstrate that NEK7 is an essential protein that acts downstream of potassium efflux to mediate NLRP3 inflammasome assembly and activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcHD1JcxOIqrVg90H21EOLACvtfcHk0lhR3L5QURRvWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFyitbY%253D&md5=ff385d4ed4c8d8861059772c2cb26f19</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnature16959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature16959%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DM.%2BY.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DMotro%26aufirst%3DB.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DG.%26atitle%3DNEK7%2520is%2520an%2520essential%2520mediator%2520of%2520NLRP3%2520activation%2520downstream%2520of%2520potassium%2520efflux%26jtitle%3DNature%26date%3D2016%26volume%3D530%26spage%3D354%26epage%3D357%26doi%3D10.1038%2Fnature16959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">NEK7: a novel promising therapy target for NLRP3-related inflammatory diseases</span>. <i>Acta Biochim. Biophys. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">966</span>– <span class="NLM_lpage">968</span>, <span class="refDoi"> DOI: 10.1093/abbs/gmw080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1093%2Fabbs%2Fgmw080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=27563009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlalu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=966-968&author=J.+Xuauthor=L.+Luauthor=L.+Li&title=NEK7%3A+a+novel+promising+therapy+target+for+NLRP3-related+inflammatory+diseases&doi=10.1093%2Fabbs%2Fgmw080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">NEK7: a novel promising therapy target for NLRP3-related inflammatory diseases</span></div><div class="casAuthors">Xu, Jin; Lu, Liqun; Li, Lanfang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica et Biophysica Sinica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">966-968</span>CODEN:
                <span class="NLM_cas:coden">ABBSC2</span>;
        ISSN:<span class="NLM_cas:issn">1672-9145</span>.
    
            (<span class="NLM_cas:orgname">ABBS Editorial Office</span>)
        </div><div class="casAbstract">A review discussing NEK7 a novel promising therapy target for NLRP3-related inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ8zz8onqBvrVg90H21EOLACvtfcHk0lhG5OrrhGKbqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlalu7Y%253D&md5=7a0e702f00aac3bec701e4510f7b5a9b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1093%2Fabbs%2Fgmw080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fabbs%252Fgmw080%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DNEK7%253A%2520a%2520novel%2520promising%2520therapy%2520target%2520for%2520NLRP3-related%2520inflammatory%2520diseases%26jtitle%3DActa%2520Biochim.%2520Biophys.%2520Sin.%26date%3D2016%26volume%3D48%26spage%3D966%26epage%3D968%26doi%3D10.1093%2Fabbs%2Fgmw080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamkanfi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Inflammasomes and their roles in health and disease</span>. <i>Annu. Rev. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1146/annurev-cellbio-101011-155745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1146%2Fannurev-cellbio-101011-155745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=22974247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslagtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2012&pages=137-161&author=M.+Lamkanfiauthor=V.+M.+Dixit&title=Inflammasomes+and+their+roles+in+health+and+disease&doi=10.1146%2Fannurev-cellbio-101011-155745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammasomes and their roles in health and disease</span></div><div class="casAuthors">Lamkanfi, Mohamed; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell and Developmental Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">137-161</span>CODEN:
                <span class="NLM_cas:coden">ARDBF8</span>;
        ISSN:<span class="NLM_cas:issn">1081-0706</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Inflammasomes are a set of intracellular protein complexes that enable autocatalytic activation of inflammatory caspases, which drive host and immune responses by releasing cytokines and alarmins into circulation and by inducing pyroptosis, a proinflammatory cell death mode.  The inflammasome type mediating these responses varies with the microbial pathogen or stress factor that poses a threat to the organism.  Since the discovery that polymorphisms in inflammasome genes are linked to common autoimmune diseases and less frequent periodic fever syndromes, inflammasome signaling has been dissected at the mol. level.  In this review, we present recently gained insight on the distinct inflammasome types, their activation and effector mechanisms, and their modulation by microbial virulence factors.  In addn., we discuss recently gained knowledge on the role of deregulated inflammasome activity in human autoinflammatory, autoimmune, and infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXur5D3kH6ALVg90H21EOLACvtfcHk0lhG5OrrhGKbqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslagtb3J&md5=a81d32647c7a9a8f710b38e0965a7f57</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1146%2Fannurev-cellbio-101011-155745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-cellbio-101011-155745%26sid%3Dliteratum%253Aachs%26aulast%3DLamkanfi%26aufirst%3DM.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DInflammasomes%2520and%2520their%2520roles%2520in%2520health%2520and%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D2012%26volume%3D28%26spage%3D137%26epage%3D161%26doi%3D10.1146%2Fannurev-cellbio-101011-155745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tardivel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorens, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span> <span> </span><span class="NLM_article-title">Thioredoxin-interacting protein links oxidative stress to inflammasome activation</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1038/ni.1831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fni.1831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=20023662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFyhsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=136-140&author=R.+Zhouauthor=A.+Tardivelauthor=B.+Thorensauthor=I.+Choiauthor=J.+Tschopp&title=Thioredoxin-interacting+protein+links+oxidative+stress+to+inflammasome+activation&doi=10.1038%2Fni.1831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Thioredoxin-interacting protein links oxidative stress to inflammasome activation</span></div><div class="casAuthors">Zhou, Rongbin; Tardivel, Aubry; Thorens, Bernard; Choi, Inpyo; Tschopp, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">136-140</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The NLRP3 inflammasome has a major role in regulating innate immunity.  Deregulated inflammasome activity is assocd. with several inflammatory diseases, yet little is known about the signaling pathways that lead to its activation.  Here the authors show that NLRP3 interacted with thioredoxin (TRX)-interacting protein (TXNIP), a protein linked to insulin resistance.  Inflammasome activators such as uric acid crystals induced the dissocn. of TXNIP from thioredoxin in a reactive oxygen species (ROS)-sensitive manner and allowed it to bind NLRP3.  TXNIP deficiency impaired activation of the NLRP3 inflammasome and subsequent secretion of interleukin 1β (IL-1β).  Akin to Txnip-/- mice, Nlrp3-/- mice showed improved glucose tolerance and insulin sensitivity.  The participation of TXNIP in the NLRP3 inflammasome activation may provide a mechanistic link to the obsd. involvement of IL-1β in the pathogenesis of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph6WgKbKxmNLVg90H21EOLACvtfcHk0lhG5OrrhGKbqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFyhsLrJ&md5=70a8f699c4e13fefc96a80fa75ae5a20</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fni.1831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1831%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DTardivel%26aufirst%3DA.%26aulast%3DThorens%26aufirst%3DB.%26aulast%3DChoi%26aufirst%3DI.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DThioredoxin-interacting%2520protein%2520links%2520oxidative%2520stress%2520to%2520inflammasome%2520activation%26jtitle%3DNat.%2520Immunol.%26date%3D2010%26volume%3D11%26spage%3D136%26epage%3D140%26doi%3D10.1038%2Fni.1831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span> <span> </span><span class="NLM_article-title">Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2550</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-04947-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fs41467-018-04947-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=29959312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FjsVKrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=2550&author=H.+Heauthor=H.+Jiangauthor=Y.+Chenauthor=J.+Yeauthor=A.+Wangauthor=C.+Wangauthor=Q.+Liuauthor=G.+Liangauthor=X.+Dengauthor=W.+Jiangauthor=R.+Zhou&title=Oridonin+is+a+covalent+NLRP3+inhibitor+with+strong+anti-inflammasome+activity&doi=10.1038%2Fs41467-018-04947-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity</span></div><div class="casAuthors">He Hongbin; Jiang Hua; Ye Jin; Wang Chao; Jiang Wei; Zhou Rongbin; He Hongbin; Zhou Rongbin; Chen Yun; Deng Xianming; Wang Aoli; Liu Qingsong; Liang Gaolin</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2550</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oridonin (Ori) is the major active ingredient of the traditional Chinese medicinal herb Rabdosia rubescens and has anti-inflammatory activity, but the target of Ori remains unknown.  NLRP3 is a central component of NLRP3 inflammasome and has been involved in a wide variety of chronic inflammation-driven human diseases.  Here, we show that Ori is a specific and covalent inhibitor for NLRP3 inflammasome.  Ori forms a covalent bond with the cysteine 279 of NLRP3 in NACHT domain to block the interaction between NLRP3 and NEK7, thereby inhibiting NLRP3 inflammasome assembly and activation.  Importantly, Ori has both preventive or therapeutic effects on mouse models of peritonitis, gouty arthritis and type 2 diabetes, via inhibition of NLRP3 activation.  Our results thus identify NLRP3 as the direct target of Ori for mediating Ori's anti-inflammatory activity.  Ori could serve as a lead for developing new therapeutics against NLRP3-driven diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfgXJ7_Tz1NrZpSb_XWfMrfW6udTcc2eZ589f_vESCILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FjsVKrsA%253D%253D&md5=d041a8a1af6dc9fc6c0166ebf446799d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-04947-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-04947-6%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DR.%26atitle%3DOridonin%2520is%2520a%2520covalent%2520NLRP3%2520inhibitor%2520with%2520strong%2520anti-inflammasome%2520activity%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D2550%26doi%3D10.1038%2Fs41467-018-04947-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, F.</span></span> <span> </span><span class="NLM_article-title">Chemical probing reveals insights into the signaling mechanism of inflammasome activation</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1289</span>– <span class="NLM_lpage">1305</span>, <span class="refDoi"> DOI: 10.1038/cr.2010.135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fcr.2010.135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=20856264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWqu7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1289-1305&author=Y.-N.+Gongauthor=X.+Wangauthor=J.+Wangauthor=Z.+Yangauthor=S.+Liauthor=J.+Yangauthor=L.+Liuauthor=X.+Leiauthor=F.+Shao&title=Chemical+probing+reveals+insights+into+the+signaling+mechanism+of+inflammasome+activation&doi=10.1038%2Fcr.2010.135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical probing reveals insights into the signaling mechanism of inflammasome activation</span></div><div class="casAuthors">Gong, Yi-Nan; Wang, Xiaoming; Wang, Jiayi; Yang, Zhenxiao; Li, Shan; Yang, Jieling; Liu, Liping; Lei, Xiaoguang; Shao, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1289-1305</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Caspase-1-mediated IL-1β prodn. is generally controlled by two pathways.  Toll-like receptors (TLRs) recognize pathogen-derived products and induce NF-κB-dependent pro-IL-1β transcription; NOD-like receptors (NLRs) assemble caspase-1-activating inflammasome complexes that sense bacterial products/danger signals.  Through a targeted chem. screen, we identify bromoxone, a marine natural product, as a specific and potent inhibitor of the caspase-1 pathway.  Bromoxone is effective over diverse inflammatory stimuli including TLR ligands plus ATP/nigericin, cytosolic DNA, flagellin and Bacillus anthracis lethal toxin.  Bromoxone also efficiently suppresses caspase-1 activation triggered by several types of bacterial infection.  Bromoxone acts upstream or at the level of the inflammasome in a transcription-independent manner.  Bromoxone also inhibits pro-IL-1β expression by targeting components upstream of IKK in the TLR-NF-κB pathway.  The unique dual activities of bromoxone are shared by the known TAK1 inhibitor that specifically blocks Nalp3 inflammasome activation.  Hinted from the mechanistic and pharmacol. properties of bromoxone, we further discover that several known NF-κB inhibitors that act upstream of IKK, but not those targeting IKK or IKK downstream, are potent blockers of different NLRs-mediated caspase-1 activation.  Our study uncovers a possible non-transcriptional mol. link between the NLR (Nalp3)-mediated inflammasome pathway and TLR-NF-κB signaling, and suggests a potential strategy to develop new anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppjC16zIWsMbVg90H21EOLACvtfcHk0lgmyjuJRirQDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWqu7nP&md5=efe3462264b2a58c9d54fd8fee8a06b1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.135%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DY.-N.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DShao%26aufirst%3DF.%26atitle%3DChemical%2520probing%2520reveals%2520insights%2520into%2520the%2520signaling%2520mechanism%2520of%2520inflammasome%2520activation%26jtitle%3DCell%2520Res.%26date%3D2010%26volume%3D20%26spage%3D1289%26epage%3D1305%26doi%3D10.1038%2Fcr.2010.135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, D. Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new berberine derivatives as cancer immunotherapy agents through targeting IDO1</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">1858</span>– <span class="NLM_lpage">1868</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.10.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.ejmech.2017.10.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=29133053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWntLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=1858-1868&author=Y.+X.+Wangauthor=W.+Q.+Pangauthor=Q.+X.+Zengauthor=Z.+S.+Dengauthor=T.+Y.+Fanauthor=J.+D.+Jiangauthor=H.+B.+Dengauthor=D.+Q.+Song&title=Synthesis+and+biological+evaluation+of+new+berberine+derivatives+as+cancer+immunotherapy+agents+through+targeting+IDO1&doi=10.1016%2Fj.ejmech.2017.10.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new berberine derivatives as cancer immunotherapy agents through targeting IDO1</span></div><div class="casAuthors">Wang, Yan-Xiang; Pang, Wei-Qiang; Zeng, Qing-Xuan; Deng, Zhe-Song; Fan, Tian-Yun; Jiang, Jian-Dong; Deng, Hong-Bin; Song, Dan-Qing</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1858-1868</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To discover small-mol. cancer immunotherapy candidates through targeting Indoleamine 2,3-dioxygenase 1 (IDO1), twenty-five new berberine (BBR) derivs. defined with substituents on position 3 or 9 were synthesized and examd. for repression of IFN-γ-induced IDO1 promoter activities.  Structure-activity relationship (SAR) indicated that large vol. groups at the 9-position might be beneficial for potency.  Among them, several compds. exhibited increased activities, with inhibition rate of 71-90% compared with BBR.  Their effects on IDO1 expression were further confirmed by protein level as well.  Furthermore, two compds. exhibited anticancer activity by enhancing the specific lysis of NK cells to A549 through IDO1, but not cytotoxicity.  Preliminary mechanism revealed that both of them inhibited IFN-γ-induced IDO1 expression through activating AMPK and subsequent inhibition of STAT1 phosphorylation.  Therefore, the two compds. have been selected as IDO1 modulators for small-mol. cancer immunotherapy for next investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1E45i_TsGWLVg90H21EOLACvtfcHk0lgmyjuJRirQDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWntLrK&md5=4da11c693f294bdc4c07e2fa10f5d303</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.10.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.10.078%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BX.%26aulast%3DPang%26aufirst%3DW.%2BQ.%26aulast%3DZeng%26aufirst%3DQ.%2BX.%26aulast%3DDeng%26aufirst%3DZ.%2BS.%26aulast%3DFan%26aufirst%3DT.%2BY.%26aulast%3DJiang%26aufirst%3DJ.%2BD.%26aulast%3DDeng%26aufirst%3DH.%2BB.%26aulast%3DSong%26aufirst%3DD.%2BQ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%2520berberine%2520derivatives%2520as%2520cancer%2520immunotherapy%2520agents%2520through%2520targeting%2520IDO1%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D143%26spage%3D1858%26epage%3D1868%26doi%3D10.1016%2Fj.ejmech.2017.10.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, M. E.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a tag-free chemical probe for photoaffinity labeling</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2007</i></span>,  <span class="NLM_fpage">4711</span>– <span class="NLM_lpage">4720</span>, <span class="refDoi"> DOI: 10.1002/ejoc.200700188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1002%2Fejoc.200700188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2007&publication_year=2007&pages=4711-4720&author=T.+Mayerauthor=M.+E.+Maier&title=Design+and+synthesis+of+a+tag-free+chemical+probe+for+photoaffinity+labeling&doi=10.1002%2Fejoc.200700188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200700188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200700188%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DT.%26aulast%3DMaier%26aufirst%3DM.%2BE.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520tag-free%2520chemical%2520probe%2520for%2520photoaffinity%2520labeling%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2007%26volume%3D2007%26spage%3D4711%26epage%3D4720%26doi%3D10.1002%2Fejoc.200700188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, L.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, H.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, K.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, P.-F.</span></span> <span> </span><span class="NLM_article-title">Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E5986</span>– <span class="NLM_lpage">E5994</span>, <span class="refDoi"> DOI: 10.1073/pnas.1706778114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1073%2Fpnas.1706778114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28674004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSmtrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E5986-E5994&author=L.-X.+Liaoauthor=X.-M.+Songauthor=L.-C.+Wangauthor=H.-N.+Lvauthor=J.-F.+Chenauthor=D.+Liuauthor=G.+Fuauthor=M.-B.+Zhaoauthor=Y.+Jiangauthor=K.-W.+Zengauthor=P.-F.+Tu&title=Highly+selective+inhibition+of+IMPDH2+provides+the+basis+of+antineuroinflammation+therapy&doi=10.1073%2Fpnas.1706778114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy</span></div><div class="casAuthors">Liao, Li-Xi; Song, Xiao-Min; Wang, Li-Chao; Lv, Hai-Ning; Chen, Jin-Feng; Liu, Dan; Fu, Ge; Zhao, Ming-Bo; Jiang, Yong; Zeng, Ke-Wu; Tu, Peng-Fei</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">E5986-E5994</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inosine monophosphate dehydrogenase (IMPDH) of human is an attractive target for immunosuppressive agents.  Currently, small-mol. inhibitors do not show good selectivity for different IMPDH isoforms (IMPDH1 and IMPDH2), resulting in some adverse effects, which limit their use.  Herein, we used a small-mol. probe specifically targeting IMPDH2 and identified Cysteine residue 140 (Cys140) as a selective druggable site.  On covalently binding to Cys140, the probe exerts an allosteric regulation to block the catalytic pocket of IMPDH2 and further induces IMPDH2 inactivation, leading to an effective suppression of neuroinflammatory responses.  However, the probe does not covalently bind to IMPDH1.  Taken together, our study shows Cys140 as a druggable site for selectively inhibiting IMPDH2, which provides great potential for development of therapy agents for autoimmune and neuroinflammatory diseases with less unfavorable tolerability profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Ye3vnWJhirVg90H21EOLACvtfcHk0livVm4cQGpCpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSmtrfO&md5=c527f08deaef9d821fe3428c8c16ad83</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1706778114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1706778114%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DL.-X.%26aulast%3DSong%26aufirst%3DX.-M.%26aulast%3DWang%26aufirst%3DL.-C.%26aulast%3DLv%26aufirst%3DH.-N.%26aulast%3DChen%26aufirst%3DJ.-F.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DFu%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DM.-B.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DK.-W.%26aulast%3DTu%26aufirst%3DP.-F.%26atitle%3DHighly%2520selective%2520inhibition%2520of%2520IMPDH2%2520provides%2520the%2520basis%2520of%2520antineuroinflammation%2520therapy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3DE5986%26epage%3DE5994%26doi%3D10.1073%2Fpnas.1706778114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donadi, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bologa, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Lazikani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span> <span> </span><span class="NLM_article-title">A comprehensive map of molecular drug targets</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fnrd.2016.230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=27910877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVSms7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=19-34&author=R.+Santosauthor=O.+Ursuauthor=A.+Gaultonauthor=A.+P.+Bentoauthor=R.+S.+Donadiauthor=C.+G.+Bologaauthor=A.+Karlssonauthor=B.+Al-Lazikaniauthor=A.+Herseyauthor=T.+I.+Opreaauthor=J.+P.+Overington&title=A+comprehensive+map+of+molecular+drug+targets&doi=10.1038%2Fnrd.2016.230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive map of molecular drug targets</span></div><div class="casAuthors">Santos, Rita; Ursu, Oleg; Gaulton, Anna; Bento, A. Patricia; Donadi, Ramesh S.; Bologa, Cristian G.; Karlsson, Anneli; Al-Lazikani, Bissan; Hersey, Anne; Oprea, Tudor I.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-34</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The success of mechanism-based drug discovery depends on the definition of the drug target.  This definition becomes even more important as we try to link drug response to genetic variation, understand stratified clin. efficacy and safety, rationalize the differences between drugs in the same therapeutic class and predict drug utility in patient subgroups.  However, drug targets are often poorly defined in the literature, both for launched drugs and for potential therapeutic agents in discovery and development.  Here, we present an updated comprehensive map of mol. targets of approved drugs.  We curate a total of 893 human and pathogen-derived biomols. through which 1,578 US FDA-approved drugs act.  These biomols. include 667 human-genome-derived proteins targeted by drugs for human disease.  Anal. of these drug targets indicates the continued dominance of privileged target families across disease areas, but also the growth of novel first-in-class mechanisms, particularly in oncol.  We explore the relationships between bioactivity class and clin. success, as well as the presence of orthologues between human and animal models and between pathogen and human genomes.  Through the collaboration of three independent teams, we highlight some of the ongoing challenges in accurately defining the targets of mol. therapeutics and present conventions for deconvoluting the complexities of mol. pharmacol. and drug efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTfWwWkoZnbrVg90H21EOLACvtfcHk0livVm4cQGpCpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVSms7rK&md5=7437d4b678ac75dac0a5e3248df98761</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.230%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DR.%26aulast%3DUrsu%26aufirst%3DO.%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DDonadi%26aufirst%3DR.%2BS.%26aulast%3DBologa%26aufirst%3DC.%2BG.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DA%2520comprehensive%2520map%2520of%2520molecular%2520drug%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D19%26epage%3D34%26doi%3D10.1038%2Fnrd.2016.230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lafferty-Whyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mormeneo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Fresno
Marimon, M.</span></span> <span> </span><span class="NLM_article-title">Opportunities and challenges of the 2016 target landscape</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fnrd.2016.263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=27980340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsl2ktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=10-11&author=K.+Lafferty-Whyteauthor=D.+Mormeneoauthor=M.+Del+Fresno%0AMarimon&title=Opportunities+and+challenges+of+the+2016+target+landscape&doi=10.1038%2Fnrd.2016.263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Trial watch Opportunities and challenges of the 2016 target landscape</span></div><div class="casAuthors">Lafferty-Whyte, Kyle; Mormeneo, David; del Fresno Marimon, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-11</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_2vJUgPIFrVg90H21EOLACvtfcHk0livVm4cQGpCpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsl2ktg%253D%253D&md5=55ef7648b80f23e4da99ceb92bf40db1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.263%26sid%3Dliteratum%253Aachs%26aulast%3DLafferty-Whyte%26aufirst%3DK.%26aulast%3DMormeneo%26aufirst%3DD.%26aulast%3DDel%2BFresno%2BMarimon%26aufirst%3DM.%26atitle%3DOpportunities%2520and%2520challenges%2520of%2520the%25202016%2520target%2520landscape%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D10%26epage%3D11%26doi%3D10.1038%2Fnrd.2016.263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcsisin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">Structures of PGAM5 Provide Insight into Active Site Plasticity and Multimeric Assembly</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1089</span>– <span class="NLM_lpage">1099</span>, <span class="refDoi"> DOI: 10.1016/j.str.2017.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.str.2017.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28648608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVOjtr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1089-1099&author=A.+Chaikuadauthor=P.+Filippakopoulosauthor=S.+R.+Marcsisinauthor=S.+Picaudauthor=M.+Schr%C3%B6derauthor=S.+Sekineauthor=H.+Ichijoauthor=J.+R.+Engenauthor=K.+Takedaauthor=S.+Knapp&title=Structures+of+PGAM5+Provide+Insight+into+Active+Site+Plasticity+and+Multimeric+Assembly&doi=10.1016%2Fj.str.2017.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of PGAM5 Provide Insight into Active Site Plasticity and Multimeric Assembly</span></div><div class="casAuthors">Chaikuad, Apirat; Filippakopoulos, Panagis; Marcsisin, Sean R.; Picaud, Sarah; Schroeder, Martin; Sekine, Shiori; Ichijo, Hidenori; Engen, John R.; Takeda, Kohsuke; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1089-1099.e3</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">PGAM5 is a mitochondrial membrane protein that functions as an atypical Ser/Thr phosphatase and is a regulator of oxidative stress response, necroptosis, and autophagy.  Here we present several crystal structures of PGAM5 including the activating N-terminal regulatory sequences, providing a model for structural plasticity, dimerization of the catalytic domain, and the assembly into an enzymically active dodecameric form.  Oligomeric states obsd. in structures were supported by hydrogen exchange mass spectrometry, size-exclusion chromatog., and anal. ultracentrifugation expts. in soln.  We report that the catalytically important N-terminal WDPNWD motif acts as a structural integrator assembling PGAM5 into a dodecamer, allosterically activating the phosphatase by promoting an ordering of the catalytic loop.  Addnl. the obsd. active site plasticity enabled visualization of essential conformational rearrangements of catalytic elements.  The comprehensive biophys. characterization offers detailed structural models of this key mitochondrial phosphatase that has been assocd. with the development of diverse diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuIcOHKWyNx7Vg90H21EOLACvtfcHk0liHqt2vAVdtFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVOjtr3N&md5=e39b0adb63106a9441e195f7d6ad779c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2017.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2017.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DMarcsisin%26aufirst%3DS.%2BR.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DM.%26aulast%3DSekine%26aufirst%3DS.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DStructures%2520of%2520PGAM5%2520Provide%2520Insight%2520into%2520Active%2520Site%2520Plasticity%2520and%2520Multimeric%2520Assembly%26jtitle%3DStructure%26date%3D2017%26volume%3D25%26spage%3D1089%26epage%3D1099%26doi%3D10.1016%2Fj.str.2017.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurnasov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomchick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binns, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grishin, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquez, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osterman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">13148</span>– <span class="NLM_lpage">13154</span>, <span class="refDoi"> DOI: 10.1074/jbc.m111469200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1074%2Fjbc.M111469200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=11788603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFSjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=13148-13154&author=T.+Zhouauthor=O.+Kurnasovauthor=D.+R.+Tomchickauthor=D.+D.+Binnsauthor=N.+V.+Grishinauthor=V.+E.+Marquezauthor=A.+L.+Ostermanauthor=H.+Zhang&title=Structure+of+human+nicotinamide%2Fnicotinic+acid+mononucleotide+adenylyltransferase.+Basis+for+the+dual+substrate+specificity+and+activation+of+the+oncolytic+agent+tiazofurin&doi=10.1074%2Fjbc.m111469200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin</span></div><div class="casAuthors">Zhou, Tianjun; Kurnasov, Oleg; Tomchick, Diana R.; Binns, Derk D.; Grishin, Nick V.; Marquez, Victor E.; Osterman, Andrei L.; Zhang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">13148-13154</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nicotinamide/nicotinate mononucleotide (NMN/NaMN)adenylyltransferase (NMNAT) is an indispensable enzyme in the biosynthesis of NAD+ and NADP+.  Human NMNAT displays unique dual substrate specificity toward both NMN and NaMN, thus flexible in participating in both de novo and salvage pathways of NAD synthesis.  Human NMNAT also catalyzes the rate-limiting step of the metabolic conversion of the anticancer agent tiazofurin to its active form tiazofurin adenine dinucleotide (TAD).  The tiazofurin resistance is mainly assocd. with the low NMNAT activity in the cell.  We have solved the crystal structures of human NMNAT in complex with NAD, deamido-NAD, and a non-hydrolyzable TAD analog β-CH2-TAD.  These complex structures delineate the broad substrate specificity of the enzyme toward both NMN and NaMN and reveal the structural mechanism for adenylation of tiazofurin nucleotide.  The crystal structure of human NMNAT also shows that it forms a barrel-like hexamer with the predicted nuclear localization signal sequence located on the outside surface of the barrel, supporting its functional role of interacting with the nuclear transporting proteins.  The results from the anal. ultracentrifugation studies are consistent with the formation of a hexamer in soln. under certain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrac3zSglWuLLVg90H21EOLACvtfcHk0liHqt2vAVdtFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFSjt74%253D&md5=09bb80db010adff5f2c516d060801d0b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111469200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111469200%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DKurnasov%26aufirst%3DO.%26aulast%3DTomchick%26aufirst%3DD.%2BR.%26aulast%3DBinns%26aufirst%3DD.%2BD.%26aulast%3DGrishin%26aufirst%3DN.%2BV.%26aulast%3DMarquez%26aufirst%3DV.%2BE.%26aulast%3DOsterman%26aufirst%3DA.%2BL.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DStructure%2520of%2520human%2520nicotinamide%252Fnicotinic%2520acid%2520mononucleotide%2520adenylyltransferase.%2520Basis%2520for%2520the%2520dual%2520substrate%2520specificity%2520and%2520activation%2520of%2520the%2520oncolytic%2520agent%2520tiazofurin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D13148%26epage%3D13154%26doi%3D10.1074%2Fjbc.m111469200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koizumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inagaki, F.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the specificity, catalysis, and regulation of human uridine-cytidine kinase</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">764</span>, <span class="refDoi"> DOI: 10.1016/j.str.2004.02.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.str.2004.02.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=15130468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVamsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=751-764&author=N.+N.+Suzukiauthor=K.+Koizumiauthor=M.+Fukushimaauthor=A.+Matsudaauthor=F.+Inagaki&title=Structural+basis+for+the+specificity%2C+catalysis%2C+and+regulation+of+human+uridine-cytidine+kinase&doi=10.1016%2Fj.str.2004.02.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Specificity, Catalysis, and Regulation of Human Uridine-Cytidine Kinase</span></div><div class="casAuthors">Suzuki, Nobuo N.; Koizumi, Katsuhisa; Fukushima, Masanori; Matsuda, Akira; Inagaki, Fuyuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">751-764</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Uridine-cytidine kinase (UCK) catalyzes the phosphorylation of uridine and cytidine and activates pharmacol. ribonucleoside analogs.  Here we present the crystal structures of human UCK alone and in complexes with a substrate, cytidine, a feedback inhibitor, CTP or UTP, and with phosphorylation products, CMP and ADP, resp.  Free UCK takes an α/β mononucleotide binding fold and exists as a homotetramer with 222 symmetry.  Upon inhibitor binding, one loop region was loosened, causing the UCK tetramer to be distorted.  Upon cytidine binding, a large induced fit was obsd. at the uridine/cytidine binding site, which endows UCK with a strict specificity for pyrimidine ribonucleosides.  The first UCK structure provided the structural basis for the specificity, catalysis, and regulation of human uridine-cytidine kinase, which give clues for the design of novel antitumor and antiviral ribonucleoside analogs that inhibit RNA synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMSToRoYA7obVg90H21EOLACvtfcHk0liHqt2vAVdtFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVamsr4%253D&md5=52972cc765bd6f7ebf2a15e5f8498aaa</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2004.02.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2004.02.038%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DN.%2BN.%26aulast%3DKoizumi%26aufirst%3DK.%26aulast%3DFukushima%26aufirst%3DM.%26aulast%3DMatsuda%26aufirst%3DA.%26aulast%3DInagaki%26aufirst%3DF.%26atitle%3DStructural%2520basis%2520for%2520the%2520specificity%252C%2520catalysis%252C%2520and%2520regulation%2520of%2520human%2520uridine-cytidine%2520kinase%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D751%26epage%3D764%26doi%3D10.1016%2Fj.str.2004.02.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richards, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Regan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mas-Droux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blot, J. M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, R.</span></span> <span> </span><span class="NLM_article-title">An autoinhibitory tyrosine motif in the cell-cycle-regulated Nek7 kinase is released through binding of Nek9</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2009.09.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.molcel.2009.09.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=19941817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFWnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=560-570&author=M.+W.+Richardsauthor=L.+O%E2%80%99Reganauthor=C.+Mas-Drouxauthor=J.+M.+Y.+Blotauthor=J.+Cheungauthor=S.+Hoelderauthor=A.+M.+Fryauthor=R.+Bayliss&title=An+autoinhibitory+tyrosine+motif+in+the+cell-cycle-regulated+Nek7+kinase+is+released+through+binding+of+Nek9&doi=10.1016%2Fj.molcel.2009.09.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">An autoinhibitory tyrosine motif in the cell-cycle-regulated Nek7 kinase is released through binding of Nek9</span></div><div class="casAuthors">Richards, Mark W.; O'Regan, Laura; Mas-Droux, Corine; Blot, Joelle M. Y.; Cheung, Jack; Hoelder, Swen; Fry, Andrew M.; Bayliss, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">560-570</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Mitosis is controlled by multiple protein kinases, many of which are abnormally expressed in human cancers.  Nek2, Nek6, Nek7, and Nek9 are NIMA-related kinases essential for proper mitotic progression.  We detd. the at. structure of Nek7 and discovered an autoinhibited conformation that suggests a regulatory mechanism not previously described in kinases.  Addnl., Nek2 adopts the same conformation when bound to a drug-like mol.  In both structures, a tyrosine side chain points into the active site, interacts with the activation loop, and blocks the αC helix.  Tyrosine mutants of Nek7 and the related kinase Nek6 are constitutively active.  The activity of Nek6 and Nek7, but not the tyrosine mutant, is increased by interaction with the Nek9 noncatalytic C-terminal domain, suggesting a mechanism in which the tyrosine is released from its autoinhibitory position.  The autoinhibitory conformation is common to three Neks and provides a potential target for selective kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-_yOHUGTAiLVg90H21EOLACvtfcHk0lipsuXSDty25A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFWnsQ%253D%253D&md5=f44726d978afcadbf9e7387ede8fa012</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2009.09.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2009.09.038%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DM.%2BW.%26aulast%3DO%25E2%2580%2599Regan%26aufirst%3DL.%26aulast%3DMas-Droux%26aufirst%3DC.%26aulast%3DBlot%26aufirst%3DJ.%2BM.%2BY.%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DFry%26aufirst%3DA.%2BM.%26aulast%3DBayliss%26aufirst%3DR.%26atitle%3DAn%2520autoinhibitory%2520tyrosine%2520motif%2520in%2520the%2520cell-cycle-regulated%2520Nek7%2520kinase%2520is%2520released%2520through%2520binding%2520of%2520Nek9%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D36%26spage%3D560%26epage%3D570%26doi%3D10.1016%2Fj.molcel.2009.09.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liew, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Z. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Q.</span></span> <span> </span><span class="NLM_article-title">Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">10111</span>, <span class="refDoi"> DOI: 10.1038/ncomms10111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fncomms10111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=26694030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVynsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=10111&author=J.+Wangauthor=C.+J.+Zhangauthor=W.+N.+Chiaauthor=C.+C.+Lohauthor=Z.+Liauthor=Y.+M.+Leeauthor=Y.+Heauthor=L.+X.+Yuanauthor=T.+K.+Limauthor=M.+Liuauthor=C.+X.+Liewauthor=Y.+Q.+Leeauthor=J.+Zhangauthor=N.+Luauthor=C.+T.+Limauthor=Z.+C.+Huaauthor=B.+Liuauthor=H.+M.+Shenauthor=K.+S.+Tanauthor=Q.+Lin&title=Haem-activated+promiscuous+targeting+of+artemisinin+in+Plasmodium+falciparum&doi=10.1038%2Fncomms10111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum</span></div><div class="casAuthors">Wang, Jigang; Zhang, Chong-Jing; Chia, Wan Ni; Loh, Cheryl C. Y.; Li, Zhengjun; Lee, Yew Mun; He, Yingke; Yuan, Li-Xia; Lim, Teck Kwang; Liu, Min; Liew, Chin Xia; Lee, Yan Quan; Zhang, Jianbin; Lu, Nianci; Lim, Chwee Teck; Hua, Zi-Chun; Liu, Bin; Shen, Han-Ming; Tan, Kevin S. W.; Lin, Qingsong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10111</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mechanism of action of artemisinin and its derivs., the most potent of the anti-malarial drugs, is not completely understood.  Here we present an unbiased chem. proteomics anal. to directly explore this mechanism in Plasmodium falciparum.  We use an alkyne-tagged artemisinin analog coupled with biotin to identify 124 artemisinin covalent binding protein targets, many of which are involved in the essential biol. processes of the parasite.  Such a broad targeting spectrum disrupts the biochem. landscape of the parasite and causes its death.  Furthermore, using alkyne-tagged artemisinin coupled with a fluorescent dye to monitor protein binding, we show that haem, rather than free ferrous iron, is predominantly responsible for artemisinin activation.  The haem derives primarily from the parasite's haem biosynthesis pathway at the early ring stage and from Hb digestion at the latter stages.  Our results support a unifying model to explain the action and specificity of artemisinin in parasite killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsYEHWprDdeLVg90H21EOLACvtfcHk0lipsuXSDty25A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVynsLjO&md5=a532a76cdd2f33b0ca23e733e6247a0c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fncomms10111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10111%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%2BJ.%26aulast%3DChia%26aufirst%3DW.%2BN.%26aulast%3DLoh%26aufirst%3DC.%2BC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DL.%2BX.%26aulast%3DLim%26aufirst%3DT.%2BK.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLiew%26aufirst%3DC.%2BX.%26aulast%3DLee%26aufirst%3DY.%2BQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DN.%26aulast%3DLim%26aufirst%3DC.%2BT.%26aulast%3DHua%26aufirst%3DZ.%2BC.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DShen%26aufirst%3DH.%2BM.%26aulast%3DTan%26aufirst%3DK.%2BS.%26aulast%3DLin%26aufirst%3DQ.%26atitle%3DHaem-activated%2520promiscuous%2520targeting%2520of%2520artemisinin%2520in%2520Plasmodium%2520falciparum%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D10111%26doi%3D10.1038%2Fncomms10111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belham, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avruch, J.</span></span> <span> </span><span class="NLM_article-title">A Mitotic Cascade of NIMA Family Kinases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">34897</span>– <span class="NLM_lpage">34909</span>, <span class="refDoi"> DOI: 10.1074/jbc.m303663200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1074%2Fjbc.M303663200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=12840024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVWqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=34897-34909&author=C.+Belhamauthor=J.+Roigauthor=J.+A.+Caldwellauthor=Y.+Aoyamaauthor=B.+E.+Kempauthor=M.+Combauthor=J.+Avruch&title=A+Mitotic+Cascade+of+NIMA+Family+Kinases&doi=10.1074%2Fjbc.m303663200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A Mitotic Cascade of NIMA Family Kinases: Nercc1/Nek9 Activates THE Nek6 AND Nek7 Kinases</span></div><div class="casAuthors">Belham, Christopher; Roig, Joan; Caldwell, Jennifer A.; Aoyama, Yumi; Kemp, Bruce E.; Comb, Michael; Avruch, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">34897-34909</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The Nek family of protein kinases in humans is composed of 11 members that share an amino-terminal catalytic domain related to NIMA, an Aspergillus kinase involved in the control of several aspects of mitosis, and divergent carboxyl-terminal tails of varying length.  Nek6 (314AA) and Nek7 (303AA), 76% identical, have little noncatalytic sequence but bind to the carboxyl-terminal noncatalytic tail of Nercc1/Nek9, a NIMA family protein kinase that is activated in mitosis.  Microinjection of anti-Nercc1 antibodies leads to spindle abnormalities and prometaphase arrest or chromosome missegregation.  Herein we show that Nek6 is increased in abundance and activity during mitosis; activation requires the phosphorylation of Ser206 on the Nek6 activation loop.  This phosphorylation and the activity of recombinant Nek6 is stimulated by coexpression with an activated mutant of Nercc1.  Moreover, Nercc1 catalyzes the direct phosphorylation of prokaryotic recombinant Nek6 at Ser206 in vitro concomitant with 20-25-fold activation of Nek6 activity; Nercc1 activates Nek7 in vitro in a similar manner.  Nercc1/Nek9 is likely to be responsible for the activation of Nek6 during mitosis and probably participates in the regulation of Nek7 as well.  These findings support the conclusion that Nercc1/Nek9 and Nek6 represent a novel cascade of mitotic NIMA family protein kinases whose combined function is important for mitotic progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3XdKs42nzO7Vg90H21EOLACvtfcHk0liBFbdr068SrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVWqsbs%253D&md5=819b13884b15b079e0d10582021a2fbb</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M303663200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M303663200%26sid%3Dliteratum%253Aachs%26aulast%3DBelham%26aufirst%3DC.%26aulast%3DRoig%26aufirst%3DJ.%26aulast%3DCaldwell%26aufirst%3DJ.%2BA.%26aulast%3DAoyama%26aufirst%3DY.%26aulast%3DKemp%26aufirst%3DB.%2BE.%26aulast%3DComb%26aufirst%3DM.%26aulast%3DAvruch%26aufirst%3DJ.%26atitle%3DA%2520Mitotic%2520Cascade%2520of%2520NIMA%2520Family%2520Kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D34897%26epage%3D34909%26doi%3D10.1074%2Fjbc.m303663200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magupalli, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreeva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauenstein, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span> <span> </span><span class="NLM_article-title">Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>570</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1295-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fs41586-019-1295-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=31189953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFKgs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=570&publication_year=2019&pages=338-343&author=H.+Sharifauthor=L.+Wangauthor=W.+L.+Wangauthor=V.+G.+Magupalliauthor=L.+Andreevaauthor=Q.+Qiaoauthor=A.+V.+Hauensteinauthor=Z.+Wuauthor=G.+N%C3%BA%C3%B1ezauthor=Y.+Maoauthor=H.+Wu&title=Structural+mechanism+for+NEK7-licensed+activation+of+NLRP3+inflammasome&doi=10.1038%2Fs41586-019-1295-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome</span></div><div class="casAuthors">Sharif, Humayun; Wang, Li; Wang, Wei Li; Magupalli, Venkat Giri; Andreeva, Liudmila; Qiao, Qi; Hauenstein, Arthur V.; Wu, Zhaolong; Nunez, Gabriel; Mao, Youdong; Wu, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">570</span>
        (<span class="NLM_cas:issue">7761</span>),
    <span class="NLM_cas:pages">338-343</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The NLRP3 inflammasome can be activated by stimuli that include nigericin, uric acid crystals, amyloid-β fibrils and extracellular ATP.  The mitotic kinase NEK7 licenses the assembly and activation of the NLRP3 inflammasome in interphase.  Here we report a cryo-electron microscopy structure of inactive human NLRP3 in complex with NEK7, at a resoln. of 3.8 Å.  The earring-shaped NLRP3 consists of curved leucine-rich-repeat and globular NACHT domains, and the C-terminal lobe of NEK7 nestles against both NLRP3 domains.  Structural recognition between NLRP3 and NEK7 is confirmed by mutagenesis both in vitro and in cells.  Modeling of an active NLRP3-NEK7 conformation based on the NLRC4 inflammasome predicts an addnl. contact between an NLRP3-bound NEK7 and a neighboring NLRP3.  Mutations to this interface abolish the ability of NEK7 or NLRP3 to rescue NLRP3 activation in NEK7-knockout or NLRP3-knockout cells.  These data suggest that NEK7 bridges adjacent NLRP3 subunits with bipartite interactions to mediate the activation of the NLRP3 inflammasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKz2yqOHis9bVg90H21EOLACvtfcHk0liBFbdr068SrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFKgs7vP&md5=e6d535e4d91e360ce82c1f4327e10e24</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1295-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1295-z%26sid%3Dliteratum%253Aachs%26aulast%3DSharif%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DW.%2BL.%26aulast%3DMagupalli%26aufirst%3DV.%2BG.%26aulast%3DAndreeva%26aufirst%3DL.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DHauenstein%26aufirst%3DA.%2BV.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DG.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DStructural%2520mechanism%2520for%2520NEK7-licensed%2520activation%2520of%2520NLRP3%2520inflammasome%26jtitle%3DNature%26date%3D2019%26volume%3D570%26spage%3D338%26epage%3D343%26doi%3D10.1038%2Fs41586-019-1295-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span> <span> </span><span class="NLM_article-title">Berberine inhibits the LPS-induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling pathway</span>. <i>Exp. Ther. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">6125</span>– <span class="NLM_lpage">6130</span>, <span class="refDoi"> DOI: 10.3892/etm.2017.5316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.3892%2Fetm.2017.5316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=29285168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2jsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=6125-6130&author=L.+Liuauthor=L.+Chenauthor=C.+Jiangauthor=J.+Guoauthor=Y.+Xieauthor=L.+Kangauthor=Z.+Cheng&title=Berberine+inhibits+the+LPS-induced+proliferation+and+inflammatory+response+of+stromal+cells+of+adenomyosis+tissues+mediated+by+the+LPS%2FTLR4+signaling+pathway&doi=10.3892%2Fetm.2017.5316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine inhibits the LPS-induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling pathway</span></div><div class="casAuthors">Liu, Li; Chen, Li; Jiang, Caixia; Guo, Jing; Xie, Yan; Kang, Le; Cheng, Zhongping</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Therapeutic Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">6125-6130</span>CODEN:
                <span class="NLM_cas:coden">ETMXA2</span>;
        ISSN:<span class="NLM_cas:issn">1792-1015</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">A previous study by our group has demonstrated that lipopolysaccharide (LPS) induces adenomyosis through stimulating inflammatory cell proliferation and invasive growth of stromal cells via Toll-like receptor 4 (TLR4) signaling.  The present study aimed to investigate the effects of berberine (BBR) on LPS-induced ectopic endometrial stromal cells (EESCs) isolated from patients with adenomyosis.  The viability of EESCs treated with LPS or LPS plus BBR was detected by a cell counting kit-8 assay, and the cell cycle distribution and apoptosis were evaluated by flow cytometry.  The effect of BBR on the expression of key mols. of inflammatory proliferation and invasive growth of LPS-induced EESCs was also evaluated.  BBR significantly inhibited the LPS-induced proliferation of EESCs in a dose- and time-dependent manner.  BBR induced cell cycle arrest in G0/G1 phase and enhanced apoptosis of LPS-induced EESCs.  Furthermore, BBR inhibited the expression of interleukin (IL)-6, IL-8, transforming growth factor-β, epithelial growth factor, vascular endothelial growth factor and matrix metalloproteinase 2 in LPS-induced EESCs.  To the best of our knowledge, the present study was the first to demonstrate that BBR has a protective effect on ameliorating the LPS-induced progression of adenomyosis.  This result may provide a novel therapeutic strategy for the clin. treatment of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXIiGR5RJPk7Vg90H21EOLACvtfcHk0liBFbdr068SrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2jsb7K&md5=2c0e04bad4a05037f06b1ec818e6a341</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3892%2Fetm.2017.5316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fetm.2017.5316%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DKang%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DZ.%26atitle%3DBerberine%2520inhibits%2520the%2520LPS-induced%2520proliferation%2520and%2520inflammatory%2520response%2520of%2520stromal%2520cells%2520of%2520adenomyosis%2520tissues%2520mediated%2520by%2520the%2520LPS%252FTLR4%2520signaling%2520pathway%26jtitle%3DExp.%2520Ther.%2520Med.%26date%3D2017%26volume%3D14%26spage%3D6125%26epage%3D6130%26doi%3D10.3892%2Fetm.2017.5316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, W.</span></span> <span> </span><span class="NLM_article-title">Berberine suppresses LPS-induced inflammation through modulating Sirt1/NF-κB signaling pathway in RAW264.7 cells</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2017.08.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.intimp.2017.08.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28888780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOhsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2017&pages=93-100&author=H.+Zhangauthor=Y.+Shanauthor=Y.+Wuauthor=C.+Xuauthor=X.+Yuauthor=J.+Zhaoauthor=J.+Yanauthor=W.+Shang&title=Berberine+suppresses+LPS-induced+inflammation+through+modulating+Sirt1%2FNF-%CE%BAB+signaling+pathway+in+RAW264.7+cells&doi=10.1016%2Fj.intimp.2017.08.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine suppresses LPS-induced inflammation through modulating Sirt1/NF-κB signaling pathway in RAW264.7 cells</span></div><div class="casAuthors">Zhang, Hao; Shan, Yun; Wu, Yun; Xu, Chuanchong; Yu, Xizhong; Zhao, Juan; Yan, Jing; Shang, Wenbin</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-100</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Chronic inflammation is a major contributing factor in the pathogenesis of many diseases.  Natural product berberine (BBR) exhibits potent anti-inflammatory effect in vitro and in vivo, while the underlying mechanisms remain elusive.  Sirt1, a NAD+-dependent protein deacetylase, was recently found to play an important role in modulating the development and progression of inflammation.  Thus, we speculate that Sirt1 might mediate the inhibitory effect of BBR on inflammation.  In LPS-stimulated RAW264.7 macrophages, BBR treatment significantly downregulated the expression of proinflammatory cytokines such as MCP-1, IL-6 and TNF-α.  Importantly, BBR potently reversed LPS-induced down-regulation of Sirt1.  Consistently, the inhibitory effects of BBR on proinflammatory cytokines expression was largely abrogated by Sirt1 inhibition either by EX527, a Sirt1 inhibitor or Sirt1 siRNA.  Further mechanistic studies revealed that BBR-induced inhibition of NF-κB is Sirt1-dependent, as either pharmacol. or genetically inactivating Sirt1 enhanced the IκΒα degrdn., IKK phosphorylation, NF-κB p65 acetylation and DNA-binding activity.  Taken together, our results provide the first evidence that BBR potently suppressed inflammatory responses in macrophages through inhibition of NF-κB signaling via Sirt1-dependent mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoySSx700k9_rVg90H21EOLACvtfcHk0liGmMyZYBZgVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOhsb%252FI&md5=fbce2640e79ec916c8f311729cddb1d9</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2017.08.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2017.08.032%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DShan%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DShang%26aufirst%3DW.%26atitle%3DBerberine%2520suppresses%2520LPS-induced%2520inflammation%2520through%2520modulating%2520Sirt1%252FNF-%25CE%25BAB%2520signaling%2520pathway%2520in%2520RAW264.7%2520cells%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2017%26volume%3D52%26spage%3D93%26epage%3D100%26doi%3D10.1016%2Fj.intimp.2017.08.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vivoli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piombanti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provenzano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narducci, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannaioni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moneti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marra, F.</span></span> <span> </span><span class="NLM_article-title">NLRP3 inflammasome as a target of berberine in experimental murine liver injury: interference with P2X7 signalling</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">1793</span>– <span class="NLM_lpage">1806</span>, <span class="refDoi"> DOI: 10.1042/cs20160400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1042%2FCS20160400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWrtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2016&pages=1793-1806&author=E.+Vivoliauthor=A.+Capponauthor=S.+Milaniauthor=B.+Piombantiauthor=A.+Provenzanoauthor=E.+Novoauthor=A.+Masiauthor=N.+Navariauthor=R.+Narducciauthor=G.+Mannaioniauthor=G.+Monetiauthor=C.+P.+Oliveiraauthor=M.+Parolaauthor=F.+Marra&title=NLRP3+inflammasome+as+a+target+of+berberine+in+experimental+murine+liver+injury%3A+interference+with+P2X7+signalling&doi=10.1042%2Fcs20160400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">NLRP3 inflammasome as a target of berberine in experimental murine liver injury: interference with P2X7 signalling</span></div><div class="casAuthors">Vivoli, Elisa; Cappon, Andrea; Milani, Stefano; Piombanti, Benedetta; Provenzano, Angela; Novo, Erica; Masi, Alessio; Navari, Nadia; Narducci, Roberto; Mannaioni, Guido; Moneti, Gloriano; Oliveira, Claudia P.; Parola, Maurizio; Marra, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1793-1806</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Berberine (BRB) is commonly used in herbal medicine, but its mechanisms of action are poorly understood.  In the present study, we tested BRB in steatohepatitis induced by a methionine- and choline-deficient (MCD) diet, in acute acetaminophen intoxication and in cultured murine macrophages.  BRB markedly improved parameters of liver injury and necroinflammation induced by the MCD diet, although increased mortality was obsd. by mechanisms independent of bacterial infections or plasma levels of BRB.  The MCD diet induced up-regulation of all components of the NLRP3 (NACHT, LRR and PYD domain-contg. protein 3) inflammasome, and increased hepatic levels of mature IL-1 β (interleukin 1 β).  All of these parameters were significantly reduced in mice treated with BRB.  In mice administered an acetaminophen overdose, a model dependent on inflammasome activation, BRB reduced mortality and ALT (alanine aminotransferase) elevation, and limited the expression of inflammasome components.  In vitro, LPS (lipopolysaccharide)-induced activation of NLRP3 inflammasome in RAW264.7 murine macrophages was markedly decreased by pre-incubation with BRB.  BRB significantly limited the activation of the purinergic receptor P2X7, involved in the late phases of inflammasome activation.  Upon P2X7 knockdown, the ability of BRB to block LPS-induced secretion of IL-1 β was lost.  These data indicate that administration of BRB ameliorates inflammation and injury in two unrelated murine models of liver damage.  We demonstrate for the first time that BRB interferes with activation of the NLRP3 inflammasome pathway in vivo and in vitro, through a mechanism based on interference with activation of P2X7, a purinergic receptor involved in inflammasome activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv0vWMAKKJILVg90H21EOLACvtfcHk0liGmMyZYBZgVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWrtb3I&md5=3d80c338e8512b66a0ddc7a0dba1b28d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1042%2FCS20160400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20160400%26sid%3Dliteratum%253Aachs%26aulast%3DVivoli%26aufirst%3DE.%26aulast%3DCappon%26aufirst%3DA.%26aulast%3DMilani%26aufirst%3DS.%26aulast%3DPiombanti%26aufirst%3DB.%26aulast%3DProvenzano%26aufirst%3DA.%26aulast%3DNovo%26aufirst%3DE.%26aulast%3DMasi%26aufirst%3DA.%26aulast%3DNavari%26aufirst%3DN.%26aulast%3DNarducci%26aufirst%3DR.%26aulast%3DMannaioni%26aufirst%3DG.%26aulast%3DMoneti%26aufirst%3DG.%26aulast%3DOliveira%26aufirst%3DC.%2BP.%26aulast%3DParola%26aufirst%3DM.%26aulast%3DMarra%26aufirst%3DF.%26atitle%3DNLRP3%2520inflammasome%2520as%2520a%2520target%2520of%2520berberine%2520in%2520experimental%2520murine%2520liver%2520injury%253A%2520interference%2520with%2520P2X7%2520signalling%26jtitle%3DClin.%2520Sci.%26date%3D2016%26volume%3D130%26spage%3D1793%26epage%3D1806%26doi%3D10.1042%2Fcs20160400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell</span>. <i>BMC Complementary Altern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">216</span>, <span class="refDoi"> DOI: 10.1186/s12906-019-2615-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1186%2Fs12906-019-2615-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=31412862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A280%3ADC%252BB3MvotVSgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&pages=216&author=M.+Yaoauthor=X.+Fanauthor=B.+Yuanauthor=N.+Takagiauthor=S.+Liuauthor=X.+Hanauthor=J.+Renauthor=J.+Liu&title=Berberine+inhibits+NLRP3+Inflammasome+pathway+in+human+triple-negative+breast+cancer+MDA-MB-231+cell&doi=10.1186%2Fs12906-019-2615-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell</span></div><div class="casAuthors">Yao Mingjiang; Fan Xiaodi; Liu Sai; Han Xiao; Ren Junguo; Liu Jianxun; Yao Mingjiang; Fan Xiaodi; Liu Sai; Han Xiao; Ren Junguo; Liu Jianxun; Yuan Bo; Takagi Norio</div><div class="citationInfo"><span class="NLM_cas:title">BMC complementary and alternative medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">216</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Breast cancer is still the most common malignant tumor that threatens the female's life in the world, especially triple-negative breast cancer (TNBC), one of the most difficult subtypes.  Lack of targeted therapies brings about urgent demand for novel treatments.  In this study we aim to investigate the anti-tumor activity of Berberine (BBR), a Chinese plant-derived alkaloid, against the TNBC cell line MDA-MB-231 and elucidate its mechanism referring to anti-inflammation.  METHODS:  Cell inhibition rate was measured by Cell Proliferation Assay, the cytotoxic effects was detected by Lactate dehydrogenase (LDH) leakage assay, the colony formation and migration potential were evaluated by colony formation assay and wound healing assay, the release of inflammatory cytokines was detected by EMD multifactor detection, and alterations of proteins and genes related to the NLR family pyrin domain containing 3 (NLRP3) inflammasome pathway were analyzed using western blotting and real-time Polymerase Chain Reaction (PCR).  RESULTS:  BBR reduce the viability of MDA-MB-231 cells and increased the release of LDH from the cells in a dose-dependent manner, with and inhibition of colony formation potential and migration of the cells.  BBR also caused a marked reduction in the secretion of proinflammatory cytokines, Interleukin-1α (IL-1α), Interleukin-1β (IL-1β), Interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α).  Besides, a down-regulated behavior was observed with the expression of P2X purinoceptor 7 (P2X7), NLRP3, pro-caspase-1, apoptosis-associated speck-like protein containing a caspase-activation and recruitment domain (ASC), caspase-1 p20, Interleukin-18 (IL-18), IL-1β proteins and NLRP3, Caspase-1 and ASC mRNAs in the NLRP3 inflammasome cascade.  CONCLUSIONS:  Our results confirmed that BBR can effectively affect both tumor outgrowth and spontaneous metastasis in TNBC, and that we identified a new mechanism associated with inhibition the NLRP3 inflammasome pathway, suggesting its potential therapeutic relevance in clinical use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTtPOdZuvheesve_zCu79I8fW6udTcc2eYeExXuy1qr3bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvotVSgsw%253D%253D&md5=298fe0bf90e618ea3410b93312c1932b</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1186%2Fs12906-019-2615-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12906-019-2615-4%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DB.%26aulast%3DTakagi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DBerberine%2520inhibits%2520NLRP3%2520Inflammasome%2520pathway%2520in%2520human%2520triple-negative%2520breast%2520cancer%2520MDA-MB-231%2520cell%26jtitle%3DBMC%2520Complementary%2520Altern.%2520Med.%26date%3D2019%26volume%3D19%26spage%3D216%26doi%3D10.1186%2Fs12906-019-2615-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, S. H.</span></span> <span> </span><span class="NLM_article-title">Effects of Berberine on NLRP3 and IL-1beta expressions in monocytic THP-1 cells with monosodium urate crystals-induced inflammation</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">2503703</span>, <span class="refDoi"> DOI: 10.1155/2016/2503703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1155%2F2016%2F2503703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=27689075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A280%3ADC%252BC2svovVCmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=2503703&author=Y.+F.+Liuauthor=C.+Y.+Wenauthor=Z.+Chenauthor=Y.+Wangauthor=Y.+Huangauthor=S.+H.+Tu&title=Effects+of+Berberine+on+NLRP3+and+IL-1beta+expressions+in+monocytic+THP-1+cells+with+monosodium+urate+crystals-induced+inflammation&doi=10.1155%2F2016%2F2503703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Berberine on NLRP3 and IL-1β Expressions in Monocytic THP-1 Cells with Monosodium Urate Crystals-Induced Inflammation</span></div><div class="casAuthors">Liu Ya-Fei; Wen Cai-Yu-Zhu; Chen Zhe; Wang Yu; Huang Ying; Tu Sheng-Hao</div><div class="citationInfo"><span class="NLM_cas:title">BioMed research international</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2503703</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Background.  Urate crystals-induced inflammation is a critical factor during the initiation of gouty arthritis.  Berberine is well known for its anti-inflammatory activity.  However, the underlying effects of berberine on monosodium urate crystals-induced inflammation remain obscure.  Objectives.  This study is set to explore the protective effect and mechanism of berberine on monosodium urate crystals-induced inflammation in human monocytic THP-1 cells.  Methods.  The mRNA levels of NLRP3 and IL-1β were measured by Real-Time PCR, and the protein levels of NLRP3 and IL-1β were determined by ELISA, Western blot, and immunofluorescence.  Results.  The NLRP3 and IL-1β expressions were significantly increased in model group compared to that in normal group (P < 0.05).  Meanwhile, there was significant reduction in the expressions of NLRP3 and IL-1β mRNA in groups 6.25 μM berberine and 25 μM berberine when compared with model group (P < 0.05).  Conclusions.  Therefore, berberine alleviates monosodium urate crystals-induced inflammation by downregulating NLRP3 and IL-1β expressions.  The regulatory effects of berberine may be related to the inactivation of NLRP3 inflammasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRiLVV98luOElWTCLT8lX9SfW6udTcc2ebjw0of7giFW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svovVCmsQ%253D%253D&md5=defe28ac39a3e35503de6584d088854c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1155%2F2016%2F2503703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F2503703%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%2BF.%26aulast%3DWen%26aufirst%3DC.%2BY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DTu%26aufirst%3DS.%2BH.%26atitle%3DEffects%2520of%2520Berberine%2520on%2520NLRP3%2520and%2520IL-1beta%2520expressions%2520in%2520monocytic%2520THP-1%2520cells%2520with%2520monosodium%2520urate%2520crystals-induced%2520inflammation%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2016%26volume%3D2016%26spage%3D2503703%26doi%3D10.1155%2F2016%2F2503703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinesh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasool, M.</span></span> <span> </span><span class="NLM_article-title">Berberine, an isoquinoline alkaloid suppresses TXNIP mediated NLRP3 inflammasome activation in MSU crystal stimulated RAW 264.7 macrophages through the upregulation of Nrf2 transcription factor and alleviates MSU crystal induced inflammation in rats</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2016.12.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.intimp.2016.12.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28068647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsVyktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2017&pages=26-37&author=P.+Dineshauthor=M.+Rasool&title=Berberine%2C+an+isoquinoline+alkaloid+suppresses+TXNIP+mediated+NLRP3+inflammasome+activation+in+MSU+crystal+stimulated+RAW+264.7+macrophages+through+the+upregulation+of+Nrf2+transcription+factor+and+alleviates+MSU+crystal+induced+inflammation+in+rats&doi=10.1016%2Fj.intimp.2016.12.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine, an isoquinoline alkaloid suppresses TXNIP mediated NLRP3 inflammasome activation in MSU crystal stimulated RAW 264.7 macrophages through the upregulation of Nrf2 transcription factor and alleviates MSU crystal induced inflammation in rats</span></div><div class="casAuthors">Dinesh, Palani; Rasool, MahaboobKhan</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-37</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The current study was designed to investigate the therapeutic potential of berberine on monosodium urate (MSU) crystal stimulated RAW 264.7 macrophages and in MSU crystal induced rats.  Our results indicate that berberine (25, 50 and 75 μM) suppressed the levels of pro-inflammatory cytokines (interleukin-1beta (IL-1β) and tumor necrosis factor alpha (TNFα)) and intracellular reactive oxygen species in MSU crystal stimulated RAW 264.7 macrophages.  The mRNA expression levels of IL-1β, caspase 1, nucleotide-binding oligomerization domain-like receptor pyrin domain contg. 3 (NLRP3), thioredoxin interacting protein (TXNIP) and kelch-like ECH-assocd. protein 1 (Keap1) were found downregulated with the upregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) transcription factor and its assocd. anti-oxidant enzymes: Heme oxygenase I (HO-1), superoxide dismutase (SOD1), glutathione peroxidase (GPx), NADPH quinone oxidoreductase-1 (NQO1) and catalase (CAT) in MSU crystal stimulated RAW 264.7 macrophages upon berberine treatment.  Subsequently, western blot anal. revealed that berberine decreased the protein expression of IL-1β and caspase 1 and increased Nrf2 expression in RAW 264.7 macrophages.  Immunofluorescence anal. also explored increased expression of Nrf2 in MSU crystal stimulated RAW 264.7 macrophages by berberine treatment.  In addn., the paw edema, pain score, pro-inflammatory cytokines (IL-1β and TNFα) and articular elastase activity were found significantly reduced in berberine (50 mg/kg b·wt) administered MSU crystal-induced rats.  Conclusively, our current findings suggest that berberine may represent as a potential candidate for the treatment of gouty arthritis by suppressing inflammatory mediators and activating Nrf2 anti-oxidant pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGproz_gsU6__rVg90H21EOLACvtfcHk0liPH7rgzpDTMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsVyktQ%253D%253D&md5=de900f890d65715ed7e2f4102f1ea093</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2016.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2016.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DDinesh%26aufirst%3DP.%26aulast%3DRasool%26aufirst%3DM.%26atitle%3DBerberine%252C%2520an%2520isoquinoline%2520alkaloid%2520suppresses%2520TXNIP%2520mediated%2520NLRP3%2520inflammasome%2520activation%2520in%2520MSU%2520crystal%2520stimulated%2520RAW%2520264.7%2520macrophages%2520through%2520the%2520upregulation%2520of%2520Nrf2%2520transcription%2520factor%2520and%2520alleviates%2520MSU%2520crystal%2520induced%2520inflammation%2520in%2520rats%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2017%26volume%3D44%26spage%3D26%26epage%3D37%26doi%3D10.1016%2Fj.intimp.2016.12.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.-J.</span></span> <span> </span><span class="NLM_article-title">Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1779</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.033936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1124%2Fdmd.110.033936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=20634337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1eisLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1779-1784&author=Y.-T.+Liuauthor=H.-P.+Haoauthor=H.-G.+Xieauthor=L.+Laiauthor=Q.+Wangauthor=C.-X.+Liuauthor=G.-J.+Wang&title=Extensive+intestinal+first-pass+elimination+and+predominant+hepatic+distribution+of+berberine+explain+its+low+plasma+levels+in+rats&doi=10.1124%2Fdmd.110.033936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats</span></div><div class="casAuthors">Liu, Yi-Tong; Hao, Hai-Ping; Xie, Hong-Guang; Lai, Li; Wang, Qiong; Liu, Chang-Xiao; Wang, Guang-Ji</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1779-1784</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Berberine, one of the most commonly used natural products, exhibits a poor plasma concn.-effect relationship whose underlying mechanisms remain largely unclear.  This study was designed to test the hypothesis that extensive first-pass elimination and abundant tissue distribution of berberine may be its specific pharmacokinetic properties.  For that, four different dosing routes, intragastric, intraduodenal, intraportal, and i.v., were used to investigate the gastric, intestinal, and hepatic first-pass elimination of berberine.  After intragastric dosing, approx. half of berberine ran intact through the gastrointestinal tract and another half was disposed of by the small intestine, leading to an extremely low extent of abs. oral bioavailability in rats (0.36%).  Moreover, the major berberine metabolites were identified and quantified in rat enterocyte S9 fractions, portal vein plasma, and intestinal perfusates; plasma concns. and tissue distribution of berberine and its major metabolites were detd. as well.  Data indicated that M1, M2 glucuronide, and M3 were the major metabolites generated from the small intestine and that there was a 70-fold increase in the ratio of the area under the concn.-time curve value for berberine (liver vs. plasma).  We conclude that intestinal first-pass elimination of berberine is the major barrier of its oral bioavailability and that its high extn. and distribution in the liver could be other important factors that lead to its low plasma levels in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSRl-e66RvrrVg90H21EOLACvtfcHk0liPH7rgzpDTMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1eisLnP&md5=21dc5c66ad38611e86f0f28f01bd5867</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.033936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.033936%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DHao%26aufirst%3DH.-P.%26aulast%3DXie%26aufirst%3DH.-G.%26aulast%3DLai%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.-X.%26aulast%3DWang%26aufirst%3DG.-J.%26atitle%3DExtensive%2520intestinal%2520first-pass%2520elimination%2520and%2520predominant%2520hepatic%2520distribution%2520of%2520berberine%2520explain%2520its%2520low%2520plasma%2520levels%2520in%2520rats%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D1779%26epage%3D1784%26doi%3D10.1124%2Fdmd.110.033936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shou, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-D.</span></span> <span> </span><span class="NLM_article-title">Tissue distribution of berberine and its metabolites after oral administration in rats</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e77969</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0077969</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1371%2Fjournal.pone.0077969" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=24205048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsleqt7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=X.-S.+Tanauthor=J.-Y.+Maauthor=R.+Fengauthor=C.+Maauthor=W.-J.+Chenauthor=Y.-P.+Sunauthor=J.+Fuauthor=M.+Huangauthor=C.-Y.+Heauthor=J.-W.+Shouauthor=W.-Y.+Heauthor=Y.+Wangauthor=J.-D.+Jiang&title=Tissue+distribution+of+berberine+and+its+metabolites+after+oral+administration+in+rats&doi=10.1371%2Fjournal.pone.0077969"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue distribution of berberine and its metabolites after oral administration in rats</span></div><div class="casAuthors">Tan, Xiang-Shan; Ma, Jing-Yi; Feng, Ru; Ma, Chao; Chen, Wen-Jing; Sun, Yu-Peng; Fu, Jie; Huang, Min; He, Chi-Yu; Shou, Jia-Wen; He, Wen-Yi; Wang, Yan; Jiang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e77969</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Berberine (BBR) has been confirmed to have multiple bioactivities in clinic, such as cholesterol-lowering, anti-diabetes, cardiovascular protection and anti-inflammation.  However, BBR's plasma level is very low; it cannot explain its pharmacol. effects in patients.  We consider that the in vivo distribution of BBR as well as of its bioactive metabolites might provide part of the explanation for this question.  In this study, liq. chromatog. coupled to ion trap time-of-flight mass spectrometry (LC/MSn-IT-TOF) as well as liq. chromatog. that coupled with tandem mass spectrometry (LC-MS/MS) was used for the study of tissue distribution and pharmacokinetics of BBR in rats after oral administration (200 mg/kg).  The results indicated that BBR was quickly distributed in the liver, kidneys, muscle, lungs, brain, heart, pancreas and fat in a descending order of its amt.  The pharmacokinetic profile indicated that BBR's level in most of studied tissues was higher (or much higher) than that in plasma 4 h after administration.  BBR remained relatively stable in the tissues like liver, heart, brain, muscle, pancreas etc.  Organ distribution of BBR's metabolites was also investigated paralleled with that of BBR.  Thalifendine (M1), berberrubine (M2) and jatrorrhizine (M4), which the metabolites with moderate bioactivity, were easily detected in organs like the liver and kidney.  For instance, M1, M2 and M4 were the major metabolites in the liver, among which the percentage of M2 was up to 65.1%; the level of AUC(0-t) (area under the concn.-time curve) for BBR or the metabolites in the liver was 10-fold or 30-fold higher than that in plasma, resp.  In summary, the organ concn. of BBR (as well as its bioactive metabolites) was higher than its concn. in the blood after oral administration.  It might explain BBR's pharmacol. effects on human diseases in clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTzoRHHPfq0LVg90H21EOLACvtfcHk0liPH7rgzpDTMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsleqt7zK&md5=44801c62ae509198ae45bdf6726828a7</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0077969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0077969%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DX.-S.%26aulast%3DMa%26aufirst%3DJ.-Y.%26aulast%3DFeng%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DW.-J.%26aulast%3DSun%26aufirst%3DY.-P.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DC.-Y.%26aulast%3DShou%26aufirst%3DJ.-W.%26aulast%3DHe%26aufirst%3DW.-Y.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DJ.-D.%26atitle%3DTissue%2520distribution%2520of%2520berberine%2520and%2520its%2520metabolites%2520after%2520oral%2520administration%2520in%2520rats%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0077969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, G.</span></span> <span> </span><span class="NLM_article-title">Update on berberine in nonalcoholic Fatty liver disease</span>. <i>J. Evidence-Based Complementary Altern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">308134</span>, <span class="refDoi"> DOI: 10.1155/2013/308134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1155%2F2013%2F308134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=23843872" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=308134&author=Y.+Liuauthor=L.+Zhangauthor=H.+Songauthor=G.+Ji&title=Update+on+berberine+in+nonalcoholic+Fatty+liver+disease&doi=10.1155%2F2013%2F308134"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1155%2F2013%2F308134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F308134%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DG.%26atitle%3DUpdate%2520on%2520berberine%2520in%2520nonalcoholic%2520Fatty%2520liver%2520disease%26jtitle%3DJ.%2520Evidence-Based%2520Complementary%2520Altern.%2520Med.%26date%3D2013%26volume%3D2013%26spage%3D308134%26doi%3D10.1155%2F2013%2F308134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, J.</span></span> <span> </span><span class="NLM_article-title">Identification of berberine as a novel drug for the treatment of multiple myeloma via targeting UHRF1</span>. <i>BMC Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">33</span>, <span class="refDoi"> DOI: 10.1186/s12915-020-00766-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1186%2Fs12915-020-00766-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=32213189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslSjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2020&pages=33&author=C.+Guauthor=Z.+Yinauthor=H.+Nieauthor=Y.+Liuauthor=J.+Yangauthor=G.+Huangauthor=J.+Shenauthor=L.+Chenauthor=J.+Fei&title=Identification+of+berberine+as+a+novel+drug+for+the+treatment+of+multiple+myeloma+via+targeting+UHRF1&doi=10.1186%2Fs12915-020-00766-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of berberine as a novel drug for the treatment of multiple myeloma via targeting UHRF1</span></div><div class="casAuthors">Gu, Chunming; Yin, Zhao; Nie, Hong; Liu, Yanjun; Yang, Juhua; Huang, Guiping; Shen, Jianping; Chen, Liguo; Fei, Jia</div><div class="citationInfo"><span class="NLM_cas:title">BMC Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33</span>CODEN:
                <span class="NLM_cas:coden">BBMIF7</span>;
        ISSN:<span class="NLM_cas:issn">1741-7007</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Abstr.: Background: Current therapies for multiple myeloma (MM) are assocd. with toxicity and resistance, highlighting the need for novel effective therapeutics.  Berberine (BBR), a botanical alkaloid derived from several Berberis medicinal plants, has exhibited anti-tumor effects, including against multiple myeloma (MM); however, the mol. mechanism underlying the anti-MM effect has not been previously described.  This study aimed to identify the target of berberine and related mechanisms involved in its therapeutic activity against MM.  Results: Here, we demonstrated that BBR treatment killed MM cells in vitro and prolonged the survival of mice bearing MM xenografts in vivo.  A screening approach integrating surface plasmon resonance (SPR) with liq. chromatog.-tandem mass spectrometry (LC-MS/MS) identified UHRF1 (ubiquitin-like with PHD and RING Finger domains 1) as a potential target of BBR.  Combining mol. docking and SPR anal., we confirmed UHRF1 as a BBR-binding protein and discovered that BBR binds UHRF1 in the tandem tudor domain and plant homeodomain (TTD-PHD domain).  BBR treatment induced UHRF1 degrdn. via the ubiquitin-dependent proteasome system and reactivated p16INK4A and p73 in MM cells.  Overexpression of UHRF1 promoted the MM cell proliferation and rendered MM cells more resistant to BBR, while silencing of UHRF1 with siRNA attenuated BBR-induced cytotoxicity.  Conclusions: In summary, our study has identified UHRF1 as a direct target of BBR and uncovered mol. mechanisms involved in the anti-MM activity of BBR.  Targeting UHRF1 through BBR may be a novel therapeutic strategy against MM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsQMzWkih-nbVg90H21EOLACvtfcHk0li9eR4wEbeUrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslSjt70%253D&md5=122544c61520be962411dfb600aff4fc</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1186%2Fs12915-020-00766-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12915-020-00766-8%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DC.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DNie%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DFei%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520berberine%2520as%2520a%2520novel%2520drug%2520for%2520the%2520treatment%2520of%2520multiple%2520myeloma%2520via%2520targeting%2520UHRF1%26jtitle%3DBMC%2520Biol.%26date%3D2020%26volume%3D18%26spage%3D33%26doi%3D10.1186%2Fs12915-020-00766-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yi, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inn, K.-S.</span></span> <span> </span><span class="NLM_article-title">Identification of actin as a direct proteomic target of berberine using an affinity-based chemical probe and elucidation of its modulatory role in actin assembly</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7045</span>– <span class="NLM_lpage">7047</span>, <span class="refDoi"> DOI: 10.1039/c7cc02789c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1039%2FC7CC02789C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28653701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXps1Gnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=7045-7047&author=C.-M.+Yiauthor=J.+Yuauthor=H.+Kimauthor=N.-R.+Leeauthor=S.+W.+Kimauthor=N.-J.+Leeauthor=J.+Leeauthor=J.+Seongauthor=N.-J.+Kimauthor=K.-S.+Inn&title=Identification+of+actin+as+a+direct+proteomic+target+of+berberine+using+an+affinity-based+chemical+probe+and+elucidation+of+its+modulatory+role+in+actin+assembly&doi=10.1039%2Fc7cc02789c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of actin as a direct proteomic target of berberine using an affinity-based chemical probe and elucidation of its modulatory role in actin assembly</span></div><div class="casAuthors">Yi, Chae-Min; Yu, Jihyun; Kim, Hyunbin; Lee, Na-Rae; Kim, Sang Won; Lee, Noh-Jin; Lee, Jun; Seong, Jihye; Kim, Nam-Jung; Inn, Kyung-Soo</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">7045-7047</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Despite the diverse pharmacol. activities of berberine, including anti-cancer and anti-inflammatory effects, the direct proteomic targets of berberine have remained largely unknown.  Here, we have identified actin as a direct proteomic target of berberine using an affinity-based chem. probe.  In addn., we found that actin assembly was significantly modulated by berberine in vitro at the biochem. level and cellular level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaNu5q1j_Ra7Vg90H21EOLACvtfcHk0li9eR4wEbeUrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXps1Gnsrw%253D&md5=b214af89872976ef23b68a2084c90a77</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1039%2FC7CC02789C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC02789C%26sid%3Dliteratum%253Aachs%26aulast%3DYi%26aufirst%3DC.-M.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DN.-R.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DN.-J.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSeong%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DN.-J.%26aulast%3DInn%26aufirst%3DK.-S.%26atitle%3DIdentification%2520of%2520actin%2520as%2520a%2520direct%2520proteomic%2520target%2520of%2520berberine%2520using%2520an%2520affinity-based%2520chemical%2520probe%2520and%2520elucidation%2520of%2520its%2520modulatory%2520role%2520in%2520actin%2520assembly%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D7045%26epage%3D7047%26doi%3D10.1039%2Fc7cc02789c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Berberine inhibits the proliferation and migration of breast cancer ZR-75-30 cells by targeting Ephrin-B2</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2016.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.phymed.2016.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28190470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvFegsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=45-51&author=W.+Maauthor=M.+Zhuauthor=D.+Zhangauthor=L.+Yangauthor=T.+Yangauthor=X.+Liauthor=Y.+Zhang&title=Berberine+inhibits+the+proliferation+and+migration+of+breast+cancer+ZR-75-30+cells+by+targeting+Ephrin-B2&doi=10.1016%2Fj.phymed.2016.12.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine inhibits the proliferation and migration of breast cancer ZR-75-30 cells by targeting Ephrin-B2</span></div><div class="casAuthors">Ma, Weina; Zhu, Man; Zhang, Dongdong; Yang, Liu; Yang, Tianfeng; Li, Xin; Zhang, Yanmin</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Berberine, a plant-derived compd. isolated from Coptis chinensis used in traditional Chinese medicine, has been shown to possess anti-cancer properties.  However, no study has shown that berberine could target ephrin-B2, which plays a crit. role in cell proliferation and migration.  The aim of this study is to investigate the effect of berberine on cancer cell growth and migration, through the regulation of ephrin-B2 and downstream signaling mols.  In this study, a high ephrin-B2-expressing cell membrane chromatog. method was developed to investigate 48 crude exts. from traditional Chinese medicine that could act on ephrin-B2.  Cell proliferative and wound-healing assays were used to study the effect of berberine on cancer cell growth and migration.  The mechanism of berberine was investigated using western blot.Berberine was isolated from C. chinensis exts. and showed activity on the HEK293/ephrin-B2 cell membrane chromatog. column.  Berberine showed a greater inhibitory effect in high-expressing ephrin-B2 cells (HEK293/ephrin-B2 cells) than in normal HEK293 cells, and decreased the expression of ephrin-B2 and its PDZ binding proteins, which indicates that ephrin-B2 is a target of berberine.  Furthermore, berberine downregulates the phosphorylation of VEGFR2 and downstream signaling members (AKT and Erk1/2), which in turn downregulates the expression of MMP2 and MMP9.  The above data confirm the inhibitory effects of berberine on ZR-75-30 cell proliferation and cell migration.  Overall, our studies demonstrate that berberine inhibits cell growth and migration by targeting ephrin-B2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRex5I7d1sebVg90H21EOLACvtfcHk0lj95yCBlE9sug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvFegsw%253D%253D&md5=bcb96b4d4604cbd181dc26d30f534f08</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2016.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2016.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DBerberine%2520inhibits%2520the%2520proliferation%2520and%2520migration%2520of%2520breast%2520cancer%2520ZR-75-30%2520cells%2520by%2520targeting%2520Ephrin-B2%26jtitle%3DPhytomedicine%26date%3D2017%26volume%3D25%26spage%3D45%26epage%3D51%26doi%3D10.1016%2Fj.phymed.2016.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span> <span> </span><span class="NLM_article-title">Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">6906</span>– <span class="NLM_lpage">6918</span>, <span class="refDoi"> DOI: 10.1038/onc.2017.296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fonc.2017.296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28846104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2hsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=6906-6918&author=H.+Ruanauthor=Y.+Y.+Zhanauthor=J.+Houauthor=B.+Xuauthor=B.+Chenauthor=Y.+Tianauthor=D.+Wuauthor=Y.+Zhaoauthor=Y.+Zhangauthor=X.+Chenauthor=P.+Miauthor=L.+Zhangauthor=S.+Zhangauthor=X.+Wangauthor=H.+Caoauthor=W.+Zhangauthor=H.+Wangauthor=H.+Liauthor=Y.+Suauthor=X.+K.+Zhangauthor=T.+Hu&title=Berberine+binds+RXR%CE%B1+to+suppress+%CE%B2-catenin+signaling+in+colon+cancer+cells&doi=10.1038%2Fonc.2017.296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells</span></div><div class="casAuthors">Ruan, H.; Zhan, Y. Y.; Hou, J.; Xu, B.; Chen, B.; Tian, Y.; Wu, D.; Zhao, Y.; Zhang, Y.; Chen, X.; Mi, P.; Zhang, L.; Zhang, S.; Wang, X.; Cao, H.; Zhang, W.; Wang, H.; Li, H.; Su, Y.; Zhang, X. K.; Hu, T.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">6906-6918</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Berberine, an isoquinoline alkaloid, is a traditional oriental medicine used to treat diarrhea and gastroenteritis.  Recently, we reported that it could inhibit the growth of intestinal polyp in animals and in patients with the familial adenomatous polyposis by downregulating β-catenin signaling.  However, the intracellular target mediating the effects of berberine remains elusive.  Here, we provide evidence that berberine inhibits β-catenin function via directly binding to a unique region comprising residues Gln275, Arg316 and Arg371 in nuclear receptor retinoid X receptor alpha (RXRα), where berberine concomitantly binding to and synergistically activating RXRα with 9-cis-retinoic acid (9-cis-RA), a natural ligand binding to the classical ligand-binding pocket of RXRα.  Berberine binding promotes RXRα interaction with nuclear β-catenin, leading to c-Cbl mediated degrdn. of β-catenin, and consequently inhibits the proliferation of colon cancer cells.  Furthermore, berberine suppresses the growth of human colon carcinoma xenograft in nude mice in an RXRα-dependent manner.  Together, our study not only identifies RXRα as a direct protein target for berberine but also dissects their binding mode and validates that berberine indeed suppresses β-catenin signaling and cell growth in colon cancer via binding RXRα, which provide new strategies for the design of new RXRα-based antitumor agents and drug combinations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHhbQsQonEJbVg90H21EOLACvtfcHk0lj95yCBlE9sug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2hsrrP&md5=a239206ffe6bb076ea2f0bbc89a9b224</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fonc.2017.296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2017.296%26sid%3Dliteratum%253Aachs%26aulast%3DRuan%26aufirst%3DH.%26aulast%3DZhan%26aufirst%3DY.%2BY.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DMi%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%2BK.%26aulast%3DHu%26aufirst%3DT.%26atitle%3DBerberine%2520binds%2520RXR%25CE%25B1%2520to%2520suppress%2520%25CE%25B2-catenin%2520signaling%2520in%2520colon%2520cancer%2520cells%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D6906%26epage%3D6918%26doi%3D10.1038%2Fonc.2017.296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gejing  De</span>, <span class="hlFld-ContribAuthor ">Apeng  Chen</span>, <span class="hlFld-ContribAuthor ">Qinghe  Zhao</span>, <span class="hlFld-ContribAuthor ">Ran  Xie</span>, <span class="hlFld-ContribAuthor ">Chaoxi  Wang</span>, <span class="hlFld-ContribAuthor ">Meng  Li</span>, <span class="hlFld-ContribAuthor ">Haiyu  Zhao</span>, <span class="hlFld-ContribAuthor ">Xinru  Gu</span>, <span class="hlFld-ContribAuthor ">Lauren H.  McCarl</span>, <span class="hlFld-ContribAuthor ">Fangbo  Zhang</span>, <span class="hlFld-ContribAuthor ">Weiyan  Cai</span>, <span class="hlFld-ContribAuthor ">Miyi  Yang</span>, <span class="hlFld-ContribAuthor ">Peihui  Lin</span>, <span class="hlFld-ContribAuthor ">Shaorong  Liu</span>, <span class="hlFld-ContribAuthor ">Baolin  Bian</span>. </span><span class="cited-content_cbyCitation_article-title">A multi-herb-combined remedy to overcome hyper-inflammatory response by reprogramming transcription factor profile and shaping monocyte subsets. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>169 </em>, 105617. <a href="https://doi.org/10.1016/j.phrs.2021.105617" title="DOI URL">https://doi.org/10.1016/j.phrs.2021.105617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2021.105617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2021.105617%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DA%252Bmulti-herb-combined%252Bremedy%252Bto%252Bovercome%252Bhyper-inflammatory%252Bresponse%252Bby%252Breprogramming%252Btranscription%252Bfactor%252Bprofile%252Band%252Bshaping%252Bmonocyte%252Bsubsets%26aulast%3DDe%26aufirst%3DGejing%26date%3D2021%26volume%3D169%26spage%3D105617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miroslava  Šudomová</span>, <span class="hlFld-ContribAuthor ">Kateřina  Berchová-Bímová</span>, <span class="hlFld-ContribAuthor ">Stefania  Marzocco</span>, <span class="hlFld-ContribAuthor ">Alena  Liskova</span>, <span class="hlFld-ContribAuthor ">Peter  Kubatka</span>, <span class="hlFld-ContribAuthor ">Sherif T.S.  Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers. </span><span class="cited-content_cbyCitation_journal-name">Viruses</span><span> <strong>2021,</strong> <em>13 </em>
                                    (6)
                                     , 1014. <a href="https://doi.org/10.3390/v13061014" title="DOI URL">https://doi.org/10.3390/v13061014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/v13061014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fv13061014%26sid%3Dliteratum%253Aachs%26jtitle%3DViruses%26atitle%3DBerberine%252Bin%252BHuman%252BOncogenic%252BHerpesvirus%252BInfections%252Band%252BTheir%252BLinked%252BCancers%26aulast%3D%25C5%25A0udomov%25C3%25A1%26aufirst%3DMiroslava%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D6%26spage%3D1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structure of BBR and the rational design of BBR probes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis Scheme for <b>4a–d</b>, <b>8a–d</b>, <b>11a–d</b>, and <b>15a–d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Br-R-NHBoc or TsO-R-NHBoc, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux; (b) CH<sub>3</sub>OH/HCl; (c) <span class="smallcaps smallerCapital">D</span>-biotin, EDCI/HOBT, DMF.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis Scheme for <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EDCI/HOBT, DMF.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. BBR labeling of the direct proteomic target. (a,e) Structures of <b>8d</b>, <b>15d</b>, and <b>16</b>. (b) General workflow of the ABPP approach. (c,d) Cell lysates of PMA-THP-1 cells that were pulled down. The total proteins were silver-stained (c) and proteins pulled down were immunoblotted (d). (f) Cy3<b>-</b>labeled target proteins identified using fluorescent gel imaging. (g) Biotin-labeled target proteins identified using immunoblotting. (h) Purified human NEK7 protein pulled down with or without BBR pretreatment. (i) Dose-dependent labeling of NEK7 recombinant proteins with <b>8d</b> beads. (j) ATPase activity assay for purified human NEK7 in the presence of different concentrations of BBR. (k) SPR sensorgrams obtained on an NEK7-coated chip at different concentrations of BBR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. BBR interaction with NEK7. (a) HEK-293 cells transfected with Flag-tagged WT or the indicated mutant NEK7 constructs. The lysates were pulled down using <b>8d</b> beads. (b) WT or mutant NEK7 was pulled down with <b>8d</b> beads in HEK-293 cells and analyzed by immunoblotting. (c) Structure of <i>O</i>-BBR. (d) Immunoblot analysis of cleaved IL-1β and activated caspase-1 in the SN from LPS/nigericin-stimulated PMA-THP-1 cells pretreated with BBR (10 μM) or <i>O</i>-BBR (10 μM). (e) Molecular docking results for NEK7 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2%2520WQN">2 WQN</a>) with BBR or ATP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. BBR blocking the NEK7 and NLRP3 interaction. (a) Co-IP and immunoblot analysis of the NEK7–NLRP3 interaction with different concentrations of BBR in HEK-293 cells. (b) Endogenous Co-IP with the NLRP3 antibody or isotype antibody performed in PMA-THP-1 cells stimulated with LPS/nigericin with or without BBR (10 μM). (c) Co-IP and immunoblot analysis of the NEK7–NLRP3 interaction with BBR (10 μM) or <i>O</i>-BBR (10 μM) in HEK-293T cells. (d) Co-IP and immunoblot analysis of the interaction between NLRP3 and WT or mutant NEK7 in HEK-293T cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. BBR specifically inhibits the NEK7–NLRP3 pathway. (a) PMA-THP-1 cells primed with LPS and stimulated with nigericin with or without BBR (10 μM) pretreatment for 4 h. Immunoblot analysis of cleaved IL-1β and activated caspase-1 in the SN and pro-IL-1β, procaspase-1, and NLRP3 in lysates of PMA-THP-1 cells. (b,c) Immunoblot analysis of ASC oligomerization (b) and ASC pyroptosome immunofluorescence analysis (c) of PMA-THP-1 cells stimulated with LPS/nigericin, with or without BBR (10 μM) pretreatment for 4 h. (d,e) PMA-THP-1 cells pretreated with or without BBR (10 μM) for 2 h, followed by transfection with 1 μg of poly(dA:dT) using lipofectamine (d) or stimulation with Salmonella (e). The SN and lysates were collected 8 h after transfection or infection and analyzed for IL-1β and caspase-1 activation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. BBR inhibits IL-1β <i>via</i> NEK7 <i>in vivo</i>. (a) Mice transfected with Adv for 10 days and treated with BBR three times every 12 h before LPS stimulation. (b) Immunoblot analysis of NEK7 expression in mouse livers. (c) ELISA of IL-1β in mouse serum. (d) Representative H&E staining of liver sections of mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/medium/jm0c01743_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Proposed model of BBR inhibiting NLRP3 inflammasome activation by targeting NEK7.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01743/20210107/images/large/jm0c01743_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01743&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28555" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28555" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 55 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span> <span> </span><span class="NLM_article-title">Learning from berberine: Treating chronic diseases through multiple targets</span>. <i>Sci. China: Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">854</span>– <span class="NLM_lpage">859</span>, <span class="refDoi"> DOI: 10.1007/s11427-013-4568-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1007%2Fs11427-013-4568-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=24174332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSlsr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=854-859&author=J.+Yaoauthor=W.+Kongauthor=J.+Jiang&title=Learning+from+berberine%3A+Treating+chronic+diseases+through+multiple+targets&doi=10.1007%2Fs11427-013-4568-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Learning from berberine: Treating chronic diseases through multiple targets</span></div><div class="casAuthors">Yao, Jing; Kong, WeiJia; Jiang, JianDong</div><div class="citationInfo"><span class="NLM_cas:title">Science China: Life Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">854-859</span>CODEN:
                <span class="NLM_cas:coden">SCLSCJ</span>;
        ISSN:<span class="NLM_cas:issn">1674-7305</span>.
    
            (<span class="NLM_cas:orgname">Science China Press</span>)
        </div><div class="casAbstract">Although advances have been made, chemotherapy for chronic, multifactorial diseases such as cancers, Alzheimer's disease, cardiovascular diseases and diabetes is far from satisfactory.  Agents with different mechanisms of action are required.  The botanic compd. berberine (BBR) has been used as an over-the-counter antibacterial for diarrhea in China for many decades.  Recent clin. studies have shown that BBR may be therapeutic in various types of chronic diseases.  This review addresses BBR's mol. mechanisms of action and clin. efficacy and safety in patients with type 2 diabetes, hyperlipidemia, heart diseases, cancers and inflammation.  One of the advantages of BBR is its multiple-target effects in each of these diseases.  The therapeutic efficacy of BBR may reflect a synergistic regulation of these targets, resulting in a comprehensive effect against these various chronic disorders.  The safety of BBR may be due to its harmonious distribution into those targets.  Although the single-target concept is still the principle for drug discovery and research, this review emphasizes the concept of a multiple target strategy, which may be an important approach toward the successful treatment of multifactorial chronic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVDNoyh8G5D7Vg90H21EOLACvtfcHk0lhbY35NXv0kGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSlsr7N&md5=a65a056b9c6a1fddfca5b991e0480020</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs11427-013-4568-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11427-013-4568-z%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DJ.%26atitle%3DLearning%2520from%2520berberine%253A%2520Treating%2520chronic%2520diseases%2520through%2520multiple%2520targets%26jtitle%3DSci.%2520China%253A%2520Life%2520Sci.%26date%3D2015%26volume%3D58%26spage%3D854%26epage%3D859%26doi%3D10.1007%2Fs11427-013-4568-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heidarian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafieian-Kopaei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoshdel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakhshesh, M.</span></span> <span> </span><span class="NLM_article-title">Metabolic effects of berberine on liver phosphatidate phosphohydrolase in rats fed on high lipogenic diet: an additional mechanism for the hypolipidemic effects of berberine</span>. <i>Asian Pac. J. Trop. Biomed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">S429</span>– <span class="NLM_lpage">S435</span>, <span class="refDoi"> DOI: 10.12980/apjtb.4.2014c474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.12980%2FAPJTB.4.2014C474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=25183123" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=S429-S435&author=E.+Heidarianauthor=M.+Rafieian-Kopaeiauthor=A.+Khoshdelauthor=M.+Bakhshesh&title=Metabolic+effects+of+berberine+on+liver+phosphatidate+phosphohydrolase+in+rats+fed+on+high+lipogenic+diet%3A+an+additional+mechanism+for+the+hypolipidemic+effects+of+berberine&doi=10.12980%2Fapjtb.4.2014c474"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.12980%2FAPJTB.4.2014C474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12980%252FAPJTB.4.2014C474%26sid%3Dliteratum%253Aachs%26aulast%3DHeidarian%26aufirst%3DE.%26aulast%3DRafieian-Kopaei%26aufirst%3DM.%26aulast%3DKhoshdel%26aufirst%3DA.%26aulast%3DBakhshesh%26aufirst%3DM.%26atitle%3DMetabolic%2520effects%2520of%2520berberine%2520on%2520liver%2520phosphatidate%2520phosphohydrolase%2520in%2520rats%2520fed%2520on%2520high%2520lipogenic%2520diet%253A%2520an%2520additional%2520mechanism%2520for%2520the%2520hypolipidemic%2520effects%2520of%2520berberine%26jtitle%3DAsian%2520Pac.%2520J.%2520Trop.%2520Biomed.%26date%3D2014%26volume%3D4%26spage%3DS429%26epage%3DS435%26doi%3D10.12980%2Fapjtb.4.2014c474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, T.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, D.-Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Identification of Novel Berberine Derivatives as Potent Inhibitors against TNF-α-Induced NF-κB Activation</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1257</span>, <span class="refDoi"> DOI: 10.3390/molecules22081257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.3390%2Fmolecules22081257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1ektLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1257&author=Y.-X.+Wangauthor=L.+Liuauthor=Q.-X.+Zengauthor=T.-Y.+Fanauthor=J.-D.+Jiangauthor=H.-B.+Dengauthor=D.-Q.+Song&title=Synthesis+and+Identification+of+Novel+Berberine+Derivatives+as+Potent+Inhibitors+against+TNF-%CE%B1-Induced+NF-%CE%BAB+Activation&doi=10.3390%2Fmolecules22081257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and identification of novel berberine derivatives as potent inhibitors against TNF-α-induced NF-κB activation</span></div><div class="casAuthors">Wang, Yan-Xiang; Liu, Lu; Zeng, Qing-Xuan; Fan, Tian-Yun; Jiang, Jian-Dong; Deng, Hong-Bin; Song, Dan-Qing</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1257/1-1257/14</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Twenty-three new berberine (BBR) analogs contg. substituents on ring D, I [R1 = OMe, NH2, cyclopropanecarbonyloxy, (4-nitrophenyl)sulfonyloxy, etc., R2 = OMe, (adamantan-1-yl)acetoxy, (adamantane-10-carbonyloxy)], were synthesized and evaluated for their activity for suppression of tumor necrosis factor (TNF)-α-induced nuclear factor (NF)-κB activation.  Structure-activity relationship (SAR) anal. indicated that suitable tertiary/quaternary carbon substitutions at the 9-position or a rigid fragment at position 10 might be beneficial for enhancing their anti-inflammatory potency.  Among them, compds. I [R1 = (1-methylcyclohexane-1-carbonyl)oxy, 2-(bicyclo[2.2.1]heptan-2-yl)acetoxy, (2'-propylpentanoyl)oxy, (p-tert-butylbenzoyl)oxy, R2 = OMe] exhibited satisfactory inhibitory potency against NF-κB activation, with an inhibitory rate of around 90% (5 μM), much better than BBR.  A preliminary mechanism study revealed that all of them could inhibit TNF-α-induced NF-κB activation via impairing IκB kinase (IKK) phosphorylation as well as cytokines interleukin (IL)-6 and IL-8 induced by TNF-α.  Therefore, the results provided powerful information on further structural modifications and development of BBR derivs. into a new class of anti-inflammatory candidates for the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsD1huNq0TDrVg90H21EOLACvtfcHk0liPK9k9l2wHVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1ektLnN&md5=098585ac3341d2b4684d21a0aebe7fc3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22081257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22081257%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-X.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DQ.-X.%26aulast%3DFan%26aufirst%3DT.-Y.%26aulast%3DJiang%26aufirst%3DJ.-D.%26aulast%3DDeng%26aufirst%3DH.-B.%26aulast%3DSong%26aufirst%3DD.-Q.%26atitle%3DSynthesis%2520and%2520Identification%2520of%2520Novel%2520Berberine%2520Derivatives%2520as%2520Potent%2520Inhibitors%2520against%2520TNF-%25CE%25B1-Induced%2520NF-%25CE%25BAB%2520Activation%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D1257%26doi%3D10.3390%2Fmolecules22081257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span> <span> </span><span class="NLM_article-title">Cardiovascular actions of berberine</span>. <i>Cardiovasc. Drug Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1111/j.1527-3466.2001.tb00068.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1111%2Fj.1527-3466.2001.tb00068.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=11607041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD38XktFKntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=234-244&author=C.+W.+Lauauthor=X.+Q.+Yaoauthor=Z.+Y.+Chenauthor=W.+H.+Koauthor=Y.+Huang&title=Cardiovascular+actions+of+berberine&doi=10.1111%2Fj.1527-3466.2001.tb00068.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular actions of berberine</span></div><div class="casAuthors">Lau, Chi-Wai; Yao, Xiao-Qiang; Chen, Zhen-Yu; Ko, Wing-Hung; Huang, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Drug Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">234-244</span>CODEN:
                <span class="NLM_cas:coden">CDREEA</span>;
        ISSN:<span class="NLM_cas:issn">0897-5957</span>.
    
            (<span class="NLM_cas:orgname">Neva Press</span>)
        </div><div class="casAbstract">A review.  Berberine, is an alkaloid from Hydrastis canadensis L., Chinese herb Huanglian, and many other plants.  It is widely used in traditional Chinese medicine as an antimicrobial in the treatment of dysentery and infectious diarrhea.  This manuscript describes cardiovascular effects of berberine and its derivs., tetrahydroberberine and 8-oxoberberine.  Berberine has pos. inotropic, neg. chronotropic, antiarrhythmic, and vasodilator properties.  Both derivs. of berberine have antiarrhythmic activity.  Some of cardiovascular effects of berberine and its derivs. are attributed to the blockade of K+ channels (delayed rectifier and KATP) and stimulation of Na+-Ca2+ exchanger.  Berberine has been shown to prolong the duration of ventricular action potential.  Its vasodilator activity has been attributed to multiple cellular mechanisms.  The cardiovascular effects of berberine suggest its possible clin. usefulness in the treatment of arrhythmias and/or heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAAoHvb0M7v7Vg90H21EOLACvtfcHk0liPK9k9l2wHVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktFKntQ%253D%253D&md5=41741fa9c29ae0730f7801bd88b15bc5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3466.2001.tb00068.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3466.2001.tb00068.x%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DC.%2BW.%26aulast%3DYao%26aufirst%3DX.%2BQ.%26aulast%3DChen%26aufirst%3DZ.%2BY.%26aulast%3DKo%26aufirst%3DW.%2BH.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DCardiovascular%2520actions%2520of%2520berberine%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D2001%26volume%3D19%26spage%3D234%26epage%3D244%26doi%3D10.1111%2Fj.1527-3466.2001.tb00068.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, D.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-D.</span></span> <span> </span><span class="NLM_article-title">Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression</span>. <i>Metabolism</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1016/j.metabol.2008.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.metabol.2008.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=19059538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOjurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2009&pages=109-119&author=W.-J.+Kongauthor=H.+Zhangauthor=D.-Q.+Songauthor=R.+Xueauthor=W.+Zhaoauthor=J.+Weiauthor=Y.-M.+Wangauthor=N.+Shanauthor=Z.-X.+Zhouauthor=P.+Yangauthor=X.-F.+Youauthor=Z.-R.+Liauthor=S.-Y.+Siauthor=L.-X.+Zhaoauthor=H.-N.+Panauthor=J.-D.+Jiang&title=Berberine+reduces+insulin+resistance+through+protein+kinase+C-dependent+up-regulation+of+insulin+receptor+expression&doi=10.1016%2Fj.metabol.2008.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression</span></div><div class="casAuthors">Kong, Wei-Jia; Zhang, Hao; Song, Dan-Qing; Xue, Rong; Zhao, Wei; Wei, Jing; Wang, Yue-Ming; Shan, Ning; Zhou, Zhen-Xian; Yang, Peng; You, Xue-Fu; Li, Zhuo-Rong; Si, Shu-Yi; Zhao, Li-Xun; Pan, Huai-Ning; Jiang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-119</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Natural product berberine (BBR) was reported to have hypoglycemic and insulin-sensitizing activities; however, its mechanism remains unclear.  This study was designed to investigate the mol. mechanism of BBR against insulin resistance.  Here, we identify insulin receptor (InsR) as a target of BBR to increase insulin sensitivity.  In cultured human liver cells, BBR increased InsR mRNA and protein expression in a dose- and time-dependent manner.  Berberine increased InsR expression in the L6 rat skeletal muscle cells as well.  Berberine-enhanced InsR expression improved cellular glucose consumption only in the presence of insulin.  Silencing InsR gene with small interfering RNA or blocking the phosphoinositol-3-kinase diminished this effect.  Berberine induced InsR gene expression through a protein kinase C (PKC)-dependent activation of its promoter.  Inhibition of PKC abolished BBR-caused InsR promoter activation and InsR mRNA transcription.  In animal models, treatment of type 2 diabetes mellitus rats with BBR lowered fasting blood glucose and fasting serum insulin, increased insulin sensitivity, and elevated InsR mRNA as well as PKC activity in the liver.  In addn., BBR lowered blood glucose in KK-Ay type 2 but not in NOD/LtJ type 1 diabetes mellitus mice that were insulin deficient.  Our results suggest that BBR is a unique natural medicine against insulin resistance in type 2 diabetes mellitus and metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9ThdnyQdtPbVg90H21EOLACvtfcHk0lhpux_l-iXSng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOjurfL&md5=2c3757c097e4b3b8b49b20466df8977c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2008.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2008.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DW.-J.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSong%26aufirst%3DD.-Q.%26aulast%3DXue%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.-M.%26aulast%3DShan%26aufirst%3DN.%26aulast%3DZhou%26aufirst%3DZ.-X.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DYou%26aufirst%3DX.-F.%26aulast%3DLi%26aufirst%3DZ.-R.%26aulast%3DSi%26aufirst%3DS.-Y.%26aulast%3DZhao%26aufirst%3DL.-X.%26aulast%3DPan%26aufirst%3DH.-N.%26aulast%3DJiang%26aufirst%3DJ.-D.%26atitle%3DBerberine%2520reduces%2520insulin%2520resistance%2520through%2520protein%2520kinase%2520C-dependent%2520up-regulation%2520of%2520insulin%2520receptor%2520expression%26jtitle%3DMetabolism%26date%3D2009%26volume%3D58%26spage%3D109%26epage%3D119%26doi%3D10.1016%2Fj.metabol.2008.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abidi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-D.</span></span> <span> </span><span class="NLM_article-title">Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1344</span>– <span class="NLM_lpage">1351</span>, <span class="refDoi"> DOI: 10.1038/nm1135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fnm1135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=15531889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCisbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1344-1351&author=W.+Kongauthor=J.+Weiauthor=P.+Abidiauthor=M.+Linauthor=S.+Inabaauthor=C.+Liauthor=Y.+Wangauthor=Z.+Wangauthor=S.+Siauthor=H.+Panauthor=S.+Wangauthor=J.+Wuauthor=Y.+Wangauthor=Z.+Liauthor=J.+Liuauthor=J.-D.+Jiang&title=Berberine+is+a+novel+cholesterol-lowering+drug+working+through+a+unique+mechanism+distinct+from+statins&doi=10.1038%2Fnm1135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins</span></div><div class="casAuthors">Kong, Weijia; Wei, Jing; Abidi, Parveen; Lin, Meihong; Inaba, Satoru; Li, Cong; Wang, Yanling; Wang, Zizheng; Si, Shuyi; Pan, Huaining; Wang, Shukui; Wu, Jingdan; Wang, Yue; Li, Zhuorong; Liu, Jingwen; Jiang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1344-1351</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We identify berberine (BBR), a compd. isolated from a Chinese herb, as a new cholesterol-lowering drug.  Oral administration of BBR in 32 hypercholesterolemic patients for 3 mo reduced serum cholesterol by 29%, triglycerides by 35% and LDL-cholesterol by 25%.  Treatment of hyperlipidemic hamsters with BBR reduced serum cholesterol by 40% and LDL-cholesterol by 42%, with a 3.5-fold increase in hepatic LDLR mRNA and a 2.6-fold increase in hepatic LDLR protein.  Using human hepatoma cells, we show that BBR upregulates LDLR expression independent of sterol regulatory element binding proteins, but dependent on ERK activation.  BBR elevates LDLR expression through a post-transcriptional mechanism that stabilizes the mRNA.  Using a heterologous system with luciferase as a reporter, we further identify the 5' proximal section of the LDLR mRNA 3' untranslated region responsible for the regulatory effect of BBR.  These findings show BBR as a new hypolipidemic drug with a mechanism of action different from that of statin drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2ndzFTq9UTLVg90H21EOLACvtfcHk0lhpux_l-iXSng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCisbfK&md5=624ed3ede1279d0da1afcda5a7682360</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnm1135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1135%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DW.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DAbidi%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DInaba%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DSi%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DJ.-D.%26atitle%3DBerberine%2520is%2520a%2520novel%2520cholesterol-lowering%2520drug%2520working%2520through%2520a%2520unique%2520mechanism%2520distinct%2520from%2520statins%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D1344%26epage%3D1351%26doi%3D10.1038%2Fnm1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span> <span> </span><span class="NLM_article-title">Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer’s disease</span>. <i>BMC Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">78</span>, <span class="refDoi"> DOI: 10.1186/1471-2202-7-78</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1186%2F1471-2202-7-78" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=17137520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A280%3ADC%252BD28jhvVCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=78&author=F.+Zhuauthor=C.+Qian&title=Berberine+chloride+can+ameliorate+the+spatial+memory+impairment+and+increase+the+expression+of+interleukin-1beta+and+inducible+nitric+oxide+synthase+in+the+rat+model+of+Alzheimer%E2%80%99s+disease&doi=10.1186%2F1471-2202-7-78"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease</span></div><div class="casAuthors">Zhu Feiqi; Qian Caiyun</div><div class="citationInfo"><span class="NLM_cas:title">BMC neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">78</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Berberine is the major alkaloidal component of Rhizoma coptidis, and has multiple pharmacological effects including inhibiting acetylcholinesterase, reducing cholesterol and glucose, lowering mortality in patients with chronic congestive heart failure and anti-inflammation etc.  Thus berberine is a promising drug for diabetes, hyperlipemia, coronary artery disease and ischemic stroke etc.  The present study was carried out to investigate the effect of berberine chloride on the spatial memory, inflammation factors interleukin-1 beta (IL-1beta) and inducible nitric oxide synthase (iNOS) expression in the rat model of Alzheimer's disease (AD) which was established by injecting Abeta (1-40) (5 microgram) into the rats hippocampuses bilaterally.  RESULTS:  The rats were given berberine chloride (50 mg/kg) by intragastric administration once daily for 14 days.  The spatial memory was assayed by Morris water maze test, IL-1beta and iNOS in the hippocampus were assayed by immunohistochemistry and real time polymerase chain reaction (PCR).  Intragastric administration of berberine significantly ameliorated the spatial memory impairment and increased the expression of IL-1beta, iNOS in the rat model of AD.  CONCLUSION:  Berberine might be beneficial to AD by intragastric administration though it might exaggerate the inflammation reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMRFyXK2nLlrHHuJhbyicZfW6udTcc2eaQGwRczVkjPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jhvVCmsA%253D%253D&md5=50b4ad0c040a6ab25aa43d96ae57182e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-7-78&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-7-78%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DF.%26aulast%3DQian%26aufirst%3DC.%26atitle%3DBerberine%2520chloride%2520can%2520ameliorate%2520the%2520spatial%2520memory%2520impairment%2520and%2520increase%2520the%2520expression%2520of%2520interleukin-1beta%2520and%2520inducible%2520nitric%2520oxide%2520synthase%2520in%2520the%2520rat%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBMC%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D78%26doi%3D10.1186%2F1471-2202-7-78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span> <span> </span><span class="NLM_article-title">Suppressive effects of berberine on atherosclerosis via downregulating visfatin expression and attenuating visfatin-induced endothelial dysfunction</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1939</span>– <span class="NLM_lpage">1948</span>, <span class="refDoi"> DOI: 10.3892/ijmm.2018.3440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.3892%2Fijmm.2018.3440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=29393413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFGru7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2018&pages=1939-1948&author=Q.+Wanauthor=Z.+Liuauthor=Y.+Yangauthor=X.+Cui&title=Suppressive+effects+of+berberine+on+atherosclerosis+via+downregulating+visfatin+expression+and+attenuating+visfatin-induced+endothelial+dysfunction&doi=10.3892%2Fijmm.2018.3440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Suppressive effects of berberine on atherosclerosis via downregulating visfatin expression and attenuating visfatin-induced endothelial dysfunction</span></div><div class="casAuthors">Wan, Qiang; Liu, Zhongyong; Yang, Yuping; Cui, Xiaobing</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1939-1948</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1791-244X</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Berberine (BBR) possesses significant anti-atherosclerosis properties.  Visfatin is one of the most promising biomarkers of incoming atherosclerosis.  However, research on the effect of BBR on regulating visfatin expression in atherogenesis remains largely unknown.  In this study, we investigated the effects of BBR on visfatin expression and atherogenesis in apolipoprotein E knockout (ApoE-/-) mice.  The effect of BBR on attenuating visfatin-induced endothelial dysfunction was also evaluated in cultured human umbilical vein endothelial cells (HUVECs).  In vivo expts. showed that BBR treatment (5 mg/kg/day) significantly reduced the serum levels of visfatin, lipid, interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), the protein expression of visfatin, p-p38 MAPK and p-c-Jun N-terminal kinase (JNK) in mice aorta and the distribution of visfatin in the atherosclerotic lesions in ApoE-/- mice fed with a Western diet.  In addn., in vitro expts. indicated that visfatin (100μg/l) significantly increased apoptosis, the contents of IL-6 and TNF-α, the protein levels of p-p38 MAPK, p-JNK and Bax in HUVECs, which were reversed by BBR administration (50μmol/l).  Our findings suggest that BBR significantly ameliorates Western diet-induced atherosclerosis in ApoE-/- mice via downregulating visfatin expression, which is related to the inhibition of p38 MAPK and JNK signaling pathways and subsequent suppression of visfatin-induced endothelial dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqmQNRJKWDQrVg90H21EOLACvtfcHk0ljbKpXqU_zFmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFGru7%252FF&md5=621de13319dc2a79662adc54b454e535</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2018.3440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2018.3440%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCui%26aufirst%3DX.%26atitle%3DSuppressive%2520effects%2520of%2520berberine%2520on%2520atherosclerosis%2520via%2520downregulating%2520visfatin%2520expression%2520and%2520attenuating%2520visfatin-induced%2520endothelial%2520dysfunction%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2018%26volume%3D41%26spage%3D1939%26epage%3D1948%26doi%3D10.3892%2Fijmm.2018.3440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Y.</span></span> <span> </span><span class="NLM_article-title">Artemisinin-A gift from traditional chinese medicine to the world (Nobel Lecture)</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10210</span>– <span class="NLM_lpage">10226</span>, <span class="refDoi"> DOI: 10.1002/anie.201601967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1002%2Fanie.201601967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=27488942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A280%3ADC%252BC2s3nsVeqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=10210-10226&author=Y.+Tu&title=Artemisinin-A+gift+from+traditional+chinese+medicine+to+the+world+%28Nobel+Lecture%29&doi=10.1002%2Fanie.201601967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin-A Gift from Traditional Chinese Medicine to the World (Nobel Lecture)</span></div><div class="casAuthors">Tu Youyou</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10210-26</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria has long been a devastating and life-threatening global epidemic disease in human history.  Artemisinin, the active substance against malaria, was first isolated and tested in the 1970s in China.  The important role played by traditional Chinese medicine in the discovery of artemisinin is described by Y.  Tu in her Nobel Lecture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5Y2rsGFOf4XWEEzDrymxmfW6udTcc2eZTbuQDh2Yqybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3nsVeqtQ%253D%253D&md5=d657305553f17af13ca043159ba97393</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fanie.201601967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201601967%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DY.%26atitle%3DArtemisinin-A%2520gift%2520from%2520traditional%2520chinese%2520medicine%2520to%2520the%2520world%2520%2528Nobel%2520Lecture%2529%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2016%26volume%3D55%26spage%3D10210%26epage%3D10226%26doi%3D10.1002%2Fanie.201601967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rena, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, E. R.</span></span> <span> </span><span class="NLM_article-title">The mechanisms of action of metformin</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1577</span>– <span class="NLM_lpage">1585</span>, <span class="refDoi"> DOI: 10.1007/s00125-017-4342-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1007%2Fs00125-017-4342-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28776086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yiurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1577-1585&author=G.+Renaauthor=D.+G.+Hardieauthor=E.+R.+Pearson&title=The+mechanisms+of+action+of+metformin&doi=10.1007%2Fs00125-017-4342-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanisms of action of metformin</span></div><div class="casAuthors">Rena, Graham; Hardie, D. Grahame; Pearson, Ewan R.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1577-1585</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Metformin is a widely-used drug that results in clear benefits in relation to glucose metab. and diabetes-related complications.  The mechanisms underlying these benefits are complex and still not fully understood.  Physiol., metformin has been shown to reduce hepatic glucose prodn., yet not all of its effects can be explained by this mechanism and there is increasing evidence of a key role for the gut.  At the mol. level the findings vary depending on the doses of metformin used and duration of treatment, with clear differences between acute and chronic administration.  Metformin has been shown to act via both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms; by inhibition of mitochondrial respiration but also perhaps by inhibition of mitochondrial glycerophosphate dehydrogenase, and a mechanism involving the lysosome.  In the last 10 years, we have moved from a simple picture, that metformin improves glycemia by acting on the liver via AMPK activation, to a much more complex picture reflecting its multiple modes of action.  More work is required to truly understand how this drug works in its target population: individuals with type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1XNiaJVVDOLVg90H21EOLACvtfcHk0ljbKpXqU_zFmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yiurvP&md5=52c9c90d4a3968f61a500ec87884dab4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00125-017-4342-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-017-4342-z%26sid%3Dliteratum%253Aachs%26aulast%3DRena%26aufirst%3DG.%26aulast%3DHardie%26aufirst%3DD.%2BG.%26aulast%3DPearson%26aufirst%3DE.%2BR.%26atitle%3DThe%2520mechanisms%2520of%2520action%2520of%2520metformin%26jtitle%3DDiabetologia%26date%3D2017%26volume%3D60%26spage%3D1577%26epage%3D1585%26doi%3D10.1007%2Fs00125-017-4342-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Berberine protects against palmitate-induced endothelial dysfunction: involvements of upregulation of AMPK and eNOS and downregulation of NOX4</span>. <i>Mediators Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">260464</span>, <span class="refDoi"> DOI: 10.1155/2013/260464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1155%2F2013%2F260464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=24385682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A280%3ADC%252BC2czhvF2itQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=260464&author=M.+Zhangauthor=C.+M.+Wangauthor=J.+Liauthor=Z.+J.+Mengauthor=S.+N.+Weiauthor=J.+Liauthor=R.+Bucalaauthor=Y.+L.+Liauthor=L.+Chen&title=Berberine+protects+against+palmitate-induced+endothelial+dysfunction%3A+involvements+of+upregulation+of+AMPK+and+eNOS+and+downregulation+of+NOX4&doi=10.1155%2F2013%2F260464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine protects against palmitate-induced endothelial dysfunction: involvements of upregulation of AMPK and eNOS and downregulation of NOX4</span></div><div class="casAuthors">Zhang Ming; Li Jing; Meng Zhao-Jie; Wei Sheng-Nan; Li Ji; Li Yu-Lin; Chen Li; Wang Chun-Mei; Bucala Richard</div><div class="citationInfo"><span class="NLM_cas:title">Mediators of inflammation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">260464</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Endothelial dysfunction is a critical factor during the initiation of cardiovascular complications in diabetes.  Berberine can ameliorate endothelial dysfunction induced by diabetes.  However, the underlying mechanisms remain unclear.  The aim of this study was to investigate the protective effect and mechanism of berberine on palmitate-induced endothelial dysfunction in human umbilical vein endothelial cells (HUVECs).  The cell viability of HUVECs was determined by MTT assays.  Nitric oxide (NO) level and production of reactive oxygen species (ROS) were determined in supernatants or in the cultured HUVECs.  The mRNA level of endothelial nitric oxide synthase (eNOS) was measured by RT-PCR, and the protein levels of eNOS, p-eNOS, Akt, p-Akt, AMPK, p-AMPK, and NADPH oxidase (NOX4) were analyzed.  The results demonstrated that berberine significantly elevated NO levels and reduced the production of ROS.  The expressions of eNOS were significantly increased, while NOX4 protein expression was decreased in berberine-treated HUVECs.  Moreover, berberine upregulated the protein expression of AMPK and p-AMPK in palmitate-treated HUVECs, but had no effect on the levels of Akt.  Therefore, berberine ameliorates palmitate-induced endothelial dysfunction by upregulating eNOS expression and downregulating expression of NOX4.  This regulatory effect of berberine may be related to the activation of AMPK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCVyomBbfR5_xQvRxYU81tfW6udTcc2ebpqDS33rwnu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czhvF2itQ%253D%253D&md5=7f4ab9f8a5626f7b1cd414c16e3379f8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1155%2F2013%2F260464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F260464%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DC.%2BM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMeng%26aufirst%3DZ.%2BJ.%26aulast%3DWei%26aufirst%3DS.%2BN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBucala%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%2BL.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DBerberine%2520protects%2520against%2520palmitate-induced%2520endothelial%2520dysfunction%253A%2520involvements%2520of%2520upregulation%2520of%2520AMPK%2520and%2520eNOS%2520and%2520downregulation%2520of%2520NOX4%26jtitle%3DMediators%2520Inflammation%26date%3D2013%26volume%3D2013%26spage%3D260464%26doi%3D10.1155%2F2013%2F260464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ansari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodagholi, F.</span></span> <span> </span><span class="NLM_article-title">Natural products as promising drug candidates for the treatment of Alzheimer’s disease: molecular mechanism aspect</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.2174/1570159x11311040005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.2174%2F1570159X11311040005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=24381531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFajs7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=414-429&author=N.+Ansariauthor=F.+Khodagholi&title=Natural+products+as+promising+drug+candidates+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+molecular+mechanism+aspect&doi=10.2174%2F1570159x11311040005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect</span></div><div class="casAuthors">Ansari, Niloufar; Khodagholi, Fariba</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">414-429</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common neurodegenerative disorder to date, with no curative or preventive therapy.  Histopathol. hallmarks of AD include deposition of β-amyloid plaques and formation of neurofibrillary tangles.  Extent studies on pathol. of the disease have made important discoveries regarding mechanism of disease and potential therapeutic targets.  Many cellular changes including oxidative stress, disruption of Ca2+ homeostasis, inflammation, metabolic disturbances, and accumulation of unfolded/misfolded proteins can lead to programmed cell death in AD.  Despite intensive research, only five approved drugs are available for the management of AD.  Hence, there is a need to look at alternative therapies.  Use of natural products and culinary herbs in medicine has gained popularity in recent years.  Several natural substances with neuroprotective effects have been widely studied.  Most of these compds. have remarkable antioxidant properties and act mainly by scavenging free radical species.  Some of them increase cell survival and improve cognition by directly affecting amyloidogenesis and programmed cell death pathways.  Further studies on these natural products and their mechanism of action, parallel with the use of novel pharmaceutical drug design and delivery techniques, enable us to offer an addn. to conventional medicine.  This review discussed some natural products with potential neuroprotective properties against Aβ with respect to their mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjnqzQt4z-pLVg90H21EOLACvtfcHk0lh53Qen8Mz_Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFajs7nI&md5=03ccd58248c1da97ee5993a4b341ba18</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1570159X11311040005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X11311040005%26sid%3Dliteratum%253Aachs%26aulast%3DAnsari%26aufirst%3DN.%26aulast%3DKhodagholi%26aufirst%3DF.%26atitle%3DNatural%2520products%2520as%2520promising%2520drug%2520candidates%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520molecular%2520mechanism%2520aspect%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2013%26volume%3D11%26spage%3D414%26epage%3D429%26doi%3D10.2174%2F1570159x11311040005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekavali</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pottabathini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhull, D. K.</span></span> <span> </span><span class="NLM_article-title">Current knowledge and pharmacological profile of berberine: An update</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>761</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2015.05.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.ejphar.2015.05.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=26092760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSitrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=761&publication_year=2015&pages=288-297&author=A.+Kumarauthor=+Ekavaliauthor=K.+Chopraauthor=M.+Mukherjeeauthor=R.+Pottabathiniauthor=D.+K.+Dhull&title=Current+knowledge+and+pharmacological+profile+of+berberine%3A+An+update&doi=10.1016%2Fj.ejphar.2015.05.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Current knowledge and pharmacological profile of berberine: An update</span></div><div class="casAuthors">Kumar, Anil; Ekavali; Chopra, Kanwaljit; Mukherjee, Madhurima; Pottabathini, Raghavender; Dhull, Dinesh K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">761</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">288-297</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Berberine, a benzylisoquinoline alkaloid, occurs as an active constituent in numerous medicinal plants and has an array of pharmacol. properties.  It has been used in Ayurvedic and Chinese medicine for its antimicrobial, antiprotozoal, antidiarrheal and antitrachoma activity.  Moreover, several clin. and preclin. studies demonstrate ameliorative effect of berberine against several disorders including metabolic, neurol. and cardiol. problems.  This review provides a summary regarding the pharmacokinetic and pharmacodynamic features of berberine, with a focus on the different mechanisms underlying its multispectrum activity.  Studies regarding the safety profile, drug interactions and important clin. trials of berberine have also been included.  Clin. trials with respect to neurol. disorders need to be undertaken to exploit the beneficiary effects of berberine against serious disorders such as Alzheimer's and Parkinson's disease.  Also, clin. studies to detect rare adverse effects of berberine need to be initiated to draw a complete safety profile of berberine and strengthen its applicability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxeLvc6JGyNLVg90H21EOLACvtfcHk0lh53Qen8Mz_Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSitrfM&md5=b0461156a3888c3c84688618f36c7f14</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.05.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.05.068%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DEkavali%26aulast%3DChopra%26aufirst%3DK.%26aulast%3DMukherjee%26aufirst%3DM.%26aulast%3DPottabathini%26aufirst%3DR.%26aulast%3DDhull%26aufirst%3DD.%2BK.%26atitle%3DCurrent%2520knowledge%2520and%2520pharmacological%2520profile%2520of%2520berberine%253A%2520An%2520update%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D761%26spage%3D288%26epage%3D297%26doi%3D10.1016%2Fj.ejphar.2015.05.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span> <span> </span><span class="NLM_article-title">Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">864</span>– <span class="NLM_lpage">874</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2017.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.biopha.2017.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28282788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvFant7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2017&pages=864-874&author=H.+Zhouauthor=L.+Fengauthor=F.+Xuauthor=Y.+Sunauthor=Y.+Maauthor=X.+Zhangauthor=H.+Liuauthor=G.+Xuauthor=X.+Wuauthor=Y.+Shenauthor=Y.+Sunauthor=X.+Wuauthor=Q.+Xu&title=Berberine+inhibits+palmitate-induced+NLRP3+inflammasome+activation+by+triggering+autophagy+in+macrophages%3A+A+new+mechanism+linking+berberine+to+insulin+resistance+improvement&doi=10.1016%2Fj.biopha.2017.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement</span></div><div class="casAuthors">Zhou, Hang; Feng, Lili; Xu, Fang; Sun, Yi; Ma, Yuxiang; Zhang, Xiong; Liu, Hailiang; Xu, Ge; Wu, Xuefeng; Shen, Yan; Sun, Yang; Wu, Xudong; Xu, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">864-874</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">NLRP3 (Nod-like receptor family pyrin domain contg. 3) inflammasome has been reported to contribute to obesity-induced inflammation and insulin resistance.  However, there are few drugs targeting NLRP3 inflammasome for the treatment of insulin resistance.  In the present study, we showed that berberine (BBR) significantly suppressed satd. fatty acid palmitate (PA)-induced NLRP3 inflammasome activation and interleukin-1β (IL-1β) release in macrophages, which was one of the most important mediators in the insulin sensitivity of adipose tissue.  BBR treatment dramatically upregulated macrophage autophagic level while knockdown beclin1 and autophagy inhibitor reversed BBR's suppression on inflammasome.  Furthermore, AMPK (adenosine monophosphate-activated protein kinase) inhibitor Adenine 9-β-D-arabinofuranoside (Ara-A) blocked most effects of BBR, suggesting that AMPK signals may be involved in BBR-induced macrophage autophagy.  Importantly, BBR also prevented NLRP3 inflammasome-dependent inflammation and metabolic disorder in a high-fat-diet-induced insulin resistance model.  Adoptive transfer of BBR-treated bone marrow-derived macrophages (BMDMs), which was induced by lipopolysaccharide (LPS) plus palmitate-bovine serum albumin (PA-BSA), significantly ameliorated insulin resistance of ob/ob mice as compared with control mice.  However, the co-treatment of the BMDMs with autophagy inhibitor 3-Methyladenine (3-MA) reversed the effect of BBR almost completely.  Taken together, BBR exerted its anti-inflammatory effects through activation of AMPK-dependent autophagy in adipose tissue macrophages (ATMs).  This study amplified the mechanisms of BBR and its potential in attenuating insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMISF82LNtL7Vg90H21EOLACvtfcHk0litMl0k8nADjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvFant7w%253D&md5=008a82c587134d63b0f6aec8e1a1b729</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2017.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2017.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26atitle%3DBerberine%2520inhibits%2520palmitate-induced%2520NLRP3%2520inflammasome%2520activation%2520by%2520triggering%2520autophagy%2520in%2520macrophages%253A%2520A%2520new%2520mechanism%2520linking%2520berberine%2520to%2520insulin%2520resistance%2520improvement%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D89%26spage%3D864%26epage%3D874%26doi%3D10.1016%2Fj.biopha.2017.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharvan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, S.</span></span> <span> </span><span class="NLM_article-title">Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1231</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2017.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.biopha.2017.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28931215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFWitLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2017&pages=1225-1231&author=L.+Liauthor=X.+Wangauthor=R.+Sharvanauthor=J.+Gaoauthor=S.+Qu&title=Berberine+could+inhibit+thyroid+carcinoma+cells+by+inducing+mitochondrial+apoptosis%2C+G0%2FG1+cell+cycle+arrest+and+suppressing+migration+via+PI3K-AKT+and+MAPK+signaling+pathways&doi=10.1016%2Fj.biopha.2017.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways</span></div><div class="casAuthors">Li, Liang; Wang, Xingchun; Sharvan, Rampersad; Gao, Jingyang; Qu, Shen</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1225-1231</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Berberine, an important natural isoquinoline alkaloid from traditional Chinese medicine, is reported to exhibit multiple pharmacol. properties, including anti-microbial, anti-diabetes, anti-obesity, anti-inflammatory and anti-carcinogenic activities.  Although studies have shown that a wide range of carcinoma cells could be inhibited by berberine, few studies involved thyroid carcinoma.  We therefore examd. the effect of berberine on papillary thyroid carcinoma (PTC, the most common subtype) and anaplastic thyroid carcinoma (ATC, the most malignant and aggressive subtype).  Three thyroid carcinoma cell lines with different aberrant genotypes and one normal thyroid cell line were selected, including C643 (ATC, with H-RAS mutation), OCUT1 (ATC, with BRAFV600E and PIK3CA mutations), TPC1 (PTC, with RET/PTC1 rearrangement) and Htori3 (normal).  We found that berberine inhibited the proliferation of C643, OCUT1 and TPC1 thyroid carcinoma cells in a dose- and time-dependent manner (p < 0.01, compared with the control), while normal human thyroid cells showed less sensitivity to the cytotoxicity of berberine.  Berberine-induced significant mitochondrial apoptosis, G0/G1 cell cycle arrest and inhibitive migration in thyroid carcinoma cells were also obsd. (p < 0.05 or p < 0.01, compared with the control).  Increased Bax/Bcl-2, cleaved Caspase 3, P21 and decreased Cyclin E1, CDK2 and Vimentin were verified by western blot.  Addnl., berberine caused markedly decreased p-AKT1 expression and disturbances in classic ERK MAPK as well as P38 and JNK MAPK pathways in diverse thyroid carcinoma cells.  Therefore, berberine could modulate PI3K-AKT and MAPK signaling pathways in thyroid carcinoma cells, which leads to mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressive migration.  Berberine may represent a promising chemotherapy for the treatment of thyroid carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEtYuURreQQLVg90H21EOLACvtfcHk0linKKaQWnPvKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFWitLjN&md5=4873ae099d833cc95a1b8b6946b25d24</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2017.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2017.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSharvan%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DS.%26atitle%3DBerberine%2520could%2520inhibit%2520thyroid%2520carcinoma%2520cells%2520by%2520inducing%2520mitochondrial%2520apoptosis%252C%2520G0%252FG1%2520cell%2520cycle%2520arrest%2520and%2520suppressing%2520migration%2520via%2520PI3K-AKT%2520and%2520MAPK%2520signaling%2520pathways%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D95%26spage%3D1225%26epage%3D1231%26doi%3D10.1016%2Fj.biopha.2017.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.-N.</span></span> <span> </span><span class="NLM_article-title">Berberine attenuates sodium palmitate-induced lipid accumulation, oxidative stress and apoptosis in grass carp(Ctenopharyngodon idella)hepatocyte in vitro</span>. <i>Fish Shellfish Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">518</span>– <span class="NLM_lpage">527</span>, <span class="refDoi"> DOI: 10.1016/j.fsi.2019.02.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.fsi.2019.02.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=30880233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtVChtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2019&pages=518-527&author=S.-S.+Yangauthor=C.-B.+Yuauthor=Z.+Luoauthor=W.-L.+Luoauthor=J.+Zhangauthor=J.-X.+Xuauthor=W.-N.+Xu&title=Berberine+attenuates+sodium+palmitate-induced+lipid+accumulation%2C+oxidative+stress+and+apoptosis+in+grass+carp%28Ctenopharyngodon+idella%29hepatocyte+in+vitro&doi=10.1016%2Fj.fsi.2019.02.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine attenuates sodium palmitate-induced lipid accumulation, oxidative stress and apoptosis in grass carp(Ctenopharyngodon idella)hepatocyte in vitro</span></div><div class="casAuthors">Yang, Shuo-Shuo; Yu, Cheng-Bing; Luo, Zhen; Luo, Wen-Li; Zhang, Jing; Xu, Jian-Xiong; Xu, Wei-Na</div><div class="citationInfo"><span class="NLM_cas:title">Fish & Shellfish Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">518-527</span>CODEN:
                <span class="NLM_cas:coden">FSIMEP</span>;
        ISSN:<span class="NLM_cas:issn">1050-4648</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The objective of this work was to investigate the effect of berberine (BBR) on the Cell viability, lipid accumulation, apoptosis, cytochrome c, caspase-9 and caspase-3 in lipid accumulation-hepatocytes induced by sodium palmitate in vitro.  The lipid accumulation-hepatocytes (induced by 0.5 mM sodium palmitate for 24 h) were treated with 5μM berberine for 12 h.  Then, the Cell viability, intracellular triglyceride (TG) content, lipid peroxide (LPO), malonaldehyde (MDA) content, cytochrome c, caspase-9, caspase-3 and apoptosis were detected.  Sodium palmitate decreased Cell viability and increased intracellular TG content, lipid droplet accumulation, LPO and MDA concns., caused caspase-3 and caspase-9 activation, then led to apoptosis accompanied by cytochrome c release from mitochondria into the cytoplasm.  Beberine could improve intracellular lipid droplet accumulation and oxidative stress, while reduce apoptosis induced by sodium palmitate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7GPyAt9fie7Vg90H21EOLACvtfcHk0linKKaQWnPvKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtVChtbg%253D&md5=409ab794892956f5f72bf0e68cda2a77</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.fsi.2019.02.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fsi.2019.02.055%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.-S.%26aulast%3DYu%26aufirst%3DC.-B.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DW.-L.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.-X.%26aulast%3DXu%26aufirst%3DW.-N.%26atitle%3DBerberine%2520attenuates%2520sodium%2520palmitate-induced%2520lipid%2520accumulation%252C%2520oxidative%2520stress%2520and%2520apoptosis%2520in%2520grass%2520carp%2528Ctenopharyngodon%2520idella%2529hepatocyte%2520in%2520vitro%26jtitle%3DFish%2520Shellfish%2520Immunol.%26date%3D2019%26volume%3D88%26spage%3D518%26epage%3D527%26doi%3D10.1016%2Fj.fsi.2019.02.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, K.</span></span> <span> </span><span class="NLM_article-title">Hypoglycemic mechanism of the berberine organic acid salt under the synergistic effect of intestinal flora and oxidative stress</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">8930374</span>, <span class="refDoi"> DOI: 10.1155/2018/8930374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1155%2F2018%2F8930374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=30662584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A280%3ADC%252BB3cjjtlGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=8930374&author=H.-X.+Cuiauthor=Y.-N.+Huauthor=J.-W.+Liauthor=K.+Yuan&title=Hypoglycemic+mechanism+of+the+berberine+organic+acid+salt+under+the+synergistic+effect+of+intestinal+flora+and+oxidative+stress&doi=10.1155%2F2018%2F8930374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoglycemic Mechanism of the Berberine Organic Acid Salt under the Synergistic Effect of Intestinal Flora and Oxidative Stress</span></div><div class="casAuthors">Cui Hong-Xin; Hu Ya-Nan; Cui Hong-Xin; Li Jing-Wan; Yuan Ke</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2018</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8930374</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Both alterations to the intestinal microflora and chronic systemic inflammation predispose towards type 2 diabetes (T2D).  Changes in the composition of the intestinal microflora are associated with glucose metabolism changes in rats with T2D.  Here, we demonstrate that a berberine fumarate (BF) has a hypoglycemic effect by regulating the intestinal microflora and metabolism of diabetic rats.  The T2D rats had disorders of glucose and lipid metabolism, an abnormal intestinal microflora, fewer butyrate-producing and probiotic-type bacteria, larger numbers of potentially pathogenic and sulfate-reducing bacteria, and tissue inflammation.  Administration of berberine fumarate significantly ameliorated the metabolic disorder; increased the populations of Bacteroidetes, Clostridia, Lactobacillales, Prevotellaceae, and Alloprevotella; and reduced those of Bacteroidales, Lachnospiraceae, Rikenellaceae, and Desulfovibrio.  In addition, it reduced inflammation, inhibiting the overexpression of TLR4 and p-JNK and increasing the expression of PI3K, GLUT2, and other proteins, which are closely related to oxidative stress, thereby promoting the metabolism of glucose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJQ-lYDmh02XT4ugvCDgnZfW6udTcc2eZbzuaWRS0Egbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjjtlGjsQ%253D%253D&md5=868429a3789e9e0145b3bf5b85c43c94</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1155%2F2018%2F8930374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2018%252F8930374%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DH.-X.%26aulast%3DHu%26aufirst%3DY.-N.%26aulast%3DLi%26aufirst%3DJ.-W.%26aulast%3DYuan%26aufirst%3DK.%26atitle%3DHypoglycemic%2520mechanism%2520of%2520the%2520berberine%2520organic%2520acid%2520salt%2520under%2520the%2520synergistic%2520effect%2520of%2520intestinal%2520flora%2520and%2520oxidative%2520stress%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2018%26volume%3D2018%26spage%3D8930374%26doi%3D10.1155%2F2018%2F8930374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shou, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, B.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-D.</span></span> <span> </span><span class="NLM_article-title">Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism</span>. <i>Metabolism</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1016/j.metabol.2017.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.metabol.2017.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28403947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVKjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2017&pages=72-84&author=Y.+Wangauthor=J.-W.+Shouauthor=X.-Y.+Liauthor=Z.-X.+Zhaoauthor=J.+Fuauthor=C.-Y.+Heauthor=R.+Fengauthor=C.+Maauthor=B.-Y.+Wenauthor=F.+Guoauthor=X.-Y.+Yangauthor=Y.-X.+Hanauthor=L.-L.+Wangauthor=Q.+Tongauthor=X.-F.+Youauthor=Y.+Linauthor=W.-J.+Kongauthor=S.-Y.+Siauthor=J.-D.+Jiang&title=Berberine-induced+bioactive+metabolites+of+the+gut+microbiota+improve+energy+metabolism&doi=10.1016%2Fj.metabol.2017.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism</span></div><div class="casAuthors">Wang, Yan; Shou, Jia-Wen; Li, Xiao-Yang; Zhao, Zhen-Xiong; Fu, Jie; He, Chi-Yu; Feng, Ru; Ma, Chao; Wen, Bao-Ying; Guo, Fang; Yang, Xin-Yi; Han, Yan-Xing; Wang, Lu-Lu; Tong, Qian; You, Xue-Fu; Lin, Yuan; Kong, Wei-Jia; Si, Shu-Yi; Jiang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">72-84</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Berberine (BBR) clin. lowers blood lipid and glucose levels via multi-target mechanisms.  One of the possible mechanisms is related to its effect on the short chain fatty acids (SCFAs) of the gut microbiota.  The goal of this study is to investigate the therapeutic effect and mode of action of BBR working through SCFAs of the gut microbiota (esp., butyrate).  Gas chromatog. (GC) was used to detect butyrate and other SCFAs chem.  The effect of BBR on butyrate prodn. was investigated in vitro as well as in several animal systems.  Microarrays were used to analyze the compn. change in the intestinal bacteria community after treatment with BBR.  BBR-induced change in the energy prodn. and gene regulation of intestinal bacteria was examd. in order to elucidate the underlying mol. mechanisms.  We show that oral administration of BBR in animals promoted the gut microbiota to produce butyrate, which then enters the blood and reduces blood lipid and glucose levels.  Incubating gut bacterial strains in vitro with BBR increased butyrate prodn.  Orally treating animals directly with butyrate reduced blood lipid and glucose levels through a mechanism different from that of BBR.  I.p. BBR administration did not increase butyrate but reduced blood lipid and glucose levels, suggesting that BBR has two modes of action: the direct effect of the circulated BBR and the indirect effect working through butyrate of the gut microbiota.  Pre-treating animals orally with antibiotics abolished the effect of BBR on butyrate.  A mechanism study showed that BBR (given orally) modified mice intestinal bacterial compn. by increasing the abundance of butyrate-producing bacteria.  Furthermore, BBR suppressed bacterial ATP prodn. and NADH levels, resulting in increased butyryl-CoA and, eventually, butyrate prodn. via upregulating phosphotransbutyrylase/butyrate kinase and butyryl-CoA:acetate-CoA transferase in bacteria.  Promotion of butyrate (etc) prodn. in gut microbiota might be one of the important mechanisms of BBR in regulating energy metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrev6tZGqob97Vg90H21EOLACvtfcHk0ljYPlwKFvs78A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVKjtbg%253D&md5=73548e9e0cf0419ea87b833b7a02d27f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2017.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2017.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DShou%26aufirst%3DJ.-W.%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DZhao%26aufirst%3DZ.-X.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DC.-Y.%26aulast%3DFeng%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DWen%26aufirst%3DB.-Y.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DX.-Y.%26aulast%3DHan%26aufirst%3DY.-X.%26aulast%3DWang%26aufirst%3DL.-L.%26aulast%3DTong%26aufirst%3DQ.%26aulast%3DYou%26aufirst%3DX.-F.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DW.-J.%26aulast%3DSi%26aufirst%3DS.-Y.%26aulast%3DJiang%26aufirst%3DJ.-D.%26atitle%3DBerberine-induced%2520bioactive%2520metabolites%2520of%2520the%2520gut%2520microbiota%2520improve%2520energy%2520metabolism%26jtitle%3DMetabolism%26date%3D2017%26volume%3D70%26spage%3D72%26epage%3D84%26doi%3D10.1016%2Fj.metabol.2017.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shou, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. D.</span></span> <span> </span><span class="NLM_article-title">Transforming berberine into its intestine-absorbable form by the gut microbiota</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">12155</span>, <span class="refDoi"> DOI: 10.1038/srep12155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fsrep12155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=26174047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlWhtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=12155&author=R.+Fengauthor=J.+W.+Shouauthor=Z.+X.+Zhaoauthor=C.+Y.+Heauthor=C.+Maauthor=M.+Huangauthor=J.+Fuauthor=X.+S.+Tanauthor=X.+Y.+Liauthor=B.+Y.+Wenauthor=X.+Chenauthor=X.+Y.+Yangauthor=G.+Renauthor=Y.+Linauthor=Y.+Chenauthor=X.+F.+Youauthor=Y.+Wangauthor=J.+D.+Jiang&title=Transforming+berberine+into+its+intestine-absorbable+form+by+the+gut+microbiota&doi=10.1038%2Fsrep12155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Transforming berberine into its intestine-absorbable form by the gut microbiota</span></div><div class="casAuthors">Feng, Ru; Shou, Jia-Wen; Zhao, Zhen-Xiong; He, Chi-Yu; Ma, Chao; Huang, Min; Fu, Jie; Tan, Xiang-Shan; Li, Xiao-Yang; Wen, Bao-Ying; Chen, Xi; Yang, Xin-Yi; Ren, Gang; Lin, Yuan; Chen, Yangchao; You, Xue-Fu; Wang, Yan; Jiang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12155</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The gut microbiota is important in the pathogenesis of energy-metab. related diseases.  We focused on the interaction between intestinal bacteria and orally administered chem. drugs.  Oral administration of berberine (BBR) effectively treats patients with metabolic disorders.  However, because BBR exhibits poor soly., its absorption mechanism remains unknown.  Here, we show that the gut microbiota converts BBR into its absorbable form of dihydroberberine (dhBBR), which has an intestinal absorption rate 5-fold that of BBR in animals.  The redn. of BBR to dhBBR was performed by nitroreductases of the gut microbiota.  DhBBR was unstable in soln. and reverted to BBR in intestine tissues via oxidization.  Heat inactivation of intestinal homogenate did not inhibit dhBBR oxidization, suggesting the process a non-enzymic reaction.  The diminution of intestinal bacteria via orally treating KK-Ay mice with antibiotics decreased the BBR-to-dhBBR conversion and blood BBR; accordingly, the lipid- and glucose-lowering efficacy of BBR was reduced.  Conclusively, the gut microbiota reduces BBR into its absorbable form of dhBBR, which then oxidizes back to BBR after absorption in intestine tissues and enters the blood.  Thus, interaction(s) between the gut microbiota and orally administrated drugs may modify the structure and function of chems. and be important in drug investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_D-NDwkLniLVg90H21EOLACvtfcHk0ljYPlwKFvs78A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlWhtbnL&md5=6c709063725e05afc77c8d8fc43d279a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsrep12155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep12155%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DR.%26aulast%3DShou%26aufirst%3DJ.%2BW.%26aulast%3DZhao%26aufirst%3DZ.%2BX.%26aulast%3DHe%26aufirst%3DC.%2BY.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DX.%2BS.%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DWen%26aufirst%3DB.%2BY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DX.%2BY.%26aulast%3DRen%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DX.%2BF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DJ.%2BD.%26atitle%3DTransforming%2520berberine%2520into%2520its%2520intestine-absorbable%2520form%2520by%2520the%2520gut%2520microbiota%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D12155%26doi%3D10.1038%2Fsrep12155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pirillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catapano, A. L.</span></span> <span> </span><span class="NLM_article-title">Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>243</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2015.09.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.atherosclerosis.2015.09.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=26520899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKgs7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=2015&pages=449-461&author=A.+Pirilloauthor=A.+L.+Catapano&title=Berberine%2C+a+plant+alkaloid+with+lipid-+and+glucose-lowering+properties%3A+From+in+vitro+evidence+to+clinical+studies&doi=10.1016%2Fj.atherosclerosis.2015.09.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies</span></div><div class="casAuthors">Pirillo, Angela; Catapano, Alberico Luigi</div><div class="citationInfo"><span class="NLM_cas:title">Atherosclerosis (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">243</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">449-461</span>CODEN:
                <span class="NLM_cas:coden">ATHSBL</span>;
        ISSN:<span class="NLM_cas:issn">0021-9150</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Berberine (BBR) is an isoquinoline plant alkaloid endowed with several pharmacol. activities, including anti-microbial, glucose- and cholesterol-lowering, anti-tumoral and immunomodulatory properties.  The main mechanism by which BBR exerts a protective role in atherosclerosis relates to its cholesterol-lowering activity.  BBR significantly increases hepatic low d. lipoprotein receptor (LDLR) expression and reduces the expression and secretion of the LDLR modulator proprotein convertase subtilisin/kexin type 9 (PCSK9).  In addn. to this, several other atheroprotective effects have been ascribed to BBR, including anti-inflammatory and anti-oxidant properties, inhibition of vascular smooth muscle cell proliferation and improvement of endothelial dysfunction.  BBR also increases glucose utilization in adipocytes and myocytes, while decreases glucose absorption in intestinal cells, resulting in a net hypoglycemic effect.  In hypercholesterolemic animals, BBR significantly decreases LDL-C and total cholesterol (TC) levels and reduces aortic lesions, an effect similar to that of statins.  In diabetic animals, BBR significantly reduces glucose levels, improves glucose tolerance, reduces body wt. gain and adipose tissue mass.  Several clin. studies have also tested the efficacy of BBR in humans.  In hypercholesterolemic subjects, BBR induces a significant redn. of TC, triglycerides and LDL-C levels and a significant increase of HDL-C levels, without major adverse effects.  BBR also reduces glycemia and plasma cholesterol in diabetic patients, improves lipid and glucose profile and decreases body mass index and waist circumference in subjects with metabolic syndrome.  These findings, together with the good tolerability, suggest that BBR administration might be considered a potential therapeutic approach for the treatment of hypercholesterolemia or diabetes.  Given the level of evidence available to date well-designed randomized controlled trials to test safety and efficacy of BBR are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9FC5DQK4Ir7Vg90H21EOLACvtfcHk0ljYPlwKFvs78A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKgs7vM&md5=e78fdb4c6b43a60c17bad780785a85df</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2015.09.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2015.09.032%26sid%3Dliteratum%253Aachs%26aulast%3DPirillo%26aufirst%3DA.%26aulast%3DCatapano%26aufirst%3DA.%2BL.%26atitle%3DBerberine%252C%2520a%2520plant%2520alkaloid%2520with%2520lipid-%2520and%2520glucose-lowering%2520properties%253A%2520From%2520in%2520vitro%2520evidence%2520to%2520clinical%2520studies%26jtitle%3DAtherosclerosis%26date%3D2015%26volume%3D243%26spage%3D449%26epage%3D461%26doi%3D10.1016%2Fj.atherosclerosis.2015.09.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W. J.</span></span> <span> </span><span class="NLM_article-title">Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus</span>. <i>J. Evidence-Based Complementary Altern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2014</i></span>,  <span class="NLM_fpage">289264</span>, <span class="refDoi"> DOI: 10.1155/2014/289264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1155%2F2014%2F289264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=24669227" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=289264&author=Z.+Liauthor=Y.+N.+Gengauthor=J.+D.+Jiangauthor=W.+J.+Kong&title=Antioxidant+and+anti-inflammatory+activities+of+berberine+in+the+treatment+of+diabetes+mellitus&doi=10.1155%2F2014%2F289264"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1155%2F2014%2F289264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F289264%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGeng%26aufirst%3DY.%2BN.%26aulast%3DJiang%26aufirst%3DJ.%2BD.%26aulast%3DKong%26aufirst%3DW.%2BJ.%26atitle%3DAntioxidant%2520and%2520anti-inflammatory%2520activities%2520of%2520berberine%2520in%2520the%2520treatment%2520of%2520diabetes%2520mellitus%26jtitle%3DJ.%2520Evidence-Based%2520Complementary%2520Altern.%2520Med.%26date%3D2014%26volume%3D2014%26spage%3D289264%26doi%3D10.1155%2F2014%2F289264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunnumakkara, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, B. B.</span></span> <span> </span><span class="NLM_article-title">Berberine Modifies Cysteine 179 of IκBα Kinase, Suppresses Nuclear Factor-κB-Regulated Antiapoptotic Gene Products, and Potentiates Apoptosis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">5370</span>– <span class="NLM_lpage">5379</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-08-0511</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1158%2F0008-5472.CAN-08-0511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=18593939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFyjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=5370-5379&author=M.+K.+Pandeyauthor=B.+Sungauthor=A.+B.+Kunnumakkaraauthor=G.+Sethiauthor=M.+M.+Chaturvediauthor=B.+B.+Aggarwal&title=Berberine+Modifies+Cysteine+179+of+I%CE%BAB%CE%B1+Kinase%2C+Suppresses+Nuclear+Factor-%CE%BAB-Regulated+Antiapoptotic+Gene+Products%2C+and+Potentiates+Apoptosis&doi=10.1158%2F0008-5472.can-08-0511"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine Modifies Cysteine 179 of IκBα Kinase, Suppresses Nuclear Factor-κB-Regulated Antiapoptotic Gene Products, and Potentiates Apoptosis</span></div><div class="casAuthors">Pandey, Manoj K.; Sung, Bokyung; Kunnumakkara, Ajaikumar B.; Sethi, Gautam; Chaturvedi, Madan M.; Aggarwal, Bharat B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5370-5379</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Berberine, an isoquinoline alkaloid derived from a plant used traditionally in Chinese and Ayurvedic medicine, has been reported to exhibit chemopreventive and anti-inflammatory activities through unknown mechanism.  Because of the crit. role of the transcription factor nuclear factor-κB (NF-κB) in these processes, we investigated the effect of berberine on this pathway.  We found that berberine suppressed NF-κB activation induced by various inflammatory agents and carcinogens.  This alkaloid also suppressed constitutive NF-κB activation found in certain tumor cells.  Suppression of NF-κB activation occurred through the inhibition of phosphorylation and degrdn. of IκBα by the inhibition of IκB kinase (IKK) activation, leading to suppression of phosphorylation and nuclear translocation of p65, and finally to inhibition of NF-κB reporter activity.  Inhibition of IKK by berbeine was direct and could be reversed by reducing agents.  Site-specific mutagenesis suggested the involvement of cysteine residue 179 in IKK.  Berberine also suppressed the expression of NF-κB-regulated gene products involved in antiapoptosis (Bcl-xL, Survivin, IAP1, IAP2, and cFLIP), proliferation (cyclin D1), inflammation (cyclooxygenase-2), and invasion (matrix metalloproteinase-9).  Suppression of antiapoptotic gene products correlated with enhancement of apoptosis induced by tumor necrosis factor (TNF)-α and chemotherapeutic agents and with inhibition of TNF-induced cellular invasion.  Overall, our results indicate that chemopreventive, apoptotic, and anti-inflammatory activities displayed by berberine may be mediated in part through the suppression of the NF-κB activation pathway.  This may provide the mol. basis for the ability of berberine to act as an anticancer and anti-inflammatory agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBbwsRNYck3bVg90H21EOLACvtfcHk0lhbJ53byHRAyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFyjtL8%253D&md5=ab890bc1897177be9b22ae873b52d0e6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-0511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-0511%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DM.%2BK.%26aulast%3DSung%26aufirst%3DB.%26aulast%3DKunnumakkara%26aufirst%3DA.%2BB.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DM.%2BM.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DBerberine%2520Modifies%2520Cysteine%2520179%2520of%2520I%25CE%25BAB%25CE%25B1%2520Kinase%252C%2520Suppresses%2520Nuclear%2520Factor-%25CE%25BAB-Regulated%2520Antiapoptotic%2520Gene%2520Products%252C%2520and%2520Potentiates%2520Apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D5370%26epage%3D5379%26doi%3D10.1158%2F0008-5472.can-08-0511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ridker, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuren, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFadyen, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballantyne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anker, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastelein, J. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornel, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pais, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genest, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cifkova, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzatti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forster, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobalava, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vida-Simiti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flather, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dellborg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, P. R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troquay, R. P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libby, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynn, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Group, C. T.</span></span> <span> </span><span class="NLM_article-title">Antiinflammatory therapy with canakinumab for atherosclerotic disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>377</i></span>,  <span class="NLM_fpage">1119</span>– <span class="NLM_lpage">1131</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1707914</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1056%2FNEJMoa1707914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28845751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOqurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2017&pages=1119-1131&author=P.+M.+Ridkerauthor=B.+M.+Everettauthor=T.+Thurenauthor=J.+G.+MacFadyenauthor=W.+H.+Changauthor=C.+Ballantyneauthor=F.+Fonsecaauthor=J.+Nicolauauthor=W.+Koenigauthor=S.+D.+Ankerauthor=J.+J.+P.+Kasteleinauthor=J.+H.+Cornelauthor=P.+Paisauthor=D.+Pellaauthor=J.+Genestauthor=R.+Cifkovaauthor=A.+Lorenzattiauthor=T.+Forsterauthor=Z.+Kobalavaauthor=L.+Vida-Simitiauthor=M.+Flatherauthor=H.+Shimokawaauthor=H.+Ogawaauthor=M.+Dellborgauthor=P.+R.+F.+Rossiauthor=R.+P.+T.+Troquayauthor=P.+Libbyauthor=R.+J.+Glynnauthor=C.+T.+Group&title=Antiinflammatory+therapy+with+canakinumab+for+atherosclerotic+disease&doi=10.1056%2Fnejmoa1707914"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Antiinflammatory therapy with canakinumab for atherosclerotic disease</span></div><div class="casAuthors">Ridker, P. M.; Everett, B. M.; Thuren, T.; MacFadyen, J. G.; Chang, W. H.; Ballantyne, C.; Fonseca, F.; Nicolau, J.; Koenig, W.; Anker, S. D.; Kastelein, J. J. P.; Cornel, J. H.; Pais, P.; Pella, D.; Genest, J.; Cifkova, R.; Lorenzatti, A.; Forster, T.; Kobalava, Z.; Vida-Simiti, L.; Flather, M.; Shimokawa, H.; Ogawa, H.; Dellborg, M.; Rossi, P. R. F.; Troquay, R. P. T.; Libby, P.; Glynn, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1119-1131</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background Exptl. and clin. data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease.  Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. methods We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per L.  The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered s.c. every 3 mo) with placebo.  The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. results At 48 mo, the median redn. from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group.  There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). conclusions Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 mo led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfwYFxFQ_i_LVg90H21EOLACvtfcHk0lhbJ53byHRAyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOqurnE&md5=50570e06cca89d8b3f654333047f223d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1707914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1707914%26sid%3Dliteratum%253Aachs%26aulast%3DRidker%26aufirst%3DP.%2BM.%26aulast%3DEverett%26aufirst%3DB.%2BM.%26aulast%3DThuren%26aufirst%3DT.%26aulast%3DMacFadyen%26aufirst%3DJ.%2BG.%26aulast%3DChang%26aufirst%3DW.%2BH.%26aulast%3DBallantyne%26aufirst%3DC.%26aulast%3DFonseca%26aufirst%3DF.%26aulast%3DNicolau%26aufirst%3DJ.%26aulast%3DKoenig%26aufirst%3DW.%26aulast%3DAnker%26aufirst%3DS.%2BD.%26aulast%3DKastelein%26aufirst%3DJ.%2BJ.%2BP.%26aulast%3DCornel%26aufirst%3DJ.%2BH.%26aulast%3DPais%26aufirst%3DP.%26aulast%3DPella%26aufirst%3DD.%26aulast%3DGenest%26aufirst%3DJ.%26aulast%3DCifkova%26aufirst%3DR.%26aulast%3DLorenzatti%26aufirst%3DA.%26aulast%3DForster%26aufirst%3DT.%26aulast%3DKobalava%26aufirst%3DZ.%26aulast%3DVida-Simiti%26aufirst%3DL.%26aulast%3DFlather%26aufirst%3DM.%26aulast%3DShimokawa%26aufirst%3DH.%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DDellborg%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DP.%2BR.%2BF.%26aulast%3DTroquay%26aufirst%3DR.%2BP.%2BT.%26aulast%3DLibby%26aufirst%3DP.%26aulast%3DGlynn%26aufirst%3DR.%2BJ.%26aulast%3DGroup%26aufirst%3DC.%2BT.%26atitle%3DAntiinflammatory%2520therapy%2520with%2520canakinumab%2520for%2520atherosclerotic%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2017%26volume%3D377%26spage%3D1119%26epage%3D1131%26doi%3D10.1056%2Fnejmoa1707914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ridker, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFadyen, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuren, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libby, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynn, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Group, C. T.</span></span> <span> </span><span class="NLM_article-title">Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">1833</span>– <span class="NLM_lpage">1842</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(17)32247-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2FS0140-6736%2817%2932247-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28855077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2gurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2017&pages=1833-1842&author=P.+M.+Ridkerauthor=J.+G.+MacFadyenauthor=T.+Thurenauthor=B.+M.+Everettauthor=P.+Libbyauthor=R.+J.+Glynnauthor=C.+T.+Group&title=Effect+of+interleukin-1%CE%B2+inhibition+with+canakinumab+on+incident+lung+cancer+in+patients+with+atherosclerosis%3A+exploratory+results+from+a+randomised%2C+double-blind%2C+placebo-controlled+trial&doi=10.1016%2FS0140-6736%2817%2932247-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomized, double-blind, placebo-controlled trial</span></div><div class="casAuthors">Ridker, Paul M.; MacFadyen, Jean G.; Thuren, Tom; Everett, Brendan M.; Libby, Peter; Glynn, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">390</span>
        (<span class="NLM_cas:issue">10105</span>),
    <span class="NLM_cas:pages">1833-1842</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Inflammation in the tumor microenvironment mediated by interleukin 1β is hypothesised to have a major role in cancer invasiveness, progression, and metastases.  We did an addnl. anal. in the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS), a randomized trial of the role of interleukin-1β inhibition in atherosclerosis, with the aim of establishing whether inhibition of a major product of the Nod-like receptor protein 3 (NLRP3) inflammasome with canakinumab might alter cancer incidence.  We did a randomized, double-blind, placebo-controlled trial of canakinumab in 10 061 patients with atherosclerosis who had had a myocardial infarction, were free of previously diagnosed cancer, and had concns. of high-sensitivity C-reactive protein (hsCRP) of 2 mg/L or greater.  To assess dose-response effects, patients were randomly assigned by computer-generated codes to three canakinumab doses (50 mg, 150 mg, and 300 mg, s.c. every 3 mo) or placebo.  Participants were followed up for incident cancer diagnoses, which were adjudicated by an oncol. endpoint committee masked to drug or dose allocation.  Anal. was by intention to treat.  The trial is registered with ClinicalTrials.gov, NCT01327846.  The trial is closed (the last patient visit was in June, 2017).  Baseline concns. of hsCRP (median 6·0 mg/L vs 4·2 mg/L; p<0·0001) and interleukin 6 (3·2 vs 2·6 ng/L; p<0·0001) were significantly higher among participants subsequently diagnosed with lung cancer than among those not diagnosed with cancer.  During median follow-up of 3·7 years, compared with placebo, canakinumab was assocd. with dose-dependent redns. in concns. of hsCRP of 26-41% and of interleukin 6 of 25-43% (p<0·0001 for all comparisons).  Total cancer mortality (n=196) was significantly lower in the pooled canakinumab group than in the placebo group (p=0·0007 for trend across groups), but was significantly lower than placebo only in the 300 mg group individually (hazard ratio [HR] 0·49 [95% CI 0·31-0·75]; p=0·0009).  Incident lung cancer (n=129) was significantly less frequent in the 150 mg (HR 0·61 [95% CI 0·39-0·97]; p=0·034) and 300 mg groups (HR 0·33 [95% CI 0·18-0·59]; p<0·0001; p<0·0001 for trend across groups).  Lung cancer mortality was significantly less common in the canakinumab 300 mg group than in the placebo group (HR 0·23 [95% CI 0·10-0·54]; p=0·0002) and in the pooled canakinumab population than in the placebo group (p=0·0002 for trend across groups).  Fatal infections or sepsis were significantly more common in the canakinumab groups than in the placebo group.  All-cause mortality did not differ significantly between the canakinumab and placebo groups (HR 0·94 [95% CI 0·83-1·06]; p=0·31).  Our hypothesis-generating data suggest the possibility that anti-inflammatory therapy with canakinumab targeting the interleukin-1β innate immunity pathway could significantly reduce incident lung cancer and lung cancer mortality.  Replication of these data in formal settings of cancer screening and treatment is required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxUhgLfpzhtbVg90H21EOLACvtfcHk0lgzUIfme0Y8hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2gurvL&md5=d95abebf214508583dfb7f27c4e999af</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2932247-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252932247-X%26sid%3Dliteratum%253Aachs%26aulast%3DRidker%26aufirst%3DP.%2BM.%26aulast%3DMacFadyen%26aufirst%3DJ.%2BG.%26aulast%3DThuren%26aufirst%3DT.%26aulast%3DEverett%26aufirst%3DB.%2BM.%26aulast%3DLibby%26aufirst%3DP.%26aulast%3DGlynn%26aufirst%3DR.%2BJ.%26aulast%3DGroup%26aufirst%3DC.%2BT.%26atitle%3DEffect%2520of%2520interleukin-1%25CE%25B2%2520inhibition%2520with%2520canakinumab%2520on%2520incident%2520lung%2520cancer%2520in%2520patients%2520with%2520atherosclerosis%253A%2520exploratory%2520results%2520from%2520a%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DLancet%26date%3D2017%26volume%3D390%26spage%3D1833%26epage%3D1842%26doi%3D10.1016%2FS0140-6736%2817%2932247-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motro, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, G.</span></span> <span> </span><span class="NLM_article-title">NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>530</i></span>,  <span class="NLM_fpage">354</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1038/nature16959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fnature16959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=26814970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFyitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=530&publication_year=2016&pages=354-357&author=Y.+Heauthor=M.+Y.+Zengauthor=D.+Yangauthor=B.+Motroauthor=G.+N%C3%BA%C3%B1ez&title=NEK7+is+an+essential+mediator+of+NLRP3+activation+downstream+of+potassium+efflux&doi=10.1038%2Fnature16959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux</span></div><div class="casAuthors">He, Yuan; Zeng, Melody Y.; Yang, Dahai; Motro, Benny; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">530</span>
        (<span class="NLM_cas:issue">7590</span>),
    <span class="NLM_cas:pages">354-357</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inflammasomes are intracellular protein complexes that drive the activation of inflammatory caspases.  So far, four inflammasomes involving NLRP1, NLRP3, NLRC4 and AIM2 have been described that recruit the common adaptor protein ASC to activate caspase-1, leading to the secretion of mature IL-1β and IL-18 proteins.  The NLRP3 inflammasome has been implicated in the pathogenesis of several acquired inflammatory diseases as well as cryopyrin-assocd. periodic fever syndromes (CAPS) caused by inherited NLRP3 mutations.  Potassium efflux is a common step that is essential for NLRP3 inflammasome activation induced by many stimuli.  Despite extensive investigation, the mol. mechanism leading to NLRP3 activation in response to potassium efflux remains unknown.  Here the authors report the identification of NEK7, a member of the family of mammalian NIMA-related kinases (NEK proteins), as an NLRP3-binding protein that acts downstream of potassium efflux to regulate NLRP3 oligomerization and activation.  In the absence of NEK7, caspase-1 activation and IL-1β release were abrogated in response to signals that activate NLRP3, but not NLRC4 or AIM2 inflammasomes.  NLRP3-activating stimuli promoted the NLRP3-NEK7 interaction in a process that was dependent on potassium efflux.  NLRP3 assocd. with the catalytic domain of NEK7, but the catalytic activity of NEK7 was shown to be dispensable for activation of the NLRP3 inflammasome.  Activated macrophages formed a high-mol.-mass NLRP3-NEK7 complex, which, along with ASC oligomerization and ASC speck formation, was abrogated in the absence of NEK7.  NEK7 was required for macrophages contg. the CAPS-assocd. NLRP3(R258W) activating mutation to activate caspase-1.  Mouse chimeras reconstituted with wild-type, Nek7-/- or Nlrp3-/- hematopoietic cells showed that NEK7 was required for NLRP3 inflammasome activation in vivo.  These studies demonstrate that NEK7 is an essential protein that acts downstream of potassium efflux to mediate NLRP3 inflammasome assembly and activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcHD1JcxOIqrVg90H21EOLACvtfcHk0lgzUIfme0Y8hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFyitbY%253D&md5=ff385d4ed4c8d8861059772c2cb26f19</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnature16959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature16959%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DM.%2BY.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DMotro%26aufirst%3DB.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DG.%26atitle%3DNEK7%2520is%2520an%2520essential%2520mediator%2520of%2520NLRP3%2520activation%2520downstream%2520of%2520potassium%2520efflux%26jtitle%3DNature%26date%3D2016%26volume%3D530%26spage%3D354%26epage%3D357%26doi%3D10.1038%2Fnature16959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">NEK7: a novel promising therapy target for NLRP3-related inflammatory diseases</span>. <i>Acta Biochim. Biophys. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">966</span>– <span class="NLM_lpage">968</span>, <span class="refDoi"> DOI: 10.1093/abbs/gmw080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1093%2Fabbs%2Fgmw080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=27563009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlalu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=966-968&author=J.+Xuauthor=L.+Luauthor=L.+Li&title=NEK7%3A+a+novel+promising+therapy+target+for+NLRP3-related+inflammatory+diseases&doi=10.1093%2Fabbs%2Fgmw080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">NEK7: a novel promising therapy target for NLRP3-related inflammatory diseases</span></div><div class="casAuthors">Xu, Jin; Lu, Liqun; Li, Lanfang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica et Biophysica Sinica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">966-968</span>CODEN:
                <span class="NLM_cas:coden">ABBSC2</span>;
        ISSN:<span class="NLM_cas:issn">1672-9145</span>.
    
            (<span class="NLM_cas:orgname">ABBS Editorial Office</span>)
        </div><div class="casAbstract">A review discussing NEK7 a novel promising therapy target for NLRP3-related inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ8zz8onqBvrVg90H21EOLACvtfcHk0lgzUIfme0Y8hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlalu7Y%253D&md5=7a0e702f00aac3bec701e4510f7b5a9b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1093%2Fabbs%2Fgmw080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fabbs%252Fgmw080%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DNEK7%253A%2520a%2520novel%2520promising%2520therapy%2520target%2520for%2520NLRP3-related%2520inflammatory%2520diseases%26jtitle%3DActa%2520Biochim.%2520Biophys.%2520Sin.%26date%3D2016%26volume%3D48%26spage%3D966%26epage%3D968%26doi%3D10.1093%2Fabbs%2Fgmw080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamkanfi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Inflammasomes and their roles in health and disease</span>. <i>Annu. Rev. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1146/annurev-cellbio-101011-155745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1146%2Fannurev-cellbio-101011-155745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=22974247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslagtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2012&pages=137-161&author=M.+Lamkanfiauthor=V.+M.+Dixit&title=Inflammasomes+and+their+roles+in+health+and+disease&doi=10.1146%2Fannurev-cellbio-101011-155745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammasomes and their roles in health and disease</span></div><div class="casAuthors">Lamkanfi, Mohamed; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell and Developmental Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">137-161</span>CODEN:
                <span class="NLM_cas:coden">ARDBF8</span>;
        ISSN:<span class="NLM_cas:issn">1081-0706</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Inflammasomes are a set of intracellular protein complexes that enable autocatalytic activation of inflammatory caspases, which drive host and immune responses by releasing cytokines and alarmins into circulation and by inducing pyroptosis, a proinflammatory cell death mode.  The inflammasome type mediating these responses varies with the microbial pathogen or stress factor that poses a threat to the organism.  Since the discovery that polymorphisms in inflammasome genes are linked to common autoimmune diseases and less frequent periodic fever syndromes, inflammasome signaling has been dissected at the mol. level.  In this review, we present recently gained insight on the distinct inflammasome types, their activation and effector mechanisms, and their modulation by microbial virulence factors.  In addn., we discuss recently gained knowledge on the role of deregulated inflammasome activity in human autoinflammatory, autoimmune, and infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXur5D3kH6ALVg90H21EOLACvtfcHk0ljbow9DI7siww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslagtb3J&md5=a81d32647c7a9a8f710b38e0965a7f57</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1146%2Fannurev-cellbio-101011-155745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-cellbio-101011-155745%26sid%3Dliteratum%253Aachs%26aulast%3DLamkanfi%26aufirst%3DM.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DInflammasomes%2520and%2520their%2520roles%2520in%2520health%2520and%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D2012%26volume%3D28%26spage%3D137%26epage%3D161%26doi%3D10.1146%2Fannurev-cellbio-101011-155745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tardivel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorens, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span> <span> </span><span class="NLM_article-title">Thioredoxin-interacting protein links oxidative stress to inflammasome activation</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1038/ni.1831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fni.1831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=20023662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFyhsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=136-140&author=R.+Zhouauthor=A.+Tardivelauthor=B.+Thorensauthor=I.+Choiauthor=J.+Tschopp&title=Thioredoxin-interacting+protein+links+oxidative+stress+to+inflammasome+activation&doi=10.1038%2Fni.1831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Thioredoxin-interacting protein links oxidative stress to inflammasome activation</span></div><div class="casAuthors">Zhou, Rongbin; Tardivel, Aubry; Thorens, Bernard; Choi, Inpyo; Tschopp, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">136-140</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The NLRP3 inflammasome has a major role in regulating innate immunity.  Deregulated inflammasome activity is assocd. with several inflammatory diseases, yet little is known about the signaling pathways that lead to its activation.  Here the authors show that NLRP3 interacted with thioredoxin (TRX)-interacting protein (TXNIP), a protein linked to insulin resistance.  Inflammasome activators such as uric acid crystals induced the dissocn. of TXNIP from thioredoxin in a reactive oxygen species (ROS)-sensitive manner and allowed it to bind NLRP3.  TXNIP deficiency impaired activation of the NLRP3 inflammasome and subsequent secretion of interleukin 1β (IL-1β).  Akin to Txnip-/- mice, Nlrp3-/- mice showed improved glucose tolerance and insulin sensitivity.  The participation of TXNIP in the NLRP3 inflammasome activation may provide a mechanistic link to the obsd. involvement of IL-1β in the pathogenesis of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph6WgKbKxmNLVg90H21EOLACvtfcHk0ljbow9DI7siww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFyhsLrJ&md5=70a8f699c4e13fefc96a80fa75ae5a20</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fni.1831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1831%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DTardivel%26aufirst%3DA.%26aulast%3DThorens%26aufirst%3DB.%26aulast%3DChoi%26aufirst%3DI.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DThioredoxin-interacting%2520protein%2520links%2520oxidative%2520stress%2520to%2520inflammasome%2520activation%26jtitle%3DNat.%2520Immunol.%26date%3D2010%26volume%3D11%26spage%3D136%26epage%3D140%26doi%3D10.1038%2Fni.1831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span> <span> </span><span class="NLM_article-title">Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2550</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-04947-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fs41467-018-04947-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=29959312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FjsVKrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=2550&author=H.+Heauthor=H.+Jiangauthor=Y.+Chenauthor=J.+Yeauthor=A.+Wangauthor=C.+Wangauthor=Q.+Liuauthor=G.+Liangauthor=X.+Dengauthor=W.+Jiangauthor=R.+Zhou&title=Oridonin+is+a+covalent+NLRP3+inhibitor+with+strong+anti-inflammasome+activity&doi=10.1038%2Fs41467-018-04947-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity</span></div><div class="casAuthors">He Hongbin; Jiang Hua; Ye Jin; Wang Chao; Jiang Wei; Zhou Rongbin; He Hongbin; Zhou Rongbin; Chen Yun; Deng Xianming; Wang Aoli; Liu Qingsong; Liang Gaolin</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2550</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oridonin (Ori) is the major active ingredient of the traditional Chinese medicinal herb Rabdosia rubescens and has anti-inflammatory activity, but the target of Ori remains unknown.  NLRP3 is a central component of NLRP3 inflammasome and has been involved in a wide variety of chronic inflammation-driven human diseases.  Here, we show that Ori is a specific and covalent inhibitor for NLRP3 inflammasome.  Ori forms a covalent bond with the cysteine 279 of NLRP3 in NACHT domain to block the interaction between NLRP3 and NEK7, thereby inhibiting NLRP3 inflammasome assembly and activation.  Importantly, Ori has both preventive or therapeutic effects on mouse models of peritonitis, gouty arthritis and type 2 diabetes, via inhibition of NLRP3 activation.  Our results thus identify NLRP3 as the direct target of Ori for mediating Ori's anti-inflammatory activity.  Ori could serve as a lead for developing new therapeutics against NLRP3-driven diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfgXJ7_Tz1NrZpSb_XWfMrfW6udTcc2ebzNPkBVKgHRrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FjsVKrsA%253D%253D&md5=d041a8a1af6dc9fc6c0166ebf446799d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-04947-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-04947-6%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DR.%26atitle%3DOridonin%2520is%2520a%2520covalent%2520NLRP3%2520inhibitor%2520with%2520strong%2520anti-inflammasome%2520activity%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D2550%26doi%3D10.1038%2Fs41467-018-04947-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, F.</span></span> <span> </span><span class="NLM_article-title">Chemical probing reveals insights into the signaling mechanism of inflammasome activation</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1289</span>– <span class="NLM_lpage">1305</span>, <span class="refDoi"> DOI: 10.1038/cr.2010.135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fcr.2010.135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=20856264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWqu7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1289-1305&author=Y.-N.+Gongauthor=X.+Wangauthor=J.+Wangauthor=Z.+Yangauthor=S.+Liauthor=J.+Yangauthor=L.+Liuauthor=X.+Leiauthor=F.+Shao&title=Chemical+probing+reveals+insights+into+the+signaling+mechanism+of+inflammasome+activation&doi=10.1038%2Fcr.2010.135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical probing reveals insights into the signaling mechanism of inflammasome activation</span></div><div class="casAuthors">Gong, Yi-Nan; Wang, Xiaoming; Wang, Jiayi; Yang, Zhenxiao; Li, Shan; Yang, Jieling; Liu, Liping; Lei, Xiaoguang; Shao, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1289-1305</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Caspase-1-mediated IL-1β prodn. is generally controlled by two pathways.  Toll-like receptors (TLRs) recognize pathogen-derived products and induce NF-κB-dependent pro-IL-1β transcription; NOD-like receptors (NLRs) assemble caspase-1-activating inflammasome complexes that sense bacterial products/danger signals.  Through a targeted chem. screen, we identify bromoxone, a marine natural product, as a specific and potent inhibitor of the caspase-1 pathway.  Bromoxone is effective over diverse inflammatory stimuli including TLR ligands plus ATP/nigericin, cytosolic DNA, flagellin and Bacillus anthracis lethal toxin.  Bromoxone also efficiently suppresses caspase-1 activation triggered by several types of bacterial infection.  Bromoxone acts upstream or at the level of the inflammasome in a transcription-independent manner.  Bromoxone also inhibits pro-IL-1β expression by targeting components upstream of IKK in the TLR-NF-κB pathway.  The unique dual activities of bromoxone are shared by the known TAK1 inhibitor that specifically blocks Nalp3 inflammasome activation.  Hinted from the mechanistic and pharmacol. properties of bromoxone, we further discover that several known NF-κB inhibitors that act upstream of IKK, but not those targeting IKK or IKK downstream, are potent blockers of different NLRs-mediated caspase-1 activation.  Our study uncovers a possible non-transcriptional mol. link between the NLR (Nalp3)-mediated inflammasome pathway and TLR-NF-κB signaling, and suggests a potential strategy to develop new anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppjC16zIWsMbVg90H21EOLACvtfcHk0lhs0bQQHmLBmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWqu7nP&md5=efe3462264b2a58c9d54fd8fee8a06b1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.135%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DY.-N.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DShao%26aufirst%3DF.%26atitle%3DChemical%2520probing%2520reveals%2520insights%2520into%2520the%2520signaling%2520mechanism%2520of%2520inflammasome%2520activation%26jtitle%3DCell%2520Res.%26date%3D2010%26volume%3D20%26spage%3D1289%26epage%3D1305%26doi%3D10.1038%2Fcr.2010.135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, D. Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new berberine derivatives as cancer immunotherapy agents through targeting IDO1</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">1858</span>– <span class="NLM_lpage">1868</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.10.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.ejmech.2017.10.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=29133053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWntLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=1858-1868&author=Y.+X.+Wangauthor=W.+Q.+Pangauthor=Q.+X.+Zengauthor=Z.+S.+Dengauthor=T.+Y.+Fanauthor=J.+D.+Jiangauthor=H.+B.+Dengauthor=D.+Q.+Song&title=Synthesis+and+biological+evaluation+of+new+berberine+derivatives+as+cancer+immunotherapy+agents+through+targeting+IDO1&doi=10.1016%2Fj.ejmech.2017.10.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new berberine derivatives as cancer immunotherapy agents through targeting IDO1</span></div><div class="casAuthors">Wang, Yan-Xiang; Pang, Wei-Qiang; Zeng, Qing-Xuan; Deng, Zhe-Song; Fan, Tian-Yun; Jiang, Jian-Dong; Deng, Hong-Bin; Song, Dan-Qing</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1858-1868</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To discover small-mol. cancer immunotherapy candidates through targeting Indoleamine 2,3-dioxygenase 1 (IDO1), twenty-five new berberine (BBR) derivs. defined with substituents on position 3 or 9 were synthesized and examd. for repression of IFN-γ-induced IDO1 promoter activities.  Structure-activity relationship (SAR) indicated that large vol. groups at the 9-position might be beneficial for potency.  Among them, several compds. exhibited increased activities, with inhibition rate of 71-90% compared with BBR.  Their effects on IDO1 expression were further confirmed by protein level as well.  Furthermore, two compds. exhibited anticancer activity by enhancing the specific lysis of NK cells to A549 through IDO1, but not cytotoxicity.  Preliminary mechanism revealed that both of them inhibited IFN-γ-induced IDO1 expression through activating AMPK and subsequent inhibition of STAT1 phosphorylation.  Therefore, the two compds. have been selected as IDO1 modulators for small-mol. cancer immunotherapy for next investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1E45i_TsGWLVg90H21EOLACvtfcHk0lhs0bQQHmLBmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWntLrK&md5=4da11c693f294bdc4c07e2fa10f5d303</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.10.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.10.078%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BX.%26aulast%3DPang%26aufirst%3DW.%2BQ.%26aulast%3DZeng%26aufirst%3DQ.%2BX.%26aulast%3DDeng%26aufirst%3DZ.%2BS.%26aulast%3DFan%26aufirst%3DT.%2BY.%26aulast%3DJiang%26aufirst%3DJ.%2BD.%26aulast%3DDeng%26aufirst%3DH.%2BB.%26aulast%3DSong%26aufirst%3DD.%2BQ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%2520berberine%2520derivatives%2520as%2520cancer%2520immunotherapy%2520agents%2520through%2520targeting%2520IDO1%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D143%26spage%3D1858%26epage%3D1868%26doi%3D10.1016%2Fj.ejmech.2017.10.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, M. E.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a tag-free chemical probe for photoaffinity labeling</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2007</i></span>,  <span class="NLM_fpage">4711</span>– <span class="NLM_lpage">4720</span>, <span class="refDoi"> DOI: 10.1002/ejoc.200700188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1002%2Fejoc.200700188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2007&publication_year=2007&pages=4711-4720&author=T.+Mayerauthor=M.+E.+Maier&title=Design+and+synthesis+of+a+tag-free+chemical+probe+for+photoaffinity+labeling&doi=10.1002%2Fejoc.200700188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200700188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200700188%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DT.%26aulast%3DMaier%26aufirst%3DM.%2BE.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520tag-free%2520chemical%2520probe%2520for%2520photoaffinity%2520labeling%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2007%26volume%3D2007%26spage%3D4711%26epage%3D4720%26doi%3D10.1002%2Fejoc.200700188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, L.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, H.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, K.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, P.-F.</span></span> <span> </span><span class="NLM_article-title">Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E5986</span>– <span class="NLM_lpage">E5994</span>, <span class="refDoi"> DOI: 10.1073/pnas.1706778114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1073%2Fpnas.1706778114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28674004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSmtrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E5986-E5994&author=L.-X.+Liaoauthor=X.-M.+Songauthor=L.-C.+Wangauthor=H.-N.+Lvauthor=J.-F.+Chenauthor=D.+Liuauthor=G.+Fuauthor=M.-B.+Zhaoauthor=Y.+Jiangauthor=K.-W.+Zengauthor=P.-F.+Tu&title=Highly+selective+inhibition+of+IMPDH2+provides+the+basis+of+antineuroinflammation+therapy&doi=10.1073%2Fpnas.1706778114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy</span></div><div class="casAuthors">Liao, Li-Xi; Song, Xiao-Min; Wang, Li-Chao; Lv, Hai-Ning; Chen, Jin-Feng; Liu, Dan; Fu, Ge; Zhao, Ming-Bo; Jiang, Yong; Zeng, Ke-Wu; Tu, Peng-Fei</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">E5986-E5994</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inosine monophosphate dehydrogenase (IMPDH) of human is an attractive target for immunosuppressive agents.  Currently, small-mol. inhibitors do not show good selectivity for different IMPDH isoforms (IMPDH1 and IMPDH2), resulting in some adverse effects, which limit their use.  Herein, we used a small-mol. probe specifically targeting IMPDH2 and identified Cysteine residue 140 (Cys140) as a selective druggable site.  On covalently binding to Cys140, the probe exerts an allosteric regulation to block the catalytic pocket of IMPDH2 and further induces IMPDH2 inactivation, leading to an effective suppression of neuroinflammatory responses.  However, the probe does not covalently bind to IMPDH1.  Taken together, our study shows Cys140 as a druggable site for selectively inhibiting IMPDH2, which provides great potential for development of therapy agents for autoimmune and neuroinflammatory diseases with less unfavorable tolerability profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Ye3vnWJhirVg90H21EOLACvtfcHk0lhf-blGTs3fzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSmtrfO&md5=c527f08deaef9d821fe3428c8c16ad83</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1706778114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1706778114%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DL.-X.%26aulast%3DSong%26aufirst%3DX.-M.%26aulast%3DWang%26aufirst%3DL.-C.%26aulast%3DLv%26aufirst%3DH.-N.%26aulast%3DChen%26aufirst%3DJ.-F.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DFu%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DM.-B.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DK.-W.%26aulast%3DTu%26aufirst%3DP.-F.%26atitle%3DHighly%2520selective%2520inhibition%2520of%2520IMPDH2%2520provides%2520the%2520basis%2520of%2520antineuroinflammation%2520therapy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3DE5986%26epage%3DE5994%26doi%3D10.1073%2Fpnas.1706778114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donadi, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bologa, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Lazikani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span> <span> </span><span class="NLM_article-title">A comprehensive map of molecular drug targets</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fnrd.2016.230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=27910877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVSms7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=19-34&author=R.+Santosauthor=O.+Ursuauthor=A.+Gaultonauthor=A.+P.+Bentoauthor=R.+S.+Donadiauthor=C.+G.+Bologaauthor=A.+Karlssonauthor=B.+Al-Lazikaniauthor=A.+Herseyauthor=T.+I.+Opreaauthor=J.+P.+Overington&title=A+comprehensive+map+of+molecular+drug+targets&doi=10.1038%2Fnrd.2016.230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive map of molecular drug targets</span></div><div class="casAuthors">Santos, Rita; Ursu, Oleg; Gaulton, Anna; Bento, A. Patricia; Donadi, Ramesh S.; Bologa, Cristian G.; Karlsson, Anneli; Al-Lazikani, Bissan; Hersey, Anne; Oprea, Tudor I.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-34</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The success of mechanism-based drug discovery depends on the definition of the drug target.  This definition becomes even more important as we try to link drug response to genetic variation, understand stratified clin. efficacy and safety, rationalize the differences between drugs in the same therapeutic class and predict drug utility in patient subgroups.  However, drug targets are often poorly defined in the literature, both for launched drugs and for potential therapeutic agents in discovery and development.  Here, we present an updated comprehensive map of mol. targets of approved drugs.  We curate a total of 893 human and pathogen-derived biomols. through which 1,578 US FDA-approved drugs act.  These biomols. include 667 human-genome-derived proteins targeted by drugs for human disease.  Anal. of these drug targets indicates the continued dominance of privileged target families across disease areas, but also the growth of novel first-in-class mechanisms, particularly in oncol.  We explore the relationships between bioactivity class and clin. success, as well as the presence of orthologues between human and animal models and between pathogen and human genomes.  Through the collaboration of three independent teams, we highlight some of the ongoing challenges in accurately defining the targets of mol. therapeutics and present conventions for deconvoluting the complexities of mol. pharmacol. and drug efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTfWwWkoZnbrVg90H21EOLACvtfcHk0lhf-blGTs3fzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVSms7rK&md5=7437d4b678ac75dac0a5e3248df98761</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.230%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DR.%26aulast%3DUrsu%26aufirst%3DO.%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DDonadi%26aufirst%3DR.%2BS.%26aulast%3DBologa%26aufirst%3DC.%2BG.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DA%2520comprehensive%2520map%2520of%2520molecular%2520drug%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D19%26epage%3D34%26doi%3D10.1038%2Fnrd.2016.230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lafferty-Whyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mormeneo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Fresno
Marimon, M.</span></span> <span> </span><span class="NLM_article-title">Opportunities and challenges of the 2016 target landscape</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fnrd.2016.263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=27980340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsl2ktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=10-11&author=K.+Lafferty-Whyteauthor=D.+Mormeneoauthor=M.+Del+Fresno%0AMarimon&title=Opportunities+and+challenges+of+the+2016+target+landscape&doi=10.1038%2Fnrd.2016.263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Trial watch Opportunities and challenges of the 2016 target landscape</span></div><div class="casAuthors">Lafferty-Whyte, Kyle; Mormeneo, David; del Fresno Marimon, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-11</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_2vJUgPIFrVg90H21EOLACvtfcHk0lhf-blGTs3fzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsl2ktg%253D%253D&md5=55ef7648b80f23e4da99ceb92bf40db1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.263%26sid%3Dliteratum%253Aachs%26aulast%3DLafferty-Whyte%26aufirst%3DK.%26aulast%3DMormeneo%26aufirst%3DD.%26aulast%3DDel%2BFresno%2BMarimon%26aufirst%3DM.%26atitle%3DOpportunities%2520and%2520challenges%2520of%2520the%25202016%2520target%2520landscape%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D10%26epage%3D11%26doi%3D10.1038%2Fnrd.2016.263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcsisin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">Structures of PGAM5 Provide Insight into Active Site Plasticity and Multimeric Assembly</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1089</span>– <span class="NLM_lpage">1099</span>, <span class="refDoi"> DOI: 10.1016/j.str.2017.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.str.2017.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28648608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVOjtr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1089-1099&author=A.+Chaikuadauthor=P.+Filippakopoulosauthor=S.+R.+Marcsisinauthor=S.+Picaudauthor=M.+Schr%C3%B6derauthor=S.+Sekineauthor=H.+Ichijoauthor=J.+R.+Engenauthor=K.+Takedaauthor=S.+Knapp&title=Structures+of+PGAM5+Provide+Insight+into+Active+Site+Plasticity+and+Multimeric+Assembly&doi=10.1016%2Fj.str.2017.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of PGAM5 Provide Insight into Active Site Plasticity and Multimeric Assembly</span></div><div class="casAuthors">Chaikuad, Apirat; Filippakopoulos, Panagis; Marcsisin, Sean R.; Picaud, Sarah; Schroeder, Martin; Sekine, Shiori; Ichijo, Hidenori; Engen, John R.; Takeda, Kohsuke; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1089-1099.e3</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">PGAM5 is a mitochondrial membrane protein that functions as an atypical Ser/Thr phosphatase and is a regulator of oxidative stress response, necroptosis, and autophagy.  Here we present several crystal structures of PGAM5 including the activating N-terminal regulatory sequences, providing a model for structural plasticity, dimerization of the catalytic domain, and the assembly into an enzymically active dodecameric form.  Oligomeric states obsd. in structures were supported by hydrogen exchange mass spectrometry, size-exclusion chromatog., and anal. ultracentrifugation expts. in soln.  We report that the catalytically important N-terminal WDPNWD motif acts as a structural integrator assembling PGAM5 into a dodecamer, allosterically activating the phosphatase by promoting an ordering of the catalytic loop.  Addnl. the obsd. active site plasticity enabled visualization of essential conformational rearrangements of catalytic elements.  The comprehensive biophys. characterization offers detailed structural models of this key mitochondrial phosphatase that has been assocd. with the development of diverse diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuIcOHKWyNx7Vg90H21EOLACvtfcHk0lilT10OvW191Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVOjtr3N&md5=e39b0adb63106a9441e195f7d6ad779c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2017.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2017.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DMarcsisin%26aufirst%3DS.%2BR.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DM.%26aulast%3DSekine%26aufirst%3DS.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DStructures%2520of%2520PGAM5%2520Provide%2520Insight%2520into%2520Active%2520Site%2520Plasticity%2520and%2520Multimeric%2520Assembly%26jtitle%3DStructure%26date%3D2017%26volume%3D25%26spage%3D1089%26epage%3D1099%26doi%3D10.1016%2Fj.str.2017.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurnasov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomchick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binns, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grishin, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquez, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osterman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">13148</span>– <span class="NLM_lpage">13154</span>, <span class="refDoi"> DOI: 10.1074/jbc.m111469200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1074%2Fjbc.M111469200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=11788603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFSjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=13148-13154&author=T.+Zhouauthor=O.+Kurnasovauthor=D.+R.+Tomchickauthor=D.+D.+Binnsauthor=N.+V.+Grishinauthor=V.+E.+Marquezauthor=A.+L.+Ostermanauthor=H.+Zhang&title=Structure+of+human+nicotinamide%2Fnicotinic+acid+mononucleotide+adenylyltransferase.+Basis+for+the+dual+substrate+specificity+and+activation+of+the+oncolytic+agent+tiazofurin&doi=10.1074%2Fjbc.m111469200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin</span></div><div class="casAuthors">Zhou, Tianjun; Kurnasov, Oleg; Tomchick, Diana R.; Binns, Derk D.; Grishin, Nick V.; Marquez, Victor E.; Osterman, Andrei L.; Zhang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">13148-13154</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nicotinamide/nicotinate mononucleotide (NMN/NaMN)adenylyltransferase (NMNAT) is an indispensable enzyme in the biosynthesis of NAD+ and NADP+.  Human NMNAT displays unique dual substrate specificity toward both NMN and NaMN, thus flexible in participating in both de novo and salvage pathways of NAD synthesis.  Human NMNAT also catalyzes the rate-limiting step of the metabolic conversion of the anticancer agent tiazofurin to its active form tiazofurin adenine dinucleotide (TAD).  The tiazofurin resistance is mainly assocd. with the low NMNAT activity in the cell.  We have solved the crystal structures of human NMNAT in complex with NAD, deamido-NAD, and a non-hydrolyzable TAD analog β-CH2-TAD.  These complex structures delineate the broad substrate specificity of the enzyme toward both NMN and NaMN and reveal the structural mechanism for adenylation of tiazofurin nucleotide.  The crystal structure of human NMNAT also shows that it forms a barrel-like hexamer with the predicted nuclear localization signal sequence located on the outside surface of the barrel, supporting its functional role of interacting with the nuclear transporting proteins.  The results from the anal. ultracentrifugation studies are consistent with the formation of a hexamer in soln. under certain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrac3zSglWuLLVg90H21EOLACvtfcHk0lilT10OvW191Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFSjt74%253D&md5=09bb80db010adff5f2c516d060801d0b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111469200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111469200%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DKurnasov%26aufirst%3DO.%26aulast%3DTomchick%26aufirst%3DD.%2BR.%26aulast%3DBinns%26aufirst%3DD.%2BD.%26aulast%3DGrishin%26aufirst%3DN.%2BV.%26aulast%3DMarquez%26aufirst%3DV.%2BE.%26aulast%3DOsterman%26aufirst%3DA.%2BL.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DStructure%2520of%2520human%2520nicotinamide%252Fnicotinic%2520acid%2520mononucleotide%2520adenylyltransferase.%2520Basis%2520for%2520the%2520dual%2520substrate%2520specificity%2520and%2520activation%2520of%2520the%2520oncolytic%2520agent%2520tiazofurin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D13148%26epage%3D13154%26doi%3D10.1074%2Fjbc.m111469200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koizumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inagaki, F.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the specificity, catalysis, and regulation of human uridine-cytidine kinase</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">764</span>, <span class="refDoi"> DOI: 10.1016/j.str.2004.02.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.str.2004.02.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=15130468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVamsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=751-764&author=N.+N.+Suzukiauthor=K.+Koizumiauthor=M.+Fukushimaauthor=A.+Matsudaauthor=F.+Inagaki&title=Structural+basis+for+the+specificity%2C+catalysis%2C+and+regulation+of+human+uridine-cytidine+kinase&doi=10.1016%2Fj.str.2004.02.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Specificity, Catalysis, and Regulation of Human Uridine-Cytidine Kinase</span></div><div class="casAuthors">Suzuki, Nobuo N.; Koizumi, Katsuhisa; Fukushima, Masanori; Matsuda, Akira; Inagaki, Fuyuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">751-764</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Uridine-cytidine kinase (UCK) catalyzes the phosphorylation of uridine and cytidine and activates pharmacol. ribonucleoside analogs.  Here we present the crystal structures of human UCK alone and in complexes with a substrate, cytidine, a feedback inhibitor, CTP or UTP, and with phosphorylation products, CMP and ADP, resp.  Free UCK takes an α/β mononucleotide binding fold and exists as a homotetramer with 222 symmetry.  Upon inhibitor binding, one loop region was loosened, causing the UCK tetramer to be distorted.  Upon cytidine binding, a large induced fit was obsd. at the uridine/cytidine binding site, which endows UCK with a strict specificity for pyrimidine ribonucleosides.  The first UCK structure provided the structural basis for the specificity, catalysis, and regulation of human uridine-cytidine kinase, which give clues for the design of novel antitumor and antiviral ribonucleoside analogs that inhibit RNA synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMSToRoYA7obVg90H21EOLACvtfcHk0lilT10OvW191Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVamsr4%253D&md5=52972cc765bd6f7ebf2a15e5f8498aaa</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2004.02.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2004.02.038%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DN.%2BN.%26aulast%3DKoizumi%26aufirst%3DK.%26aulast%3DFukushima%26aufirst%3DM.%26aulast%3DMatsuda%26aufirst%3DA.%26aulast%3DInagaki%26aufirst%3DF.%26atitle%3DStructural%2520basis%2520for%2520the%2520specificity%252C%2520catalysis%252C%2520and%2520regulation%2520of%2520human%2520uridine-cytidine%2520kinase%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D751%26epage%3D764%26doi%3D10.1016%2Fj.str.2004.02.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richards, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Regan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mas-Droux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blot, J. M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, R.</span></span> <span> </span><span class="NLM_article-title">An autoinhibitory tyrosine motif in the cell-cycle-regulated Nek7 kinase is released through binding of Nek9</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2009.09.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.molcel.2009.09.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=19941817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFWnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=560-570&author=M.+W.+Richardsauthor=L.+O%E2%80%99Reganauthor=C.+Mas-Drouxauthor=J.+M.+Y.+Blotauthor=J.+Cheungauthor=S.+Hoelderauthor=A.+M.+Fryauthor=R.+Bayliss&title=An+autoinhibitory+tyrosine+motif+in+the+cell-cycle-regulated+Nek7+kinase+is+released+through+binding+of+Nek9&doi=10.1016%2Fj.molcel.2009.09.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">An autoinhibitory tyrosine motif in the cell-cycle-regulated Nek7 kinase is released through binding of Nek9</span></div><div class="casAuthors">Richards, Mark W.; O'Regan, Laura; Mas-Droux, Corine; Blot, Joelle M. Y.; Cheung, Jack; Hoelder, Swen; Fry, Andrew M.; Bayliss, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">560-570</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Mitosis is controlled by multiple protein kinases, many of which are abnormally expressed in human cancers.  Nek2, Nek6, Nek7, and Nek9 are NIMA-related kinases essential for proper mitotic progression.  We detd. the at. structure of Nek7 and discovered an autoinhibited conformation that suggests a regulatory mechanism not previously described in kinases.  Addnl., Nek2 adopts the same conformation when bound to a drug-like mol.  In both structures, a tyrosine side chain points into the active site, interacts with the activation loop, and blocks the αC helix.  Tyrosine mutants of Nek7 and the related kinase Nek6 are constitutively active.  The activity of Nek6 and Nek7, but not the tyrosine mutant, is increased by interaction with the Nek9 noncatalytic C-terminal domain, suggesting a mechanism in which the tyrosine is released from its autoinhibitory position.  The autoinhibitory conformation is common to three Neks and provides a potential target for selective kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-_yOHUGTAiLVg90H21EOLACvtfcHk0liEK2OJGYWtpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFWnsQ%253D%253D&md5=f44726d978afcadbf9e7387ede8fa012</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2009.09.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2009.09.038%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DM.%2BW.%26aulast%3DO%25E2%2580%2599Regan%26aufirst%3DL.%26aulast%3DMas-Droux%26aufirst%3DC.%26aulast%3DBlot%26aufirst%3DJ.%2BM.%2BY.%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DFry%26aufirst%3DA.%2BM.%26aulast%3DBayliss%26aufirst%3DR.%26atitle%3DAn%2520autoinhibitory%2520tyrosine%2520motif%2520in%2520the%2520cell-cycle-regulated%2520Nek7%2520kinase%2520is%2520released%2520through%2520binding%2520of%2520Nek9%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D36%26spage%3D560%26epage%3D570%26doi%3D10.1016%2Fj.molcel.2009.09.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liew, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Z. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Q.</span></span> <span> </span><span class="NLM_article-title">Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">10111</span>, <span class="refDoi"> DOI: 10.1038/ncomms10111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fncomms10111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=26694030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVynsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=10111&author=J.+Wangauthor=C.+J.+Zhangauthor=W.+N.+Chiaauthor=C.+C.+Lohauthor=Z.+Liauthor=Y.+M.+Leeauthor=Y.+Heauthor=L.+X.+Yuanauthor=T.+K.+Limauthor=M.+Liuauthor=C.+X.+Liewauthor=Y.+Q.+Leeauthor=J.+Zhangauthor=N.+Luauthor=C.+T.+Limauthor=Z.+C.+Huaauthor=B.+Liuauthor=H.+M.+Shenauthor=K.+S.+Tanauthor=Q.+Lin&title=Haem-activated+promiscuous+targeting+of+artemisinin+in+Plasmodium+falciparum&doi=10.1038%2Fncomms10111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum</span></div><div class="casAuthors">Wang, Jigang; Zhang, Chong-Jing; Chia, Wan Ni; Loh, Cheryl C. Y.; Li, Zhengjun; Lee, Yew Mun; He, Yingke; Yuan, Li-Xia; Lim, Teck Kwang; Liu, Min; Liew, Chin Xia; Lee, Yan Quan; Zhang, Jianbin; Lu, Nianci; Lim, Chwee Teck; Hua, Zi-Chun; Liu, Bin; Shen, Han-Ming; Tan, Kevin S. W.; Lin, Qingsong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10111</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mechanism of action of artemisinin and its derivs., the most potent of the anti-malarial drugs, is not completely understood.  Here we present an unbiased chem. proteomics anal. to directly explore this mechanism in Plasmodium falciparum.  We use an alkyne-tagged artemisinin analog coupled with biotin to identify 124 artemisinin covalent binding protein targets, many of which are involved in the essential biol. processes of the parasite.  Such a broad targeting spectrum disrupts the biochem. landscape of the parasite and causes its death.  Furthermore, using alkyne-tagged artemisinin coupled with a fluorescent dye to monitor protein binding, we show that haem, rather than free ferrous iron, is predominantly responsible for artemisinin activation.  The haem derives primarily from the parasite's haem biosynthesis pathway at the early ring stage and from Hb digestion at the latter stages.  Our results support a unifying model to explain the action and specificity of artemisinin in parasite killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsYEHWprDdeLVg90H21EOLACvtfcHk0liEK2OJGYWtpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVynsLjO&md5=a532a76cdd2f33b0ca23e733e6247a0c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fncomms10111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10111%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%2BJ.%26aulast%3DChia%26aufirst%3DW.%2BN.%26aulast%3DLoh%26aufirst%3DC.%2BC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DL.%2BX.%26aulast%3DLim%26aufirst%3DT.%2BK.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLiew%26aufirst%3DC.%2BX.%26aulast%3DLee%26aufirst%3DY.%2BQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DN.%26aulast%3DLim%26aufirst%3DC.%2BT.%26aulast%3DHua%26aufirst%3DZ.%2BC.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DShen%26aufirst%3DH.%2BM.%26aulast%3DTan%26aufirst%3DK.%2BS.%26aulast%3DLin%26aufirst%3DQ.%26atitle%3DHaem-activated%2520promiscuous%2520targeting%2520of%2520artemisinin%2520in%2520Plasmodium%2520falciparum%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D10111%26doi%3D10.1038%2Fncomms10111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belham, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avruch, J.</span></span> <span> </span><span class="NLM_article-title">A Mitotic Cascade of NIMA Family Kinases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">34897</span>– <span class="NLM_lpage">34909</span>, <span class="refDoi"> DOI: 10.1074/jbc.m303663200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1074%2Fjbc.M303663200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=12840024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVWqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=34897-34909&author=C.+Belhamauthor=J.+Roigauthor=J.+A.+Caldwellauthor=Y.+Aoyamaauthor=B.+E.+Kempauthor=M.+Combauthor=J.+Avruch&title=A+Mitotic+Cascade+of+NIMA+Family+Kinases&doi=10.1074%2Fjbc.m303663200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A Mitotic Cascade of NIMA Family Kinases: Nercc1/Nek9 Activates THE Nek6 AND Nek7 Kinases</span></div><div class="casAuthors">Belham, Christopher; Roig, Joan; Caldwell, Jennifer A.; Aoyama, Yumi; Kemp, Bruce E.; Comb, Michael; Avruch, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">34897-34909</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The Nek family of protein kinases in humans is composed of 11 members that share an amino-terminal catalytic domain related to NIMA, an Aspergillus kinase involved in the control of several aspects of mitosis, and divergent carboxyl-terminal tails of varying length.  Nek6 (314AA) and Nek7 (303AA), 76% identical, have little noncatalytic sequence but bind to the carboxyl-terminal noncatalytic tail of Nercc1/Nek9, a NIMA family protein kinase that is activated in mitosis.  Microinjection of anti-Nercc1 antibodies leads to spindle abnormalities and prometaphase arrest or chromosome missegregation.  Herein we show that Nek6 is increased in abundance and activity during mitosis; activation requires the phosphorylation of Ser206 on the Nek6 activation loop.  This phosphorylation and the activity of recombinant Nek6 is stimulated by coexpression with an activated mutant of Nercc1.  Moreover, Nercc1 catalyzes the direct phosphorylation of prokaryotic recombinant Nek6 at Ser206 in vitro concomitant with 20-25-fold activation of Nek6 activity; Nercc1 activates Nek7 in vitro in a similar manner.  Nercc1/Nek9 is likely to be responsible for the activation of Nek6 during mitosis and probably participates in the regulation of Nek7 as well.  These findings support the conclusion that Nercc1/Nek9 and Nek6 represent a novel cascade of mitotic NIMA family protein kinases whose combined function is important for mitotic progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3XdKs42nzO7Vg90H21EOLACvtfcHk0liEK2OJGYWtpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVWqsbs%253D&md5=819b13884b15b079e0d10582021a2fbb</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M303663200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M303663200%26sid%3Dliteratum%253Aachs%26aulast%3DBelham%26aufirst%3DC.%26aulast%3DRoig%26aufirst%3DJ.%26aulast%3DCaldwell%26aufirst%3DJ.%2BA.%26aulast%3DAoyama%26aufirst%3DY.%26aulast%3DKemp%26aufirst%3DB.%2BE.%26aulast%3DComb%26aufirst%3DM.%26aulast%3DAvruch%26aufirst%3DJ.%26atitle%3DA%2520Mitotic%2520Cascade%2520of%2520NIMA%2520Family%2520Kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D34897%26epage%3D34909%26doi%3D10.1074%2Fjbc.m303663200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magupalli, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreeva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauenstein, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span> <span> </span><span class="NLM_article-title">Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>570</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1295-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fs41586-019-1295-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=31189953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFKgs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=570&publication_year=2019&pages=338-343&author=H.+Sharifauthor=L.+Wangauthor=W.+L.+Wangauthor=V.+G.+Magupalliauthor=L.+Andreevaauthor=Q.+Qiaoauthor=A.+V.+Hauensteinauthor=Z.+Wuauthor=G.+N%C3%BA%C3%B1ezauthor=Y.+Maoauthor=H.+Wu&title=Structural+mechanism+for+NEK7-licensed+activation+of+NLRP3+inflammasome&doi=10.1038%2Fs41586-019-1295-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome</span></div><div class="casAuthors">Sharif, Humayun; Wang, Li; Wang, Wei Li; Magupalli, Venkat Giri; Andreeva, Liudmila; Qiao, Qi; Hauenstein, Arthur V.; Wu, Zhaolong; Nunez, Gabriel; Mao, Youdong; Wu, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">570</span>
        (<span class="NLM_cas:issue">7761</span>),
    <span class="NLM_cas:pages">338-343</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The NLRP3 inflammasome can be activated by stimuli that include nigericin, uric acid crystals, amyloid-β fibrils and extracellular ATP.  The mitotic kinase NEK7 licenses the assembly and activation of the NLRP3 inflammasome in interphase.  Here we report a cryo-electron microscopy structure of inactive human NLRP3 in complex with NEK7, at a resoln. of 3.8 Å.  The earring-shaped NLRP3 consists of curved leucine-rich-repeat and globular NACHT domains, and the C-terminal lobe of NEK7 nestles against both NLRP3 domains.  Structural recognition between NLRP3 and NEK7 is confirmed by mutagenesis both in vitro and in cells.  Modeling of an active NLRP3-NEK7 conformation based on the NLRC4 inflammasome predicts an addnl. contact between an NLRP3-bound NEK7 and a neighboring NLRP3.  Mutations to this interface abolish the ability of NEK7 or NLRP3 to rescue NLRP3 activation in NEK7-knockout or NLRP3-knockout cells.  These data suggest that NEK7 bridges adjacent NLRP3 subunits with bipartite interactions to mediate the activation of the NLRP3 inflammasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKz2yqOHis9bVg90H21EOLACvtfcHk0lgYEuDMUyrIfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFKgs7vP&md5=e6d535e4d91e360ce82c1f4327e10e24</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1295-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1295-z%26sid%3Dliteratum%253Aachs%26aulast%3DSharif%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DW.%2BL.%26aulast%3DMagupalli%26aufirst%3DV.%2BG.%26aulast%3DAndreeva%26aufirst%3DL.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DHauenstein%26aufirst%3DA.%2BV.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DG.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DStructural%2520mechanism%2520for%2520NEK7-licensed%2520activation%2520of%2520NLRP3%2520inflammasome%26jtitle%3DNature%26date%3D2019%26volume%3D570%26spage%3D338%26epage%3D343%26doi%3D10.1038%2Fs41586-019-1295-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span> <span> </span><span class="NLM_article-title">Berberine inhibits the LPS-induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling pathway</span>. <i>Exp. Ther. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">6125</span>– <span class="NLM_lpage">6130</span>, <span class="refDoi"> DOI: 10.3892/etm.2017.5316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.3892%2Fetm.2017.5316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=29285168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2jsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=6125-6130&author=L.+Liuauthor=L.+Chenauthor=C.+Jiangauthor=J.+Guoauthor=Y.+Xieauthor=L.+Kangauthor=Z.+Cheng&title=Berberine+inhibits+the+LPS-induced+proliferation+and+inflammatory+response+of+stromal+cells+of+adenomyosis+tissues+mediated+by+the+LPS%2FTLR4+signaling+pathway&doi=10.3892%2Fetm.2017.5316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine inhibits the LPS-induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling pathway</span></div><div class="casAuthors">Liu, Li; Chen, Li; Jiang, Caixia; Guo, Jing; Xie, Yan; Kang, Le; Cheng, Zhongping</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Therapeutic Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">6125-6130</span>CODEN:
                <span class="NLM_cas:coden">ETMXA2</span>;
        ISSN:<span class="NLM_cas:issn">1792-1015</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">A previous study by our group has demonstrated that lipopolysaccharide (LPS) induces adenomyosis through stimulating inflammatory cell proliferation and invasive growth of stromal cells via Toll-like receptor 4 (TLR4) signaling.  The present study aimed to investigate the effects of berberine (BBR) on LPS-induced ectopic endometrial stromal cells (EESCs) isolated from patients with adenomyosis.  The viability of EESCs treated with LPS or LPS plus BBR was detected by a cell counting kit-8 assay, and the cell cycle distribution and apoptosis were evaluated by flow cytometry.  The effect of BBR on the expression of key mols. of inflammatory proliferation and invasive growth of LPS-induced EESCs was also evaluated.  BBR significantly inhibited the LPS-induced proliferation of EESCs in a dose- and time-dependent manner.  BBR induced cell cycle arrest in G0/G1 phase and enhanced apoptosis of LPS-induced EESCs.  Furthermore, BBR inhibited the expression of interleukin (IL)-6, IL-8, transforming growth factor-β, epithelial growth factor, vascular endothelial growth factor and matrix metalloproteinase 2 in LPS-induced EESCs.  To the best of our knowledge, the present study was the first to demonstrate that BBR has a protective effect on ameliorating the LPS-induced progression of adenomyosis.  This result may provide a novel therapeutic strategy for the clin. treatment of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXIiGR5RJPk7Vg90H21EOLACvtfcHk0lgYEuDMUyrIfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2jsb7K&md5=2c0e04bad4a05037f06b1ec818e6a341</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3892%2Fetm.2017.5316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fetm.2017.5316%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DKang%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DZ.%26atitle%3DBerberine%2520inhibits%2520the%2520LPS-induced%2520proliferation%2520and%2520inflammatory%2520response%2520of%2520stromal%2520cells%2520of%2520adenomyosis%2520tissues%2520mediated%2520by%2520the%2520LPS%252FTLR4%2520signaling%2520pathway%26jtitle%3DExp.%2520Ther.%2520Med.%26date%3D2017%26volume%3D14%26spage%3D6125%26epage%3D6130%26doi%3D10.3892%2Fetm.2017.5316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, W.</span></span> <span> </span><span class="NLM_article-title">Berberine suppresses LPS-induced inflammation through modulating Sirt1/NF-κB signaling pathway in RAW264.7 cells</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2017.08.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.intimp.2017.08.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28888780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOhsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2017&pages=93-100&author=H.+Zhangauthor=Y.+Shanauthor=Y.+Wuauthor=C.+Xuauthor=X.+Yuauthor=J.+Zhaoauthor=J.+Yanauthor=W.+Shang&title=Berberine+suppresses+LPS-induced+inflammation+through+modulating+Sirt1%2FNF-%CE%BAB+signaling+pathway+in+RAW264.7+cells&doi=10.1016%2Fj.intimp.2017.08.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine suppresses LPS-induced inflammation through modulating Sirt1/NF-κB signaling pathway in RAW264.7 cells</span></div><div class="casAuthors">Zhang, Hao; Shan, Yun; Wu, Yun; Xu, Chuanchong; Yu, Xizhong; Zhao, Juan; Yan, Jing; Shang, Wenbin</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-100</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Chronic inflammation is a major contributing factor in the pathogenesis of many diseases.  Natural product berberine (BBR) exhibits potent anti-inflammatory effect in vitro and in vivo, while the underlying mechanisms remain elusive.  Sirt1, a NAD+-dependent protein deacetylase, was recently found to play an important role in modulating the development and progression of inflammation.  Thus, we speculate that Sirt1 might mediate the inhibitory effect of BBR on inflammation.  In LPS-stimulated RAW264.7 macrophages, BBR treatment significantly downregulated the expression of proinflammatory cytokines such as MCP-1, IL-6 and TNF-α.  Importantly, BBR potently reversed LPS-induced down-regulation of Sirt1.  Consistently, the inhibitory effects of BBR on proinflammatory cytokines expression was largely abrogated by Sirt1 inhibition either by EX527, a Sirt1 inhibitor or Sirt1 siRNA.  Further mechanistic studies revealed that BBR-induced inhibition of NF-κB is Sirt1-dependent, as either pharmacol. or genetically inactivating Sirt1 enhanced the IκΒα degrdn., IKK phosphorylation, NF-κB p65 acetylation and DNA-binding activity.  Taken together, our results provide the first evidence that BBR potently suppressed inflammatory responses in macrophages through inhibition of NF-κB signaling via Sirt1-dependent mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoySSx700k9_rVg90H21EOLACvtfcHk0lgYEuDMUyrIfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOhsb%252FI&md5=fbce2640e79ec916c8f311729cddb1d9</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2017.08.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2017.08.032%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DShan%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DShang%26aufirst%3DW.%26atitle%3DBerberine%2520suppresses%2520LPS-induced%2520inflammation%2520through%2520modulating%2520Sirt1%252FNF-%25CE%25BAB%2520signaling%2520pathway%2520in%2520RAW264.7%2520cells%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2017%26volume%3D52%26spage%3D93%26epage%3D100%26doi%3D10.1016%2Fj.intimp.2017.08.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vivoli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piombanti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provenzano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narducci, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannaioni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moneti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marra, F.</span></span> <span> </span><span class="NLM_article-title">NLRP3 inflammasome as a target of berberine in experimental murine liver injury: interference with P2X7 signalling</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">1793</span>– <span class="NLM_lpage">1806</span>, <span class="refDoi"> DOI: 10.1042/cs20160400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1042%2FCS20160400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWrtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2016&pages=1793-1806&author=E.+Vivoliauthor=A.+Capponauthor=S.+Milaniauthor=B.+Piombantiauthor=A.+Provenzanoauthor=E.+Novoauthor=A.+Masiauthor=N.+Navariauthor=R.+Narducciauthor=G.+Mannaioniauthor=G.+Monetiauthor=C.+P.+Oliveiraauthor=M.+Parolaauthor=F.+Marra&title=NLRP3+inflammasome+as+a+target+of+berberine+in+experimental+murine+liver+injury%3A+interference+with+P2X7+signalling&doi=10.1042%2Fcs20160400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">NLRP3 inflammasome as a target of berberine in experimental murine liver injury: interference with P2X7 signalling</span></div><div class="casAuthors">Vivoli, Elisa; Cappon, Andrea; Milani, Stefano; Piombanti, Benedetta; Provenzano, Angela; Novo, Erica; Masi, Alessio; Navari, Nadia; Narducci, Roberto; Mannaioni, Guido; Moneti, Gloriano; Oliveira, Claudia P.; Parola, Maurizio; Marra, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1793-1806</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Berberine (BRB) is commonly used in herbal medicine, but its mechanisms of action are poorly understood.  In the present study, we tested BRB in steatohepatitis induced by a methionine- and choline-deficient (MCD) diet, in acute acetaminophen intoxication and in cultured murine macrophages.  BRB markedly improved parameters of liver injury and necroinflammation induced by the MCD diet, although increased mortality was obsd. by mechanisms independent of bacterial infections or plasma levels of BRB.  The MCD diet induced up-regulation of all components of the NLRP3 (NACHT, LRR and PYD domain-contg. protein 3) inflammasome, and increased hepatic levels of mature IL-1 β (interleukin 1 β).  All of these parameters were significantly reduced in mice treated with BRB.  In mice administered an acetaminophen overdose, a model dependent on inflammasome activation, BRB reduced mortality and ALT (alanine aminotransferase) elevation, and limited the expression of inflammasome components.  In vitro, LPS (lipopolysaccharide)-induced activation of NLRP3 inflammasome in RAW264.7 murine macrophages was markedly decreased by pre-incubation with BRB.  BRB significantly limited the activation of the purinergic receptor P2X7, involved in the late phases of inflammasome activation.  Upon P2X7 knockdown, the ability of BRB to block LPS-induced secretion of IL-1 β was lost.  These data indicate that administration of BRB ameliorates inflammation and injury in two unrelated murine models of liver damage.  We demonstrate for the first time that BRB interferes with activation of the NLRP3 inflammasome pathway in vivo and in vitro, through a mechanism based on interference with activation of P2X7, a purinergic receptor involved in inflammasome activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv0vWMAKKJILVg90H21EOLACvtfcHk0lgD3ILkzicnWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWrtb3I&md5=3d80c338e8512b66a0ddc7a0dba1b28d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1042%2FCS20160400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20160400%26sid%3Dliteratum%253Aachs%26aulast%3DVivoli%26aufirst%3DE.%26aulast%3DCappon%26aufirst%3DA.%26aulast%3DMilani%26aufirst%3DS.%26aulast%3DPiombanti%26aufirst%3DB.%26aulast%3DProvenzano%26aufirst%3DA.%26aulast%3DNovo%26aufirst%3DE.%26aulast%3DMasi%26aufirst%3DA.%26aulast%3DNavari%26aufirst%3DN.%26aulast%3DNarducci%26aufirst%3DR.%26aulast%3DMannaioni%26aufirst%3DG.%26aulast%3DMoneti%26aufirst%3DG.%26aulast%3DOliveira%26aufirst%3DC.%2BP.%26aulast%3DParola%26aufirst%3DM.%26aulast%3DMarra%26aufirst%3DF.%26atitle%3DNLRP3%2520inflammasome%2520as%2520a%2520target%2520of%2520berberine%2520in%2520experimental%2520murine%2520liver%2520injury%253A%2520interference%2520with%2520P2X7%2520signalling%26jtitle%3DClin.%2520Sci.%26date%3D2016%26volume%3D130%26spage%3D1793%26epage%3D1806%26doi%3D10.1042%2Fcs20160400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell</span>. <i>BMC Complementary Altern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">216</span>, <span class="refDoi"> DOI: 10.1186/s12906-019-2615-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1186%2Fs12906-019-2615-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=31412862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A280%3ADC%252BB3MvotVSgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&pages=216&author=M.+Yaoauthor=X.+Fanauthor=B.+Yuanauthor=N.+Takagiauthor=S.+Liuauthor=X.+Hanauthor=J.+Renauthor=J.+Liu&title=Berberine+inhibits+NLRP3+Inflammasome+pathway+in+human+triple-negative+breast+cancer+MDA-MB-231+cell&doi=10.1186%2Fs12906-019-2615-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell</span></div><div class="casAuthors">Yao Mingjiang; Fan Xiaodi; Liu Sai; Han Xiao; Ren Junguo; Liu Jianxun; Yao Mingjiang; Fan Xiaodi; Liu Sai; Han Xiao; Ren Junguo; Liu Jianxun; Yuan Bo; Takagi Norio</div><div class="citationInfo"><span class="NLM_cas:title">BMC complementary and alternative medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">216</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Breast cancer is still the most common malignant tumor that threatens the female's life in the world, especially triple-negative breast cancer (TNBC), one of the most difficult subtypes.  Lack of targeted therapies brings about urgent demand for novel treatments.  In this study we aim to investigate the anti-tumor activity of Berberine (BBR), a Chinese plant-derived alkaloid, against the TNBC cell line MDA-MB-231 and elucidate its mechanism referring to anti-inflammation.  METHODS:  Cell inhibition rate was measured by Cell Proliferation Assay, the cytotoxic effects was detected by Lactate dehydrogenase (LDH) leakage assay, the colony formation and migration potential were evaluated by colony formation assay and wound healing assay, the release of inflammatory cytokines was detected by EMD multifactor detection, and alterations of proteins and genes related to the NLR family pyrin domain containing 3 (NLRP3) inflammasome pathway were analyzed using western blotting and real-time Polymerase Chain Reaction (PCR).  RESULTS:  BBR reduce the viability of MDA-MB-231 cells and increased the release of LDH from the cells in a dose-dependent manner, with and inhibition of colony formation potential and migration of the cells.  BBR also caused a marked reduction in the secretion of proinflammatory cytokines, Interleukin-1α (IL-1α), Interleukin-1β (IL-1β), Interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α).  Besides, a down-regulated behavior was observed with the expression of P2X purinoceptor 7 (P2X7), NLRP3, pro-caspase-1, apoptosis-associated speck-like protein containing a caspase-activation and recruitment domain (ASC), caspase-1 p20, Interleukin-18 (IL-18), IL-1β proteins and NLRP3, Caspase-1 and ASC mRNAs in the NLRP3 inflammasome cascade.  CONCLUSIONS:  Our results confirmed that BBR can effectively affect both tumor outgrowth and spontaneous metastasis in TNBC, and that we identified a new mechanism associated with inhibition the NLRP3 inflammasome pathway, suggesting its potential therapeutic relevance in clinical use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTtPOdZuvheesve_zCu79I8fW6udTcc2eb2MFItGyx3hLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvotVSgsw%253D%253D&md5=298fe0bf90e618ea3410b93312c1932b</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1186%2Fs12906-019-2615-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12906-019-2615-4%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DB.%26aulast%3DTakagi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DBerberine%2520inhibits%2520NLRP3%2520Inflammasome%2520pathway%2520in%2520human%2520triple-negative%2520breast%2520cancer%2520MDA-MB-231%2520cell%26jtitle%3DBMC%2520Complementary%2520Altern.%2520Med.%26date%3D2019%26volume%3D19%26spage%3D216%26doi%3D10.1186%2Fs12906-019-2615-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, S. H.</span></span> <span> </span><span class="NLM_article-title">Effects of Berberine on NLRP3 and IL-1beta expressions in monocytic THP-1 cells with monosodium urate crystals-induced inflammation</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">2503703</span>, <span class="refDoi"> DOI: 10.1155/2016/2503703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1155%2F2016%2F2503703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=27689075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A280%3ADC%252BC2svovVCmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=2503703&author=Y.+F.+Liuauthor=C.+Y.+Wenauthor=Z.+Chenauthor=Y.+Wangauthor=Y.+Huangauthor=S.+H.+Tu&title=Effects+of+Berberine+on+NLRP3+and+IL-1beta+expressions+in+monocytic+THP-1+cells+with+monosodium+urate+crystals-induced+inflammation&doi=10.1155%2F2016%2F2503703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Berberine on NLRP3 and IL-1β Expressions in Monocytic THP-1 Cells with Monosodium Urate Crystals-Induced Inflammation</span></div><div class="casAuthors">Liu Ya-Fei; Wen Cai-Yu-Zhu; Chen Zhe; Wang Yu; Huang Ying; Tu Sheng-Hao</div><div class="citationInfo"><span class="NLM_cas:title">BioMed research international</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2503703</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Background.  Urate crystals-induced inflammation is a critical factor during the initiation of gouty arthritis.  Berberine is well known for its anti-inflammatory activity.  However, the underlying effects of berberine on monosodium urate crystals-induced inflammation remain obscure.  Objectives.  This study is set to explore the protective effect and mechanism of berberine on monosodium urate crystals-induced inflammation in human monocytic THP-1 cells.  Methods.  The mRNA levels of NLRP3 and IL-1β were measured by Real-Time PCR, and the protein levels of NLRP3 and IL-1β were determined by ELISA, Western blot, and immunofluorescence.  Results.  The NLRP3 and IL-1β expressions were significantly increased in model group compared to that in normal group (P < 0.05).  Meanwhile, there was significant reduction in the expressions of NLRP3 and IL-1β mRNA in groups 6.25 μM berberine and 25 μM berberine when compared with model group (P < 0.05).  Conclusions.  Therefore, berberine alleviates monosodium urate crystals-induced inflammation by downregulating NLRP3 and IL-1β expressions.  The regulatory effects of berberine may be related to the inactivation of NLRP3 inflammasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRiLVV98luOElWTCLT8lX9SfW6udTcc2eb2MFItGyx3hLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svovVCmsQ%253D%253D&md5=defe28ac39a3e35503de6584d088854c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1155%2F2016%2F2503703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F2503703%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%2BF.%26aulast%3DWen%26aufirst%3DC.%2BY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DTu%26aufirst%3DS.%2BH.%26atitle%3DEffects%2520of%2520Berberine%2520on%2520NLRP3%2520and%2520IL-1beta%2520expressions%2520in%2520monocytic%2520THP-1%2520cells%2520with%2520monosodium%2520urate%2520crystals-induced%2520inflammation%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2016%26volume%3D2016%26spage%3D2503703%26doi%3D10.1155%2F2016%2F2503703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinesh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasool, M.</span></span> <span> </span><span class="NLM_article-title">Berberine, an isoquinoline alkaloid suppresses TXNIP mediated NLRP3 inflammasome activation in MSU crystal stimulated RAW 264.7 macrophages through the upregulation of Nrf2 transcription factor and alleviates MSU crystal induced inflammation in rats</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2016.12.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.intimp.2016.12.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28068647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsVyktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2017&pages=26-37&author=P.+Dineshauthor=M.+Rasool&title=Berberine%2C+an+isoquinoline+alkaloid+suppresses+TXNIP+mediated+NLRP3+inflammasome+activation+in+MSU+crystal+stimulated+RAW+264.7+macrophages+through+the+upregulation+of+Nrf2+transcription+factor+and+alleviates+MSU+crystal+induced+inflammation+in+rats&doi=10.1016%2Fj.intimp.2016.12.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine, an isoquinoline alkaloid suppresses TXNIP mediated NLRP3 inflammasome activation in MSU crystal stimulated RAW 264.7 macrophages through the upregulation of Nrf2 transcription factor and alleviates MSU crystal induced inflammation in rats</span></div><div class="casAuthors">Dinesh, Palani; Rasool, MahaboobKhan</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-37</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The current study was designed to investigate the therapeutic potential of berberine on monosodium urate (MSU) crystal stimulated RAW 264.7 macrophages and in MSU crystal induced rats.  Our results indicate that berberine (25, 50 and 75 μM) suppressed the levels of pro-inflammatory cytokines (interleukin-1beta (IL-1β) and tumor necrosis factor alpha (TNFα)) and intracellular reactive oxygen species in MSU crystal stimulated RAW 264.7 macrophages.  The mRNA expression levels of IL-1β, caspase 1, nucleotide-binding oligomerization domain-like receptor pyrin domain contg. 3 (NLRP3), thioredoxin interacting protein (TXNIP) and kelch-like ECH-assocd. protein 1 (Keap1) were found downregulated with the upregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) transcription factor and its assocd. anti-oxidant enzymes: Heme oxygenase I (HO-1), superoxide dismutase (SOD1), glutathione peroxidase (GPx), NADPH quinone oxidoreductase-1 (NQO1) and catalase (CAT) in MSU crystal stimulated RAW 264.7 macrophages upon berberine treatment.  Subsequently, western blot anal. revealed that berberine decreased the protein expression of IL-1β and caspase 1 and increased Nrf2 expression in RAW 264.7 macrophages.  Immunofluorescence anal. also explored increased expression of Nrf2 in MSU crystal stimulated RAW 264.7 macrophages by berberine treatment.  In addn., the paw edema, pain score, pro-inflammatory cytokines (IL-1β and TNFα) and articular elastase activity were found significantly reduced in berberine (50 mg/kg b·wt) administered MSU crystal-induced rats.  Conclusively, our current findings suggest that berberine may represent as a potential candidate for the treatment of gouty arthritis by suppressing inflammatory mediators and activating Nrf2 anti-oxidant pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGproz_gsU6__rVg90H21EOLACvtfcHk0lgVF50tKOb9ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsVyktQ%253D%253D&md5=de900f890d65715ed7e2f4102f1ea093</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2016.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2016.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DDinesh%26aufirst%3DP.%26aulast%3DRasool%26aufirst%3DM.%26atitle%3DBerberine%252C%2520an%2520isoquinoline%2520alkaloid%2520suppresses%2520TXNIP%2520mediated%2520NLRP3%2520inflammasome%2520activation%2520in%2520MSU%2520crystal%2520stimulated%2520RAW%2520264.7%2520macrophages%2520through%2520the%2520upregulation%2520of%2520Nrf2%2520transcription%2520factor%2520and%2520alleviates%2520MSU%2520crystal%2520induced%2520inflammation%2520in%2520rats%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2017%26volume%3D44%26spage%3D26%26epage%3D37%26doi%3D10.1016%2Fj.intimp.2016.12.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.-J.</span></span> <span> </span><span class="NLM_article-title">Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1779</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.033936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1124%2Fdmd.110.033936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=20634337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1eisLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1779-1784&author=Y.-T.+Liuauthor=H.-P.+Haoauthor=H.-G.+Xieauthor=L.+Laiauthor=Q.+Wangauthor=C.-X.+Liuauthor=G.-J.+Wang&title=Extensive+intestinal+first-pass+elimination+and+predominant+hepatic+distribution+of+berberine+explain+its+low+plasma+levels+in+rats&doi=10.1124%2Fdmd.110.033936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats</span></div><div class="casAuthors">Liu, Yi-Tong; Hao, Hai-Ping; Xie, Hong-Guang; Lai, Li; Wang, Qiong; Liu, Chang-Xiao; Wang, Guang-Ji</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1779-1784</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Berberine, one of the most commonly used natural products, exhibits a poor plasma concn.-effect relationship whose underlying mechanisms remain largely unclear.  This study was designed to test the hypothesis that extensive first-pass elimination and abundant tissue distribution of berberine may be its specific pharmacokinetic properties.  For that, four different dosing routes, intragastric, intraduodenal, intraportal, and i.v., were used to investigate the gastric, intestinal, and hepatic first-pass elimination of berberine.  After intragastric dosing, approx. half of berberine ran intact through the gastrointestinal tract and another half was disposed of by the small intestine, leading to an extremely low extent of abs. oral bioavailability in rats (0.36%).  Moreover, the major berberine metabolites were identified and quantified in rat enterocyte S9 fractions, portal vein plasma, and intestinal perfusates; plasma concns. and tissue distribution of berberine and its major metabolites were detd. as well.  Data indicated that M1, M2 glucuronide, and M3 were the major metabolites generated from the small intestine and that there was a 70-fold increase in the ratio of the area under the concn.-time curve value for berberine (liver vs. plasma).  We conclude that intestinal first-pass elimination of berberine is the major barrier of its oral bioavailability and that its high extn. and distribution in the liver could be other important factors that lead to its low plasma levels in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSRl-e66RvrrVg90H21EOLACvtfcHk0lgVF50tKOb9ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1eisLnP&md5=21dc5c66ad38611e86f0f28f01bd5867</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.033936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.033936%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DHao%26aufirst%3DH.-P.%26aulast%3DXie%26aufirst%3DH.-G.%26aulast%3DLai%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.-X.%26aulast%3DWang%26aufirst%3DG.-J.%26atitle%3DExtensive%2520intestinal%2520first-pass%2520elimination%2520and%2520predominant%2520hepatic%2520distribution%2520of%2520berberine%2520explain%2520its%2520low%2520plasma%2520levels%2520in%2520rats%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D1779%26epage%3D1784%26doi%3D10.1124%2Fdmd.110.033936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shou, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-D.</span></span> <span> </span><span class="NLM_article-title">Tissue distribution of berberine and its metabolites after oral administration in rats</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e77969</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0077969</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1371%2Fjournal.pone.0077969" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=24205048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsleqt7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=X.-S.+Tanauthor=J.-Y.+Maauthor=R.+Fengauthor=C.+Maauthor=W.-J.+Chenauthor=Y.-P.+Sunauthor=J.+Fuauthor=M.+Huangauthor=C.-Y.+Heauthor=J.-W.+Shouauthor=W.-Y.+Heauthor=Y.+Wangauthor=J.-D.+Jiang&title=Tissue+distribution+of+berberine+and+its+metabolites+after+oral+administration+in+rats&doi=10.1371%2Fjournal.pone.0077969"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue distribution of berberine and its metabolites after oral administration in rats</span></div><div class="casAuthors">Tan, Xiang-Shan; Ma, Jing-Yi; Feng, Ru; Ma, Chao; Chen, Wen-Jing; Sun, Yu-Peng; Fu, Jie; Huang, Min; He, Chi-Yu; Shou, Jia-Wen; He, Wen-Yi; Wang, Yan; Jiang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e77969</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Berberine (BBR) has been confirmed to have multiple bioactivities in clinic, such as cholesterol-lowering, anti-diabetes, cardiovascular protection and anti-inflammation.  However, BBR's plasma level is very low; it cannot explain its pharmacol. effects in patients.  We consider that the in vivo distribution of BBR as well as of its bioactive metabolites might provide part of the explanation for this question.  In this study, liq. chromatog. coupled to ion trap time-of-flight mass spectrometry (LC/MSn-IT-TOF) as well as liq. chromatog. that coupled with tandem mass spectrometry (LC-MS/MS) was used for the study of tissue distribution and pharmacokinetics of BBR in rats after oral administration (200 mg/kg).  The results indicated that BBR was quickly distributed in the liver, kidneys, muscle, lungs, brain, heart, pancreas and fat in a descending order of its amt.  The pharmacokinetic profile indicated that BBR's level in most of studied tissues was higher (or much higher) than that in plasma 4 h after administration.  BBR remained relatively stable in the tissues like liver, heart, brain, muscle, pancreas etc.  Organ distribution of BBR's metabolites was also investigated paralleled with that of BBR.  Thalifendine (M1), berberrubine (M2) and jatrorrhizine (M4), which the metabolites with moderate bioactivity, were easily detected in organs like the liver and kidney.  For instance, M1, M2 and M4 were the major metabolites in the liver, among which the percentage of M2 was up to 65.1%; the level of AUC(0-t) (area under the concn.-time curve) for BBR or the metabolites in the liver was 10-fold or 30-fold higher than that in plasma, resp.  In summary, the organ concn. of BBR (as well as its bioactive metabolites) was higher than its concn. in the blood after oral administration.  It might explain BBR's pharmacol. effects on human diseases in clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTzoRHHPfq0LVg90H21EOLACvtfcHk0lgVF50tKOb9ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsleqt7zK&md5=44801c62ae509198ae45bdf6726828a7</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0077969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0077969%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DX.-S.%26aulast%3DMa%26aufirst%3DJ.-Y.%26aulast%3DFeng%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DW.-J.%26aulast%3DSun%26aufirst%3DY.-P.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DC.-Y.%26aulast%3DShou%26aufirst%3DJ.-W.%26aulast%3DHe%26aufirst%3DW.-Y.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DJ.-D.%26atitle%3DTissue%2520distribution%2520of%2520berberine%2520and%2520its%2520metabolites%2520after%2520oral%2520administration%2520in%2520rats%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0077969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, G.</span></span> <span> </span><span class="NLM_article-title">Update on berberine in nonalcoholic Fatty liver disease</span>. <i>J. Evidence-Based Complementary Altern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">308134</span>, <span class="refDoi"> DOI: 10.1155/2013/308134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1155%2F2013%2F308134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=23843872" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=308134&author=Y.+Liuauthor=L.+Zhangauthor=H.+Songauthor=G.+Ji&title=Update+on+berberine+in+nonalcoholic+Fatty+liver+disease&doi=10.1155%2F2013%2F308134"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1155%2F2013%2F308134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F308134%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DG.%26atitle%3DUpdate%2520on%2520berberine%2520in%2520nonalcoholic%2520Fatty%2520liver%2520disease%26jtitle%3DJ.%2520Evidence-Based%2520Complementary%2520Altern.%2520Med.%26date%3D2013%26volume%3D2013%26spage%3D308134%26doi%3D10.1155%2F2013%2F308134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, J.</span></span> <span> </span><span class="NLM_article-title">Identification of berberine as a novel drug for the treatment of multiple myeloma via targeting UHRF1</span>. <i>BMC Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">33</span>, <span class="refDoi"> DOI: 10.1186/s12915-020-00766-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1186%2Fs12915-020-00766-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=32213189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslSjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2020&pages=33&author=C.+Guauthor=Z.+Yinauthor=H.+Nieauthor=Y.+Liuauthor=J.+Yangauthor=G.+Huangauthor=J.+Shenauthor=L.+Chenauthor=J.+Fei&title=Identification+of+berberine+as+a+novel+drug+for+the+treatment+of+multiple+myeloma+via+targeting+UHRF1&doi=10.1186%2Fs12915-020-00766-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of berberine as a novel drug for the treatment of multiple myeloma via targeting UHRF1</span></div><div class="casAuthors">Gu, Chunming; Yin, Zhao; Nie, Hong; Liu, Yanjun; Yang, Juhua; Huang, Guiping; Shen, Jianping; Chen, Liguo; Fei, Jia</div><div class="citationInfo"><span class="NLM_cas:title">BMC Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33</span>CODEN:
                <span class="NLM_cas:coden">BBMIF7</span>;
        ISSN:<span class="NLM_cas:issn">1741-7007</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Abstr.: Background: Current therapies for multiple myeloma (MM) are assocd. with toxicity and resistance, highlighting the need for novel effective therapeutics.  Berberine (BBR), a botanical alkaloid derived from several Berberis medicinal plants, has exhibited anti-tumor effects, including against multiple myeloma (MM); however, the mol. mechanism underlying the anti-MM effect has not been previously described.  This study aimed to identify the target of berberine and related mechanisms involved in its therapeutic activity against MM.  Results: Here, we demonstrated that BBR treatment killed MM cells in vitro and prolonged the survival of mice bearing MM xenografts in vivo.  A screening approach integrating surface plasmon resonance (SPR) with liq. chromatog.-tandem mass spectrometry (LC-MS/MS) identified UHRF1 (ubiquitin-like with PHD and RING Finger domains 1) as a potential target of BBR.  Combining mol. docking and SPR anal., we confirmed UHRF1 as a BBR-binding protein and discovered that BBR binds UHRF1 in the tandem tudor domain and plant homeodomain (TTD-PHD domain).  BBR treatment induced UHRF1 degrdn. via the ubiquitin-dependent proteasome system and reactivated p16INK4A and p73 in MM cells.  Overexpression of UHRF1 promoted the MM cell proliferation and rendered MM cells more resistant to BBR, while silencing of UHRF1 with siRNA attenuated BBR-induced cytotoxicity.  Conclusions: In summary, our study has identified UHRF1 as a direct target of BBR and uncovered mol. mechanisms involved in the anti-MM activity of BBR.  Targeting UHRF1 through BBR may be a novel therapeutic strategy against MM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsQMzWkih-nbVg90H21EOLACvtfcHk0liYjFHWwhh6Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslSjt70%253D&md5=122544c61520be962411dfb600aff4fc</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1186%2Fs12915-020-00766-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12915-020-00766-8%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DC.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DNie%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DFei%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520berberine%2520as%2520a%2520novel%2520drug%2520for%2520the%2520treatment%2520of%2520multiple%2520myeloma%2520via%2520targeting%2520UHRF1%26jtitle%3DBMC%2520Biol.%26date%3D2020%26volume%3D18%26spage%3D33%26doi%3D10.1186%2Fs12915-020-00766-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yi, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inn, K.-S.</span></span> <span> </span><span class="NLM_article-title">Identification of actin as a direct proteomic target of berberine using an affinity-based chemical probe and elucidation of its modulatory role in actin assembly</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7045</span>– <span class="NLM_lpage">7047</span>, <span class="refDoi"> DOI: 10.1039/c7cc02789c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1039%2FC7CC02789C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28653701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXps1Gnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=7045-7047&author=C.-M.+Yiauthor=J.+Yuauthor=H.+Kimauthor=N.-R.+Leeauthor=S.+W.+Kimauthor=N.-J.+Leeauthor=J.+Leeauthor=J.+Seongauthor=N.-J.+Kimauthor=K.-S.+Inn&title=Identification+of+actin+as+a+direct+proteomic+target+of+berberine+using+an+affinity-based+chemical+probe+and+elucidation+of+its+modulatory+role+in+actin+assembly&doi=10.1039%2Fc7cc02789c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of actin as a direct proteomic target of berberine using an affinity-based chemical probe and elucidation of its modulatory role in actin assembly</span></div><div class="casAuthors">Yi, Chae-Min; Yu, Jihyun; Kim, Hyunbin; Lee, Na-Rae; Kim, Sang Won; Lee, Noh-Jin; Lee, Jun; Seong, Jihye; Kim, Nam-Jung; Inn, Kyung-Soo</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">7045-7047</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Despite the diverse pharmacol. activities of berberine, including anti-cancer and anti-inflammatory effects, the direct proteomic targets of berberine have remained largely unknown.  Here, we have identified actin as a direct proteomic target of berberine using an affinity-based chem. probe.  In addn., we found that actin assembly was significantly modulated by berberine in vitro at the biochem. level and cellular level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaNu5q1j_Ra7Vg90H21EOLACvtfcHk0liYjFHWwhh6Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXps1Gnsrw%253D&md5=b214af89872976ef23b68a2084c90a77</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1039%2FC7CC02789C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC02789C%26sid%3Dliteratum%253Aachs%26aulast%3DYi%26aufirst%3DC.-M.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DN.-R.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DN.-J.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSeong%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DN.-J.%26aulast%3DInn%26aufirst%3DK.-S.%26atitle%3DIdentification%2520of%2520actin%2520as%2520a%2520direct%2520proteomic%2520target%2520of%2520berberine%2520using%2520an%2520affinity-based%2520chemical%2520probe%2520and%2520elucidation%2520of%2520its%2520modulatory%2520role%2520in%2520actin%2520assembly%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D7045%26epage%3D7047%26doi%3D10.1039%2Fc7cc02789c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Berberine inhibits the proliferation and migration of breast cancer ZR-75-30 cells by targeting Ephrin-B2</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2016.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1016%2Fj.phymed.2016.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28190470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvFegsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=45-51&author=W.+Maauthor=M.+Zhuauthor=D.+Zhangauthor=L.+Yangauthor=T.+Yangauthor=X.+Liauthor=Y.+Zhang&title=Berberine+inhibits+the+proliferation+and+migration+of+breast+cancer+ZR-75-30+cells+by+targeting+Ephrin-B2&doi=10.1016%2Fj.phymed.2016.12.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine inhibits the proliferation and migration of breast cancer ZR-75-30 cells by targeting Ephrin-B2</span></div><div class="casAuthors">Ma, Weina; Zhu, Man; Zhang, Dongdong; Yang, Liu; Yang, Tianfeng; Li, Xin; Zhang, Yanmin</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Berberine, a plant-derived compd. isolated from Coptis chinensis used in traditional Chinese medicine, has been shown to possess anti-cancer properties.  However, no study has shown that berberine could target ephrin-B2, which plays a crit. role in cell proliferation and migration.  The aim of this study is to investigate the effect of berberine on cancer cell growth and migration, through the regulation of ephrin-B2 and downstream signaling mols.  In this study, a high ephrin-B2-expressing cell membrane chromatog. method was developed to investigate 48 crude exts. from traditional Chinese medicine that could act on ephrin-B2.  Cell proliferative and wound-healing assays were used to study the effect of berberine on cancer cell growth and migration.  The mechanism of berberine was investigated using western blot.Berberine was isolated from C. chinensis exts. and showed activity on the HEK293/ephrin-B2 cell membrane chromatog. column.  Berberine showed a greater inhibitory effect in high-expressing ephrin-B2 cells (HEK293/ephrin-B2 cells) than in normal HEK293 cells, and decreased the expression of ephrin-B2 and its PDZ binding proteins, which indicates that ephrin-B2 is a target of berberine.  Furthermore, berberine downregulates the phosphorylation of VEGFR2 and downstream signaling members (AKT and Erk1/2), which in turn downregulates the expression of MMP2 and MMP9.  The above data confirm the inhibitory effects of berberine on ZR-75-30 cell proliferation and cell migration.  Overall, our studies demonstrate that berberine inhibits cell growth and migration by targeting ephrin-B2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRex5I7d1sebVg90H21EOLACvtfcHk0liYjFHWwhh6Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvFegsw%253D%253D&md5=bcb96b4d4604cbd181dc26d30f534f08</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2016.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2016.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DBerberine%2520inhibits%2520the%2520proliferation%2520and%2520migration%2520of%2520breast%2520cancer%2520ZR-75-30%2520cells%2520by%2520targeting%2520Ephrin-B2%26jtitle%3DPhytomedicine%26date%3D2017%26volume%3D25%26spage%3D45%26epage%3D51%26doi%3D10.1016%2Fj.phymed.2016.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span> <span> </span><span class="NLM_article-title">Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">6906</span>– <span class="NLM_lpage">6918</span>, <span class="refDoi"> DOI: 10.1038/onc.2017.296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=10.1038%2Fonc.2017.296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=28846104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2hsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=6906-6918&author=H.+Ruanauthor=Y.+Y.+Zhanauthor=J.+Houauthor=B.+Xuauthor=B.+Chenauthor=Y.+Tianauthor=D.+Wuauthor=Y.+Zhaoauthor=Y.+Zhangauthor=X.+Chenauthor=P.+Miauthor=L.+Zhangauthor=S.+Zhangauthor=X.+Wangauthor=H.+Caoauthor=W.+Zhangauthor=H.+Wangauthor=H.+Liauthor=Y.+Suauthor=X.+K.+Zhangauthor=T.+Hu&title=Berberine+binds+RXR%CE%B1+to+suppress+%CE%B2-catenin+signaling+in+colon+cancer+cells&doi=10.1038%2Fonc.2017.296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells</span></div><div class="casAuthors">Ruan, H.; Zhan, Y. Y.; Hou, J.; Xu, B.; Chen, B.; Tian, Y.; Wu, D.; Zhao, Y.; Zhang, Y.; Chen, X.; Mi, P.; Zhang, L.; Zhang, S.; Wang, X.; Cao, H.; Zhang, W.; Wang, H.; Li, H.; Su, Y.; Zhang, X. K.; Hu, T.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">6906-6918</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Berberine, an isoquinoline alkaloid, is a traditional oriental medicine used to treat diarrhea and gastroenteritis.  Recently, we reported that it could inhibit the growth of intestinal polyp in animals and in patients with the familial adenomatous polyposis by downregulating β-catenin signaling.  However, the intracellular target mediating the effects of berberine remains elusive.  Here, we provide evidence that berberine inhibits β-catenin function via directly binding to a unique region comprising residues Gln275, Arg316 and Arg371 in nuclear receptor retinoid X receptor alpha (RXRα), where berberine concomitantly binding to and synergistically activating RXRα with 9-cis-retinoic acid (9-cis-RA), a natural ligand binding to the classical ligand-binding pocket of RXRα.  Berberine binding promotes RXRα interaction with nuclear β-catenin, leading to c-Cbl mediated degrdn. of β-catenin, and consequently inhibits the proliferation of colon cancer cells.  Furthermore, berberine suppresses the growth of human colon carcinoma xenograft in nude mice in an RXRα-dependent manner.  Together, our study not only identifies RXRα as a direct protein target for berberine but also dissects their binding mode and validates that berberine indeed suppresses β-catenin signaling and cell growth in colon cancer via binding RXRα, which provide new strategies for the design of new RXRα-based antitumor agents and drug combinations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHhbQsQonEJbVg90H21EOLACvtfcHk0lipdjtEk5l7fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2hsrrP&md5=a239206ffe6bb076ea2f0bbc89a9b224</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fonc.2017.296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2017.296%26sid%3Dliteratum%253Aachs%26aulast%3DRuan%26aufirst%3DH.%26aulast%3DZhan%26aufirst%3DY.%2BY.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DMi%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%2BK.%26aulast%3DHu%26aufirst%3DT.%26atitle%3DBerberine%2520binds%2520RXR%25CE%25B1%2520to%2520suppress%2520%25CE%25B2-catenin%2520signaling%2520in%2520colon%2520cancer%2520cells%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D6906%26epage%3D6918%26doi%3D10.1038%2Fonc.2017.296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MXO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MXO','PDB','3MXO'); return false;">PDB: 3MXO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KQN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KQN','PDB','1KQN'); return false;">PDB: 1KQN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UFQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UFQ','PDB','1UFQ'); return false;">PDB: 1UFQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2B9E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2B9E','PDB','2B9E'); return false;">PDB: 2B9E</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WQN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WQN','PDB','2WQN'); return false;">PDB: 2WQN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZQ9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZQ9','PDB','1ZQ9'); return false;">PDB: 1ZQ9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2%2520WQN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2%2520WQN','PDB','2%20WQN'); return false;">PDB: 2 WQN</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i38"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01743">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_34586"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01743?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01743</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Results of IL-1β release inhibition, cytotoxicity of BBR, structures of bio-BBR probes, LC–MS/MS analyses of <b>8d</b>, docking for NEK7 and BBR, pathological examinations, spectra (<sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS, and HPLC) of compounds, target identification, and sequences of primers (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES spreadsheet and molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_002.csv">CSV</a>)</p></li><li><p class="inline">Docking BBR to NEK7 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Docking ADP to NEK7 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_004.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_001.pdf">jm0c01743_si_001.pdf (1.47 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_002.csv">jm0c01743_si_002.csv (1.96 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_003.pdb">jm0c01743_si_003.pdb (362.16 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01743/suppl_file/jm0c01743_si_004.pdb">jm0c01743_si_004.pdb (336.03 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01743&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01743" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01743" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                11MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ac5b82e6c3da6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
